data_2ls6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ls6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.483 ' CD1' HG23 ' A' ' 78' ' ' ILE . 47.1 mm . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.96 0.409 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.462 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.554 HD22 ' C ' ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG13 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 32.5 t30 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.554 ' C ' HD22 ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HA ' HG22 ' A' ' 41' ' ' THR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CE1' HD22 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.882 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 68' ' ' THR . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.82 ' O ' HG22 ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.567 ' CE1' HG23 ' A' ' 138' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.483 HG23 ' CD1' ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' CB ' HG12 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.455 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.552 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.592 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.593 ' O ' ' HD1' ' A' ' 120' ' ' TYR . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.558 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.494 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.592 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.606 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.742 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.679 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.742 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.581 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.686 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 141' ' ' ILE . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.457 ' HB3' ' HG3' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.882 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.6 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.3 mp . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.776 0.322 . . . . 7.4900000000000002 110.774 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.6199999999999992 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 6.0099999999999998 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.7899999999999991 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4900000000000002 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.8399999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.3399999999999999 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.474 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 14.15 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.75 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.496 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' LEU . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.59 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 15.77 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 15.109999999999999 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.789999999999999 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.75 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.655 HG13 HG13 ' A' ' 156' ' ' ILE . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.4000000000000004 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.7699999999999996 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.65 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.92 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 14.800000000000001 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.619999999999999 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.84 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.422 ' HE2' ' HB3' ' A' ' 34' ' ' SER . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.359999999999999 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.789999999999999 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.43 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 15.73 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 18.43 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.49 112.25 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HB1' ' A' ' 145' ' ' ALA . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.76 112.196 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 10.220000000000001 113.484 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 9.2100000000000009 111.535 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.5500000000000007 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 34' ' ' SER . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 6.04 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 4.0999999999999996 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 4.5499999999999998 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 31' ' ' THR . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 9.1300000000000008 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.6 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.8900000000000006 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.68 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.471 HG21 HG21 ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.5199999999999996 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.42 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 11.130000000000001 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.44 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.566 ' CG2' HG11 ' A' ' 138' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 7.1299999999999999 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 138' ' ' VAL . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.5099999999999998 109.528 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.66 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 7.2800000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 8.2699999999999996 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.542 ' C ' ' HA3' ' A' ' 152' ' ' GLY . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.779999999999999 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.550000000000001 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 13.16 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 12.27 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.8599999999999994 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.9900000000000002 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.661 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.7400000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 142' ' ' ALA . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 6.5999999999999996 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.9000000000000004 109.292 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.645 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.7699999999999996 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.449999999999999 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 111' ' ' TRP . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.9900000000000002 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 12.460000000000001 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.989999999999998 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.493 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.56 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.970000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 104' ' ' TYR . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 10.67 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 8.5299999999999994 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.859 ' CE1' HG21 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.2599999999999998 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.661 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.7400000000000002 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.579 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 7.0199999999999996 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.558 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 8.4800000000000004 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 9.1600000000000001 109.445 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.859 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1900000000000004 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.49 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 16.09 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.48 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.779999999999999 111.083 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 13.17 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 135' ' ' VAL . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.8699999999999992 112.243 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.438 ' O ' ' CG2' ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.58 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.2699999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.535 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 9.1199999999999992 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.8000000000000007 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 65' ' ' ASP . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.9399999999999995 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.529999999999999 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 95' ' ' ASP . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.52 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.553 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 16.059999999999999 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD13 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 9.6199999999999992 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.542 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 9.4199999999999999 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.66 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 14.050000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 47' ' ' ILE . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.4100000000000001 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.655 HG13 HG13 ' A' ' 47' ' ' ILE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.6900000000000004 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.5299999999999994 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' OH ' ' A' ' 74' ' ' TYR . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.73 0.3 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 56' ' ' LEU . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.433 ' CB ' HD11 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB2' HD12 ' A' ' 47' ' ' ILE . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.485 HG12 ' CE2' ' A' ' 32' ' ' TYR . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 45.5 t30 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 59' ' ' LYS . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 64' ' ' ILE . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 64' ' ' ILE . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ILE . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 97' ' ' MET . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.509 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.634 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.614 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' HG13 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.602 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.602 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.435 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.634 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.634 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.652 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 133' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.414 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.543 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.533 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.614 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 103' ' ' GLN . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.881 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.415 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 151' ' ' LEU . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.467 HG13 ' CG1' ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.954 0.407 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 56' ' ' LEU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' ND2' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.441 ' CG2' ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 59' ' ' LYS . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.958 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.715 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.421 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 131' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.506 ' CE1' HG23 ' A' ' 102' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 97' ' ' MET . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.682 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.429 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.402 ' CA ' ' CD ' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' N ' ' HA ' ' A' ' 103' ' ' GLN . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.471 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.648 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.682 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.495 HG21 ' CE1' ' A' ' 120' ' ' TYR . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 80' ' ' LEU . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.51 ' CG2' ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' HG21 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.537 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.479 ' HB3' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.479 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.958 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 85' ' ' PHE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.484 ' CG1' ' CG2' ' A' ' 78' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.068 0.461 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.599 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CD2' HG23 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 2.4 t-20 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CB ' HG23 ' A' ' 54' ' ' THR . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.456 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 55' ' ' GLU . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.784 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.56 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.484 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.465 ' CE2' ' HA2' ' A' ' 71' ' ' GLY . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HG2' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.638 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.553 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 135' ' ' VAL . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.533 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' ILE . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.511 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.638 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.63 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 115' ' ' GLU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.784 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.405 HD11 ' CG2' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.7 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.015 0.436 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' OH ' HG22 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.3 t-20 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' CA ' ' NE ' ' A' ' 36' ' ' ARG . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 p30 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.672 ' CD2' HG13 ' A' ' 156' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.694 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.555 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 135' ' ' VAL . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.52 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.407 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.407 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.572 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.606 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.627 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.694 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.643 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.546 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.572 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 59' ' ' LYS . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.672 HG13 ' CD2' ' A' ' 85' ' ' PHE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.501 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 24.5 mm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.488 ' C ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.621 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.57 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' ASP . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.622 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.501 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.556 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.525 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.622 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.64 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 122' ' ' MET . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.517 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.539 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.588 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.621 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.531 HD13 HG12 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.465 ' N ' HG22 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.5 mp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.972 0.415 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HD1' ' N ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.507 HG23 ' CG1' ' A' ' 156' ' ' ILE . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 11.9 t30 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 59' ' ' LYS . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.472 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.801 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.524 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 131' ' ' LEU . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.427 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.656 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.552 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 2.0 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.584 ' CD1' HG22 ' A' ' 135' ' ' VAL . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.582 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.582 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.503 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 103' ' ' GLN . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.544 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.638 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.656 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.642 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.434 ' O ' HG21 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.554 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.401 ' HB3' ' CG2' ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.801 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 56' ' ' LEU . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' LEU . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 78' ' ' ILE . 9.0 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HD2' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 55' ' ' GLU . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.625 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 ' CG1' HG22 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.415 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 t-20 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 59' ' ' LYS . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.701 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.561 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.598 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 85' ' ' PHE . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.425 ' HG2' ' CG1' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.512 ' N ' ' OG1' ' A' ' 96' ' ' THR . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.741 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.555 HG13 ' CE2' ' A' ' 120' ' ' TYR . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.501 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.59 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 104' ' ' TYR . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.488 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 100' ' ' ALA . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.564 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.691 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.741 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.693 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.501 HG21 ' CE1' ' A' ' 120' ' ' TYR . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' HG21 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.59 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.491 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.426 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m120 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.701 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.697 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 58' ' ' TYR . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 56' ' ' LEU . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.459 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.489 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.533 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.533 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 31' ' ' THR . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.525 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 2.3 m120 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.435 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE1' HG23 ' A' ' 102' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.522 ' N ' ' OG1' ' A' ' 96' ' ' THR . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.714 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.569 HG21 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 135' ' ' VAL . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.413 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.55 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.642 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.714 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.613 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.642 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.566 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' LEU . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.573 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.436 ' O ' HG21 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.55 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.406 ' HB3' HG23 ' A' ' 149' ' ' THR . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 146' ' ' ARG . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.461 HG21 ' CD2' ' A' ' 85' ' ' PHE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.421 ' N ' HG22 ' A' ' 156' ' ' ILE . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.608 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CE1' HG22 ' A' ' 70' ' ' VAL . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 43' ' ' ASN . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.56 HD22 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.532 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' CD1' ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.714 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.583 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 4.6 m120 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CD2' HG21 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 155' ' ' ASP . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.478 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.686 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.608 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.514 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.671 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.686 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.625 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.671 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.714 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.518 HG21 ' CD2' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.873 0.368 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 56' ' ' LEU . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' ND2' HG22 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.44 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 41' ' ' THR . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.473 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 138' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.432 HG23 ' HB ' ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 82' ' ' ASN . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.544 ' N ' ' OG1' ' A' ' 96' ' ' THR . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.548 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.526 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.444 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 102' ' ' ILE . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.649 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.712 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.657 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.552 HG21 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.511 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 103' ' ' GLN . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.657 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.403 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.405 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 4.9 m120 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.2 mp . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.981 0.42 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.568 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.519 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.547 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.57 ' CG ' HG22 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 46' ' ' ASN . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.57 HG22 ' CG ' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.825 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 58' ' ' TYR . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.888 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.532 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.53 ' CD2' HG21 ' A' ' 156' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.449 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.551 ' C ' ' HB ' ' A' ' 121' ' ' THR . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 111' ' ' TRP . 5.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.561 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.519 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.561 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.649 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.629 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.649 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.552 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 133' ' ' LEU . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.532 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.825 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.449 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.53 HG21 ' CD2' ' A' ' 85' ' ' PHE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.1 mp . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.868 0.366 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.2 t-20 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' ND2' HG22 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.509 HG22 HD13 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.468 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 34' ' ' SER . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.952 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 65' ' ' ASP . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.44 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' CB ' ' CG2' ' A' ' 64' ' ' ILE . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.734 ' O ' HG22 ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 138' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.523 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.53 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.662 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 139' ' ' ARG . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.527 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.591 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.593 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.483 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.654 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.662 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.654 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.436 HD12 ' CE2' ' A' ' 69' ' ' TYR . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.952 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.417 HG13 ' CZ ' ' A' ' 74' ' ' TYR . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 78' ' ' ILE . 3.8 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' LYS . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.419 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.446 ' ND2' HG22 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.52 HG12 HD12 ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.494 HD22 ' CZ ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG23 ' HB ' ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.555 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.826 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.583 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.43 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m120 -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG23 ' HB ' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.415 ' HB3' ' CG1' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.55 ' N ' ' OG1' ' A' ' 96' ' ' THR . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.631 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 142' ' ' ALA . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.428 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.79 HG13 ' CE2' ' A' ' 120' ' ' TYR . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.549 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.557 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.657 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.673 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.699 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' HG ' ' CG1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.757 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.8 p30 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 28' ' ' ILE . 22.9 mm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.9 0.381 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 151' ' ' LEU . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.471 ' CG2' HG23 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 49' ' ' ASP . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 m120 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' CZ ' ' A' ' 58' ' ' TYR . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.628 ' O ' ' O ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 85' ' ' PHE . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.697 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.466 HG23 ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.622 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 155' ' ' ASP . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.431 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.671 HG22 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.545 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.689 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.412 ' CG ' ' HB ' ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.563 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.579 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 102' ' ' ILE . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.407 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.689 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.591 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.579 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.412 ' HB ' ' CG ' ' A' ' 103' ' ' GLN . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.616 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.021 0.438 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.587 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 56' ' ' LEU . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.439 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.561 HG23 ' CG1' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.659 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 56.2 t30 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' ND2' ' A' ' 51' ' ' ASN . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.425 HG12 ' HA2' ' A' ' 152' ' ' GLY . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.412 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 131' ' ' LEU . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 102' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.424 ' HB2' HG13 ' A' ' 57' ' ' VAL . 4.6 t-20 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.735 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.593 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.442 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CD1' HG22 ' A' ' 135' ' ' VAL . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.549 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 100' ' ' ALA . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.678 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.735 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.689 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.689 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.625 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.41 ' CD ' ' N ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.521 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 149' ' ' THR . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.774 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.437 ' CG2' ' OH ' ' A' ' 58' ' ' TYR . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.561 ' CG1' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.426 HG23 ' CZ ' ' A' ' 74' ' ' TYR . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.489 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.444 ' NH1' ' HB2' ' A' ' 151' ' ' LEU . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.416 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.554 ' CG1' HG22 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' SER . 43.7 t30 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.436 ' CG2' ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.921 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' PRO . 2.3 p-10 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.633 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.457 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.889 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 155' ' ' ASP . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.413 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' ASN . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 121' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.544 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 139' ' ' ARG . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.57 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.546 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 102' ' ' ILE . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.661 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.62 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.633 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.538 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' HG21 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.539 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.921 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.444 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 81' ' ' ASN . 8.3 t-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 ' CG2' HG23 ' A' ' 78' ' ' ILE . 14.2 mm . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.431 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.409 ' C ' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.45 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 56' ' ' LEU . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' THR . 11.9 m-80 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.441 HG12 ' HA2' ' A' ' 152' ' ' GLY . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.692 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.506 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.669 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.0 m120 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.522 HG23 ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.708 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.464 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 92' ' ' ASN . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.565 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 120' ' ' TYR . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 135' ' ' VAL . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.535 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.55 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.4 ' OE1' HD13 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.671 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.698 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' TYR . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.636 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.552 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.535 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.431 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.692 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.441 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' LEU . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.465 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 12.2 m-80 . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.47 ' CG2' HG21 ' A' ' 78' ' ' ILE . 16.4 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.449 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.446 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.472 HG21 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 48.1 t30 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.474 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.811 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 8.2 p-10 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.492 ' CZ ' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 78' ' ' ILE . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' ASN . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.651 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.57 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.8 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.55 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.586 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.44 ' HG ' ' CD2' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.592 ' N ' HG23 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.628 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.651 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.586 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.811 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 151' ' ' LEU . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . 0.428 ' N ' HG22 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 3.2 m-80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.729 HG12 HD13 ' A' ' 156' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 p30 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.459 HD23 ' CZ ' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 HG12 ' HA2' ' A' ' 152' ' ' GLY . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.474 ' CD2' HG11 ' A' ' 70' ' ' VAL . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' LYS . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 64' ' ' ILE . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.436 ' OG1' ' CG2' ' A' ' 64' ' ' ILE . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.93 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.55 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.427 ' CG2' HG12 ' A' ' 28' ' ' ILE . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.535 ' CD1' HD11 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' ASP . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' THR . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.66 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' THR . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.405 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.826 HG13 ' CE2' ' A' ' 120' ' ' TYR . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.606 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.51 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 102' ' ' ILE . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.812 ' N ' ' O ' ' A' ' 116' ' ' GLU . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.842 ' CE1' HG21 ' A' ' 126' ' ' ILE . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.66 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.486 HG22 ' CD1' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.412 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.46 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.729 HD13 HG12 ' A' ' 47' ' ' ILE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.813 0.339 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.46 118.43 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -73.44 -69.0 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.5 p -83.2 178.88 7.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 160.23 9.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.57 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 10.9 m170 60.98 36.31 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m80 60.69 168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -88.35 104.02 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m170 64.17 -78.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -139.88 -67.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.827 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -66.04 146.39 54.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.09 -129.91 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.568 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp 60.08 -177.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.942 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 m -122.95 77.12 50.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.64 -29.05 39.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.588 2.192 . . . . 0.0 112.256 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -69.57 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.76 -155.45 10.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.52 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -98.6 35.91 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t60 66.15 -72.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.041 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.4 mtt 58.68 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.64 -75.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.04 78.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -59.18 109.54 1.98 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.29 -38.53 8.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.413 2.075 . . . . 0.0 112.347 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 60.19 32.1 20.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -127.07 129.58 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.483 ' CD1' HG23 ' A' ' 78' ' ' ILE . 47.1 mm -114.97 127.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.045 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB2' ' CE1' ' A' ' 48' ' ' PHE . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.538 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.462 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.476 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.425 ' HG2' ' CE2' ' A' ' 48' ' ' PHE . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.554 HD22 ' C ' ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG13 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 32.5 t30 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.554 ' C ' HD22 ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HA ' HG22 ' A' ' 41' ' ' THR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' CE1' HD22 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.882 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 68' ' ' THR . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.686 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.82 ' O ' HG22 ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.567 ' CE1' HG23 ' A' ' 138' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.483 HG23 ' CD1' ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' CB ' HG12 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.455 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.425 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.552 ' N ' ' OG1' ' A' ' 96' ' ' THR . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.592 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.425 ' HG3' ' HG2' ' A' ' 119' ' ' GLU . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.593 ' O ' ' HD1' ' A' ' 120' ' ' TYR . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.558 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.494 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.409 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.592 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD11 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.452 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.412 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.606 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.742 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.686 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.679 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.742 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASN . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.525 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.581 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.686 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.471 ' O ' ' CG2' ' A' ' 141' ' ' ILE . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.457 ' HB3' ' HG3' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.457 HG23 ' HG2' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.882 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.414 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 66.9 34.63 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.84 91.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.165 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 54.86 29.12 11.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.127 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -72.87 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 59.24 31.93 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.92 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' HA ' ' HA ' ' A' ' 7' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.969 0.359 . . . . 25.239999999999998 111.969 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.96 51.16 3.47 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.899 -0.667 . . . . 22.800000000000001 112.298 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -146.94 -148.97 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.407 -0.22 . . . . 22.73 110.407 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 173.69 2.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.817 0.341 . . . . 21.059999999999999 111.418 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 m80 71.64 -86.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.908 -0.587 . . . . 19.5 111.198 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -176.38 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.476 0.179 . . . . 19.879999999999999 111.135 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -134.25 -175.89 4.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.399 -0.364 . . . . 17.41 111.256 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -54.73 -57.04 13.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.287 -0.415 . . . . 17.690000000000001 111.191 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -77.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.197 -0.456 . . . . 16.559999999999999 110.976 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 73.5 m-70 -138.5 36.72 2.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.781 0.324 . . . . 15.130000000000001 110.658 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -104.69 116.22 31.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.234 -0.439 . . . . 14.33 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 56.13 60.47 3.19 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 13.49 111.141 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.81 -62.65 0.31 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.83 -0.7 . . . . 12.800000000000001 112.713 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 2.4 mp 64.3 177.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.83 0.348 . . . . 13.050000000000001 111.25 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.2 109.26 13.83 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.31 -0.405 . . . . 11.51 111.31 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.12 107.88 1.43 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.767 2.312 . . . . 11.44 111.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttm105 -135.71 70.69 1.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.188 -0.46 . . . . 11.33 110.975 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.46 49.06 82.59 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.139 -0.553 . . . . 9.1300000000000008 112.753 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.92 135.81 22.3 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.476 0.179 . . . . 9.9100000000000001 110.995 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.5 p80 43.16 -151.77 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.05 -0.523 . . . . 11.039999999999999 111.464 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 71.58 164.42 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.411 0.285 . . . . 8.7899999999999991 111.19 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.79 93.24 4.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.037 0.384 . . . . 7.8099999999999996 112.037 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.4 m 52.89 37.16 23.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.999 -0.546 . . . . 9.1400000000000006 111.609 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.3 t70 63.35 109.52 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.886 -0.597 . . . . 8.7799999999999994 111.432 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.55 140.98 75.13 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.725 2.284 . . . . 7.2599999999999998 112.214 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.25 -79.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.148 -0.478 . . . . 10.029999999999999 111.08 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 51.08 38.03 19.63 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.94 0.4 . . . . 10.52 111.528 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.6 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.3 mp -72.98 128.87 36.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.263 -0.426 . . . . 7.4900000000000002 110.774 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.6199999999999992 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' HB2' HG22 ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 6.0099999999999998 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.7899999999999991 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.508 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4900000000000002 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.8399999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.3399999999999999 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.474 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 14.15 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.75 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.496 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.515 HG23 ' HA ' ' A' ' 56' ' ' LEU . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.59 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 15.77 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 15.109999999999999 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.789999999999999 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.75 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.655 HG13 HG13 ' A' ' 156' ' ' ILE . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.4000000000000004 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.543 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.7699999999999996 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.65 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.92 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.458 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 14.800000000000001 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.526 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.619999999999999 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.512 HG23 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.84 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.422 ' HE2' ' HB3' ' A' ' 34' ' ' SER . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.359999999999999 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.553 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.789999999999999 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.572 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.43 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.572 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 15.73 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.548 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 18.43 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.49 112.25 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HB1' ' A' ' 145' ' ' ALA . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.76 112.196 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 10.220000000000001 113.484 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 9.2100000000000009 111.535 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.5500000000000007 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 34' ' ' SER . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 6.04 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 4.0999999999999996 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 4.5499999999999998 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 31' ' ' THR . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 9.1300000000000008 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.6 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.8900000000000006 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.68 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.471 HG21 HG21 ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.5199999999999996 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.42 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 11.130000000000001 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.44 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.566 ' CG2' HG11 ' A' ' 138' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 7.1299999999999999 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.554 ' CZ ' ' HB ' ' A' ' 138' ' ' VAL . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.5099999999999998 109.528 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.66 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 7.2800000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 8.2699999999999996 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' C ' ' HA3' ' A' ' 152' ' ' GLY . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.779999999999999 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.550000000000001 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 13.16 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 12.27 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.8599999999999994 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.593 HG22 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.9900000000000002 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.661 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.7400000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 142' ' ' ALA . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 6.5999999999999996 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.9000000000000004 109.292 178.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.645 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.7699999999999996 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.449999999999999 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.487 ' HB ' ' CE2' ' A' ' 111' ' ' TRP . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.9900000000000002 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 12.460000000000001 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.989999999999998 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.493 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.56 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.970000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.672 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 104' ' ' TYR . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.564 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 10.67 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.585 HG11 ' CD2' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 8.5299999999999994 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.859 ' CE1' HG21 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.2599999999999998 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.661 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.7400000000000002 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.579 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 7.0199999999999996 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.558 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 8.4800000000000004 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 9.1600000000000001 109.445 177.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.859 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1900000000000004 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.534 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.49 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.451 ' CG2' ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 16.09 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.464 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.48 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.779999999999999 111.083 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 13.17 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 135' ' ' VAL . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.8699999999999992 112.243 -177.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.438 ' O ' ' CG2' ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.58 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.445 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.2699999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.535 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 9.1199999999999992 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.502 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.8000000000000007 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.49 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.509 ' HB1' ' HA ' ' A' ' 65' ' ' ASP . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.9399999999999995 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.529999999999999 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 95' ' ' ASP . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.52 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.553 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 16.059999999999999 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD13 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 9.6199999999999992 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.542 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 9.4199999999999999 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.66 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 14.050000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.408 ' HA ' HD12 ' A' ' 47' ' ' ILE . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.4100000000000001 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.655 HG13 HG13 ' A' ' 47' ' ' ILE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.6900000000000004 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.5299999999999994 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.457 HG12 ' OH ' ' A' ' 74' ' ' TYR . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.537 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 66.63 11.73 8.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.01 63.87 2.03 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 109.659 -0.497 . . . . 12.449999999999999 109.659 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.11 37.83 1.17 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.489 -0.778 . . . . 14.710000000000001 110.069 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 58.32 67.73 0.91 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.867 -0.606 . . . . 13.19 110.787 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' A' ' 159' ' ' ASN . 26.9 t70 -133.4 -81.46 0.47 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.271 -0.422 . . . . 11.779999999999999 111.703 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.697 -0.668 . . . . 13.66 111.4 -179.355 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.833 0.349 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.01 167.45 15.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.46 -50.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 60.32 79.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m170 60.34 161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.57 30.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.43 137.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -103.68 91.65 4.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -175.94 104.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -102.64 79.45 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.58 123.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 -31.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.32 -70.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.32 156.66 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.7 m -128.33 71.65 79.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.28 -56.52 2.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -82.35 -178.14 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.97 28.83 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -106.47 114.93 29.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -110.19 -31.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.5 ttm -133.34 139.57 46.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.96 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.3 m -120.51 -69.66 0.83 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.32 143.75 2.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.799 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.25 94.27 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.479 2.12 . . . . 0.0 112.322 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.17 -56.7 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.922 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.04 150.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.01 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.459 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -112.76 137.95 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.515 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.448 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CE2' HD12 ' A' ' 56' ' ' LEU . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.433 ' CB ' HD11 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' HB2' HD12 ' A' ' 47' ' ' ILE . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG12 ' CE2' ' A' ' 32' ' ' TYR . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.458 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 45.5 t30 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.528 HD12 ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 59' ' ' LYS . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.485 ' CE1' HD22 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.881 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.478 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 64' ' ' ILE . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.432 HG23 ' CD1' ' A' ' 64' ' ' ILE . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.522 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.696 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 126' ' ' ILE . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.491 ' CE1' HG23 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 97' ' ' MET . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.509 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.634 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.614 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.485 ' HB2' HG13 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.602 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.602 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.405 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 102' ' ' ILE . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.435 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.556 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.539 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.634 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.634 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.652 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.542 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' A' ' 133' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.414 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.543 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.533 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.614 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.485 HG13 ' HB2' ' A' ' 103' ' ' GLN . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.881 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.45 ' HB3' ' HB2' ' A' ' 58' ' ' TYR . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.415 ' HA2' HG13 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.415 ' CG1' ' CD1' ' A' ' 151' ' ' LEU . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.467 HG13 ' CG1' ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 64.68 31.03 12.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 80.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.8 44.17 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 61.27 47.77 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t0 68.64 -67.99 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.014 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.898 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.18 -29.19 56.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.412 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t 63.05 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m 60.66 -172.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 6' ' ' HIS . 0.6 OUTLIER -99.03 -59.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 7' ' ' HIS . 5.9 p80 -177.73 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -144.43 172.88 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.04 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -101.75 54.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m170 60.89 164.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -127.02 -45.32 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -174.16 -43.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m 60.3 -169.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -62.56 -117.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp 62.76 119.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t 64.13 77.27 0.31 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.91 -28.03 37.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.7 mtm-85 60.97 31.1 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 163.73 19.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t 60.13 30.98 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -112.15 -34.95 5.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -155.67 120.29 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.58 -69.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -113.71 29.78 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -73.45 -60.81 1.58 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 59.4 Cg_endo -72.19 72.17 2.83 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.49 2.126 . . . . 0.0 112.408 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.1 m-20 -69.79 -47.46 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.1 mmm-85 63.4 72.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.9 mp -144.02 118.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.47 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.453 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.46 HG21 ' HA ' ' A' ' 56' ' ' LEU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' ND2' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.482 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.441 ' CG2' ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG22 ' HG2' ' A' ' 59' ' ' LYS . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.958 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.527 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.444 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.537 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.715 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.551 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.421 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 131' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.436 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.506 ' CE1' HG23 ' A' ' 102' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.452 ' HG2' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.543 ' OG1' ' N ' ' A' ' 97' ' ' MET . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.682 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' HG2' ' HG2' ' A' ' 119' ' ' GLU . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.429 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.548 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.402 ' CA ' ' CD ' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' N ' ' HA ' ' A' ' 103' ' ' GLN . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.471 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.592 HG12 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.648 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.682 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.495 HG21 ' CE1' ' A' ' 120' ' ' TYR . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' A' ' 80' ' ' LEU . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.51 ' CG2' ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' O ' HG21 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.494 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.537 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.579 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.422 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.446 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.479 ' HB3' ' CG2' ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.479 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.958 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.407 ' CG2' ' HG3' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.491 HG21 ' CD2' ' A' ' 85' ' ' PHE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.89 27.89 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.55 85.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.966 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.04 37.36 26.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 69.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.86 83.05 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.782 0.325 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.73 78.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -134.15 31.92 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.0 76.3 3.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.73 30.86 20.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.957 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.09 -170.84 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.36 -63.5 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.14 80.55 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -144.06 32.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -149.0 160.11 43.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m 60.66 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t -173.76 84.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.57 -93.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' O ' HG13 ' A' ' 15' ' ' VAL . 12.1 mt 60.59 -169.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER 77.75 148.41 0.12 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.117 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.22 98.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.535 2.157 . . . . 0.0 112.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -176.66 -64.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.97 102.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.515 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -127.66 137.38 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -176.66 164.82 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.97 86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.35 133.65 17.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 t 59.85 29.26 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.88 156.19 0.11 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 -167.34 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.0 112.234 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.14 -25.77 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 62.62 102.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.484 ' CG1' ' CG2' ' A' ' 78' ' ' ILE . 3.7 mp -102.08 119.27 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.599 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' CD2' HG23 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 2.4 t-20 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.41 ' CG2' ' N ' ' A' ' 42' ' ' GLY . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' N ' ' CG2' ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CB ' HG23 ' A' ' 54' ' ' THR . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.456 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.528 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 55' ' ' GLU . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.784 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.56 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.562 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.518 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.532 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.634 ' O ' HG22 ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.484 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.465 ' CE2' ' HA2' ' A' ' 71' ' ' GLY . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HG2' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.633 HG22 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.638 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.553 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.428 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.608 ' CD1' HG22 ' A' ' 135' ' ' VAL . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.533 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 102' ' ' ILE . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.511 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.595 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.638 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.63 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.646 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.416 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.4 ' CG1' ' HG2' ' A' ' 115' ' ' GLU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.485 ' O ' ' O ' ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.608 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.401 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.501 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.532 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.551 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.441 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.784 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.405 HD11 ' CG2' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.469 HD12 ' CG2' ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.405 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.49 36.73 16.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 60.63 -157.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -69.71 66.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.941 0.4 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -152.79 -54.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.5 t0 65.79 146.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.956 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.766 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.87 109.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.5 -75.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.328 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -177.29 -176.48 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -119.91 85.84 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -81.89 -54.7 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -165.82 34.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 60.34 -176.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -138.55 -62.75 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 t60 63.59 139.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -176.14 37.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.92 -170.02 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.23 -100.16 1.88 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.17 31.74 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -82.77 -45.55 0.9 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.482 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.17 -61.28 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.327 2.018 . . . . 0.0 112.384 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -61.34 176.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 113.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -103.69 79.44 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.866 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 19' ' ' SER . 6.6 m80 -169.64 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptp -132.47 -48.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.11 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -159.45 38.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.38 155.0 0.11 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 84.9 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.532 2.155 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.92 79.92 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -146.59 34.87 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.7 mp -64.33 142.46 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.847 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.405 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' OH ' HG22 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.458 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.443 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.3 t-20 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' CA ' ' NE ' ' A' ' 36' ' ' ARG . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.473 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' N ' ' O ' ' A' ' 44' ' ' PRO . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 p30 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.529 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.543 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.453 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.672 ' CD2' HG13 ' A' ' 156' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 121' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.694 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.542 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.555 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.546 ' CD1' HG22 ' A' ' 135' ' ' VAL . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.52 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.407 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.407 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.572 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.425 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.606 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.627 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.694 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.643 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.643 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.546 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.426 ' O ' ' CG2' ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.572 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.571 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.447 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.488 ' CE2' ' HB3' ' A' ' 59' ' ' LYS . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.485 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.672 HG13 ' CD2' ' A' ' 85' ' ' PHE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 65.36 54.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.99 76.48 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.41 38.9 19.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 61.05 79.26 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.32 157.11 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.932 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.71 129.21 6.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -91.87 80.19 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.346 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -165.86 87.27 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -91.59 91.67 8.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -131.21 -55.74 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -155.36 87.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -77.3 71.3 3.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 62.77 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.74 174.28 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.796 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.24 149.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 -68.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.63 -74.7 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.598 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mt 60.7 99.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.2 m -130.33 88.33 47.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.93 -61.16 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.545 2.163 . . . . 0.0 112.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -174.93 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.07 -131.91 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -104.68 82.12 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -166.21 32.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -127.44 -73.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 57.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.8 t 60.56 32.77 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 161.64 0.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.001 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 -47.01 1.22 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.584 2.189 . . . . 0.0 112.208 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 62.87 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -172.48 3.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.501 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 24.5 mm -66.2 127.68 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.485 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.488 HD22 ' C ' ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 HG12 HD13 ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.431 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.488 ' C ' HD22 ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.621 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.57 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.408 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.588 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.51 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.462 ' CE1' HG23 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 155' ' ' ASP . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.5 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.622 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.41 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.556 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.501 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.556 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.525 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.57 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.622 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.64 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.64 ' HD3' ' N ' ' A' ' 122' ' ' MET . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.522 HG22 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.517 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.539 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.588 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.412 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.621 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.531 HD13 HG12 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.465 ' N ' HG22 ' A' ' 156' ' ' ILE . 0.4 OUTLIER -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 69.76 76.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.95 43.23 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt 61.82 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 45.29 36.62 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.56 -68.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 tpp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.18 28.25 7.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.571 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -105.16 -74.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.99 32.75 2.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -96.45 -168.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 m80 61.54 89.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 13.6 p-80 -140.38 31.22 1.92 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 7' ' ' HIS . 6.7 m-70 -176.57 82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -35.74 76.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -102.43 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.35 149.16 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.1 m -60.38 157.83 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 -31.86 7.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -114.77 156.66 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.347 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -153.95 139.34 11.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -51.98 135.09 50.79 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.508 2.139 . . . . 0.0 112.28 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -107.26 148.87 28.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.62 -91.68 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 m 68.49 -68.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 m170 60.85 79.35 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.1 mtm -150.34 -169.28 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 68.16 -69.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -59.64 -31.85 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.05 87.74 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 158.85 55.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -129.82 136.34 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtm-85 60.54 172.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.5 mp -88.21 126.33 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' HD1' ' N ' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.516 HG21 ' HA ' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.543 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.507 HG23 ' CG1' ' A' ' 156' ' ' ILE . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.543 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 11.9 t30 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.481 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.46 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 41' ' ' THR . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 HG22 ' HG2' ' A' ' 59' ' ' LYS . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.472 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.801 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.524 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.475 HG21 HD12 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.515 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 131' ' ' LEU . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.426 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.488 ' CE1' HG23 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 155' ' ' ASP . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.427 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.656 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.529 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.552 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 2.0 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.584 ' CD1' HG22 ' A' ' 135' ' ' VAL . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.582 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.582 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.503 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 103' ' ' GLN . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.544 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.576 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.528 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.638 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.656 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.642 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.642 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.545 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.4 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.434 ' O ' HG21 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.554 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.572 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.485 ' O ' ' CG2' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.401 ' HB3' ' CG2' ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.401 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.801 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.428 ' HB ' ' CD2' ' A' ' 56' ' ' LEU . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 86' ' ' LEU . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.411 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER 70.53 52.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -58.88 136.23 57.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? 56.31 23.6 7.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.37 -65.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.411 ' HA ' ' HB3' ' A' ' 159' ' ' ASN . 11.8 m-20 69.17 -67.5 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.935 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.855 0.36 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.13 -64.98 0.59 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.543 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t 60.58 31.36 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.08 -70.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -120.7 105.86 11.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.74 82.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.31 -56.98 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -174.75 79.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -108.19 80.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -173.34 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.02 -70.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m 60.37 -171.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.15 108.67 0.67 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tp 61.17 112.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.1 m -133.69 81.79 52.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.37 92.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.252 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -151.79 -46.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.59 112.32 0.98 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 t -64.13 81.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -136.9 -47.59 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -160.5 138.0 9.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.4 -73.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -105.26 31.08 5.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 83.1 m-20 61.08 54.06 3.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 58.7 Cg_endo -71.67 162.41 42.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.61 2.207 . . . . 0.0 112.308 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -177.03 -69.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -176.56 -170.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 ' HB ' HG23 ' A' ' 78' ' ' ILE . 9.0 tp -144.26 159.99 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.464 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.415 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.438 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HD2' ' CG1' ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 55' ' ' GLU . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.435 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.625 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 ' CG1' HG22 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.415 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.625 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 t-20 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.517 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.46 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 HG22 ' HG2' ' A' ' 59' ' ' LYS . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.701 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.561 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 64' ' ' ILE . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.491 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.473 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.68 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.598 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.531 HG23 ' HB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.431 HG23 ' CZ ' ' A' ' 85' ' ' PHE . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.652 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.425 ' HG2' ' CG1' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.512 ' N ' ' OG1' ' A' ' 96' ' ' THR . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.741 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.555 HG13 ' CE2' ' A' ' 120' ' ' TYR . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.501 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.59 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.436 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 104' ' ' TYR . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.488 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' O ' ' A' ' 100' ' ' ALA . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.564 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.691 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.741 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.693 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.693 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.501 HG21 ' CE1' ' A' ' 120' ' ' TYR . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' HG21 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.522 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.68 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.59 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.491 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.426 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m120 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.701 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.425 ' CG1' ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.652 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.415 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 64.1 47.46 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 76.43 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 36.96 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.78 75.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.28 132.03 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.937 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.765 0.317 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.61 -85.37 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.74 88.41 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.865 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 m -104.51 178.02 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.41 39.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.1 172.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.6 166.77 22.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -147.89 82.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.51 103.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -141.47 -47.63 0.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -164.03 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.7 m -63.57 -47.94 79.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -91.14 50.51 3.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mp -146.73 75.42 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 4.6 t -83.45 -45.79 0.81 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 53.9 Cg_exo -52.29 107.11 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.32 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -177.3 126.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.99 2.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.48 31.81 5.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.16 -174.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt 62.53 118.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.68 -47.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -107.15 -43.7 4.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.7 147.59 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.38 -35.9 4.5 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.478 2.119 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.3 31.13 0.53 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.92 141.0 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.0 OUTLIER -69.1 138.47 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.697 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' OD2' ' HB3' ' A' ' 58' ' ' TYR . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.479 HG23 ' HA ' ' A' ' 56' ' ' LEU . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.459 ' ND2' HG22 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 47' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.446 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.459 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.489 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.505 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.469 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.533 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.533 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 31' ' ' THR . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.525 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 2.3 m120 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.435 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.477 ' CE1' HG23 ' A' ' 102' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.707 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.522 ' N ' ' OG1' ' A' ' 96' ' ' THR . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.714 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.547 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.455 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.569 HG21 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.43 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.573 ' CD1' HG22 ' A' ' 135' ' ' VAL . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.511 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.413 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.55 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.43 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.515 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.642 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.714 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.613 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.642 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.566 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' LEU . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.573 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.436 ' O ' HG21 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.493 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.55 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.569 ' HG ' HG21 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.406 ' HB3' HG23 ' A' ' 149' ' ' THR . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 146' ' ' ARG . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.707 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.409 ' N ' HG12 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.461 HG21 ' CD2' ' A' ' 85' ' ' PHE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.421 ' N ' HG22 ' A' ' 156' ' ' ILE . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 75.41 69.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -97.37 105.31 17.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.31 31.51 20.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 60.7 84.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 60.73 111.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.779 0.323 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.88 -44.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -143.26 110.98 5.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.986 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 m -141.14 120.5 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -107.12 109.06 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -106.04 31.29 5.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.48 ' CD2' ' CE1' ' A' ' 9' ' ' HIS . 2.2 t60 -176.73 83.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -85.18 108.79 17.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.48 ' CE1' ' CD2' ' A' ' 7' ' ' HIS . 2.5 m80 -123.19 78.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -88.39 -172.54 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -56.52 105.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.007 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m 59.58 23.68 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.141 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.74 -29.19 9.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.79 -68.79 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -138.16 68.13 47.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.52 -61.81 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.617 2.211 . . . . 0.0 112.242 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.85 79.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.54 -133.74 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.6 m -80.19 62.05 4.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 68.93 -67.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 176.44 7.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.4 55.25 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t 60.95 30.84 19.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.61 88.52 0.12 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.61 141.61 46.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.609 2.206 . . . . 0.0 112.19 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -125.58 43.77 2.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.64 150.45 48.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.5 tp -100.75 155.36 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.608 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.495 ' CE1' HG22 ' A' ' 70' ' ' VAL . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.437 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.532 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' H ' ' C ' ' A' ' 43' ' ' ASN . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.56 HD22 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.532 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' CD1' ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.714 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.583 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.583 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.891 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.4 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 4.6 m120 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.518 ' CD2' HG21 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 155' ' ' ASP . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.478 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.505 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.686 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.473 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.581 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.608 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.514 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.411 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.411 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.608 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.418 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.6 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.671 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.686 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.625 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.671 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.537 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.428 HG22 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.513 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.714 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.422 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.478 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.518 HG21 ' CD2' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 64.5 30.3 12.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 82.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt 60.17 36.62 21.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 62.21 68.92 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.72 153.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.9 -141.3 15.27 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -139.05 -60.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.66 121.54 4.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 60.84 156.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -172.35 35.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -106.16 99.63 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -85.87 126.97 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -63.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -106.74 35.76 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -88.62 145.63 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 144.37 38.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.4 44.51 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.2 mt -156.0 172.54 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.4 m -58.31 110.0 2.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.33 127.41 23.76 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.444 2.096 . . . . 0.0 112.317 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.85 124.51 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.9 42.98 1.81 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.441 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.39 164.57 13.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 60.63 82.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -80.73 141.1 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.21 -45.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 p -154.38 33.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.04 138.57 89.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 123.0 9.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.571 2.181 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -169.27 141.5 2.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 59.53 89.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -109.41 142.7 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.527 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 56' ' ' LEU . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' ND2' HG22 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG21 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.44 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.434 ' HA ' HG23 ' A' ' 41' ' ' THR . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HA ' ' HA2' ' A' ' 152' ' ' GLY . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.473 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.657 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.47 ' N ' ' CD1' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' CG2' ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.539 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.757 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.585 ' CE1' HG23 ' A' ' 138' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.432 HG23 ' HB ' ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 82' ' ' ASN . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.407 ' N ' HD12 ' A' ' 80' ' ' LEU . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.602 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.524 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.418 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.544 ' N ' ' OG1' ' A' ' 96' ' ' THR . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.434 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.548 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 139' ' ' ARG . 0.0 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.526 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.595 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.444 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 102' ' ' ILE . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.486 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.678 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.649 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.712 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.657 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.657 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.552 HG21 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.511 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.757 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.428 HD11 ' HB2' ' A' ' 103' ' ' GLN . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.657 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.524 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.602 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.403 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.431 ' HB2' ' CB ' ' A' ' 163' ' ' ASP . 4.9 m120 56.03 76.85 0.26 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -79.86 14.66 1.68 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -153.04 24.25 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.963 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -155.92 -46.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -120.27 -179.71 4.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.901 0.382 . . . . 0.0 111.064 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.784 0.326 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.81 44.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.58 107.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -163.79 115.2 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -150.86 91.44 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m170 60.35 85.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -110.98 34.17 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -131.9 -50.7 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -128.86 154.69 46.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -146.64 175.92 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -160.5 146.05 14.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -60.25 -62.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.05 -88.66 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.496 ' O ' ' CG2' ' A' ' 15' ' ' VAL . 0.2 OUTLIER -98.46 92.28 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 110.928 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 14' ' ' LEU . 17.3 m 50.86 164.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.018 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.97 -177.0 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.591 2.194 . . . . 0.0 112.26 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.3 31.21 6.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 79.42 1.13 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.528 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.7 t -108.34 121.31 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -176.76 -41.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.97 -168.27 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.86 -69.74 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -90.87 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -179.16 147.51 0.51 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 -41.0 2.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.07 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 79.58 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.2 mp -59.17 122.39 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.568 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.519 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.547 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.463 HG21 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.57 ' CG ' HG22 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 46' ' ' ASN . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.57 HG22 ' CG ' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.48 HD22 ' CE1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.825 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.547 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 58' ' ' TYR . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.888 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.532 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.401 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.53 ' CD2' HG21 ' A' ' 156' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.449 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.4 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.544 ' O ' ' HA ' ' A' ' 121' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.551 ' C ' ' HB ' ' A' ' 121' ' ' THR . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.527 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.565 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 111' ' ' TRP . 5.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.561 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.519 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.561 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.467 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.649 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.551 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.629 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.649 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.552 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 133' ' ' LEU . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.532 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.541 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.465 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.825 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.407 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.449 ' HA ' ' CB ' ' A' ' 87' ' ' MET . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.53 HG21 ' CD2' ' A' ' 85' ' ' PHE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.4 75.17 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -132.67 68.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 52.66 51.73 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.68 49.82 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.6 t70 62.61 148.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.903 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.14 -168.23 51.76 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.436 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -68.68 94.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 p -140.17 125.31 18.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.55 31.45 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -176.47 90.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -106.31 120.48 41.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.967 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -94.79 143.01 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -79.39 -75.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.25 37.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.04 176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 t -176.55 -64.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.04 143.52 14.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tp -105.73 35.89 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.35 63.6 4.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.052 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.71 101.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.427 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 60.79 178.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.62 -86.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.4 p -103.38 76.82 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 60.56 31.59 20.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.99 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.826 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . 76.26 5.51 3.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.474 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 t -108.93 -23.63 11.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 64.19 92.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.89 63.54 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.444 2.096 . . . . 0.0 112.315 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.91 -169.69 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.98 131.74 48.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.1 mp -65.05 116.91 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.424 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.524 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.49 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.2 t-20 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HB3' HD11 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' ND2' HG22 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.509 HG22 HD13 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.468 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.469 HD22 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' CE2' ' HB3' ' A' ' 34' ' ' SER . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.952 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.44 HG23 ' N ' ' A' ' 65' ' ' ASP . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.44 ' N ' HG23 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' CB ' ' CG2' ' A' ' 64' ' ' ILE . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.527 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.734 ' O ' HG22 ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.623 ' CE1' HG23 ' A' ' 138' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.736 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.523 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.416 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.53 ' N ' ' OG1' ' A' ' 96' ' ' THR . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.662 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.521 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 139' ' ' ARG . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.527 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.591 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.593 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.429 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.483 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.609 HG12 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.654 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.662 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.607 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.654 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.432 ' O ' HG21 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.495 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.734 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.436 HD12 ' CE2' ' A' ' 69' ' ' TYR . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.418 ' O ' ' HB ' ' A' ' 64' ' ' ILE . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.952 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.414 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.523 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.736 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.417 HG13 ' CZ ' ' A' ' 74' ' ' TYR . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.5 m120 71.88 29.87 2.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttm 47.34 92.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 60.59 27.6 17.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.636 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 62.54 67.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.07 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.972 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.876 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.894 0.378 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.48 43.45 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.524 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -176.23 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -173.37 39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 68.73 -67.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.025 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -108.39 -175.74 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -99.0 31.65 2.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.29 87.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -165.82 85.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -128.84 116.83 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 t -163.79 71.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p 49.98 80.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 153.94 22.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.89 158.13 44.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.45 87.58 14.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.13 -40.87 67.84 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 112.331 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -176.45 131.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.08 108.16 2.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -173.38 -41.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 60.42 84.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.2 174.21 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.46 -162.63 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.791 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -94.88 32.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.37 148.84 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 108.67 2.45 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.5 2.133 . . . . 0.0 112.247 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -67.34 160.7 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.4 158.89 11.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 ' HB ' HG23 ' A' ' 78' ' ' ILE . 3.8 tp -106.09 159.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.482 ' HA ' ' O ' ' A' ' 73' ' ' LYS . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.499 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.419 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.446 ' ND2' HG22 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.52 HG12 HD12 ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.494 HD22 ' CZ ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG23 ' HB ' ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CZ ' HD22 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.757 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.555 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.518 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.826 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.583 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.43 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m120 -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG23 ' HB ' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.54 ' CD1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.415 ' HB3' ' CG1' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.55 ' N ' ' OG1' ' A' ' 96' ' ' THR . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.631 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.482 ' CB ' ' HA ' ' A' ' 142' ' ' ALA . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.428 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.79 HG13 ' CE2' ' A' ' 120' ' ' TYR . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.46 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.545 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.549 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.46 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.57 ' N ' ' O ' ' A' ' 102' ' ' ILE . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.557 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.79 ' CE2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.657 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.673 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.699 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.753 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 104' ' ' TYR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' O ' ' CG2' ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.583 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.826 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' HG ' ' CG1' ' A' ' 102' ' ' ILE . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.459 ' CD1' ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.485 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.757 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.415 ' CG1' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.52 HD12 HG12 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.8 p30 45.58 30.13 0.73 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.15 133.89 43.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.9 tptp 59.8 30.96 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -148.65 -73.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t0 60.43 79.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.944 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.5 -137.6 8.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -106.56 34.03 3.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.09 79.97 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -141.26 -58.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -140.52 31.66 1.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -139.41 44.87 1.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -59.56 140.4 56.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.15 119.18 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 60.33 89.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -74.08 -176.1 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 p -97.99 36.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.71 -103.13 1.58 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.3 tt -176.59 -40.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.5 p 42.85 61.32 9.56 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.588 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -51.23 169.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.628 2.219 . . . . 0.0 112.333 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -126.0 133.47 51.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.59 138.06 40.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -129.97 31.27 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.99 72.94 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtp 63.32 -80.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -179.08 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -58.95 -27.92 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.27 155.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.978 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 171.97 13.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.655 2.237 . . . . 0.0 112.286 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 60.56 33.51 20.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -66.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 HG22 ' A' ' 28' ' ' ILE . 22.9 mm 63.81 127.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' HB2' ' A' ' 151' ' ' LEU . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.471 ' CG2' HG23 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 49' ' ' ASP . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 154' ' ' ARG . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 m120 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.453 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD23 ' CZ ' ' A' ' 58' ' ' TYR . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.628 ' O ' ' O ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.618 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.479 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.492 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 85' ' ' PHE . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.697 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.584 ' CE1' HG23 ' A' ' 138' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.481 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.466 HG23 ' CG2' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.622 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' N ' ' A' ' 155' ' ' ASP . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.431 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.671 HG22 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.545 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.689 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.412 ' CG ' ' HB ' ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.563 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.554 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.579 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' A' ' 102' ' ' ILE . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.407 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.671 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.537 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.689 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.591 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.53 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.42 ' O ' HG21 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.579 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.412 ' HB ' ' CG ' ' A' ' 103' ' ' GLN . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.616 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.402 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.622 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.87 76.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -85.42 23.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 34.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.281 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 60.73 43.2 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.692 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.06 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.852 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.75 -136.4 3.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.608 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -176.19 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -94.38 145.27 24.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 60.28 75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 76.02 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.73 31.05 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.5 m80 59.66 -172.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -116.21 -69.54 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.18 106.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -130.82 107.88 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -132.41 120.1 21.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.38 -143.09 12.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.89 -31.55 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t 63.82 80.02 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.114 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.5 -28.77 37.37 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.658 2.239 . . . . 0.0 112.168 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 60.17 101.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.01 -152.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.412 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 m -130.48 -169.89 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -60.28 -178.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.9 tpp -106.24 -60.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.01 -54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p -131.75 44.13 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 8.3 m-20 -59.3 -60.87 9.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 58.4 Cg_endo -71.78 161.77 44.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.284 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -154.34 79.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -105.2 107.59 18.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.5 mp -92.78 131.6 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.587 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 56' ' ' LEU . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.439 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.659 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.561 HG23 ' CG1' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.439 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.659 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 56.2 t30 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' ND2' ' A' ' 51' ' ' ASN . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.425 HG12 ' HA2' ' A' ' 152' ' ' GLY . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.655 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.774 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.559 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.655 HG11 ' CZ ' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.507 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.518 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.412 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 131' ' ' LEU . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CE1' HG23 ' A' ' 102' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.424 ' HB2' HG13 ' A' ' 57' ' ' VAL . 4.6 t-20 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.735 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.55 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.593 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.442 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.625 ' CD1' HG22 ' A' ' 135' ' ' VAL . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.549 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.549 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.418 ' CG ' ' OH ' ' A' ' 120' ' ' TYR . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.482 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 100' ' ' ALA . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.678 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.735 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.689 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.689 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.625 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' CD ' ' N ' ' A' ' 136' ' ' ARG . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.506 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.521 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.559 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.442 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.429 HG22 ' O ' ' A' ' 149' ' ' THR . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.774 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' HB3' ' CE1' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.437 ' CG2' ' OH ' ' A' ' 58' ' ' TYR . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.561 ' CG1' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.426 HG23 ' CZ ' ' A' ' 74' ' ' TYR . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER 70.6 25.78 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm 53.71 87.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp 58.8 37.18 24.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 61.31 62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 45.63 -169.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.877 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.846 0.355 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.44 140.8 4.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -73.12 86.75 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.853 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.56 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -60.35 -64.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -60.49 165.27 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 60.55 171.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -153.72 -179.8 8.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 63.2 122.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 35.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 p 58.14 32.38 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 58.88 78.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.91 -74.53 1.98 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.437 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.46 -169.47 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -64.6 139.36 97.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 -177.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.484 2.123 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 -34.2 15.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.84 -93.75 0.22 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -152.05 80.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.66 31.15 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.2 tpp 59.78 85.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.62 37.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m 66.88 96.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.8 m-20 -57.29 -60.75 8.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 58.8 Cg_endo -71.81 154.6 58.79 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.462 2.108 . . . . 0.0 112.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -84.88 -74.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.7 mtp180 -122.72 146.58 47.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 3.9 mp -133.13 131.39 58.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.434 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CE1' ' O ' ' A' ' 33' ' ' ILE . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.489 ' O ' ' CE1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.546 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.444 ' NH1' ' HB2' ' A' ' 151' ' ' LEU . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.416 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.442 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.554 ' CG1' HG22 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 53' ' ' SER . 43.7 t30 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.436 ' CG2' ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.475 HD22 ' CE1' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.921 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 61' ' ' PRO . 2.3 p-10 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.546 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.524 ' N ' ' CG2' ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.633 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.573 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.425 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.457 ' CG2' ' CG1' ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.889 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 155' ' ' ASP . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.413 ' HB2' ' CG1' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' ASN . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.531 ' O ' ' HA ' ' A' ' 121' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.517 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.544 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.415 ' N ' ' O ' ' A' ' 139' ' ' ARG . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.57 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.546 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' 112' ' ' ILE . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 102' ' ' ILE . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.421 ' HG2' ' OH ' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.516 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.661 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.62 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.633 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.538 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.502 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.43 ' O ' HG21 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.542 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.539 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.482 ' O ' ' CG ' ' A' ' 69' ' ' TYR . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.921 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.444 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.413 ' CG1' ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.889 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 81' ' ' ASN . 8.3 t-20 62.93 49.58 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.98 -162.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 64.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 0.0 110.548 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -147.35 -58.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.4 t70 61.16 40.82 14.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.796 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.894 179.974 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.63 28.45 21.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.53 -177.8 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 p -113.81 134.22 54.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -174.84 166.76 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m170 60.81 111.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -126.75 -58.92 1.3 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.11 -169.4 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -97.97 133.64 42.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -88.54 -74.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m 60.18 80.33 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.32 79.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.78 -149.39 40.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.79 108.63 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.76 139.21 29.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.61 152.49 16.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.389 2.059 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -168.56 35.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -88.83 0.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.533 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.1 m 60.96 169.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 176.21 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -133.5 -64.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 -62.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 -67.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -177.53 81.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.53 -47.34 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.588 2.192 . . . . 0.0 112.279 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 m120 59.03 79.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.017 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -69.5 142.05 53.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 ' CG2' HG23 ' A' ' 78' ' ' ILE . 14.2 mm -77.75 135.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.409 ' C ' HG21 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.45 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 56' ' ' LEU . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' O ' HG22 ' A' ' 54' ' ' THR . 11.9 m-80 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.47 HG12 HG22 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.421 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.441 HG12 ' HA2' ' A' ' 152' ' ' GLY . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.692 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.509 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.669 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.428 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.574 ' CE1' HG23 ' A' ' 138' ' ' VAL . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.444 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.0 m120 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.522 HG23 ' CG2' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.708 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.464 ' CG ' ' N ' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 92' ' ' ASN . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.581 ' O ' ' HA ' ' A' ' 121' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.565 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' ' CD2' ' A' ' 120' ' ' TYR . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.411 ' O ' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.431 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.636 ' CD1' HG22 ' A' ' 135' ' ' VAL . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.535 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.55 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 112' ' ' ILE . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 102' ' ' ILE . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.4 ' OE1' HD13 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.671 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.582 ' H ' ' C ' ' A' ' 119' ' ' GLU . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.698 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.698 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.531 HG21 ' CE1' ' A' ' 120' ' ' TYR . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.636 HG22 ' CD1' ' A' ' 104' ' ' TYR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.552 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.669 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.535 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.431 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.692 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.441 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' LEU . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.708 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.42 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.465 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 12.2 m-80 79.86 -2.32 2.06 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tptp 45.6 33.03 1.28 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.772 0.32 . . . . 0.0 111.078 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.45 34.62 12.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -137.47 -49.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.152 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.417 ' CA ' ' HB3' ' A' ' 159' ' ' ASN . 0.6 OUTLIER 64.47 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.378 . . . . 0.0 110.975 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tpp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.718 0.294 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.65 -72.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.32 34.04 20.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -101.93 82.94 2.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -70.55 79.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -176.31 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.05 -37.92 87.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -106.54 144.61 32.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.6 -169.59 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -133.44 -179.17 5.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m 60.52 38.25 19.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -59.93 -41.97 92.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -28.21 1.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.552 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 58.44 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.5 t -82.97 -45.62 0.87 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.368 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 74.3 Cg_exo -50.71 96.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.371 2.048 . . . . 0.0 112.372 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -176.64 -65.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.29 47.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.31 122.82 15.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.0 m80 60.63 -176.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.9 mtt -60.17 107.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.04 -48.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -118.96 -48.36 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 62.0 151.62 0.1 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.54 64.04 2.25 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.54 2.16 . . . . 0.0 112.332 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -153.76 -172.76 4.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 60.85 77.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.47 ' CG2' HG21 ' A' ' 78' ' ' ILE . 16.4 mm -91.11 133.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.449 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.561 ' O ' HG21 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.446 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.486 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.472 HG21 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 48.1 t30 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.474 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HA ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 151' ' ' LEU . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.811 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 8.2 p-10 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.401 ' CD1' ' CB ' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.688 ' O ' HG22 ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.492 ' CZ ' HG23 ' A' ' 138' ' ' VAL . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 78' ' ' ILE . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' CG2' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.407 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.554 ' CE1' HD12 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' ASN . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.651 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.57 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.8 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.55 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.516 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.447 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.586 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.44 ' HG ' ' CD2' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.592 ' N ' HG23 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.695 ' N ' ' O ' ' A' ' 116' ' ' GLU . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.651 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.448 ' O ' HG21 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.688 HG22 ' O ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.586 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.535 ' HA ' HG12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' CB ' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.811 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.438 ' CD1' ' CG2' ' A' ' 153' ' ' VAL . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 151' ' ' LEU . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . 0.428 ' N ' HG22 ' A' ' 156' ' ' ILE . 0.1 OUTLIER -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.407 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 3.2 m-80 64.93 47.02 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 162' ' ' GLU . 21.0 mtmt -62.07 -150.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.391 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -67.35 67.21 0.08 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.894 0.378 . . . . 0.0 110.679 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 160' ' ' LYS . 1.4 mt-10 -174.56 -49.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.76 -69.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.867 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.71 154.51 7.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.85 113.56 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -107.61 100.23 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.68 71.49 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 59.35 29.28 18.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -62.23 -28.18 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 7' ' ' HIS . 16.0 m170 -92.58 -178.4 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -175.03 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -101.84 91.75 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 t -162.35 153.42 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -82.07 123.98 29.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.4 -106.06 3.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.53 -68.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 m -148.7 79.17 8.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.78 -61.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.596 2.197 . . . . 0.0 112.238 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -108.17 -175.34 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.76 -49.74 0.84 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.469 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.7 m -104.77 140.28 38.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.762 0.315 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -60.31 139.81 57.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.18 123.22 49.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.44 58.15 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t 61.31 30.69 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.964 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.38 67.68 1.8 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.44 -44.52 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.523 2.149 . . . . 0.0 112.296 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.38 137.57 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -110.3 -24.01 10.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 ' CG2' ' HB3' ' A' ' 74' ' ' TYR . 1.2 mp -55.44 116.3 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.417 ' N ' ' CG2' ' A' ' 29' ' ' ILE . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.599 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 33' ' ' ILE . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.517 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.729 HG12 HD13 ' A' ' 156' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 p30 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.459 HD23 ' CZ ' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 HG12 ' HA2' ' A' ' 152' ' ' GLY . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.474 ' CD2' HG11 ' A' ' 70' ' ' VAL . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.536 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.521 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' LYS . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 64' ' ' ILE . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.436 ' OG1' ' CG2' ' A' ' 64' ' ' ILE . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 33' ' ' ILE . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.93 ' O ' HG22 ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.55 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.436 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.427 ' CG2' HG12 ' A' ' 28' ' ' ILE . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.441 ' CG2' ' CE1' ' A' ' 85' ' ' PHE . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.535 ' CD1' HD11 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 155' ' ' ASP . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 92' ' ' ASN . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.42 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.529 ' O ' ' HA ' ' A' ' 121' ' ' THR . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.66 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 121' ' ' THR . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.405 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.826 HG13 ' CE2' ' A' ' 120' ' ' TYR . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.606 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.51 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' A' ' 102' ' ' ILE . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.812 ' N ' ' O ' ' A' ' 116' ' ' GLU . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.842 ' CE1' HG21 ' A' ' 126' ' ' ILE . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.66 ' HB ' ' C ' ' A' ' 98' ' ' GLN . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.842 HG21 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.486 HG22 ' CD1' ' A' ' 104' ' ' TYR . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.412 ' O ' ' CG2' ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.55 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.93 HG22 ' O ' ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.531 ' O ' ' HB2' ' A' ' 69' ' ' TYR . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.46 ' HB ' ' HG3' ' A' ' 103' ' ' GLN . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' TRP . . . . . 0.536 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.458 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.729 HD13 HG12 ' A' ' 47' ' ' ILE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 59.8 34.19 21.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.13 125.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.071 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 57.29 28.78 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.098 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 43.53 61.21 2.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.05 120.29 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.813 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.952 HG13 HG21 ' A' ' 78' ' ' ILE . 47.1 mm . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.96 0.409 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.717 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 41' ' ' THR . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.674 ' HA ' HD12 ' A' ' 56' ' ' LEU . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.769 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.943 ' ND2' HG23 ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.1 t-20 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.943 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.765 HD21 ' CE1' ' A' ' 58' ' ' TYR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.765 ' CE1' HD21 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.929 HD12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' ILE . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 144' ' ' GLU . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.929 ' HB ' HD12 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.757 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 158' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.952 HG21 HG13 ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.612 HD13 HG11 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 84' ' ' GLU . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 83' ' ' VAL . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.574 ' C ' ' HB ' ' A' ' 121' ' ' THR . 1.1 tm0? -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.632 ' O ' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.869 HG23 ' HG ' ' A' ' 140' ' ' LEU . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.583 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 128' ' ' VAL . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.667 HG12 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.743 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.707 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.529 HG21 ' OE1' ' A' ' 115' ' ' GLU . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 128' ' ' VAL . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.589 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' HD13 ' A' ' 141' ' ' ILE . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 99' ' ' LYS . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 68' ' ' THR . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.714 HG21 ' NE ' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.648 HG21 ' OH ' ' A' ' 32' ' ' TYR . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.587 HG21 ' OH ' ' A' ' 74' ' ' TYR . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 78' ' ' ILE . 1.3 mp . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.776 0.322 . . . . 7.2300000000000004 110.774 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.25 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.7 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 5.9100000000000001 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.1099999999999994 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HE2' HG11 ' A' ' 153' ' ' VAL . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4100000000000001 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.1299999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.1400000000000006 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' HD3' HG21 ' A' ' 64' ' ' ILE . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 13.449999999999999 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.41 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 57' ' ' VAL . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.130000000000001 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 14.94 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 14.77 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.31 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.42 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.876 HD13 HD12 ' A' ' 56' ' ' LEU . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.0999999999999996 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.2300000000000004 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.220000000000001 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.65 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 13.98 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.56 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.33 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 151' ' ' LEU . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.16 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.460000000000001 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.19 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 14.91 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 17.82 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.646 HG21 ' HD3' ' A' ' 36' ' ' ARG . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.050000000000001 112.25 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.380000000000001 112.196 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 9.4700000000000006 113.484 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 8.7599999999999998 111.535 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.3300000000000001 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.667 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 5.4800000000000004 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 3.75 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 3.96 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 8.8000000000000007 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.5099999999999998 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.01 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.75 HG21 ' HB ' ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.4399999999999995 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.08 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 83' ' ' VAL . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 10.9 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.210000000000001 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.881 HG23 HG12 ' A' ' 158' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 6.8499999999999996 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 156' ' ' ILE . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD22 ' HB1' ' A' ' 125' ' ' ALA . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.1600000000000001 109.528 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 6.7400000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 7.6500000000000004 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.27 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.449999999999999 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 12.82 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 11.76 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.5099999999999998 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.8600000000000003 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.62 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.657 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.4900000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 5.8399999999999999 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.6199999999999992 109.292 178.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.712 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.1199999999999992 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.15 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 136' ' ' ARG . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.6600000000000001 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 11.609999999999999 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.32 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CD2' ' HB ' ' A' ' 105' ' ' THR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.01 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.630000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.712 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.924 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.579 ' OE2' HG22 ' A' ' 128' ' ' VAL . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 9.9100000000000001 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.774 HG11 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 7.9699999999999998 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.907 ' CE1' HG23 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.3600000000000003 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.597 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 6.7400000000000002 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.556 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 7.75 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 8.7400000000000002 109.445 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.907 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1699999999999999 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.24 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 15.51 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 80' ' ' LEU . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.460000000000001 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 131' ' ' LEU . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.380000000000001 111.083 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 12.81 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.5999999999999996 112.243 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.738 ' O ' HG23 ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.02 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.859 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.0199999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 8.4399999999999995 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.796 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.3900000000000006 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 66' ' ' VAL . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' N ' ' HB3' ' A' ' 98' ' ' GLN . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.6999999999999993 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HG2' HG21 ' A' ' 149' ' ' THR . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.08 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 146' ' ' ARG . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.26 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.543 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 15.23 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 8.9900000000000002 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 8.8000000000000007 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.673 HG11 ' HE2' ' A' ' 32' ' ' TYR . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 13.460000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.1199999999999992 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 85' ' ' PHE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.2999999999999998 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.1799999999999997 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.881 HG12 HG23 ' A' ' 83' ' ' VAL . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.556 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' HB3' ' A' ' 74' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.73 0.3 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.792 HG22 ' HB2' ' A' ' 75' ' ' SER . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.446 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.901 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.649 ' NH2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' H ' HG23 ' A' ' 41' ' ' THR . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HA ' HD12 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 17.2 t-20 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.82 HD13 ' CG2' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 41' ' ' THR . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.649 HD13 ' NH2' ' A' ' 36' ' ' ARG . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 144' ' ' GLU . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.836 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.799 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.792 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.464 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.658 ' CD2' HD23 ' A' ' 131' ' ' LEU . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 114' ' ' LEU . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.695 ' HB3' HG12 ' A' ' 153' ' ' VAL . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' OD1' HG21 ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.663 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 121' ' ' THR . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD12 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.688 HD11 HG11 ' A' ' 83' ' ' VAL . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.783 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.794 ' CE1' HG11 ' A' ' 118' ' ' VAL . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG22 ' CD ' ' A' ' 115' ' ' GLU . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 80' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.799 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.556 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.793 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.836 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 143' ' ' THR . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.864 ' HG3' HG21 ' A' ' 149' ' ' THR . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.864 HG21 ' HG3' ' A' ' 146' ' ' ARG . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.694 ' CD1' HG13 ' A' ' 153' ' ' VAL . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.901 HG11 ' OH ' ' A' ' 32' ' ' TYR . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.543 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 79' ' ' THR . 6.7 m120 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 HG22 ' A' ' 78' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.954 0.407 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 30' ' ' ALA . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.763 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 55' ' ' GLU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 41' ' ' THR . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' OD1' HG21 ' A' ' 54' ' ' THR . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 56' ' ' LEU . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.921 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.829 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' A' ' 157' ' ' ASN . 1.7 m120 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.921 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.804 ' HG2' HG21 ' A' ' 41' ' ' THR . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.999 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 HG12 ' HB1' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 143' ' ' THR . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.866 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.754 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.695 HG22 HD13 ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 4.2 p-10 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.688 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 121' ' ' THR . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' O ' HG22 ' A' ' 143' ' ' THR . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.841 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 126' ' ' ILE . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.81 ' HB3' HD12 ' A' ' 114' ' ' LEU . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.652 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' CA ' ' HD3' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 105' ' ' THR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.851 HG11 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.851 ' CE1' HG11 ' A' ' 118' ' ' VAL . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.688 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 102' ' ' ILE . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 115' ' ' GLU . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 128' ' ' VAL . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 128' ' ' VAL . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.499 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.866 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 102' ' ' ILE . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.596 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.841 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 64' ' ' ILE . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.726 ' HB3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.999 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' SD ' ' A' ' 87' ' ' MET . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.829 ' HB ' HG23 ' A' ' 47' ' ' ILE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.481 ' HA ' ' ND2' ' A' ' 50' ' ' ASN . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.754 HG11 ' OH ' ' A' ' 74' ' ' TYR . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 79' ' ' THR . 7.7 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.876 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.068 0.461 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.794 HG22 ' HB3' ' A' ' 75' ' ' SER . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.753 ' CD2' HD13 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t30 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.632 ' N ' HG23 ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' CA ' HD12 ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.753 HD13 ' CD2' ' A' ' 32' ' ' TYR . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 55' ' ' GLU . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.792 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.758 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.76 HG12 ' CA ' ' A' ' 144' ' ' GLU . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.76 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.76 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.891 HG13 ' CG2' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.794 ' HB3' HG22 ' A' ' 29' ' ' ILE . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.447 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG11 HD11 ' A' ' 114' ' ' LEU . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 102' ' ' ILE . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.712 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.47 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 26.4 t30 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.625 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.714 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 114' ' ' LEU . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.654 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.802 HD12 ' HB3' ' A' ' 104' ' ' TYR . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HG2' HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 122' ' ' MET . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.614 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 131' ' ' LEU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.891 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.559 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.861 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.76 ' CA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 149' ' ' THR . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 146' ' ' ARG . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.792 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 87' ' ' MET . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.589 HG23 ' CD1' ' A' ' 80' ' ' LEU . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 79' ' ' THR . 3.0 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.913 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.015 0.436 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.711 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.879 ' OH ' HG21 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 51.1 t30 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 61' ' ' PRO . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.756 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 41' ' ' THR . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.0 m120 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.721 ' HA ' HD12 ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.909 HG23 HD13 ' A' ' 156' ' ' ILE . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.6 p-10 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.772 ' HB2' ' CG ' ' A' ' 155' ' ' ASP . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.756 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG22 ' CA ' ' A' ' 144' ' ' GLU . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.782 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.879 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.748 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.604 ' OH ' HG11 ' A' ' 158' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.913 HG22 HD13 ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 79' ' ' THR . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 102' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.512 HD21 ' HE3' ' A' ' 150' ' ' TRP . 33.1 t30 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.91 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.728 ' N ' HG23 ' A' ' 96' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.675 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.706 ' HB3' HD12 ' A' ' 114' ' ' LEU . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.639 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.576 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG11 ' A' ' 128' ' ' VAL . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.866 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.85 ' CE1' HG11 ' A' ' 118' ' ' VAL . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 96' ' ' THR . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.605 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.866 HG22 ' OE1' ' A' ' 115' ' ' GLU . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 128' ' ' VAL . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 105' ' ' THR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.886 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.782 HD13 ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.635 ' HA ' HG13 ' A' ' 66' ' ' VAL . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.726 ' CA ' HG22 ' A' ' 66' ' ' VAL . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.657 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.9 HG21 ' HG3' ' A' ' 146' ' ' ARG . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.512 ' HE3' HD21 ' A' ' 90' ' ' ASN . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 151' ' ' LEU . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.645 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.772 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.909 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 83' ' ' VAL . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 78' ' ' ILE . 24.5 mm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' A' ' 75' ' ' SER . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.672 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.834 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.955 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.955 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 64' ' ' ILE . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 68' ' ' THR . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.834 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.754 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.624 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.625 HD21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.625 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.8 ' CE1' HG21 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 93' ' ' PRO . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.924 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.703 ' N ' HG23 ' A' ' 96' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.616 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.658 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.8 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.419 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.74 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.643 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.874 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.874 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.924 ' HD2' HG21 ' A' ' 96' ' ' THR . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.673 HG21 HD11 ' A' ' 102' ' ' ILE . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 115' ' ' GLU . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 83' ' ' VAL . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD1' HG22 ' A' ' 79' ' ' THR . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.805 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.542 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.813 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.813 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 151' ' ' LEU . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 32' ' ' TYR . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.624 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.56 ' OD1' HD12 ' A' ' 80' ' ' LEU . 2.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.872 HD13 HG22 ' A' ' 78' ' ' ILE . 3.5 mp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.972 0.415 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 30' ' ' ALA . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.698 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.3 t30 -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' CG ' HG23 ' A' ' 68' ' ' THR . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.626 HG23 ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 41' ' ' THR . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.907 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 32' ' ' TYR . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 20.8 t-20 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.907 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 41' ' ' THR . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.467 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.693 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.755 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.533 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.872 HG22 HD13 ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.453 ' OD1' ' ND2' ' A' ' 82' ' ' ASN . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 81' ' ' ASN . 6.6 p30 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 114' ' ' LEU . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 156' ' ' ILE . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CE1' HG21 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.636 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.899 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 7.4 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.814 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.687 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.41 ' HA3' ' CD ' ' A' ' 136' ' ' ARG . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.642 ' CZ2' HG22 ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.537 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.896 HD11 HG11 ' A' ' 83' ' ' VAL . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.661 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 115' ' ' GLU . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.504 ' C ' HD23 ' A' ' 133' ' ' LEU . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.864 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.558 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.486 ' C ' HG23 ' A' ' 66' ' ' VAL . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 66' ' ' VAL . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.409 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.84 ' HB3' HG21 ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.836 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 89' ' ' ALA . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 32' ' ' TYR . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 47' ' ' ILE . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.564 ' CG2' HD12 ' A' ' 80' ' ' LEU . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 75' ' ' SER . 9.0 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.822 ' OH ' HG21 ' A' ' 70' ' ' VAL . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.794 ' NH1' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.904 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 14.0 t30 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.904 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.724 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.794 HG23 ' NH1' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 64' ' ' ILE . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.822 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' ILE . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.811 HG21 ' CB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.717 ' HA ' HG12 ' A' ' 158' ' ' VAL . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 83' ' ' VAL . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.68 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.758 ' HG2' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 57' ' ' VAL . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.563 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.701 ' CE ' HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.658 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.639 ' CD2' HD13 ' A' ' 114' ' ' LEU . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.662 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.662 ' CZ2' HG22 ' A' ' 105' ' ' THR . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 131' ' ' LEU . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.658 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.787 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.787 ' CE1' HG11 ' A' ' 118' ' ' VAL . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 102' ' ' ILE . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 128' ' ' VAL . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 127' ' ' LYS . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 114' ' ' LEU . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.658 ' O ' HG23 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.818 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.598 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.701 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.439 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 143' ' ' THR . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG3' ' A' ' 146' ' ' ARG . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.724 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.711 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.758 HG13 ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.511 ' C ' HG22 ' A' ' 156' ' ' ILE . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 83' ' ' VAL . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 158' ' ' VAL . 22.6 m-80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' ILE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.701 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 57' ' ' VAL . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.828 ' ND2' HG23 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.828 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.833 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE1' HD21 ' A' ' 56' ' ' LEU . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.428 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.761 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.592 ' OH ' HG21 ' A' ' 158' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.41 ' CB ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.557 ' HB2' HD11 ' A' ' 28' ' ' ILE . 14.8 m-20 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.776 HG11 HD11 ' A' ' 114' ' ' LEU . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.763 ' HA ' HG23 ' A' ' 156' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.752 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.551 HD21 ' HE3' ' A' ' 150' ' ' TRP . 28.9 t30 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 140' ' ' LEU . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.684 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.696 ' O ' HG22 ' A' ' 143' ' ' THR . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.716 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.837 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.558 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.871 ' CE1' HG11 ' A' ' 118' ' ' VAL . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.747 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 83' ' ' VAL . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.868 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.837 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.792 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' H ' HD13 ' A' ' 141' ' ' ILE . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.835 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.752 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.781 ' HB ' HG23 ' A' ' 47' ' ' ILE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.884 HG21 HD13 ' A' ' 78' ' ' ILE . 1.5 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.812 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 47' ' ' ILE . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' NH2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.834 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.839 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.588 HD21 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.839 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD1' HG12 ' A' ' 47' ' ' ILE . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.588 ' C ' HD21 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.634 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.834 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.435 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 143' ' ' THR . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.88 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 78' ' ' ILE . 29.7 m-20 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.884 HD13 HG21 ' A' ' 28' ' ' ILE . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.833 ' CD2' HD23 ' A' ' 131' ' ' LEU . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.739 HG21 HG11 ' A' ' 138' ' ' VAL . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.786 ' HA ' HG23 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' LEU . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.6 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.67 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.91 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.789 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.894 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.917 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.596 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.618 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.917 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.574 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.642 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.507 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 80' ' ' LEU . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.88 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.894 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.91 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 66' ' ' VAL . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.855 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.855 HG21 ' HG3' ' A' ' 146' ' ' ARG . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 ' OH ' ' A' ' 32' ' ' TYR . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.786 HG23 ' HA ' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.81 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.64 ' OD1' HG22 ' A' ' 158' ' ' VAL . 1.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.857 HG21 HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.873 0.368 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 75' ' ' SER . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 153' ' ' VAL . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.515 ' NH1' ' ND2' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.735 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 41' ' ' THR . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 56' ' ' LEU . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' HG21 ' A' ' 54' ' ' THR . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.616 HG23 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 155' ' ' ASP . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.822 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.735 ' H ' HG22 ' A' ' 41' ' ' THR . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' CE1' HD21 ' A' ' 56' ' ' LEU . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.626 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.865 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 158' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.687 ' HB2' HG22 ' A' ' 29' ' ' ILE . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.662 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.857 HD13 HG21 ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 79' ' ' THR . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 158' ' ' VAL . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.678 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.54 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.817 ' CE ' HD22 ' A' ' 140' ' ' LEU . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.688 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.625 ' CB ' HD13 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.604 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 104' ' ' TYR . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.663 ' OE2' HG21 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.698 ' CE1' HG11 ' A' ' 118' ' ' VAL . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.683 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.678 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 114' ' ' LEU . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' THR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.865 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 140' ' ' LEU . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.464 ' HA ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG2' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG2' ' A' ' 146' ' ' ARG . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.665 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.731 HG21 ' OH ' ' A' ' 32' ' ' TYR . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 83' ' ' VAL . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.414 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 4.9 m120 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 78' ' ' ILE . 3.2 mp . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.981 0.42 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HD3' HG22 ' A' ' 64' ' ' ILE . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.664 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 41' ' ' THR . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.774 ' ND2' HG23 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.785 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.774 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.701 HD13 ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' CD2' HG11 ' A' ' 70' ' ' VAL . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.861 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.596 HG13 ' HB1' ' A' ' 145' ' ' ALA . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 143' ' ' THR . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.716 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.717 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.897 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.797 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.814 ' CE1' HG21 ' A' ' 102' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.774 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.719 ' N ' HG23 ' A' ' 96' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.938 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.773 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.85 HG23 ' HG ' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 140' ' ' LEU . 30.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.768 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG22 ' HE1' ' A' ' 104' ' ' TYR . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.641 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.799 ' OE2' HG13 ' A' ' 128' ' ' VAL . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.945 ' HD2' HG21 ' A' ' 96' ' ' THR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' OE2' ' A' ' 115' ' ' GLU . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.725 HD22 HG11 ' A' ' 128' ' ' VAL . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 80' ' ' LEU . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.897 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.85 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.938 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.596 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.596 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD13 ' A' ' 56' ' ' LEU . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.785 ' HB ' HG23 ' A' ' 47' ' ' ILE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 78' ' ' ILE . 3.1 mp . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.868 0.366 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.645 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.2 t30 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' NE ' ' HG3' ' A' ' 61' ' ' PRO . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 41' ' ' THR . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.896 ' CG1' HG23 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB1' HH11 ' A' ' 154' ' ' ARG . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.846 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.632 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.76 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 56' ' ' LEU . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.994 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.545 HG23 ' OG1' ' A' ' 68' ' ' THR . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 144' ' ' GLU . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 141' ' ' ILE . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.731 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.731 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' HG11 ' A' ' 158' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.855 HG22 HD13 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 79' ' ' THR . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 135' ' ' VAL . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 84' ' ' GLU . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.831 ' HD1' HD12 ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' HG21 ' A' ' 57' ' ' VAL . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.645 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.903 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.55 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' A' ' 141' ' ' ILE . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.537 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.781 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.419 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.653 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 104' ' ' TYR . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.813 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.721 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.436 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.683 HD21 HD23 ' A' ' 80' ' ' LEU . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.711 ' C ' HD23 ' A' ' 133' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.882 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.842 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.561 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.903 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 64' ' ' ILE . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.903 ' HB3' HG21 ' A' ' 149' ' ' THR . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.994 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.509 HH11 ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.896 HG23 ' CG1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 80' ' ' LEU . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 158' ' ' VAL . 5.5 m120 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.935 ' CG2' HD13 ' A' ' 78' ' ' ILE . 3.8 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 75' ' ' SER . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' THR . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' LEU . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.82 ' ND2' HG23 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.805 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.82 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.791 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.575 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.741 ' OD1' HG23 ' A' ' 66' ' ' VAL . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.741 HG23 ' OD1' ' A' ' 65' ' ' ASP . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 141' ' ' ILE . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.648 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.935 HD13 ' CG2' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 114' ' ' LEU . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.977 ' CE1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 95' ' ' ASP . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.828 ' CE ' HD22 ' A' ' 140' ' ' LEU . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.602 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.977 HD13 ' CE1' ' A' ' 85' ' ' PHE . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.441 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.554 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.856 HD11 HG11 ' A' ' 83' ' ' VAL . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CD2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.663 ' CG2' ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.6 ' CD2' HG12 ' A' ' 83' ' ' VAL . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.593 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.769 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.828 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 66' ' ' VAL . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.893 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.893 HG21 ' HG3' ' A' ' 146' ' ' ARG . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.791 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.805 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 158' ' ' VAL . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.421 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 78' ' ' ILE . 22.9 mm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.9 0.381 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.785 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' OH ' HG21 ' A' ' 70' ' ' VAL . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 HH12 HG23 ' A' ' 68' ' ' THR . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.862 HG21 HG22 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB2' HG21 ' A' ' 54' ' ' THR . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.742 ' CG ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.539 HG13 HG23 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m-20 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 54' ' ' THR . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.742 HG23 ' CG ' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.927 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 144' ' ' GLU . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.569 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.729 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.729 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.835 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.78 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 29' ' ' ILE . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.484 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.918 HG23 HG12 ' A' ' 158' ' ' VAL . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 83' ' ' VAL . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' A' ' 125' ' ' ALA . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.682 ' CE ' HD22 ' A' ' 140' ' ' LEU . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.616 ' OE1' HD13 ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.623 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.828 HD21 HG11 ' A' ' 128' ' ' VAL . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.863 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.606 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.863 HG22 ' OE1' ' A' ' 115' ' ' GLU . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 105' ' ' THR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.835 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.582 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.682 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' HG13 ' A' ' 66' ' ' VAL . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.927 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' HG21 ' A' ' 149' ' ' THR . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 146' ' ' ARG . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 56' ' ' LEU . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.918 HG12 HG23 ' A' ' 83' ' ' VAL . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 78' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.021 0.438 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.916 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE2' HG11 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.909 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CB ' HG21 ' A' ' 54' ' ' THR . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 47' ' ' ILE . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.447 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 t30 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.719 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 2.7 t-20 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.909 ' H ' HG22 ' A' ' 41' ' ' THR . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.668 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.66 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.686 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.747 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.747 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.793 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.916 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 HD13 ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 114' ' ' LEU . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.697 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.845 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 152' ' ' GLY . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.409 ' HB2' HG11 ' A' ' 57' ' ' VAL . 31.8 t30 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.7 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.908 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.667 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.7 ' OE2' HG22 ' A' ' 128' ' ' VAL . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.729 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HB3' HG22 ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.729 ' CE1' HG11 ' A' ' 118' ' ' VAL . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 96' ' ' THR . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.7 HG22 ' OE2' ' A' ' 115' ' ' GLU . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 80' ' ' LEU . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.793 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' ILE . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.604 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.908 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.686 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.489 HG23 ' HD3' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.708 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 15.7 m120 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.708 HG21 ' CG ' ' A' ' 146' ' ' ARG . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.689 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 151' ' ' LEU . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 87' ' ' MET . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.746 ' HB ' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.634 HG23 HD11 ' A' ' 80' ' ' LEU . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HG22 ' A' ' 78' ' ' ILE . 3.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 30' ' ' ALA . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.607 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.728 ' NH2' HG21 ' A' ' 64' ' ' ILE . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' H ' HG23 ' A' ' 41' ' ' THR . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 56' ' ' LEU . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.77 HG12 HG23 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 10.3 t-20 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.677 HD12 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.737 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.948 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 11.3 p30 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.728 HG21 ' NH2' ' A' ' 36' ' ' ARG . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 143' ' ' THR . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.8 HG22 HD13 ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.849 HD23 HD21 ' A' ' 131' ' ' LEU . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.915 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 125' ' ' ALA . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.816 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.761 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.908 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.726 ' N ' HG23 ' A' ' 96' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.61 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 140' ' ' LEU . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.775 ' OE1' HD13 ' A' ' 141' ' ' ILE . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 114' ' ' LEU . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.658 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.658 ' CZ2' HG22 ' A' ' 105' ' ' THR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 104' ' ' TYR . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.541 ' OE1' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.853 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.853 ' CE1' HG11 ' A' ' 118' ' ' VAL . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.729 ' O ' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.669 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.908 ' HD2' HG21 ' A' ' 96' ' ' THR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.688 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 115' ' ' GLU . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.849 HD21 HD23 ' A' ' 80' ' ' LEU . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 80' ' ' LEU . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.836 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.545 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.549 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.912 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.701 ' HA ' HG13 ' A' ' 66' ' ' VAL . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.677 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.794 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.794 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.948 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 78' ' ' ILE . 14.2 mm . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.708 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.775 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' THR . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' CG2' ' A' ' 54' ' ' THR . 3.9 m120 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.864 ' H ' HG22 ' A' ' 41' ' ' THR . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 1.005 HD12 ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.627 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.816 HG21 HD13 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.775 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.758 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m-20 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 80' ' ' LEU . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.753 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.647 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' CG ' HG21 ' A' ' 57' ' ' VAL . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.732 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.7 HG23 ' N ' ' A' ' 97' ' ' MET . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.7 ' N ' HG23 ' A' ' 96' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.62 ' O ' HG21 ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.709 ' HB3' HD12 ' A' ' 114' ' ' LEU . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.668 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.451 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.649 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.864 HD21 HG11 ' A' ' 128' ' ' VAL . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.85 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.717 ' CE1' HG11 ' A' ' 118' ' ' VAL . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.643 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.697 HG21 HD11 ' A' ' 102' ' ' ILE . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.864 HG11 HD21 ' A' ' 114' ' ' LEU . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 80' ' ' LEU . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.807 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' ILE . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.823 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 100' ' ' ALA . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 66' ' ' VAL . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 1.005 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.49 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.578 ' C ' HG22 ' A' ' 156' ' ' ILE . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.591 HG22 ' ND2' ' A' ' 159' ' ' ASN . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 158' ' ' VAL . 12.2 m-80 . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 78' ' ' ILE . 16.4 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 41' ' ' THR . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.951 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 16.8 t-20 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' ' HE ' ' A' ' 154' ' ' ARG . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.951 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.625 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.626 ' H ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.847 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.8 p30 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 143' ' ' THR . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.71 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.728 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.728 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.406 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 79' ' ' THR . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 81' ' ' ASN . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.701 ' N ' HD23 ' A' ' 80' ' ' LEU . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.451 ' N ' HD23 ' A' ' 80' ' ' LEU . 7.9 m120 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 83' ' ' VAL . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 156' ' ' ILE . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.787 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.827 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.827 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.608 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.819 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.875 ' HB3' HD12 ' A' ' 114' ' ' LEU . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.616 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.639 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.875 HD12 ' HB3' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.597 ' N ' HG22 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 120' ' ' TYR . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 HD22 ' A' ' 80' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 136' ' ' ARG . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.883 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.75 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.639 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.856 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.856 HG21 ' HG3' ' A' ' 146' ' ' ARG . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.847 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.787 HG13 ' HB2' ' A' ' 87' ' ' MET . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.412 ' HE ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.885 ' HB ' HG23 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.417 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 2.9 m120 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 78' ' ' ILE . 1.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.656 HG22 ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 41' ' ' THR . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.619 ' HB2' HD12 ' A' ' 47' ' ' ILE . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.451 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.7 p-10 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.63 ' H ' HG22 ' A' ' 41' ' ' THR . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CE1' HD21 ' A' ' 56' ' ' LEU . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 68' ' ' THR . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 143' ' ' THR . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' HG23 ' A' ' 78' ' ' ILE . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 76' ' ' ASN . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 HG11 ' A' ' 135' ' ' VAL . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 158' ' ' VAL . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.796 HG11 HD11 ' A' ' 114' ' ' LEU . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.473 HD21 ' CG ' ' A' ' 84' ' ' GLU . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 95' ' ' ASP . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.794 ' CE ' HD22 ' A' ' 140' ' ' LEU . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.637 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.856 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HA ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.935 HD13 ' CE1' ' A' ' 85' ' ' PHE . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.701 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.599 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 128' ' ' VAL . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.539 ' OE1' HG22 ' A' ' 128' ' ' VAL . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.894 HG11 ' CE1' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.894 ' CE1' HG11 ' A' ' 118' ' ' VAL . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' MET . . . . . 0.716 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 96' ' ' THR . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.666 HG21 ' CZ ' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 HD22 ' A' ' 114' ' ' LEU . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.675 ' CD1' HD23 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.769 HG11 HD22 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' HD12 ' A' ' 33' ' ' ILE . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.794 HD22 ' CE ' ' A' ' 97' ' ' MET . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.856 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.675 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.611 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.611 HG21 ' CG ' ' A' ' 146' ' ' ARG . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' TRP . . . . . 0.56 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 85' ' ' PHE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' ASN . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 39.6 t30 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.813 0.339 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.46 118.43 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -73.44 -69.0 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.5 p -83.2 178.88 7.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 160.23 9.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.57 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 60.98 36.31 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m80 60.69 168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -88.35 104.02 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m170 64.17 -78.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -139.88 -67.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.827 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -66.04 146.39 54.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.09 -129.91 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.568 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp 60.08 -177.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.942 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 m -122.95 77.12 50.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.64 -29.05 39.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.588 2.192 . . . . 0.0 112.256 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -69.57 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.76 -155.45 10.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.52 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -98.6 35.91 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t60 66.15 -72.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.041 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.4 mtt 58.68 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.64 -75.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.04 78.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -59.18 109.54 1.98 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.29 -38.53 8.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.413 2.075 . . . . 0.0 112.347 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 60.19 32.1 20.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -127.07 129.58 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.952 HG13 HG21 ' A' ' 78' ' ' ILE . 47.1 mm -114.97 127.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.045 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.717 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 41' ' ' THR . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.674 ' HA ' HD12 ' A' ' 56' ' ' LEU . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.769 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.943 ' ND2' HG23 ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.1 t-20 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.943 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.765 HD21 ' CE1' ' A' ' 58' ' ' TYR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.765 ' CE1' HD21 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.929 HD12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' ILE . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 144' ' ' GLU . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.929 ' HB ' HD12 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.757 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 158' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.952 HG21 HG13 ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.612 HD13 HG11 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.9 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 84' ' ' GLU . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 83' ' ' VAL . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.574 ' C ' ' HB ' ' A' ' 121' ' ' THR . 1.1 tm0? -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.632 ' O ' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.869 HG23 ' HG ' ' A' ' 140' ' ' LEU . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.583 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 128' ' ' VAL . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.667 HG12 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.743 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.707 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.529 HG21 ' OE1' ' A' ' 115' ' ' GLU . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 128' ' ' VAL . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.589 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' HD13 ' A' ' 141' ' ' ILE . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 99' ' ' LYS . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 68' ' ' THR . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.714 HG21 ' NE ' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.648 HG21 ' OH ' ' A' ' 32' ' ' TYR . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.587 HG21 ' OH ' ' A' ' 74' ' ' TYR . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 66.9 34.63 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.84 91.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.165 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 54.86 29.12 11.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.127 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -72.87 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 59.24 31.93 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.417 ' OXT' ' ND2' ' A' ' 82' ' ' ASN . 22.5 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.969 0.359 . . . . 25.010000000000002 111.969 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.96 51.16 3.47 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.899 -0.667 . . . . 22.800000000000001 112.298 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -146.94 -148.97 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.407 -0.22 . . . . 22.379999999999999 110.407 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 173.69 2.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.817 0.341 . . . . 20.800000000000001 111.418 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 m80 71.64 -86.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.908 -0.587 . . . . 19.18 111.198 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -176.38 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.476 0.179 . . . . 19.379999999999999 111.135 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -134.25 -175.89 4.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.399 -0.364 . . . . 17.09 111.256 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -54.73 -57.04 13.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.287 -0.415 . . . . 17.260000000000002 111.191 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -77.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.197 -0.456 . . . . 16.16 110.976 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 73.5 m-70 -138.5 36.72 2.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.781 0.324 . . . . 14.81 110.658 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -104.69 116.22 31.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.234 -0.439 . . . . 14.09 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 56.13 60.47 3.19 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 13.210000000000001 111.141 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.81 -62.65 0.31 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.83 -0.7 . . . . 12.49 112.713 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 2.4 mp 64.3 177.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.83 0.348 . . . . 12.779999999999999 111.25 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -132.2 109.26 13.83 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.31 -0.405 . . . . 11.33 111.31 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.12 107.88 1.43 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.767 2.312 . . . . 11.08 111.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttm105 -135.71 70.69 1.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.188 -0.46 . . . . 10.880000000000001 110.975 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.46 49.06 82.59 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.139 -0.553 . . . . 8.8200000000000003 112.753 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.92 135.81 22.3 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.476 0.179 . . . . 9.8100000000000005 110.995 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.5 p80 43.16 -151.77 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.05 -0.523 . . . . 10.43 111.464 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.403 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER 71.58 164.42 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.411 0.285 . . . . 8.4399999999999995 111.19 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.79 93.24 4.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.037 0.384 . . . . 7.8099999999999996 112.037 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.4 m 52.89 37.16 23.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.999 -0.546 . . . . 8.9399999999999995 111.609 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 21' ' ' MET . 16.3 t70 63.35 109.52 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.886 -0.597 . . . . 8.7799999999999994 111.432 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.55 140.98 75.13 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.725 2.284 . . . . 7.2599999999999998 112.214 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.25 -79.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.148 -0.478 . . . . 9.4700000000000006 111.08 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 51.08 38.03 19.63 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.94 0.4 . . . . 10.06 111.528 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 78' ' ' ILE . 1.3 mp -72.98 128.87 36.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.263 -0.426 . . . . 7.2300000000000004 110.774 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.25 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.7 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 5.9100000000000001 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.1099999999999994 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HE2' HG11 ' A' ' 153' ' ' VAL . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4100000000000001 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.1299999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.1400000000000006 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' HD3' HG21 ' A' ' 64' ' ' ILE . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 13.449999999999999 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.41 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 57' ' ' VAL . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.130000000000001 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 14.94 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 14.77 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.31 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.42 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.876 HD13 HD12 ' A' ' 56' ' ' LEU . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.0999999999999996 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.2300000000000004 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.220000000000001 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.65 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 13.98 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.56 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.33 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 151' ' ' LEU . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.16 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.460000000000001 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.19 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 14.91 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 17.82 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.646 HG21 ' HD3' ' A' ' 36' ' ' ARG . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.050000000000001 112.25 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.380000000000001 112.196 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 9.4700000000000006 113.484 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 8.7599999999999998 111.535 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.3300000000000001 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.667 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 5.4800000000000004 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 3.75 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 3.96 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 8.8000000000000007 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.5099999999999998 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.01 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.75 HG21 ' HB ' ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.4399999999999995 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.08 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 83' ' ' VAL . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 10.9 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.210000000000001 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.881 HG23 HG12 ' A' ' 158' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 6.8499999999999996 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 156' ' ' ILE . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD22 ' HB1' ' A' ' 125' ' ' ALA . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.1600000000000001 109.528 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 6.7400000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 7.6500000000000004 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.27 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.449999999999999 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 12.82 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 11.76 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.5099999999999998 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.8600000000000003 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.62 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.657 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.4900000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 5.8399999999999999 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.6199999999999992 109.292 178.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.712 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.1199999999999992 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.15 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 136' ' ' ARG . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.6600000000000001 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 11.609999999999999 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.32 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CD2' ' HB ' ' A' ' 105' ' ' THR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.01 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.630000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.712 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.924 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.579 ' OE2' HG22 ' A' ' 128' ' ' VAL . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 9.9100000000000001 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.774 HG11 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 7.9699999999999998 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.907 ' CE1' HG23 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.3600000000000003 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.597 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 6.7400000000000002 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.556 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 7.75 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 8.7400000000000002 109.445 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.907 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1699999999999999 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.24 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 15.51 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 80' ' ' LEU . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.460000000000001 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 131' ' ' LEU . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.380000000000001 111.083 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 12.81 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.5999999999999996 112.243 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.738 ' O ' HG23 ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.02 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.859 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.0199999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 8.4399999999999995 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.796 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.3900000000000006 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 66' ' ' VAL . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' N ' ' HB3' ' A' ' 98' ' ' GLN . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.6999999999999993 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HG2' HG21 ' A' ' 149' ' ' THR . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.08 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 146' ' ' ARG . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.26 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.543 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 15.23 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 8.9900000000000002 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 8.8000000000000007 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.673 HG11 ' HE2' ' A' ' 32' ' ' TYR . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 13.460000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.1199999999999992 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 85' ' ' PHE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.2999999999999998 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.1799999999999997 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.881 HG12 HG23 ' A' ' 83' ' ' VAL . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.556 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 66.63 11.73 8.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER 54.01 63.87 2.03 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 109.659 -0.497 . . . . 12.199999999999999 109.659 -179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.11 37.83 1.17 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.489 -0.778 . . . . 14.43 110.069 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 58.32 67.73 0.91 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.867 -0.606 . . . . 13.19 110.787 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 159' ' ' ASN . 26.9 t70 -133.4 -81.46 0.47 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.271 -0.422 . . . . 11.779999999999999 111.703 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.697 -0.668 . . . . 13.66 111.4 -179.355 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.833 0.349 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.01 167.45 15.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.46 -50.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 60.32 79.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m170 60.34 161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.57 30.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.43 137.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -103.68 91.65 4.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -175.94 104.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -102.64 79.45 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.58 123.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 -31.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.32 -70.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.32 156.66 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 15.7 m -128.33 71.65 79.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.28 -56.52 2.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -82.35 -178.14 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.97 28.83 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -106.47 114.93 29.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -110.19 -31.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.5 ttm -133.34 139.57 46.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.96 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.3 m -120.51 -69.66 0.83 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.32 143.75 2.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.799 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.25 94.27 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.479 2.12 . . . . 0.0 112.322 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.17 -56.7 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.922 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER 62.04 150.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.01 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' HB3' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -112.76 137.95 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.515 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.792 HG22 ' HB2' ' A' ' 75' ' ' SER . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.446 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.901 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.649 ' NH2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' H ' HG23 ' A' ' 41' ' ' THR . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HA ' HD12 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 17.2 t-20 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.82 HD13 ' CG2' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 41' ' ' THR . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.649 HD13 ' NH2' ' A' ' 36' ' ' ARG . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 144' ' ' GLU . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.836 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.799 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.792 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.464 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.658 ' CD2' HD23 ' A' ' 131' ' ' LEU . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 114' ' ' LEU . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.695 ' HB3' HG12 ' A' ' 153' ' ' VAL . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' OD1' HG21 ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.663 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 121' ' ' THR . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD12 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.688 HD11 HG11 ' A' ' 83' ' ' VAL . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.783 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.794 ' CE1' HG11 ' A' ' 118' ' ' VAL . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG22 ' CD ' ' A' ' 115' ' ' GLU . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 80' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.799 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.556 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.793 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.836 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 143' ' ' THR . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.864 ' HG3' HG21 ' A' ' 149' ' ' THR . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.864 HG21 ' HG3' ' A' ' 146' ' ' ARG . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.694 ' CD1' HG13 ' A' ' 153' ' ' VAL . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.901 HG11 ' OH ' ' A' ' 32' ' ' TYR . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.543 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.464 ' ND2' ' O ' ' A' ' 79' ' ' THR . 6.7 m120 64.68 31.03 12.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 80.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.8 44.17 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 61.27 47.77 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t0 68.64 -67.99 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.014 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.898 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.18 -29.19 56.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.412 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t 63.05 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m 60.66 -172.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -59.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -177.73 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -144.43 172.88 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.04 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -101.75 54.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m170 60.89 164.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -127.02 -45.32 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -174.16 -43.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m 60.3 -169.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 14' ' ' LEU . . . -62.56 -117.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 13' ' ' GLY . 5.0 mp 62.76 119.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 17' ' ' ARG . 21.6 t 64.13 77.27 0.31 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.91 -28.03 37.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.596 ' HG3' HG12 ' A' ' 15' ' ' VAL . 54.7 mtm-85 60.97 31.1 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 163.73 19.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t 60.13 30.98 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -112.15 -34.95 5.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -155.67 120.29 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.58 -69.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -113.71 29.78 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -73.45 -60.81 1.58 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 59.4 Cg_endo -72.19 72.17 2.83 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.49 2.126 . . . . 0.0 112.408 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.496 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.1 m-20 -69.79 -47.46 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.1 mmm-85 63.4 72.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 27' ' ' ARG . 1.9 mp -144.02 118.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 30' ' ' ALA . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.763 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 55' ' ' GLU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 41' ' ' THR . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' OD1' HG21 ' A' ' 54' ' ' THR . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 56' ' ' LEU . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.921 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.829 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.481 ' ND2' ' HA ' ' A' ' 157' ' ' ASN . 1.7 m120 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.921 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.804 ' HG2' HG21 ' A' ' 41' ' ' THR . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.999 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 HG12 ' HB1' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 143' ' ' THR . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.866 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.754 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.695 HG22 HD13 ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.479 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 1.9 p30 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.688 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 121' ' ' THR . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' O ' HG22 ' A' ' 143' ' ' THR . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.841 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 126' ' ' ILE . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.81 ' HB3' HD12 ' A' ' 114' ' ' LEU . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.652 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' CA ' ' HD3' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 105' ' ' THR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.851 HG11 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.851 ' CE1' HG11 ' A' ' 118' ' ' VAL . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.688 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 102' ' ' ILE . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 115' ' ' GLU . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 128' ' ' VAL . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 128' ' ' VAL . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.499 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.866 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 102' ' ' ILE . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.596 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.841 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 64' ' ' ILE . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.726 ' HB3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.999 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' SD ' ' A' ' 87' ' ' MET . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.829 ' HB ' HG23 ' A' ' 47' ' ' ILE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.481 ' HA ' ' ND2' ' A' ' 50' ' ' ASN . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.754 HG11 ' OH ' ' A' ' 74' ' ' TYR . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.54 HD21 ' HA ' ' A' ' 164' ' ' SER . 7.7 m120 61.89 27.89 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.55 85.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.966 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.04 37.36 26.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 69.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.86 83.05 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.54 ' HA ' HD21 ' A' ' 159' ' ' ASN . 60.0 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.782 0.325 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.73 78.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -134.15 31.92 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.0 76.3 3.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.73 30.86 20.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.957 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.09 -170.84 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.36 -63.5 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.14 80.55 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.478 ' O ' ' CD2' ' A' ' 10' ' ' HIS . 2.8 t-80 -144.06 32.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.478 ' CD2' ' O ' ' A' ' 9' ' ' HIS . 3.8 m-70 -149.0 160.11 43.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m 60.66 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t -173.76 84.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.57 -93.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 15' ' ' VAL . 12.1 mt 60.59 -169.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.842 HG22 ' HD2' ' A' ' 16' ' ' PRO . 0.4 OUTLIER 77.75 148.41 0.12 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.117 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.842 ' HD2' HG22 ' A' ' 15' ' ' VAL . 52.8 Cg_exo -52.22 98.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.535 2.157 . . . . 0.0 112.397 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -176.66 -64.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.97 102.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.515 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -127.66 137.38 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -176.66 164.82 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.97 86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.35 133.65 17.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 t 59.85 29.26 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.88 156.19 0.11 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 -167.34 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.0 112.234 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.14 -25.77 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 62.62 102.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.876 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp -102.08 119.27 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.794 HG22 ' HB3' ' A' ' 75' ' ' SER . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.753 ' CD2' HD13 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 11.4 t30 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.632 ' N ' HG23 ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' CA ' HD12 ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.753 HD13 ' CD2' ' A' ' 32' ' ' TYR . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 55' ' ' GLU . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.792 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.758 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.76 HG12 ' CA ' ' A' ' 144' ' ' GLU . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.76 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.76 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.891 HG13 ' CG2' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.794 ' HB3' HG22 ' A' ' 29' ' ' ILE . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.447 ' O ' ' ND2' ' A' ' 159' ' ' ASN . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG11 HD11 ' A' ' 114' ' ' LEU . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 102' ' ' ILE . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.712 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.47 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 26.4 t30 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.625 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.714 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 114' ' ' LEU . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.654 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.802 HD12 ' HB3' ' A' ' 104' ' ' TYR . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HG2' HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 122' ' ' MET . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.614 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 131' ' ' LEU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.891 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.559 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.861 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.76 ' CA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 149' ' ' THR . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 146' ' ' ARG . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.792 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 87' ' ' MET . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 163' ' ' ASP . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 79' ' ' THR . 3.0 m120 61.49 36.73 16.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 60.63 -157.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -69.71 66.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.941 0.4 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -152.79 -54.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.745 ' HA ' HG13 ' A' ' 158' ' ' VAL . 9.5 t0 65.79 146.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.624 ' O ' HG21 ' A' ' 78' ' ' ILE . 1.7 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.766 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.87 109.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.5 -75.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.328 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -177.29 -176.48 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -119.91 85.84 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -81.89 -54.7 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -165.82 34.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 60.34 -176.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -138.55 -62.75 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 t60 63.59 139.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -176.14 37.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.92 -170.02 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.23 -100.16 1.88 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.17 31.74 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -82.77 -45.55 0.9 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.482 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.17 -61.28 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.327 2.018 . . . . 0.0 112.384 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -61.34 176.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 113.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -103.69 79.44 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.866 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 19' ' ' SER . 6.6 m80 -169.64 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptp -132.47 -48.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.11 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -159.45 38.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.38 155.0 0.11 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 84.9 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.532 2.155 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.92 79.92 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -146.59 34.87 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.913 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp -64.33 142.46 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.847 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.711 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.879 ' OH ' HG21 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 51.1 t30 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 61' ' ' PRO . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.756 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 41' ' ' THR . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 12.0 m120 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.721 ' HA ' HD12 ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.909 HG23 HD13 ' A' ' 156' ' ' ILE . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.6 p-10 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.772 ' HB2' ' CG ' ' A' ' 155' ' ' ASP . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.756 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.726 HG22 ' CA ' ' A' ' 144' ' ' GLU . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.782 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.879 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.748 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.604 ' OH ' HG11 ' A' ' 158' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.913 HG22 HD13 ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 79' ' ' THR . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 102' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.512 HD21 ' HE3' ' A' ' 150' ' ' TRP . 33.1 t30 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.91 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.728 ' N ' HG23 ' A' ' 96' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.675 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.706 ' HB3' HD12 ' A' ' 114' ' ' LEU . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.639 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.576 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG11 ' A' ' 128' ' ' VAL . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.866 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.85 ' CE1' HG11 ' A' ' 118' ' ' VAL . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 96' ' ' THR . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.605 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.866 HG22 ' OE1' ' A' ' 115' ' ' GLU . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 128' ' ' VAL . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 105' ' ' THR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.886 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.782 HD13 ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.635 ' HA ' HG13 ' A' ' 66' ' ' VAL . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.726 ' CA ' HG22 ' A' ' 66' ' ' VAL . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.657 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.9 HG21 ' HG3' ' A' ' 146' ' ' ARG . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.512 ' HE3' HD21 ' A' ' 90' ' ' ASN . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 151' ' ' LEU . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.645 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.772 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.909 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 83' ' ' VAL . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 65.36 54.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.99 76.48 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.41 38.9 19.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 61.05 79.26 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.32 157.11 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.932 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.71 129.21 6.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -91.87 80.19 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.346 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -165.86 87.27 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -91.59 91.67 8.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -131.21 -55.74 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -155.36 87.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.3 71.3 3.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 62.77 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.74 174.28 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.796 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.24 149.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 -68.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.63 -74.7 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.598 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mt 60.7 99.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.2 m -130.33 88.33 47.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.93 -61.16 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.545 2.163 . . . . 0.0 112.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -174.93 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.07 -131.91 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -104.68 82.12 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -166.21 32.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -127.44 -73.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 57.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.8 t 60.56 32.77 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 161.64 0.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.001 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 -47.01 1.22 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.584 2.189 . . . . 0.0 112.208 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 62.87 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -172.48 3.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 78' ' ' ILE . 24.5 mm -66.2 127.68 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' A' ' 75' ' ' SER . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.672 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.834 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.955 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.955 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 68' ' ' THR . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.834 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.754 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.624 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.625 HD21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.625 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.8 ' CE1' HG21 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 93' ' ' PRO . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.924 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.703 ' N ' HG23 ' A' ' 96' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.616 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.658 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.8 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.419 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.74 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.643 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.874 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.874 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.924 ' HD2' HG21 ' A' ' 96' ' ' THR . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.673 HG21 HD11 ' A' ' 102' ' ' ILE . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 115' ' ' GLU . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 83' ' ' VAL . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD1' HG22 ' A' ' 79' ' ' THR . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.805 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.542 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.813 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.813 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 32' ' ' TYR . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.624 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.56 ' OD1' HD12 ' A' ' 80' ' ' LEU . 2.0 m-20 69.76 76.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.95 43.23 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt 61.82 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 45.29 36.62 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.56 -68.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 tpp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.18 28.25 7.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.571 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -105.16 -74.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.99 32.75 2.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -96.45 -168.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 m80 61.54 89.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 13.6 p-80 -140.38 31.22 1.92 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 7' ' ' HIS . 6.7 m-70 -176.57 82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -35.74 76.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -102.43 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.35 149.16 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.1 m -60.38 157.83 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 -31.86 7.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -114.77 156.66 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.347 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 16' ' ' PRO . 10.7 p -153.95 139.34 11.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 15' ' ' VAL . 56.6 Cg_exo -51.98 135.09 50.79 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.508 2.139 . . . . 0.0 112.28 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -107.26 148.87 28.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.62 -91.68 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 m 68.49 -68.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 m170 60.85 79.35 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.422 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.1 mtm -150.34 -169.28 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . 68.16 -69.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -59.64 -31.85 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.05 87.74 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 158.85 55.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -129.82 136.34 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtm-85 60.54 172.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.872 HD13 HG22 ' A' ' 78' ' ' ILE . 3.5 mp -88.21 126.33 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 30' ' ' ALA . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.698 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.3 t30 -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' CG ' HG23 ' A' ' 68' ' ' THR . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.626 HG23 ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 41' ' ' THR . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.907 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 32' ' ' TYR . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 20.8 t-20 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.907 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 41' ' ' THR . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.6 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.693 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.755 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.533 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.872 HG22 HD13 ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' OD1' ' ND2' ' A' ' 82' ' ' ASN . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' ND2' ' OD1' ' A' ' 81' ' ' ASN . 6.6 p30 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 114' ' ' LEU . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 156' ' ' ILE . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CE1' HG21 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.636 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.899 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 7.4 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.814 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.687 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' HA3' ' CD ' ' A' ' 136' ' ' ARG . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.642 ' CZ2' HG22 ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.537 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.896 HD11 HG11 ' A' ' 83' ' ' VAL . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.661 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 115' ' ' GLU . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.504 ' C ' HD23 ' A' ' 133' ' ' LEU . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.864 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.558 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.486 ' C ' HG23 ' A' ' 66' ' ' VAL . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 66' ' ' VAL . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.409 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.84 ' HB3' HG21 ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.836 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 89' ' ' ALA . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 32' ' ' TYR . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 47' ' ' ILE . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.564 ' CG2' HD12 ' A' ' 80' ' ' LEU . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER 70.53 52.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -58.88 136.23 57.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? 56.31 23.6 7.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.37 -65.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 159' ' ' ASN . 11.8 m-20 69.17 -67.5 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.935 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.855 0.36 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.13 -64.98 0.59 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.543 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t 60.58 31.36 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.08 -70.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -120.7 105.86 11.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.74 82.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.31 -56.98 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -174.75 79.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -108.19 80.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -173.34 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.02 -70.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m 60.37 -171.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.15 108.67 0.67 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tp 61.17 112.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.1 m -133.69 81.79 52.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.37 92.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.252 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -151.79 -46.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.59 112.32 0.98 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 t -64.13 81.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -136.9 -47.59 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -160.5 138.0 9.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.4 -73.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -105.26 31.08 5.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 83.1 m-20 61.08 54.06 3.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 58.7 Cg_endo -71.67 162.41 42.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.61 2.207 . . . . 0.0 112.308 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -177.03 -69.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -176.56 -170.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 75' ' ' SER . 9.0 tp -144.26 159.99 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.822 ' OH ' HG21 ' A' ' 70' ' ' VAL . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.794 ' NH1' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.904 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 14.0 t30 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.904 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.724 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.794 HG23 ' NH1' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 64' ' ' ILE . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.822 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' ILE . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.811 HG21 ' CB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.717 ' HA ' HG12 ' A' ' 158' ' ' VAL . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 83' ' ' VAL . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.68 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.758 ' HG2' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 57' ' ' VAL . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.563 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.701 ' CE ' HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.658 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.639 ' CD2' HD13 ' A' ' 114' ' ' LEU . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.662 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.662 ' CZ2' HG22 ' A' ' 105' ' ' THR . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 131' ' ' LEU . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.658 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.787 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.787 ' CE1' HG11 ' A' ' 118' ' ' VAL . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 102' ' ' ILE . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 128' ' ' VAL . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 127' ' ' LYS . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 114' ' ' LEU . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.658 ' O ' HG23 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.818 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.598 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.701 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.439 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 143' ' ' THR . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG3' ' A' ' 146' ' ' ARG . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.724 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.711 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.758 HG13 ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.511 ' C ' HG22 ' A' ' 156' ' ' ILE . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 83' ' ' VAL . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 158' ' ' VAL . 22.6 m-80 64.1 47.46 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 76.43 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 36.96 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.78 75.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.28 132.03 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.937 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.765 0.317 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.61 -85.37 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.74 88.41 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.865 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 m -104.51 178.02 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -97.41 39.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.1 172.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.6 166.77 22.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -147.89 82.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.51 103.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -141.47 -47.63 0.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -164.03 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.7 m -63.57 -47.94 79.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' C ' HD12 ' A' ' 14' ' ' LEU . . . -91.14 50.51 3.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.453 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 13' ' ' GLY . 3.1 mp -146.73 75.42 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 4.6 t -83.45 -45.79 0.81 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 53.9 Cg_exo -52.29 107.11 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.32 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -177.3 126.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.99 2.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.48 31.81 5.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.16 -174.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt 62.53 118.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.68 -47.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -107.15 -43.7 4.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.7 147.59 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.38 -35.9 4.5 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.478 2.119 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.3 31.13 0.53 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.92 141.0 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -69.1 138.47 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' ILE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.701 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 57' ' ' VAL . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.828 ' ND2' HG23 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.828 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.833 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE1' HD21 ' A' ' 56' ' ' LEU . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.428 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.761 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.592 ' OH ' HG21 ' A' ' 158' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.41 ' CB ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.557 ' HB2' HD11 ' A' ' 28' ' ' ILE . 14.8 m-20 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.776 HG11 HD11 ' A' ' 114' ' ' LEU . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.763 ' HA ' HG23 ' A' ' 156' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.752 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.551 HD21 ' HE3' ' A' ' 150' ' ' TRP . 28.9 t30 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 140' ' ' LEU . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.684 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.696 ' O ' HG22 ' A' ' 143' ' ' THR . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.716 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.837 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.558 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.871 ' CE1' HG11 ' A' ' 118' ' ' VAL . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.747 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 83' ' ' VAL . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.868 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.837 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.792 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' H ' HD13 ' A' ' 141' ' ' ILE . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.835 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.752 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.781 ' HB ' HG23 ' A' ' 47' ' ' ILE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 75.41 69.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -97.37 105.31 17.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.31 31.51 20.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 60.7 84.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 60.73 111.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.779 0.323 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.88 -44.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -143.26 110.98 5.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.986 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 m -141.14 120.5 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -107.12 109.06 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -106.04 31.29 5.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.42 ' CE1' ' NE2' ' A' ' 9' ' ' HIS . 2.6 t-80 -176.73 83.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -85.18 108.79 17.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.42 ' NE2' ' CE1' ' A' ' 7' ' ' HIS . 2.6 m-70 -123.19 78.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -88.39 -172.54 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -56.52 105.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.007 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m 59.58 23.68 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.141 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.74 -29.19 9.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 68.79 -68.79 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 14' ' ' LEU . 21.8 t -138.16 68.13 47.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.52 -61.81 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.617 2.211 . . . . 0.0 112.242 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.85 79.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.54 -133.74 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.6 m -80.19 62.05 4.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 68.93 -67.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 176.44 7.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.4 55.25 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t 60.95 30.84 19.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.61 88.52 0.12 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.61 141.61 46.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.609 2.206 . . . . 0.0 112.19 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -125.58 43.77 2.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.64 150.45 48.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.884 HG21 HD13 ' A' ' 78' ' ' ILE . 1.5 tp -100.75 155.36 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.812 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 47' ' ' ILE . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' NH2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.834 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.839 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.588 HD21 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.839 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD1' HG12 ' A' ' 47' ' ' ILE . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.588 ' C ' HD21 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.634 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.834 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.435 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.4 p30 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 143' ' ' THR . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.88 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 78' ' ' ILE . 29.7 m-20 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.884 HD13 HG21 ' A' ' 28' ' ' ILE . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.833 ' CD2' HD23 ' A' ' 131' ' ' LEU . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.739 HG21 HG11 ' A' ' 138' ' ' VAL . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.786 ' HA ' HG23 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' LEU . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.6 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.67 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.91 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.789 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.894 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.917 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.596 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.618 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.917 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.574 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.642 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.507 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 80' ' ' LEU . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.88 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.894 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.91 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 66' ' ' VAL . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.855 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.855 HG21 ' HG3' ' A' ' 146' ' ' ARG . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 ' OH ' ' A' ' 32' ' ' TYR . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.786 HG23 ' HA ' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.81 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.64 ' OD1' HG22 ' A' ' 158' ' ' VAL . 1.7 m-20 64.5 30.3 12.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 82.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt 60.17 36.62 21.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 62.21 68.92 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.72 153.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.9 -141.3 15.27 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -139.05 -60.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.66 121.54 4.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 60.84 156.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -172.35 35.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -106.16 99.63 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -85.87 126.97 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -63.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -106.74 35.76 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -88.62 145.63 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 144.37 38.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.4 44.51 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 14' ' ' LEU . 14.2 mt -156.0 172.54 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.4 m -58.31 110.0 2.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.33 127.41 23.76 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.444 2.096 . . . . 0.0 112.317 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.85 124.51 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.9 42.98 1.81 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.441 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.39 164.57 13.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 60.63 82.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -80.73 141.1 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.21 -45.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 p -154.38 33.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.04 138.57 89.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 123.0 9.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.571 2.181 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.491 HD21 ' C ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -169.27 141.5 2.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 59.53 89.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.857 HG21 HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -109.41 142.7 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 75' ' ' SER . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 153' ' ' VAL . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.515 ' NH1' ' ND2' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.735 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 41' ' ' THR . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 56' ' ' LEU . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' HG21 ' A' ' 54' ' ' THR . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.616 HG23 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 155' ' ' ASP . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.822 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.735 ' H ' HG22 ' A' ' 41' ' ' THR . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' CE1' HD21 ' A' ' 56' ' ' LEU . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.544 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.626 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.865 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 158' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.687 ' HB2' HG22 ' A' ' 29' ' ' ILE . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.662 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.857 HD13 HG21 ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 79' ' ' THR . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 158' ' ' VAL . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.678 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.54 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.817 ' CE ' HD22 ' A' ' 140' ' ' LEU . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.688 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' CB ' HD13 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.604 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 104' ' ' TYR . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.663 ' OE2' HG21 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.698 ' CE1' HG11 ' A' ' 118' ' ' VAL . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.683 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.678 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 114' ' ' LEU . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' THR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.865 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 140' ' ' LEU . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.464 ' HA ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG2' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG2' ' A' ' 146' ' ' ARG . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.665 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.731 HG21 ' OH ' ' A' ' 32' ' ' TYR . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 83' ' ' VAL . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 163' ' ' ASP . 4.9 m120 56.03 76.85 0.26 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -79.86 14.66 1.68 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -153.04 24.25 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.963 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 79' ' ' THR . 7.1 mm-40 -155.92 -46.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' CB ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -120.27 -179.71 4.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.901 0.382 . . . . 0.0 111.064 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.784 0.326 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.81 44.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.58 107.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -163.79 115.2 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -150.86 91.44 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m170 60.35 85.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -110.98 34.17 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -131.9 -50.7 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -128.86 154.69 46.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -146.64 175.92 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -160.5 146.05 14.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -60.25 -62.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.05 -88.66 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -98.46 92.28 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 110.928 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 14' ' ' LEU . 17.3 m 50.86 164.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.018 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 31.2 Cg_exo -59.97 -177.0 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.591 2.194 . . . . 0.0 112.26 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.3 31.21 6.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 79.42 1.13 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.528 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.7 t -108.34 121.31 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -176.76 -41.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.97 -168.27 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.86 -69.74 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -90.87 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -179.16 147.51 0.51 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 -41.0 2.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.07 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 79.58 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 78' ' ' ILE . 3.2 mp -59.17 122.39 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HD3' HG22 ' A' ' 64' ' ' ILE . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.664 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 41' ' ' THR . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.774 ' ND2' HG23 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.785 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.774 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.701 HD13 ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' CD2' HG11 ' A' ' 70' ' ' VAL . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.861 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.596 HG13 ' HB1' ' A' ' 145' ' ' ALA . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 143' ' ' THR . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.716 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.897 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.797 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.814 ' CE1' HG21 ' A' ' 102' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.774 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.719 ' N ' HG23 ' A' ' 96' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.938 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.773 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.85 HG23 ' HG ' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.434 ' NE2' ' O ' ' A' ' 140' ' ' LEU . 30.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.768 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG22 ' HE1' ' A' ' 104' ' ' TYR . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.641 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.799 ' OE2' HG13 ' A' ' 128' ' ' VAL . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.945 ' HD2' HG21 ' A' ' 96' ' ' THR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' OE2' ' A' ' 115' ' ' GLU . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.725 HD22 HG11 ' A' ' 128' ' ' VAL . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 80' ' ' LEU . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.897 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.85 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.938 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.596 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.596 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD13 ' A' ' 56' ' ' LEU . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.785 ' HB ' HG23 ' A' ' 47' ' ' ILE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.4 75.17 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -132.67 68.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 52.66 51.73 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.68 49.82 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.6 t70 62.61 148.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.903 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.14 -168.23 51.76 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.436 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -68.68 94.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 p -140.17 125.31 18.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.55 31.45 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -176.47 90.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -106.31 120.48 41.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.967 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -94.79 143.01 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -79.39 -75.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.25 37.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.04 176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 t -176.55 -64.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.04 143.52 14.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tp -105.73 35.89 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.35 63.6 4.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.052 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.71 101.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.427 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 60.79 178.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.62 -86.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.4 p -103.38 76.82 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 60.56 31.59 20.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mmt -59.99 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.826 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . 76.26 5.51 3.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.474 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 t -108.93 -23.63 11.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 64.19 92.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.89 63.54 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.444 2.096 . . . . 0.0 112.315 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.91 -169.69 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.98 131.74 48.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 78' ' ' ILE . 3.1 mp -65.05 116.91 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.2 t30 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' NE ' ' HG3' ' A' ' 61' ' ' PRO . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 41' ' ' THR . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.896 ' CG1' HG23 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB1' HH11 ' A' ' 154' ' ' ARG . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.846 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.632 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.76 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 56' ' ' LEU . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.994 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.545 HG23 ' OG1' ' A' ' 68' ' ' THR . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 144' ' ' GLU . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.467 ' O ' ' ND2' ' A' ' 35' ' ' ASN . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 141' ' ' ILE . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.731 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.731 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' HG11 ' A' ' 158' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.855 HG22 HD13 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 79' ' ' THR . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 135' ' ' VAL . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 84' ' ' GLU . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.831 ' HD1' HD12 ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' HG21 ' A' ' 57' ' ' VAL . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.645 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.903 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.55 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' A' ' 141' ' ' ILE . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.537 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.781 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.419 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.653 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 104' ' ' TYR . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.813 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.721 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.436 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.683 HD21 HD23 ' A' ' 80' ' ' LEU . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.711 ' C ' HD23 ' A' ' 133' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.882 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.842 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.561 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.903 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 64' ' ' ILE . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.903 ' HB3' HG21 ' A' ' 149' ' ' THR . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.994 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.509 HH11 ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.896 HG23 ' CG1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 80' ' ' LEU . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 158' ' ' VAL . 5.5 m120 71.88 29.87 2.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttm 47.34 92.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 60.59 27.6 17.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.636 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 62.54 67.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.07 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.972 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.876 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.894 0.378 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.48 43.45 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.524 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -176.23 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -173.37 39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 24.4 m80 68.73 -67.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.025 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -108.39 -175.74 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -99.0 31.65 2.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.29 87.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -165.82 85.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -128.84 116.83 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 t -163.79 71.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p 49.98 80.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 153.94 22.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.89 158.13 44.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.45 87.58 14.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.13 -40.87 67.84 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 112.331 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -176.45 131.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.08 108.16 2.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -173.38 -41.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 60.42 84.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.2 174.21 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.46 -162.63 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.791 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -94.88 32.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.37 148.84 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 108.67 2.45 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.5 2.133 . . . . 0.0 112.247 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -67.34 160.7 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.4 158.89 11.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.935 ' CG2' HD13 ' A' ' 78' ' ' ILE . 3.8 tp -106.09 159.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 75' ' ' SER . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' THR . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' LEU . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.82 ' ND2' HG23 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.805 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.82 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.791 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.575 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.741 ' OD1' HG23 ' A' ' 66' ' ' VAL . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.741 HG23 ' OD1' ' A' ' 65' ' ' ASP . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 141' ' ' ILE . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.648 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.935 HD13 ' CG2' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 114' ' ' LEU . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.977 ' CE1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 95' ' ' ASP . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.828 ' CE ' HD22 ' A' ' 140' ' ' LEU . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.602 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.977 HD13 ' CE1' ' A' ' 85' ' ' PHE . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.441 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.554 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.856 HD11 HG11 ' A' ' 83' ' ' VAL . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CD2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.663 ' CG2' ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.6 ' CD2' HG12 ' A' ' 83' ' ' VAL . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.593 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.769 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.828 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 66' ' ' VAL . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.893 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.893 HG21 ' HG3' ' A' ' 146' ' ' ARG . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.791 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.805 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 158' ' ' VAL . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 158' ' ' VAL . 16.8 p30 45.58 30.13 0.73 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.15 133.89 43.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.9 tptp 59.8 30.96 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -148.65 -73.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t0 60.43 79.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.944 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.5 -137.6 8.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -106.56 34.03 3.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.09 79.97 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -141.26 -58.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -140.52 31.66 1.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -139.41 44.87 1.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -59.56 140.4 56.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.15 119.18 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 60.33 89.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -74.08 -176.1 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 p -97.99 36.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.71 -103.13 1.58 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' A' ' 16' ' ' PRO . 2.3 tt -176.59 -40.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.5 p 42.85 61.32 9.56 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.588 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG3' HD22 ' A' ' 14' ' ' LEU . 62.2 Cg_exo -51.23 169.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.628 2.219 . . . . 0.0 112.333 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -126.0 133.47 51.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.59 138.06 40.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -129.97 31.27 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -143.99 72.94 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtp 63.32 -80.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -179.08 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -58.95 -27.92 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.27 155.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.978 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 171.97 13.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.655 2.237 . . . . 0.0 112.286 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 60.56 33.51 20.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -66.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 78' ' ' ILE . 22.9 mm 63.81 127.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.785 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' OH ' HG21 ' A' ' 70' ' ' VAL . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 HH12 HG23 ' A' ' 68' ' ' THR . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.862 HG21 HG22 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB2' HG21 ' A' ' 54' ' ' THR . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.742 ' CG ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.539 HG13 HG23 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m-20 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 54' ' ' THR . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.742 HG23 ' CG ' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.927 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 144' ' ' GLU . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.569 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.729 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.729 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.835 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.78 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 29' ' ' ILE . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.484 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.918 HG23 HG12 ' A' ' 158' ' ' VAL . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 83' ' ' VAL . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' A' ' 125' ' ' ALA . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.682 ' CE ' HD22 ' A' ' 140' ' ' LEU . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.616 ' OE1' HD13 ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.623 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.828 HD21 HG11 ' A' ' 128' ' ' VAL . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.863 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.606 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.863 HG22 ' OE1' ' A' ' 115' ' ' GLU . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 105' ' ' THR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.835 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.582 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.682 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' HG13 ' A' ' 66' ' ' VAL . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.927 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' HG21 ' A' ' 149' ' ' THR . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 146' ' ' ARG . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 56' ' ' LEU . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.918 HG12 HG23 ' A' ' 83' ' ' VAL . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.87 76.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -85.42 23.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 34.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.281 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 60.73 43.2 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.692 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.06 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.852 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.75 -136.4 3.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.608 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -176.19 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -94.38 145.27 24.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 60.28 75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 76.02 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.73 31.05 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.5 m80 59.66 -172.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -116.21 -69.54 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.18 106.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -130.82 107.88 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -132.41 120.1 21.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.38 -143.09 12.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -72.89 -31.55 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 17' ' ' ARG . 21.6 t 63.82 80.02 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.5 -28.77 37.37 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.658 2.239 . . . . 0.0 112.168 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 15' ' ' VAL . 0.6 OUTLIER 60.17 101.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.01 -152.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.412 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 m -130.48 -169.89 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -60.28 -178.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.9 tpp -106.24 -60.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.01 -54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p -131.75 44.13 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 8.3 m-20 -59.3 -60.87 9.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 58.4 Cg_endo -71.78 161.77 44.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.284 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -154.34 79.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -105.2 107.59 18.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 78' ' ' ILE . 1.5 mp -92.78 131.6 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.916 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE2' HG11 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.909 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CB ' HG21 ' A' ' 54' ' ' THR . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 47' ' ' ILE . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 t30 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.719 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 2.7 t-20 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.909 ' H ' HG22 ' A' ' 41' ' ' THR . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.668 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.66 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.686 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.747 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.747 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.793 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.916 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 HD13 ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 114' ' ' LEU . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.697 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.845 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 152' ' ' GLY . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.409 ' HB2' HG11 ' A' ' 57' ' ' VAL . 31.8 t30 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.7 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.908 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.667 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.7 ' OE2' HG22 ' A' ' 128' ' ' VAL . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.729 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HB3' HG22 ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.729 ' CE1' HG11 ' A' ' 118' ' ' VAL . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 96' ' ' THR . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.7 HG22 ' OE2' ' A' ' 115' ' ' GLU . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 80' ' ' LEU . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.793 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' ILE . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.604 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.908 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.686 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.489 HG23 ' HD3' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.708 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 15.7 m120 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.708 HG21 ' CG ' ' A' ' 146' ' ' ARG . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.689 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 151' ' ' LEU . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 87' ' ' MET . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.746 ' HB ' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.634 HG23 HD11 ' A' ' 80' ' ' LEU . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER 70.6 25.78 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm 53.71 87.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp 58.8 37.18 24.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 61.31 62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 45.63 -169.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.877 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.846 0.355 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.44 140.8 4.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -73.12 86.75 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.853 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.56 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -60.35 -64.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -60.49 165.27 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 60.55 171.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -153.72 -179.8 8.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 63.2 122.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 35.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 p 58.14 32.38 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 58.88 78.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.91 -74.53 1.98 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.437 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.46 -169.47 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -64.6 139.36 97.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 -177.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.484 2.123 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 -34.2 15.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.84 -93.75 0.22 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -152.05 80.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.66 31.15 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.2 tpp 59.78 85.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.62 37.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m 66.88 96.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.8 m-20 -57.29 -60.75 8.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HB2' HD11 ' A' ' 28' ' ' ILE . 58.8 Cg_endo -71.81 154.6 58.79 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.462 2.108 . . . . 0.0 112.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -84.88 -74.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 35.7 mtp180 -122.72 146.58 47.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HG22 ' A' ' 78' ' ' ILE . 3.9 mp -133.13 131.39 58.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 30' ' ' ALA . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.607 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.728 ' NH2' HG21 ' A' ' 64' ' ' ILE . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' H ' HG23 ' A' ' 41' ' ' THR . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 56' ' ' LEU . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.77 HG12 HG23 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 10.3 t-20 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.677 HD12 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.737 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.948 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 11.3 p30 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.728 HG21 ' NH2' ' A' ' 36' ' ' ARG . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 143' ' ' THR . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.8 HG22 HD13 ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.849 HD23 HD21 ' A' ' 131' ' ' LEU . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.915 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 125' ' ' ALA . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.816 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.761 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.908 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.726 ' N ' HG23 ' A' ' 96' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.61 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 140' ' ' LEU . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.775 ' OE1' HD13 ' A' ' 141' ' ' ILE . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 114' ' ' LEU . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.658 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.658 ' CZ2' HG22 ' A' ' 105' ' ' THR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 104' ' ' TYR . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.541 ' OE1' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.853 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.853 ' CE1' HG11 ' A' ' 118' ' ' VAL . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.729 ' O ' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.669 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.908 ' HD2' HG21 ' A' ' 96' ' ' THR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.688 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 115' ' ' GLU . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.849 HD21 HD23 ' A' ' 80' ' ' LEU . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 80' ' ' LEU . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.836 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.545 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.549 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.912 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.701 ' HA ' HG13 ' A' ' 66' ' ' VAL . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.677 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.794 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.794 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.948 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 163' ' ' ASP . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 52.1 t30 62.93 49.58 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.98 -162.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 64.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 0.0 110.548 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -147.35 -58.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 158' ' ' VAL . 7.4 t70 61.16 40.82 14.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.796 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.764 ' OG ' HD12 ' A' ' 78' ' ' ILE . 71.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.63 28.45 21.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.53 -177.8 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 p -113.81 134.22 54.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -174.84 166.76 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m170 60.81 111.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -126.75 -58.92 1.3 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.11 -169.4 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -97.97 133.64 42.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -88.54 -74.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m 60.18 80.33 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.32 79.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.78 -149.39 40.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.79 108.63 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.76 139.21 29.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.61 152.49 16.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.389 2.059 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -168.56 35.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -88.83 0.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.533 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.1 m 60.96 169.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 176.21 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -133.5 -64.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 -62.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 -67.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -177.53 81.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.53 -47.34 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.588 2.192 . . . . 0.0 112.279 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 m120 59.03 79.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.017 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -69.5 142.05 53.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 78' ' ' ILE . 14.2 mm -77.75 135.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.708 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.775 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' THR . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' CG2' ' A' ' 54' ' ' THR . 3.9 m120 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.864 ' H ' HG22 ' A' ' 41' ' ' THR . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 1.005 HD12 ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.627 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.816 HG21 HD13 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.775 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.758 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 30.3 m-20 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 80' ' ' LEU . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.753 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.647 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' CG ' HG21 ' A' ' 57' ' ' VAL . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.732 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.7 HG23 ' N ' ' A' ' 97' ' ' MET . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.7 ' N ' HG23 ' A' ' 96' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.62 ' O ' HG21 ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.709 ' HB3' HD12 ' A' ' 114' ' ' LEU . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.668 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.451 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.649 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.864 HD21 HG11 ' A' ' 128' ' ' VAL . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.85 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.717 ' CE1' HG11 ' A' ' 118' ' ' VAL . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.643 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.697 HG21 HD11 ' A' ' 102' ' ' ILE . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.864 HG11 HD21 ' A' ' 114' ' ' LEU . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 80' ' ' LEU . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.807 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' ILE . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.823 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 100' ' ' ALA . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 66' ' ' VAL . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 1.005 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.49 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.578 ' C ' HG22 ' A' ' 156' ' ' ILE . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.591 HG22 ' ND2' ' A' ' 159' ' ' ASN . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 158' ' ' VAL . 12.2 m-80 79.86 -2.32 2.06 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tptp 45.6 33.03 1.28 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.772 0.32 . . . . 0.0 111.078 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.45 34.62 12.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -137.47 -49.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.152 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CA ' ' HB3' ' A' ' 159' ' ' ASN . 0.6 OUTLIER 64.47 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.378 . . . . 0.0 110.975 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tpp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.718 0.294 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.65 -72.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.32 34.04 20.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -101.93 82.94 2.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -70.55 79.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -176.31 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.05 -37.92 87.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -106.54 144.61 32.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.6 -169.59 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -133.44 -179.17 5.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m 60.52 38.25 19.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -59.93 -41.97 92.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -28.21 1.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.552 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 58.44 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.5 t -82.97 -45.62 0.87 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.368 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 74.3 Cg_exo -50.71 96.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.371 2.048 . . . . 0.0 112.372 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -176.64 -65.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.29 47.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.31 122.82 15.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.0 m80 60.63 -176.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.9 mtt -60.17 107.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.04 -48.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -118.96 -48.36 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 62.0 151.62 0.1 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.54 64.04 2.25 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.54 2.16 . . . . 0.0 112.332 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -153.76 -172.76 4.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 60.85 77.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 78' ' ' ILE . 16.4 mm -91.11 133.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 41' ' ' THR . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.951 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 16.8 t-20 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' ' HE ' ' A' ' 154' ' ' ARG . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.951 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.625 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.626 ' H ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.847 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.8 p30 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 143' ' ' THR . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.71 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.728 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.728 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.406 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 79' ' ' THR . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 81' ' ' ASN . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.701 ' N ' HD23 ' A' ' 80' ' ' LEU . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.451 ' N ' HD23 ' A' ' 80' ' ' LEU . 7.9 m120 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 83' ' ' VAL . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 156' ' ' ILE . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.787 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.827 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.827 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.608 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.819 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.875 ' HB3' HD12 ' A' ' 114' ' ' LEU . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.616 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.639 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.875 HD12 ' HB3' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.597 ' N ' HG22 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 120' ' ' TYR . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 HD22 ' A' ' 80' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 136' ' ' ARG . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.883 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.75 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.639 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.856 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.856 HG21 ' HG3' ' A' ' 146' ' ' ARG . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.847 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.787 HG13 ' HB2' ' A' ' 87' ' ' MET . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.412 ' HE ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.885 ' HB ' HG23 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.42 ' ND2' ' HG ' ' A' ' 80' ' ' LEU . 3.2 m-80 64.93 47.02 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 162' ' ' GLU . 21.0 mtmt -62.07 -150.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.391 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -67.35 67.21 0.08 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.894 0.378 . . . . 0.0 110.679 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 160' ' ' LYS . 1.4 mt-10 -174.56 -49.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.76 -69.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.867 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.71 154.51 7.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.85 113.56 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -107.61 100.23 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -160.68 71.49 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 59.35 29.28 18.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -62.23 -28.18 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 7' ' ' HIS . 16.0 m170 -92.58 -178.4 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -175.03 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -101.84 91.75 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 t -162.35 153.42 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -82.07 123.98 29.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.4 -106.06 3.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.53 -68.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.3 m -148.7 79.17 8.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.78 -61.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.596 2.197 . . . . 0.0 112.238 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -108.17 -175.34 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.76 -49.74 0.84 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.469 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.7 m -104.77 140.28 38.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.762 0.315 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -60.31 139.81 57.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.18 123.22 49.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' PRO . . . -155.44 58.15 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t 61.31 30.69 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.964 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.38 67.68 1.8 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 22' ' ' ALA . 59.4 Cg_endo -72.44 -44.52 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.523 2.149 . . . . 0.0 112.296 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -170.38 137.57 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -110.3 -24.01 10.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 78' ' ' ILE . 1.2 mp -55.44 116.3 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.656 HG22 ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 41' ' ' THR . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.619 ' HB2' HD12 ' A' ' 47' ' ' ILE . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.451 ' O ' ' ND2' ' A' ' 50' ' ' ASN . 3.7 p-10 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.63 ' H ' HG22 ' A' ' 41' ' ' THR . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CE1' HD21 ' A' ' 56' ' ' LEU . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 68' ' ' THR . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 143' ' ' THR . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' HG23 ' A' ' 78' ' ' ILE . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 76' ' ' ASN . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 HG11 ' A' ' 135' ' ' VAL . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 158' ' ' VAL . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.796 HG11 HD11 ' A' ' 114' ' ' LEU . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.473 HD21 ' CG ' ' A' ' 84' ' ' GLU . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 95' ' ' ASP . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.794 ' CE ' HD22 ' A' ' 140' ' ' LEU . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.637 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.856 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HA ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.935 HD13 ' CE1' ' A' ' 85' ' ' PHE . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.701 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.599 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 128' ' ' VAL . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.539 ' OE1' HG22 ' A' ' 128' ' ' VAL . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.894 HG11 ' CE1' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.894 ' CE1' HG11 ' A' ' 118' ' ' VAL . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' MET . . . . . 0.716 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 96' ' ' THR . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.666 HG21 ' CZ ' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 HD22 ' A' ' 114' ' ' LEU . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.675 ' CD1' HD23 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.769 HG11 HD22 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' HD12 ' A' ' 33' ' ' ILE . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.794 HD22 ' CE ' ' A' ' 97' ' ' MET . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.856 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.675 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.611 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.611 HG21 ' CG ' ' A' ' 146' ' ' ARG . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' TRP . . . . . 0.56 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 85' ' ' PHE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' ASN . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 59.8 34.19 21.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.13 125.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.071 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 57.29 28.78 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.098 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 43.53 61.21 2.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.05 120.29 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.813 -179.959 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.952 HG13 HG21 ' A' ' 78' ' ' ILE . 47.1 mm . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.96 0.409 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.717 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 41' ' ' THR . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.674 ' HA ' HD12 ' A' ' 56' ' ' LEU . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.769 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.943 ' ND2' HG23 ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 32.5 t30 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.943 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.765 HD21 ' CE1' ' A' ' 58' ' ' TYR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.765 ' CE1' HD21 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.929 HD12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' ILE . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 144' ' ' GLU . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.929 ' HB ' HD12 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.757 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 158' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.952 HG21 HG13 ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.612 HD13 HG11 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 84' ' ' GLU . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 83' ' ' VAL . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.401 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.574 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.632 ' O ' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.545 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.869 HG23 ' HG ' ' A' ' 140' ' ' LEU . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.583 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 128' ' ' VAL . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.667 HG12 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.743 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.707 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.529 HG21 ' OE1' ' A' ' 115' ' ' GLU . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 128' ' ' VAL . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.589 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' HD13 ' A' ' 141' ' ' ILE . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 99' ' ' LYS . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 68' ' ' THR . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.714 HG21 ' NE ' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.648 HG21 ' OH ' ' A' ' 32' ' ' TYR . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.587 HG21 ' OH ' ' A' ' 74' ' ' TYR . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 78' ' ' ILE . 1.3 mp . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.776 0.322 . . . . 7.2300000000000004 110.774 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.25 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.7 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 5.9100000000000001 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.1099999999999994 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HE2' HG11 ' A' ' 153' ' ' VAL . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4100000000000001 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.1299999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.1400000000000006 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.646 ' HD3' HG21 ' A' ' 64' ' ' ILE . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 13.449999999999999 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.41 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 57' ' ' VAL . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.130000000000001 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 14.94 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 14.77 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.31 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.42 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.876 HD13 HD12 ' A' ' 56' ' ' LEU . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.0999999999999996 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.2300000000000004 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.220000000000001 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.65 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 13.98 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.56 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.33 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 151' ' ' LEU . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.16 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.460000000000001 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.584 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.19 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 14.91 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 17.82 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.646 HG21 ' HD3' ' A' ' 36' ' ' ARG . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.050000000000001 112.25 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.380000000000001 112.196 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 9.4700000000000006 113.484 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 8.7599999999999998 111.535 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.3300000000000001 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.667 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 5.4800000000000004 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 3.75 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 3.96 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 8.8000000000000007 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.5099999999999998 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.01 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.75 HG21 ' HB ' ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.4399999999999995 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.08 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 83' ' ' VAL . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 10.9 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.210000000000001 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.881 HG23 HG12 ' A' ' 158' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 6.8499999999999996 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 156' ' ' ILE . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 HD22 ' HB1' ' A' ' 125' ' ' ALA . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.1600000000000001 109.528 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 6.7400000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 7.6500000000000004 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.27 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.449999999999999 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 12.82 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 11.76 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.5099999999999998 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.8600000000000003 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.62 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.657 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.4900000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 5.8399999999999999 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.6199999999999992 109.292 178.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.712 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.1199999999999992 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.15 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 136' ' ' ARG . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.6600000000000001 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 11.609999999999999 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.32 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CD2' ' HB ' ' A' ' 105' ' ' THR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.01 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.630000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.712 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.924 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.579 ' OE2' HG22 ' A' ' 128' ' ' VAL . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 9.9100000000000001 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.774 HG11 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 7.9699999999999998 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.907 ' CE1' HG23 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.3600000000000003 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.597 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 6.7400000000000002 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.556 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 7.75 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 8.7400000000000002 109.445 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.907 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1699999999999999 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.24 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 15.51 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 80' ' ' LEU . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.460000000000001 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 131' ' ' LEU . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.380000000000001 111.083 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 12.81 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.5999999999999996 112.243 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.738 ' O ' HG23 ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.02 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.859 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.0199999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 8.4399999999999995 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.796 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.3900000000000006 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 66' ' ' VAL . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' N ' ' HB3' ' A' ' 98' ' ' GLN . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.6999999999999993 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HG2' HG21 ' A' ' 149' ' ' THR . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.08 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 146' ' ' ARG . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.26 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.543 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 15.23 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 8.9900000000000002 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 8.8000000000000007 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.673 HG11 ' HE2' ' A' ' 32' ' ' TYR . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 13.460000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.1199999999999992 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 85' ' ' PHE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.2999999999999998 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.1799999999999997 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.881 HG12 HG23 ' A' ' 83' ' ' VAL . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.556 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 . . . . . 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' HB3' ' A' ' 74' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.73 0.3 . . . . 0.0 110.515 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.792 HG22 ' HB2' ' A' ' 75' ' ' SER . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.446 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.901 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.649 ' NH2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' H ' HG23 ' A' ' 41' ' ' THR . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HA ' HD12 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 45.5 t30 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.82 HD13 ' CG2' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 41' ' ' THR . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.649 HD13 ' NH2' ' A' ' 36' ' ' ARG . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 144' ' ' GLU . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.836 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.799 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.792 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.658 ' CD2' HD23 ' A' ' 131' ' ' LEU . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 114' ' ' LEU . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.695 ' HB3' HG12 ' A' ' 153' ' ' VAL . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.464 ' OD1' HG21 ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.663 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 121' ' ' THR . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD12 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.688 HD11 HG11 ' A' ' 83' ' ' VAL . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.783 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.794 ' CE1' HG11 ' A' ' 118' ' ' VAL . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.783 HG22 ' CD ' ' A' ' 115' ' ' GLU . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 80' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.799 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.556 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.793 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.836 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 143' ' ' THR . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.864 ' HG3' HG21 ' A' ' 149' ' ' THR . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.864 HG21 ' HG3' ' A' ' 146' ' ' ARG . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.694 ' CD1' HG13 ' A' ' 153' ' ' VAL . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.901 HG11 ' OH ' ' A' ' 32' ' ' TYR . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.543 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 158' ' ' VAL . 3.3 m-80 . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.695 HD13 HG22 ' A' ' 78' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.954 0.407 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 30' ' ' ALA . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.763 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 55' ' ' GLU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 41' ' ' THR . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.58 ' OD1' HG21 ' A' ' 54' ' ' THR . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 56' ' ' LEU . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.921 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.829 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.921 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.804 ' HG2' HG21 ' A' ' 41' ' ' THR . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.999 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 HG12 ' HB1' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 143' ' ' THR . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.866 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.754 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.695 HG22 HD13 ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 4.2 p-10 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.688 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 121' ' ' THR . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.742 ' O ' HG22 ' A' ' 143' ' ' THR . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.841 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 126' ' ' ILE . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.81 ' HB3' HD12 ' A' ' 114' ' ' LEU . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.652 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.412 ' CA ' ' HD3' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.402 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 105' ' ' THR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.851 HG11 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.851 ' CE1' HG11 ' A' ' 118' ' ' VAL . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.688 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 102' ' ' ILE . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 115' ' ' GLU . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 128' ' ' VAL . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 128' ' ' VAL . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.499 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.866 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 102' ' ' ILE . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.596 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.841 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 64' ' ' ILE . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.726 ' HB3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.999 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' SD ' ' A' ' 87' ' ' MET . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.829 ' HB ' HG23 ' A' ' 47' ' ' ILE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.754 HG11 ' OH ' ' A' ' 74' ' ' TYR . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.876 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.231 0.083 0 CA-C-O 121.068 0.461 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.794 HG22 ' HB3' ' A' ' 75' ' ' SER . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.753 ' CD2' HD13 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 2.4 t-20 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.632 ' N ' HG23 ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.554 ' CA ' HD12 ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.753 HD13 ' CD2' ' A' ' 32' ' ' TYR . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 46' ' ' ASN . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.592 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.792 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.758 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.76 HG12 ' CA ' ' A' ' 144' ' ' GLU . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.76 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.76 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.891 HG13 ' CG2' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.794 ' HB3' HG22 ' A' ' 29' ' ' ILE . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.52 HG11 HD11 ' A' ' 114' ' ' LEU . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 102' ' ' ILE . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.712 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.418 ' ND2' HG11 ' A' ' 57' ' ' VAL . 6.3 t-20 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.625 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.518 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.714 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 114' ' ' LEU . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.654 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.802 HD12 ' HB3' ' A' ' 104' ' ' TYR . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HG2' HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 122' ' ' MET . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.614 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 131' ' ' LEU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.891 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.559 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.861 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.76 ' CA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 149' ' ' THR . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 146' ' ' ARG . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.792 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 87' ' ' MET . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.608 HG22 HD22 ' A' ' 159' ' ' ASN . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.608 HD22 HG22 ' A' ' 158' ' ' VAL . 2.1 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.913 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.231 0.079 0 CA-C-O 121.015 0.436 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.711 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.879 ' OH ' HG21 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.3 t-20 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 61' ' ' PRO . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.756 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 41' ' ' THR . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 35.5 m-80 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.721 ' HA ' HD12 ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.909 HG23 HD13 ' A' ' 156' ' ' ILE . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 p30 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.772 ' HB2' ' CG ' ' A' ' 155' ' ' ASP . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.756 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.726 HG22 ' CA ' ' A' ' 144' ' ' GLU . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.782 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.879 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.748 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.604 ' OH ' HG11 ' A' ' 158' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.913 HG22 HD13 ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 79' ' ' THR . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.722 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 102' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 4.7 t-20 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.91 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.728 ' N ' HG23 ' A' ' 96' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.675 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.706 ' HB3' HD12 ' A' ' 114' ' ' LEU . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.639 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.576 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG11 ' A' ' 128' ' ' VAL . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.866 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.85 ' CE1' HG11 ' A' ' 118' ' ' VAL . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 96' ' ' THR . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.605 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.866 HG22 ' OE1' ' A' ' 115' ' ' GLU . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 128' ' ' VAL . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 105' ' ' THR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.886 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.782 HD13 ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.635 ' HA ' HG13 ' A' ' 66' ' ' VAL . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.726 ' CA ' HG22 ' A' ' 66' ' ' VAL . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.657 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.9 HG21 ' HG3' ' A' ' 146' ' ' ARG . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.495 ' CH2' ' HD2' ' A' ' 59' ' ' LYS . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 151' ' ' LEU . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.645 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.772 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.909 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 83' ' ' VAL . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 78' ' ' ILE . 24.5 mm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' A' ' 75' ' ' SER . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.672 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.834 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.955 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.955 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.581 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 64' ' ' ILE . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.542 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 68' ' ' THR . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.834 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.754 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.624 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.625 HD21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.625 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.8 ' CE1' HG21 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 93' ' ' PRO . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.924 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.703 ' N ' HG23 ' A' ' 96' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.616 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.658 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.8 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.419 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.74 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.643 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.874 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.874 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.924 ' HD2' HG21 ' A' ' 96' ' ' THR . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.673 HG21 HD11 ' A' ' 102' ' ' ILE . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 115' ' ' GLU . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 83' ' ' VAL . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD1' HG22 ' A' ' 79' ' ' THR . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.651 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.805 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.542 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.813 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.813 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.543 ' C ' HD13 ' A' ' 151' ' ' LEU . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 32' ' ' TYR . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.624 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.56 ' OD1' HD12 ' A' ' 80' ' ' LEU . 2.0 m-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.872 HD13 HG22 ' A' ' 78' ' ' ILE . 3.5 mp . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.972 0.415 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 30' ' ' ALA . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.698 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' CG ' HG23 ' A' ' 68' ' ' THR . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.626 HG23 ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 41' ' ' THR . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.907 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 32' ' ' TYR . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 11.9 t30 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.907 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 41' ' ' THR . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.467 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.693 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.755 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.533 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.872 HG22 HD13 ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.684 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 114' ' ' LEU . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 156' ' ' ILE . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CE1' HG21 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.636 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.899 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 2.0 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.814 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.687 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.41 ' HA3' ' CD ' ' A' ' 136' ' ' ARG . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.642 ' CZ2' HG22 ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.537 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.896 HD11 HG11 ' A' ' 83' ' ' VAL . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.661 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 115' ' ' GLU . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.504 ' C ' HD23 ' A' ' 133' ' ' LEU . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.864 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.558 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.486 ' C ' HG23 ' A' ' 66' ' ' VAL . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 66' ' ' VAL . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.409 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.84 ' HB3' HG21 ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.836 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 89' ' ' ALA . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 32' ' ' TYR . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 47' ' ' ILE . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.564 ' CG2' HD12 ' A' ' 80' ' ' LEU . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 75' ' ' SER . 9.0 tp . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.822 ' OH ' HG21 ' A' ' 70' ' ' VAL . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.794 ' NH1' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.904 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 t-20 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.904 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.724 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.794 HG23 ' NH1' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 64' ' ' ILE . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.822 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.73 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.818 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' ILE . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.811 HG21 ' CB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.717 ' HA ' HG12 ' A' ' 158' ' ' VAL . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 83' ' ' VAL . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.68 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.758 ' HG2' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 57' ' ' VAL . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.563 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.701 ' CE ' HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.658 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.639 ' CD2' HD13 ' A' ' 114' ' ' LEU . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.662 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.478 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.662 ' CZ2' HG22 ' A' ' 105' ' ' THR . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 131' ' ' LEU . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.658 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.787 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.787 ' CE1' HG11 ' A' ' 118' ' ' VAL . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 102' ' ' ILE . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 128' ' ' VAL . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 127' ' ' LYS . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 114' ' ' LEU . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.658 ' O ' HG23 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.818 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.598 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.701 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.439 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 143' ' ' THR . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m120 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG3' ' A' ' 146' ' ' ARG . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.724 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.711 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.758 HG13 ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.511 ' C ' HG22 ' A' ' 156' ' ' ILE . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 83' ' ' VAL . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 158' ' ' VAL . 22.6 m-80 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' ILE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.701 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 57' ' ' VAL . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.828 ' ND2' HG23 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.828 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.833 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE1' HD21 ' A' ' 56' ' ' LEU . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.428 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.761 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.592 ' OH ' HG21 ' A' ' 158' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.41 ' CB ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.557 ' HB2' HD11 ' A' ' 28' ' ' ILE . 2.3 m120 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.776 HG11 HD11 ' A' ' 114' ' ' LEU . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.763 ' HA ' HG23 ' A' ' 156' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.752 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 140' ' ' LEU . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.684 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.696 ' O ' HG22 ' A' ' 143' ' ' THR . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.716 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.837 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.558 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.871 ' CE1' HG11 ' A' ' 118' ' ' VAL . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.747 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 83' ' ' VAL . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.868 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.837 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.792 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.55 ' H ' HD13 ' A' ' 141' ' ' ILE . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.835 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.752 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.781 ' HB ' HG23 ' A' ' 47' ' ' ILE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.469 HD21 HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.884 HG21 HD13 ' A' ' 78' ' ' ILE . 1.5 tp . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.765 0.317 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.812 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 47' ' ' ILE . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.421 ' NH2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.834 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.839 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.588 HD21 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.839 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD1' HG12 ' A' ' 47' ' ' ILE . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.588 ' C ' HD21 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.634 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.834 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.435 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.607 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 143' ' ' THR . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.88 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 78' ' ' ILE . 4.6 m120 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.884 HD13 HG21 ' A' ' 28' ' ' ILE . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.833 ' CD2' HD23 ' A' ' 131' ' ' LEU . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.739 HG21 HG11 ' A' ' 138' ' ' VAL . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.786 ' HA ' HG23 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' LEU . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.412 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.6 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.67 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.91 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.789 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.894 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.917 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.596 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.618 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.917 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.574 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.642 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.507 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 80' ' ' LEU . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.88 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.894 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.91 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 66' ' ' VAL . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.855 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.855 HG21 ' HG3' ' A' ' 146' ' ' ARG . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 ' OH ' ' A' ' 32' ' ' TYR . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.786 HG23 ' HA ' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.81 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.64 ' OD1' HG22 ' A' ' 158' ' ' VAL . 1.7 m-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.857 HG21 HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.873 0.368 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 75' ' ' SER . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 153' ' ' VAL . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.735 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 41' ' ' THR . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 56' ' ' LEU . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' HG21 ' A' ' 54' ' ' THR . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.616 HG23 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 155' ' ' ASP . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.822 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.735 ' H ' HG22 ' A' ' 41' ' ' THR . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' CE1' HD21 ' A' ' 56' ' ' LEU . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.608 HD21 HG21 ' A' ' 64' ' ' ILE . 0.2 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.626 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.865 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 158' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.687 ' HB2' HG22 ' A' ' 29' ' ' ILE . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.662 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.857 HD13 HG21 ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 79' ' ' THR . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 158' ' ' VAL . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.678 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.54 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.817 ' CE ' HD22 ' A' ' 140' ' ' LEU . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.688 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.625 ' CB ' HD13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.604 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 104' ' ' TYR . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.663 ' OE2' HG21 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.698 ' CE1' HG11 ' A' ' 118' ' ' VAL . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.683 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.678 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 114' ' ' LEU . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' THR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.865 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 140' ' ' LEU . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.464 ' HA ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG2' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG2' ' A' ' 146' ' ' ARG . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.665 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.731 HG21 ' OH ' ' A' ' 32' ' ' TYR . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 83' ' ' VAL . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.414 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 4.9 m120 . . . . . 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 78' ' ' ILE . 3.2 mp . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.981 0.42 . . . . 0.0 110.98 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HD3' HG22 ' A' ' 64' ' ' ILE . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.664 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 41' ' ' THR . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.774 ' ND2' HG23 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.785 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.774 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.701 HD13 ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.528 ' CD2' HG11 ' A' ' 70' ' ' VAL . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.861 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.596 HG13 ' HB1' ' A' ' 145' ' ' ALA . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 143' ' ' THR . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.716 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.717 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.897 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.797 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.797 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.814 ' CE1' HG21 ' A' ' 102' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.774 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.719 ' N ' HG23 ' A' ' 96' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.938 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.773 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.85 HG23 ' HG ' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD13 ' A' ' 141' ' ' ILE . 5.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.768 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.428 HG22 ' HE1' ' A' ' 104' ' ' TYR . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.641 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.799 ' OE2' HG13 ' A' ' 128' ' ' VAL . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.945 ' HD2' HG21 ' A' ' 96' ' ' THR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' OE2' ' A' ' 115' ' ' GLU . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.725 HD22 HG11 ' A' ' 128' ' ' VAL . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 80' ' ' LEU . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.897 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.85 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.938 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.596 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.596 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD13 ' A' ' 56' ' ' LEU . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.785 ' HB ' HG23 ' A' ' 47' ' ' ILE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 78' ' ' ILE . 3.1 mp . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.868 0.366 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.645 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.2 t-20 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.419 ' NE ' ' HG3' ' A' ' 61' ' ' PRO . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 41' ' ' THR . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.846 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.896 ' CG1' HG23 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB1' HH11 ' A' ' 154' ' ' ARG . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.846 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.632 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.76 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 56' ' ' LEU . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.994 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.545 HG23 ' OG1' ' A' ' 68' ' ' THR . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 144' ' ' GLU . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 141' ' ' ILE . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.731 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.731 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' HG11 ' A' ' 158' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.855 HG22 HD13 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 79' ' ' THR . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 135' ' ' VAL . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 84' ' ' GLU . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.831 ' HD1' HD12 ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' HG21 ' A' ' 57' ' ' VAL . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.645 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.903 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.55 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' A' ' 141' ' ' ILE . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.537 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.781 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.419 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.653 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 104' ' ' TYR . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.813 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.721 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.436 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.683 HD21 HD23 ' A' ' 80' ' ' LEU . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.711 ' C ' HD23 ' A' ' 133' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.882 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.842 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.561 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.903 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 64' ' ' ILE . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.903 ' HB3' HG21 ' A' ' 149' ' ' THR . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.994 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.509 HH11 ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.896 HG23 ' CG1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 80' ' ' LEU . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 158' ' ' VAL . 5.5 m120 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.935 ' CG2' HD13 ' A' ' 78' ' ' ILE . 3.8 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.73 0.3 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 75' ' ' SER . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' THR . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' LEU . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.82 ' ND2' HG23 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.805 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.82 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.791 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.575 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.741 ' OD1' HG23 ' A' ' 66' ' ' VAL . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.741 HG23 ' OD1' ' A' ' 65' ' ' ASP . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 141' ' ' ILE . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.648 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 78' ' ' ILE . 1.5 m120 -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.935 HD13 ' CG2' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 114' ' ' LEU . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.977 ' CE1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 95' ' ' ASP . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.507 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.828 ' CE ' HD22 ' A' ' 140' ' ' LEU . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.602 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.977 HD13 ' CE1' ' A' ' 85' ' ' PHE . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.441 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.554 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.856 HD11 HG11 ' A' ' 83' ' ' VAL . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CD2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.663 ' CG2' ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.6 ' CD2' HG12 ' A' ' 83' ' ' VAL . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.593 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.769 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.828 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 66' ' ' VAL . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.893 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.893 HG21 ' HG3' ' A' ' 146' ' ' ARG . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.791 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.805 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 158' ' ' VAL . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 158' ' ' VAL . 16.8 p30 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 78' ' ' ILE . 22.9 mm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.9 0.381 . . . . 0.0 111.201 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.785 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' OH ' HG21 ' A' ' 70' ' ' VAL . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 HH12 HG23 ' A' ' 68' ' ' THR . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.862 HG21 HG22 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB2' HG21 ' A' ' 54' ' ' THR . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.742 ' CG ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.539 HG13 HG23 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 m120 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 54' ' ' THR . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.742 HG23 ' CG ' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.927 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 144' ' ' GLU . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.569 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.729 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.729 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.835 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.78 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 29' ' ' ILE . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.484 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.481 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.918 HG23 HG12 ' A' ' 158' ' ' VAL . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 83' ' ' VAL . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' A' ' 125' ' ' ALA . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.682 ' CE ' HD22 ' A' ' 140' ' ' LEU . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.616 ' OE1' HD13 ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.623 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.828 HD21 HG11 ' A' ' 128' ' ' VAL . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.863 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.606 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.863 HG22 ' OE1' ' A' ' 115' ' ' GLU . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 105' ' ' THR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.835 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.582 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.682 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' HG13 ' A' ' 66' ' ' VAL . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.927 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' HG21 ' A' ' 149' ' ' THR . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 146' ' ' ARG . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.409 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 56' ' ' LEU . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.918 HG12 HG23 ' A' ' 83' ' ' VAL . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 78' ' ' ILE . 1.5 mp . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.021 0.438 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.916 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE2' HG11 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.909 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CB ' HG21 ' A' ' 54' ' ' THR . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 47' ' ' ILE . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.447 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.746 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.719 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 56.2 t30 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' ND2' ' A' ' 51' ' ' ASN . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.909 ' H ' HG22 ' A' ' 41' ' ' THR . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.668 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.66 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.686 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.747 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.747 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.793 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.916 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 HD13 ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 114' ' ' LEU . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.697 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.845 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 152' ' ' GLY . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.409 ' HB2' HG11 ' A' ' 57' ' ' VAL . 4.6 t-20 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.7 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.908 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.667 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.7 ' OE2' HG22 ' A' ' 128' ' ' VAL . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.729 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HB3' HG22 ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.729 ' CE1' HG11 ' A' ' 118' ' ' VAL . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 96' ' ' THR . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.7 HG22 ' OE2' ' A' ' 115' ' ' GLU . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 80' ' ' LEU . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.793 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' ILE . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.604 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.908 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.686 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.489 HG23 ' HD3' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.708 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.8 m-80 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.708 HG21 ' CG ' ' A' ' 146' ' ' ARG . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.689 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 151' ' ' LEU . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 87' ' ' MET . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.746 ' HB ' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.634 HG23 HD11 ' A' ' 80' ' ' LEU . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HG22 ' A' ' 78' ' ' ILE . 3.9 mp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 30' ' ' ALA . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.607 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.728 ' NH2' HG21 ' A' ' 64' ' ' ILE . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' H ' HG23 ' A' ' 41' ' ' THR . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 56' ' ' LEU . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.77 HG12 HG23 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 43.7 t30 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.677 HD12 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.737 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.948 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 2.3 p-10 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.728 HG21 ' NH2' ' A' ' 36' ' ' ARG . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 143' ' ' THR . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.8 HG22 HD13 ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.849 HD23 HD21 ' A' ' 131' ' ' LEU . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.915 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 125' ' ' ALA . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.816 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.761 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.908 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.726 ' N ' HG23 ' A' ' 96' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.61 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 140' ' ' LEU . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.775 ' OE1' HD13 ' A' ' 141' ' ' ILE . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 114' ' ' LEU . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.658 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.658 ' CZ2' HG22 ' A' ' 105' ' ' THR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 104' ' ' TYR . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.541 ' OE1' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.853 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.853 ' CE1' HG11 ' A' ' 118' ' ' VAL . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.729 ' O ' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.669 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.908 ' HD2' HG21 ' A' ' 96' ' ' THR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.688 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 115' ' ' GLU . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.849 HD21 HD23 ' A' ' 80' ' ' LEU . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 80' ' ' LEU . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.836 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.545 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.549 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.912 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.701 ' HA ' HG13 ' A' ' 66' ' ' VAL . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.677 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.794 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.794 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.948 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 81' ' ' ASN . 8.3 t-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 78' ' ' ILE . 14.2 mm . . . . . 0 C--O 1.232 0.18 0 CA-C-O 121.012 0.434 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.708 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.775 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' THR . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' CG2' ' A' ' 54' ' ' THR . 11.9 m-80 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.864 ' H ' HG22 ' A' ' 41' ' ' THR . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 1.005 HD12 ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.627 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.816 HG21 HD13 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.775 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.758 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.0 m120 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 80' ' ' LEU . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.753 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.647 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.504 ' CG ' HG21 ' A' ' 57' ' ' VAL . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.732 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.7 HG23 ' N ' ' A' ' 97' ' ' MET . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.7 ' N ' HG23 ' A' ' 96' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.62 ' O ' HG21 ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.709 ' HB3' HD12 ' A' ' 114' ' ' LEU . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.668 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.451 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.649 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.864 HD21 HG11 ' A' ' 128' ' ' VAL . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.85 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.717 ' CE1' HG11 ' A' ' 118' ' ' VAL . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.643 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.697 HG21 HD11 ' A' ' 102' ' ' ILE . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.864 HG11 HD21 ' A' ' 114' ' ' LEU . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 80' ' ' LEU . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.807 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' ILE . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.823 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 100' ' ' ALA . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 66' ' ' VAL . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 1.005 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.49 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.578 ' C ' HG22 ' A' ' 156' ' ' ILE . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.591 HG22 ' ND2' ' A' ' 159' ' ' ASN . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 158' ' ' VAL . 12.2 m-80 . . . . . 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 78' ' ' ILE . 16.4 mm . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.836 0.35 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 41' ' ' THR . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.951 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 48.1 t30 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' ' HE ' ' A' ' 154' ' ' ARG . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.951 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.625 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.626 ' H ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.847 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 8.2 p-10 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 143' ' ' THR . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.71 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.728 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.728 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.406 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 79' ' ' THR . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 81' ' ' ASN . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.701 ' N ' HD23 ' A' ' 80' ' ' LEU . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.451 ' N ' HD23 ' A' ' 80' ' ' LEU . 36.8 m-20 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 83' ' ' VAL . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 156' ' ' ILE . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.787 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.827 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.45 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.827 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.608 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.819 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.875 ' HB3' HD12 ' A' ' 114' ' ' LEU . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.616 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.639 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.875 HD12 ' HB3' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.597 ' N ' HG22 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 120' ' ' TYR . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 HD22 ' A' ' 80' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 136' ' ' ARG . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.883 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.75 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.639 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.856 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.856 HG21 ' HG3' ' A' ' 146' ' ' ARG . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.847 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.787 HG13 ' HB2' ' A' ' 87' ' ' MET . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.412 ' HE ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.885 ' HB ' HG23 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.405 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.42 ' ND2' ' HG ' ' A' ' 80' ' ' LEU . 3.2 m-80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 78' ' ' ILE . 1.2 mp . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.656 HG22 ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.539 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 41' ' ' THR . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.619 ' HB2' HD12 ' A' ' 47' ' ' ILE . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 p30 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.63 ' H ' HG22 ' A' ' 41' ' ' THR . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CE1' HD21 ' A' ' 56' ' ' LEU . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 68' ' ' THR . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 143' ' ' THR . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' HG23 ' A' ' 78' ' ' ILE . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 76' ' ' ASN . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 HG11 ' A' ' 135' ' ' VAL . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 158' ' ' VAL . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.796 HG11 HD11 ' A' ' 114' ' ' LEU . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.473 HD21 ' CG ' ' A' ' 84' ' ' GLU . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 95' ' ' ASP . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.794 ' CE ' HD22 ' A' ' 140' ' ' LEU . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.637 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.856 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HA ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.935 HD13 ' CE1' ' A' ' 85' ' ' PHE . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.701 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.599 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 128' ' ' VAL . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.539 ' OE1' HG22 ' A' ' 128' ' ' VAL . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.894 HG11 ' CE1' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.894 ' CE1' HG11 ' A' ' 118' ' ' VAL . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' MET . . . . . 0.716 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 96' ' ' THR . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.666 HG21 ' CZ ' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 HD22 ' A' ' 114' ' ' LEU . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.675 ' CD1' HD23 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.769 HG11 HD22 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' HD12 ' A' ' 33' ' ' ILE . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.794 HD22 ' CE ' ' A' ' 97' ' ' MET . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.856 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.675 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.611 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.611 HG21 ' CG ' ' A' ' 146' ' ' ARG . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' TRP . . . . . 0.56 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 85' ' ' PHE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' ASN . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.813 0.339 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.46 118.43 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.9 t -73.44 -69.0 0.45 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 84.5 p -83.2 178.88 7.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.4 160.23 9.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.57 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.853 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.413 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 10.9 m170 60.98 36.31 18.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m80 60.69 168.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -88.35 104.02 16.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.8 m170 64.17 -78.76 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.2 t -139.88 -67.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.827 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -66.04 146.39 54.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.09 -129.91 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.568 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp 60.08 -177.82 0.1 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.942 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.5 m -122.95 77.12 50.12 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.64 -29.05 39.69 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.588 2.192 . . . . 0.0 112.256 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 68.39 -69.57 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.981 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.76 -155.45 10.47 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.52 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.8 m -98.6 35.91 1.74 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.814 0.34 . . . . 0.0 110.9 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t60 66.15 -72.45 0.08 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.041 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.4 mtt 58.68 96.84 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.931 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.64 -75.5 0.12 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.041 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -109.04 78.67 1.15 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.8 p30 -59.18 109.54 1.98 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.29 -38.53 8.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.413 2.075 . . . . 0.0 112.347 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 60.19 32.1 20.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttt-85 -127.07 129.58 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.952 HG13 HG21 ' A' ' 78' ' ' ILE . 47.1 mm -114.97 127.03 72.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.045 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.777 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.05 159.26 3.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.268 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -130.9 98.56 4.64 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.794 0.33 . . . . 0.0 111.34 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.61 142.97 28.72 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.016 179.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.717 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.0 t80 -80.92 133.28 35.51 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.23 0.538 . . . . 0.0 111.539 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.561 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -108.74 164.18 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.474 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.551 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 2.1 p -178.0 129.54 0.14 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.674 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.3 t-20 -63.55 -19.59 64.93 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -96.37 112.38 24.14 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.05 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -67.75 73.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.256 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 3.0 p-10 -120.93 178.55 4.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -115.21 144.58 32.48 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.587 179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -57.46 120.01 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.077 1.852 . . . . 0.0 111.872 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.5 t -40.47 -50.99 2.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.727 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 41' ' ' THR . . . -129.77 -79.55 0.22 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.275 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -143.8 118.7 6.14 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.698 0.285 . . . . 0.0 110.642 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.674 ' HA ' HD12 ' A' ' 56' ' ' LEU . 69.9 Cg_endo -76.47 -0.8 10.81 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.769 ' HB2' HG21 ' A' ' 54' ' ' THR . 3.4 m-20 -38.65 -31.91 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.943 ' ND2' HG23 ' A' ' 54' ' ' THR . 27.6 m-80 -50.42 -26.84 5.46 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.47 0.652 . . . . 0.0 110.171 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.687 HG23 HG12 ' A' ' 156' ' ' ILE . 2.2 mp -101.55 -50.1 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.09 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CE1' ' HB2' ' A' ' 32' ' ' TYR . 16.3 m-30 -65.38 -25.92 67.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.058 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.21 -21.02 8.98 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 32.5 t30 63.67 63.04 0.88 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.951 0.405 . . . . 0.0 110.842 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 20.4 p30 -120.11 -36.98 3.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 51' ' ' ASN . . . 69.18 37.73 2.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.336 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.46 -35.8 5.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.729 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.943 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -86.22 171.66 11.11 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.366 179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -103.04 158.28 16.41 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.878 0.371 . . . . 0.0 111.333 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.765 HD21 ' CE1' ' A' ' 58' ' ' TYR . 2.4 tt -163.87 121.23 1.77 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.8 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 2.6 m -154.32 126.57 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.942 0.401 . . . . 0.0 111.445 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.765 ' CE1' HD21 ' A' ' 56' ' ' LEU . 11.4 m-30 -93.86 141.57 28.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.03 -26.09 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -176.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.601 ' C ' ' O ' ' A' ' 59' ' ' LYS . 2.7 t30 -10.01 -67.73 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.691 0 CA-C-N 117.726 0.239 . . . . 0.0 110.986 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 60.7 Cg_endo -83.88 110.26 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.122 1.881 . . . . 0.0 110.873 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -84.25 51.61 2.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.836 0.351 . . . . 0.0 111.009 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptt-85 171.23 122.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.598 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.929 HD12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -158.02 132.42 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.828 0.347 . . . . 0.0 111.201 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.82 ' N ' HD13 ' A' ' 64' ' ' ILE . 1.7 p30 -118.9 116.38 26.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.742 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG22 ' HA ' ' A' ' 144' ' ' GLU . 26.4 t 60.91 137.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.421 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.428 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 96.61 -19.82 53.09 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.111 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.929 ' HB ' HD12 ' A' ' 64' ' ' ILE . 0.5 OUTLIER -62.56 114.67 3.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.675 0.274 . . . . 0.0 110.797 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -163.37 163.8 24.94 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.08 -177.61 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.622 178.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.757 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.7 -116.41 0.71 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.5 p -172.48 120.6 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-O 121.307 0.575 . . . . 0.0 111.96 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.6 tttp -89.98 154.8 19.56 Favored 'General case' 0 C--N 1.331 -0.229 0 O-C-N 122.029 -0.419 . . . . 0.0 111.513 -179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.587 ' OH ' HG21 ' A' ' 158' ' ' VAL . 7.5 m-30 -101.03 -172.46 2.18 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -94.87 -28.02 15.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.451 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.615 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.0 m-80 -167.6 165.99 8.16 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.201 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.71 119.94 7.46 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.464 2.109 . . . . 0.0 111.522 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.952 HG21 HG13 ' A' ' 28' ' ' ILE . 9.1 pt -128.77 -170.43 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.531 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 3.6 m -105.58 96.3 6.41 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.811 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.612 HD13 HG11 ' A' ' 135' ' ' VAL . 6.9 tt -84.79 151.86 24.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.429 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -35.66 5.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.483 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 0.2 OUTLIER 176.43 130.04 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.344 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.444 HG22 ' N ' ' A' ' 84' ' ' GLU . 7.0 p -106.17 155.58 7.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.959 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.444 ' N ' HG22 ' A' ' 83' ' ' VAL . 23.0 mt-10 -151.46 105.83 3.22 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.829 -0.349 . . . . 0.0 111.817 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 47.5 m-85 -86.9 100.12 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mt -87.86 87.75 7.45 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -142.76 158.44 43.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.778 -179.043 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -135.54 -98.18 0.55 Allowed Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.913 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.04 156.31 44.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.784 0.326 . . . . 0.0 110.899 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.401 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 22.4 t30 -66.43 -68.86 0.34 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.938 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.2 -61.62 1.42 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.956 0.408 . . . . 0.0 111.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.453 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 20.9 t-20 -93.83 122.13 62.86 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.916 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.6 Cg_endo -47.8 -19.25 1.33 Allowed 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.793 2.329 . . . . 0.0 112.983 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -89.05 26.27 1.62 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.29 96.17 5.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.687 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -176.16 -164.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.139 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.622 ' HE3' ' HA ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -40.4 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.378 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.574 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.29 -42.02 7.19 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 177.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.632 ' O ' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -176.05 122.25 0.18 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.171 -1.377 . . . . 0.0 108.663 177.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 172.64 167.04 0.12 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.545 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.2 -176.16 3.0 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.869 HG23 ' HG ' ' A' ' 140' ' ' LEU . 2.7 mt -92.54 162.53 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 118.279 0.491 . . . . 0.0 110.911 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.468 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.0 OUTLIER -128.5 177.45 6.99 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.274 0.559 . . . . 0.0 111.921 -178.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.618 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.7 p90 -175.65 132.53 0.27 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.195 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.583 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.8 t -92.25 141.41 28.59 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -91.24 -57.82 4.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 38.8 t70 -95.08 31.15 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.818 0.342 . . . . 0.0 111.168 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 52.3 37.22 47.28 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.408 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -138.97 -73.39 0.39 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.867 0.365 . . . . 0.0 110.873 -179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -89.34 158.34 17.83 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.566 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 47.6 m95 -125.31 124.62 42.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.509 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.49 163.14 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.985 0.421 . . . . 0.0 111.901 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -45.83 153.58 0.28 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.512 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.618 HD12 ' HB3' ' A' ' 104' ' ' TYR . 6.6 tt -128.6 -65.44 0.88 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.397 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.529 ' OE1' HG21 ' A' ' 128' ' ' VAL . 2.7 tp10 -99.64 161.5 13.57 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.0 tp10 -44.29 166.59 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.851 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.46 51.24 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.598 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.667 HG12 ' CD1' ' A' ' 120' ' ' TYR . 2.2 t -79.42 162.99 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-O 121.223 0.535 . . . . 0.0 109.759 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.574 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -105.53 87.67 2.66 Favored 'General case' 0 N--CA 1.432 -1.349 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.017 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.743 ' C ' ' HD3' ' A' ' 123' ' ' PRO . 3.2 m-85 -70.53 32.64 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.581 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -89.27 -19.53 25.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 177.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.707 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 1.7 mmt -129.25 36.91 0.36 Allowed Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.575 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.743 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 86.5 Cg_endo -85.09 130.2 4.02 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.828 2.352 . . . . 0.0 111.533 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -95.92 -45.12 2.94 Favored Glycine 0 CA--C 1.508 -0.363 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.05 115.74 9.15 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-N 114.984 -0.608 . . . . 0.0 109.51 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.609 HD12 ' HB2' ' A' ' 85' ' ' PHE . 3.2 mt -92.44 130.45 41.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.241 0.543 . . . . 0.0 111.927 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -159.13 138.19 11.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.327 -0.851 . . . . 0.0 111.092 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.529 HG21 ' OE1' ' A' ' 115' ' ' GLU . 18.8 t -130.8 155.9 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.596 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' N ' HG12 ' A' ' 128' ' ' VAL . 3.2 mm-40 -131.27 -176.97 4.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.896 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 9.8 p30 43.72 31.2 0.44 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.07 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 22.1 tp -101.55 32.81 3.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.956 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -61.05 89.11 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.906 0.384 . . . . 0.0 110.004 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.5 tp -156.26 130.16 8.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.687 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 35.7 mttt -54.52 139.96 36.11 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG11 HD13 ' A' ' 80' ' ' LEU . 2.9 p -153.3 158.77 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 120.071 -0.652 . . . . 0.0 112.066 -178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.491 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -111.37 127.29 55.61 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.531 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.39 -171.71 0.06 OUTLIER Glycine 0 C--N 1.314 -0.657 0 C-N-CA 120.405 -0.903 . . . . 0.0 113.194 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.88 146.43 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.589 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 22.8 ttp180 -174.12 156.61 2.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.243 0.544 . . . . 0.0 112.173 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.869 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -90.6 159.35 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.507 178.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -130.54 118.37 42.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.295 -179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.52 ' N ' HD13 ' A' ' 141' ' ' ILE . . . -89.64 149.56 22.75 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 120.896 0.379 . . . . 0.0 111.248 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 99' ' ' LYS . 7.0 t -117.9 -7.44 10.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.269 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.432 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -178.52 63.19 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.772 0.32 . . . . 0.0 110.897 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.515 ' HB2' ' CG2' ' A' ' 68' ' ' THR . . . -51.53 178.83 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.292 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.714 ' NE ' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -118.62 158.88 24.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 0.0 111.228 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.58 160.77 22.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.808 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 46.26 60.86 3.01 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.141 0.496 . . . . 0.0 110.632 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.714 HG21 ' NE ' ' A' ' 146' ' ' ARG . 13.8 t -140.86 155.61 46.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.267 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.0 m0 -117.02 -175.27 2.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.585 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.469 HD13 ' C ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER -133.8 99.06 4.34 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.775 0.321 . . . . 0.0 110.394 179.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -82.68 125.29 6.89 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.512 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.648 HG21 ' OH ' ' A' ' 32' ' ' TYR . 7.7 t -122.18 135.72 61.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.742 0.306 . . . . 0.0 110.758 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -110.28 -44.26 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.365 -179.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.4 t70 179.01 129.69 0.07 Allowed 'General case' 0 N--CA 1.461 0.125 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.763 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -135.09 127.09 47.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 178.295 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -140.42 154.76 46.78 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.645 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.587 HG21 ' OH ' ' A' ' 74' ' ' TYR . 12.0 p -113.82 126.65 71.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.65 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 66.9 34.63 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.627 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.84 91.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.165 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 18.5 mtmm 54.86 29.12 11.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.127 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -72.87 0.71 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.874 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 59.24 31.93 21.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.964 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 22.5 p . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.92 -179.943 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' HA ' ' HA ' ' A' ' 7' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 111.969 0.359 . . . . 25.010000000000002 111.969 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -89.96 51.16 3.47 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 120.899 -0.667 . . . . 22.800000000000001 112.298 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.8 m -146.94 -148.97 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 110.407 -0.22 . . . . 22.379999999999999 110.407 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 80.4 p -65.82 173.69 2.77 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.817 0.341 . . . . 20.800000000000001 111.418 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 m80 71.64 -86.87 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.908 -0.587 . . . . 19.18 111.198 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -176.38 -58.24 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.476 0.179 . . . . 19.379999999999999 111.135 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -134.25 -175.89 4.02 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.399 -0.364 . . . . 17.09 111.256 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -54.73 -57.04 13.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.287 -0.415 . . . . 17.260000000000002 111.191 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 67.69 -77.55 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.197 -0.456 . . . . 16.16 110.976 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 14' ' ' LEU . 73.5 m-70 -138.5 36.72 2.25 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.781 0.324 . . . . 14.81 110.658 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.8 t -104.69 116.22 31.67 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.234 -0.439 . . . . 14.09 110.795 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.8 m 56.13 60.47 3.19 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.067 -0.515 . . . . 13.210000000000001 111.141 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 158.81 -62.65 0.31 Allowed Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.83 -0.7 . . . . 12.49 112.713 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 2.4 mp 64.3 177.85 0.18 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 120.83 0.348 . . . . 12.779999999999999 111.25 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 15' ' ' VAL . 7.1 p -132.2 109.26 13.83 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.31 -0.405 . . . . 11.33 111.31 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.12 107.88 1.43 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.767 2.312 . . . . 11.08 111.876 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 9.3 ttm105 -135.71 70.69 1.43 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.188 -0.46 . . . . 10.880000000000001 110.975 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.46 49.06 82.59 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.139 -0.553 . . . . 8.8200000000000003 112.753 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.92 135.81 22.3 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.476 0.179 . . . . 9.8100000000000005 110.995 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 25.5 p80 43.16 -151.77 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.05 -0.523 . . . . 10.43 111.464 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.403 ' HG3' ' H ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER 71.58 164.42 0.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 122.411 0.285 . . . . 8.4399999999999995 111.19 -179.566 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.79 93.24 4.39 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 112.037 0.384 . . . . 7.8099999999999996 112.037 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 55.4 m 52.89 37.16 23.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.999 -0.546 . . . . 8.9399999999999995 111.609 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.403 ' H ' ' HG3' ' A' ' 21' ' ' MET . 16.3 t70 63.35 109.52 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.886 -0.597 . . . . 8.7799999999999994 111.432 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.55 140.98 75.13 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.725 2.284 . . . . 7.2599999999999998 112.214 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -69.25 -79.94 0.05 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.148 -0.478 . . . . 9.4700000000000006 111.08 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 mmm-85 51.08 38.03 19.63 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.94 0.4 . . . . 10.06 111.528 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 78' ' ' ILE . 1.3 mp -72.98 128.87 36.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.263 -0.426 . . . . 7.2300000000000004 110.774 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 74' ' ' TYR . 2.1 mp -81.98 144.53 10.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 8.25 110.545 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.7 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -114.69 97.74 6.45 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.082 -0.508 . . . . 5.9100000000000001 110.876 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -84.88 120.63 26.69 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 120.961 0.41 . . . . 8.1099999999999994 110.397 179.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' HE2' HG11 ' A' ' 153' ' ' VAL . 2.2 t80 -51.71 140.39 19.04 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 113.247 0.832 . . . . 7.4100000000000001 113.247 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.508 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -131.9 162.49 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 115.477 -0.783 . . . . 7.1299999999999999 111.289 178.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 77.7 p -172.52 149.05 2.07 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.934 0.397 . . . . 9.1400000000000006 111.84 178.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' HB2' ' CE1' ' A' ' 69' ' ' TYR . 13.0 t-20 -64.06 -34.39 77.93 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.674 -0.694 . . . . 11.0 110.155 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.646 ' HD3' HG21 ' A' ' 64' ' ' ILE . 4.9 mmm-85 -76.8 141.98 40.51 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.875 -0.602 . . . . 11.550000000000001 111.123 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -92.7 65.4 4.27 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.119 0.485 . . . . 15.84 110.728 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -128.8 135.67 49.47 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.765 -0.652 . . . . 13.449999999999999 110.794 -179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.11 155.24 77.35 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 115.987 -0.551 . . . . 14.41 111.025 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 44' ' ' PRO . 32.7 Cg_endo -63.39 127.57 20.33 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.652 2.235 . . . . 13.83 112.149 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.577 ' HB ' HG22 ' A' ' 57' ' ' VAL . 5.8 t -47.21 -47.16 24.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.173 -0.467 . . . . 15.130000000000001 111.094 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.95 -76.8 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.585 -0.606 . . . . 14.94 111.585 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 19.2 t30 -159.11 135.39 6.37 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.583 0.23 . . . . 14.77 111.044 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.509 ' HG3' ' HG3' ' A' ' 40' ' ' PRO . 3.0 Cg_exo -75.61 0.4 9.19 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.118 2.546 . . . . 11.31 112.519 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -37.48 -45.09 0.7 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 122.814 0.446 . . . . 12.380000000000001 112.11 -179.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.582 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -51.68 -42.63 62.31 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.058 0.456 . . . . 11.42 110.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.876 HD13 HD12 ' A' ' 56' ' ' LEU . 2.8 mp -85.57 -28.76 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.72 -0.673 . . . . 8.0999999999999996 111.404 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 4.9 m-30 -54.6 -52.62 61.61 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 112.174 0.435 . . . . 9.2300000000000004 112.174 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -140.29 31.65 1.93 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.103 0.409 . . . . 10.279999999999999 112.103 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.95 97.77 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.974 0.416 . . . . 10.74 111.867 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 39.6 t30 -173.37 83.47 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.871 -0.604 . . . . 13.220000000000001 110.182 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -68.22 63.59 0.09 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.889 0.699 . . . . 13.42 112.889 -178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 72.2 m -115.12 -40.86 3.4 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.387 -0.37 . . . . 15.65 111.149 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.582 HG23 ' ND2' ' A' ' 46' ' ' ASN . 7.0 t -85.02 176.45 8.42 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.941 -0.572 . . . . 13.98 110.466 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -106.37 157.05 17.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.218 -0.446 . . . . 15.32 110.656 -179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.876 HD12 HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -161.87 123.1 2.72 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 116.341 -0.39 . . . . 11.56 111.242 -179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.577 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.0 m -154.05 133.24 3.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-O 120.959 0.409 . . . . 12.33 111.065 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 151' ' ' LEU . 13.6 m-30 -104.05 130.81 51.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.926 -0.579 . . . . 11.16 109.982 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.543 ' HG2' ' CD2' ' A' ' 150' ' ' TRP . 3.3 mtmm -133.8 -59.72 0.84 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.798 0.666 . . . . 15.460000000000001 112.798 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.584 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 26.1 t30 26.99 -91.19 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.855 0.722 . . . . 15.19 111.302 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.584 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 54.4 Cg_endo -84.97 113.33 1.53 Allowed 'Trans proline' 0 C--N 1.364 1.381 0 CA-C-N 121.108 1.431 . . . . 14.91 111.103 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 9.6 p-10 -79.22 54.7 1.71 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.412 0.625 . . . . 15.619999999999999 110.671 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 0.0 OUTLIER 171.02 123.22 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 17.82 109.555 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.646 HG21 ' HD3' ' A' ' 36' ' ' ARG . 1.6 pp -153.23 148.55 13.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 121.122 0.487 . . . . 12.050000000000001 112.25 -179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -114.08 178.66 4.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.469 -0.787 . . . . 13.17 110.392 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.0 t -30.31 106.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 122.845 0.458 . . . . 11.380000000000001 112.196 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.562 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 149.61 -28.98 1.18 Allowed Glycine 0 C--N 1.335 0.525 0 C-N-CA 121.073 -0.584 . . . . 9.4700000000000006 113.484 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -66.09 126.12 27.64 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.868 0.334 . . . . 8.7599999999999998 111.535 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 35' ' ' ASN . 1.2 p90 -163.41 170.42 17.49 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.237 -0.438 . . . . 9.3300000000000001 111.764 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.667 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.4 m -144.73 175.58 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.15 0 CA-C-O 121.337 0.589 . . . . 5.4800000000000004 111.312 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 139' ' ' ARG . . . 177.6 -132.05 1.91 Allowed Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.119 -0.946 . . . . 3.75 111.23 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -173.25 117.9 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 121.062 0.458 . . . . 3.96 111.207 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 7.2 tmtt? -86.93 140.93 29.12 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 122.123 -0.361 . . . . 8.8000000000000007 111.873 -178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.609 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 3.9 m-30 -101.35 154.96 18.34 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.19 -0.459 . . . . 6.7999999999999998 111.383 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.2 p -64.68 -40.04 94.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.9 -0.591 . . . . 8.3699999999999992 110.513 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -145.4 155.92 53.63 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 116.111 -0.495 . . . . 9.5099999999999998 110.71 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.64 119.94 7.18 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.606 2.204 . . . . 10.01 112.045 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.75 HG21 ' HB ' ' A' ' 28' ' ' ILE . 30.0 pt -119.3 145.52 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-N 116.197 -0.456 . . . . 8.4399999999999995 111.457 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 29.6 m -63.42 95.48 0.1 Allowed 'General case' 0 C--O 1.231 0.102 0 N-CA-C 109.895 -0.409 . . . . 11.08 109.895 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.472 HD11 ' HB ' ' A' ' 83' ' ' VAL . 6.1 tt -90.02 126.33 35.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.867 -0.606 . . . . 9.5800000000000001 111.349 -178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.556 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 4.5 p-10 -85.12 -33.35 22.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.114 -0.494 . . . . 10.9 110.617 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.7 131.05 0.69 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.406 -0.361 . . . . 10.210000000000001 111.165 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.881 HG23 HG12 ' A' ' 158' ' ' VAL . 7.3 p -104.76 132.78 50.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 CA-C-N 116.077 -0.51 . . . . 6.8499999999999996 110.257 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 3.9 pt-20 -139.14 114.62 9.79 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 112.112 0.412 . . . . 8.7100000000000009 112.112 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.719 ' HD2' HD13 ' A' ' 156' ' ' ILE . 5.1 m-85 -96.85 98.31 10.01 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.941 -0.392 . . . . 4.7999999999999998 109.941 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD22 ' HB1' ' A' ' 125' ' ' ALA . 14.1 mt -82.78 87.65 6.78 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.528 -0.545 . . . . 9.1600000000000001 109.528 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.85 ' SD ' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -142.92 119.24 10.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.343 -0.39 . . . . 6.7400000000000002 111.974 -178.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.03 -97.71 2.11 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 121.115 -0.564 . . . . 7.6500000000000004 111.779 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.67 166.03 26.0 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.707 0.289 . . . . 10.539999999999999 111.154 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.1 -69.6 0.46 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.426 -0.352 . . . . 13.27 111.023 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.1 m -105.03 -61.65 1.45 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.841 0.353 . . . . 14.449999999999999 110.688 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -94.56 123.22 58.94 Favored Pre-proline 0 C--N 1.334 -0.103 0 CA-C-N 115.92 -0.582 . . . . 12.82 110.061 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.433 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.2 Cg_endo -43.78 -31.18 3.35 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.668 2.912 . . . . 11.76 114.078 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -72.89 -8.54 56.08 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.522 0.564 . . . . 9.5099999999999998 112.522 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 0.7 OUTLIER -74.86 84.39 2.19 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.01 0.434 . . . . 10.609999999999999 110.955 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 121' ' ' THR . 2.0 t -178.26 -164.39 0.08 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.692 -0.686 . . . . 6.8600000000000003 109.819 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.62 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 6.0 tpp -47.4 159.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.037 0.446 . . . . 5.1900000000000004 111.8 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.657 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.39 -34.35 10.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.979 -1.119 . . . . 7.4900000000000002 107.979 177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HA ' HG22 ' A' ' 121' ' ' THR . 0.0 OUTLIER -178.96 120.96 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.111 -0.95 . . . . 8.4900000000000002 108.688 177.269 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.796 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.57 159.34 0.71 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.309 1.226 . . . . 5.8399999999999999 114.309 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -103.55 -178.1 3.56 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 114.602 -1.181 . . . . 9.6199999999999992 109.292 178.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.678 ' HA ' ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.61 162.97 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.854 0.359 . . . . 6.6500000000000004 111.849 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.712 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 5.7 mt-30 -133.73 -170.61 2.53 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.695 -0.684 . . . . 9.1199999999999992 110.85 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.59 ' HB3' HD12 ' A' ' 114' ' ' LEU . 16.6 p90 -175.68 145.64 0.71 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.748 0.309 . . . . 11.15 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.738 HG23 ' O ' ' A' ' 136' ' ' ARG . 7.9 t -105.4 147.51 28.14 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.374 -0.973 . . . . 9.6600000000000001 108.374 177.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.74 -40.71 11.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.125 -0.63 . . . . 11.609999999999999 112.573 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -122.3 31.17 6.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.608 0.242 . . . . 13.619999999999999 111.622 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 56.92 46.82 90.47 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.978 -0.63 . . . . 11.15 112.625 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -144.32 -73.51 0.26 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.563 0.221 . . . . 16.32 110.644 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -94.02 150.71 20.11 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 109.833 -0.432 . . . . 14.66 109.833 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.519 ' CD2' ' HB ' ' A' ' 105' ' ' THR . 70.2 m95 -121.11 128.82 52.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.914 0.387 . . . . 11.01 111.714 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.72 154.53 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 115.71 -0.677 . . . . 12.630000000000001 111.007 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.712 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 1.6 m-20 -52.94 139.86 26.36 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.341 -0.391 . . . . 11.550000000000001 111.707 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.924 ' CD2' HG21 ' A' ' 128' ' ' VAL . 5.7 tt -116.12 -52.27 2.6 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.892 -0.595 . . . . 9.1300000000000008 111.635 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.579 ' OE2' HG22 ' A' ' 128' ' ' VAL . 2.5 tp10 -103.78 156.35 17.88 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.791 0.663 . . . . 8.6699999999999999 112.791 -178.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mp0 -51.66 168.76 0.07 Allowed 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 114.593 -1.185 . . . . 12.640000000000001 110.133 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.96 64.26 0.07 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.939 -0.864 . . . . 9.9100000000000001 110.939 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.774 HG11 ' CZ ' ' A' ' 120' ' ' TYR . 2.4 t -80.14 161.09 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 C-N-CA 123.548 0.739 . . . . 7.9699999999999998 111.02 -178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.465 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 3.6 mt-10 -108.66 76.15 1.01 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.421 -0.809 . . . . 8.3699999999999992 108.843 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.907 ' CE1' HG23 ' A' ' 126' ' ' ILE . 52.2 m-85 -76.67 42.7 0.3 Allowed 'General case' 0 C--N 1.341 0.2 0 CA-C-N 115.493 -0.776 . . . . 6.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.736 ' O ' HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -88.24 -27.15 21.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 108.287 -1.005 . . . . 5.3600000000000003 108.287 177.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.597 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -128.11 50.56 5.73 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.912 -1.144 . . . . 6.7400000000000002 107.912 178.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.556 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 73.7 Cg_endo -76.94 98.2 1.2 Allowed 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.057 2.505 . . . . 6.0599999999999996 112.745 -178.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.01 -49.63 9.49 Favored Glycine 0 CA--C 1.51 -0.265 0 N-CA-C 109.622 -1.391 . . . . 7.75 109.622 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.549 ' HB1' HD22 ' A' ' 86' ' ' LEU . . . -142.58 108.06 5.05 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 114.627 -0.786 . . . . 8.7400000000000002 109.445 177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.907 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.9 mt -91.71 132.29 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-N 115.472 -0.785 . . . . 6.1699999999999999 110.882 -179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -152.87 132.29 12.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.107 -0.497 . . . . 11.24 111.243 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.924 HG21 ' CD2' ' A' ' 114' ' ' LEU . 26.3 t -111.88 100.71 11.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.651 -0.704 . . . . 9.5 110.841 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -88.59 163.16 15.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 13.19 110.98 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.9 m-80 60.62 41.48 15.25 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.166 -0.47 . . . . 15.51 110.78 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.464 HD23 ' CD2' ' A' ' 80' ' ' LEU . 5.3 tp -126.86 56.0 1.52 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.996 -0.547 . . . . 11.710000000000001 110.596 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -83.57 90.88 7.31 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.087 -0.506 . . . . 13.460000000000001 111.146 -179.735 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 131' ' ' LEU . 0.5 OUTLIER -155.98 135.46 12.4 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.776 -0.647 . . . . 12.380000000000001 111.083 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 6.8 ttmm -56.93 129.99 43.99 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 108.655 -0.868 . . . . 12.81 108.655 178.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.3 p -144.46 149.68 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 120.503 -0.479 . . . . 8.5999999999999996 112.243 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.738 ' O ' HG23 ' A' ' 105' ' ' THR . 6.7 ttt180 -109.63 122.87 48.43 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.016 -1.476 . . . . 10.02 107.016 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.469 ' CA ' ' HA ' ' A' ' 73' ' ' LYS . . . 65.21 -176.78 12.17 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 120.865 -0.683 . . . . 5.6200000000000001 113.796 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.859 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -162.91 151.89 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.3 0.64 . . . . 4.0199999999999996 110.247 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.564 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.0 ttp180 -173.96 148.1 1.36 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.513 0.56 . . . . 8.4399999999999995 112.513 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.678 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.1 OUTLIER -88.93 161.51 16.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.538 -0.756 . . . . 5.2800000000000002 110.178 178.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.796 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.14 118.51 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 120.703 0.287 . . . . 8.3900000000000006 110.517 179.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.775 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -75.43 145.84 41.21 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.916 0.389 . . . . 8.4700000000000006 111.769 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 35.5 m -118.54 -27.96 5.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.786 -0.643 . . . . 9.8699999999999992 111.536 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.434 ' HA ' HG22 ' A' ' 66' ' ' VAL . 11.7 tp10 -128.9 -59.25 1.13 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 111.718 0.266 . . . . 10.619999999999999 111.718 -179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' N ' ' HB3' ' A' ' 98' ' ' GLN . . . 68.81 159.93 0.18 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.537 -0.301 . . . . 8.6999999999999993 111.111 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HG2' HG21 ' A' ' 149' ' ' THR . 4.0 ptm180 -137.21 162.72 32.72 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.102 0.477 . . . . 9.9199999999999999 112.136 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 63' ' ' ARG . 0.8 OUTLIER -87.93 157.51 18.93 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.81 -0.632 . . . . 12.91 110.649 179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 5.5 m120 50.26 73.3 0.27 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.007 0.432 . . . . 14.08 110.403 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.499 HG21 ' HG2' ' A' ' 146' ' ' ARG . 15.2 t -164.28 138.21 5.39 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.004 -0.544 . . . . 11.26 112.045 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.543 ' CD2' ' HG2' ' A' ' 59' ' ' LYS . 45.3 m0 -101.32 -172.7 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.687 -0.688 . . . . 15.23 109.414 178.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.85 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.0 tm? -133.64 97.56 3.96 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.761 -0.459 . . . . 8.9900000000000002 109.761 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -84.28 104.23 2.69 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.925 -0.655 . . . . 8.8000000000000007 113.274 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.673 HG11 ' HE2' ' A' ' 32' ' ' TYR . 3.0 t -97.82 119.72 46.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 121.032 0.444 . . . . 9.4900000000000002 111.094 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 2.5 ttm105 -93.87 -37.85 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 13.460000000000001 111.446 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 52' ' ' ALA . 29.7 t70 -177.34 162.43 1.91 Allowed 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.966 0.413 . . . . 9.1199999999999992 111.963 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 85' ' ' PHE . 71.2 mt -144.59 118.47 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 109.26 -0.644 . . . . 6.2999999999999998 109.26 177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.98 135.12 49.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.884 0.373 . . . . 8.1799999999999997 111.158 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.881 HG12 HG23 ' A' ' 83' ' ' VAL . 15.7 m -142.83 138.08 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.947 -0.57 . . . . 6.8399999999999999 110.716 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.556 ' HA ' ' OD1' ' A' ' 81' ' ' ASN . 3.7 m-80 66.63 11.73 8.34 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.142 -0.481 . . . . 9.2300000000000004 111.177 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.403 ' HE3' ' HA ' ' A' ' 160' ' ' LYS . 0.0 OUTLIER 54.01 63.87 2.03 Favored 'General case' 0 C--N 1.344 0.329 0 N-CA-C 109.659 -0.497 . . . . 12.199999999999999 109.659 -179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.11 37.83 1.17 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.489 -0.778 . . . . 14.43 110.069 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 58.32 67.73 0.91 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.867 -0.606 . . . . 13.19 110.787 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' A' ' 159' ' ' ASN . 26.9 t70 -133.4 -81.46 0.47 Allowed 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.271 -0.422 . . . . 11.779999999999999 111.703 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.697 -0.668 . . . . 13.66 111.4 -179.355 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.833 0.349 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.01 167.45 15.1 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.451 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.46 -50.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.743 0.306 . . . . 0.0 110.914 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 60.32 79.75 0.23 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 14.6 m170 60.34 161.41 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.845 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.57 30.68 0.66 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.001 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.43 137.95 0.3 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -103.68 91.65 4.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.8 t-80 -175.94 104.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -102.64 79.45 1.81 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.938 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.58 123.54 0.16 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.9 -31.06 18.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.948 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 111.32 -70.98 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.32 156.66 45.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.797 0.332 . . . . 0.0 110.871 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 15' ' ' VAL . 15.7 m -128.33 71.65 79.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.057 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.28 -56.52 2.66 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.546 2.164 . . . . 0.0 112.243 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.5 ptt85 -82.35 -178.14 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.842 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.97 28.83 0.47 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.7 m -106.47 114.93 29.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.959 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -110.19 -31.82 7.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.938 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.5 ttm -133.34 139.57 46.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -165.96 -75.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.106 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.3 m -120.51 -69.66 0.83 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.852 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -168.32 143.75 2.98 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.799 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.25 94.27 0.83 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.479 2.12 . . . . 0.0 112.322 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -60.17 -56.7 18.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.922 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.535 ' C ' HD13 ' A' ' 28' ' ' ILE . 0.0 OUTLIER 62.04 150.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.01 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.771 HG22 ' HB3' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -112.76 137.95 43.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.515 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.792 HG22 ' HB2' ' A' ' 75' ' ' SER . 0.7 OUTLIER -110.29 88.58 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.883 0.373 . . . . 0.0 111.646 -179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.499 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -72.7 98.44 2.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.829 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.446 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -106.94 121.23 44.02 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-O 121.159 0.504 . . . . 0.0 111.042 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.901 ' OH ' HG11 ' A' ' 153' ' ' VAL . 1.5 t80 -52.09 134.35 32.61 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.738 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -110.03 -177.93 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.979 179.808 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.458 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 17.7 p -177.67 165.78 2.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.524 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.9 t30 -111.84 -37.67 5.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.333 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.649 ' NH2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -68.66 137.18 53.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.208 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -71.86 64.86 0.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.119 0.485 . . . . 0.0 110.211 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.8 OUTLIER -138.79 148.57 43.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.946 -179.348 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.57 157.5 33.85 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.665 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 16.9 Cg_endo -58.18 123.87 14.63 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.179 1.919 . . . . 0.0 112.039 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.74 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.7 t -43.12 -52.69 5.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.574 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' H ' HG23 ' A' ' 41' ' ' THR . . . -124.41 -71.05 0.21 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.423 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -155.93 118.84 2.33 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.573 0.225 . . . . 0.0 110.977 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HA ' HD12 ' A' ' 56' ' ' LEU . 72.4 Cg_endo -77.19 -1.53 11.71 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.464 2.11 . . . . 0.0 111.708 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.3 t70 -43.02 -29.86 0.38 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.198 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 30.9 m-80 -47.22 -30.54 3.06 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.26 0.552 . . . . 0.0 110.447 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.811 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -101.15 -29.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.516 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.456 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 8.1 m-30 -54.17 -51.89 62.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.899 0.381 . . . . 0.0 110.848 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -117.15 10.74 13.94 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.341 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.0 m120 65.7 27.02 11.37 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.669 0.271 . . . . 0.0 111.323 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 45.5 t30 -107.07 92.18 3.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.411 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . . . -65.54 61.65 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 51' ' ' ASN . 23.1 t -113.82 28.72 8.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.022 0.439 . . . . 0.0 110.456 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.96 171.75 18.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.468 -179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.89 162.32 13.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.699 0.285 . . . . 0.0 110.815 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.82 HD13 ' CG2' ' A' ' 153' ' ' VAL . 0.6 OUTLIER -163.77 117.87 1.53 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.476 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.74 ' H ' HG22 ' A' ' 41' ' ' THR . 2.6 m -154.81 143.98 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.287 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.56 ' CE1' HD21 ' A' ' 56' ' ' LEU . 13.4 m-30 -104.2 125.82 50.8 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.92 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.22 14.94 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -177.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB3' ' A' ' 38' ' ' ASP . 1.6 t-20 -52.99 -52.72 62.66 Favored Pre-proline 0 C--N 1.333 -0.15 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.313 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 68.5 Cg_endo -101.41 110.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.736 2.957 . . . . 0.0 111.269 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -75.73 57.29 0.99 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.109 0.481 . . . . 0.0 110.72 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.3 ptp85 177.53 131.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.259 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.649 HD13 ' NH2' ' A' ' 36' ' ' ARG . 10.8 pt -145.29 155.32 13.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.145 0.498 . . . . 0.0 111.722 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.424 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 1.8 m-20 -118.66 178.05 4.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.342 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.565 HG22 ' HA ' ' A' ' 144' ' ' GLU . 21.3 t -46.84 96.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.274 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 161.92 -22.09 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.105 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.836 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -54.22 118.18 3.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.962 0.381 . . . . 0.0 110.782 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.7 OUTLIER -162.3 168.12 22.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.93 0.395 . . . . 0.0 111.576 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -154.49 -171.37 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.245 0.545 . . . . 0.0 111.763 179.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.07 -127.52 1.65 Allowed Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.18 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.799 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -173.11 118.38 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.277 0.56 . . . . 0.0 110.661 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.0 OUTLIER -89.22 146.6 24.65 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -177.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.771 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.05 -174.3 2.49 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.708 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.792 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.5 t -97.0 -51.42 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.794 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -129.23 165.82 29.74 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.07 132.61 34.96 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.585 2.19 . . . . 0.0 112.22 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.416 HG21 HG13 ' A' ' 28' ' ' ILE . 22.5 pt -135.58 136.0 50.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.292 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 96.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.902 0.382 . . . . 0.0 110.115 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.658 ' CD2' HD23 ' A' ' 131' ' ' LEU . 4.7 tt -83.23 103.56 12.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.995 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -69.58 -37.62 77.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.479 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -156.49 130.01 8.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.76 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.688 HG11 HD11 ' A' ' 114' ' ' LEU . 10.0 p -109.69 138.62 36.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.107 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 1.7 pm0 -151.54 125.59 9.22 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.771 ' CE1' HG21 ' A' ' 102' ' ' ILE . 22.3 m-85 -105.8 100.78 10.33 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.88 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 155' ' ' ASP . 4.4 mm? -77.78 101.41 6.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.435 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.695 ' HB3' HG12 ' A' ' 153' ' ' VAL . 1.7 mtm -141.97 -179.7 6.37 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.224 0.535 . . . . 0.0 111.526 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.62 -109.78 0.23 Allowed Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.674 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.663 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.19 149.1 37.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.655 0.264 . . . . 0.0 110.967 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.464 ' OD1' HG21 ' A' ' 57' ' ' VAL . 2.7 t-20 -80.66 -67.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.904 0.383 . . . . 0.0 110.325 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 54.6 p -103.39 -59.45 1.71 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.663 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 5.2 t-20 -91.48 121.6 67.18 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.762 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.434 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 4.9 Cg_endo -47.21 -25.67 4.73 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.76 2.306 . . . . 0.0 112.69 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -95.25 26.48 3.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -96.2 85.87 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.445 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 121' ' ' THR . 1.9 t -176.83 -165.19 0.12 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.52 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.4 tpp -40.92 162.9 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.071 0.463 . . . . 0.0 111.441 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.62 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -100.8 -41.43 6.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 177.434 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -177.22 122.19 0.13 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.589 176.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.793 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.93 161.69 0.97 Allowed 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 16.9 pttm -104.94 -179.5 3.96 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.387 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.771 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -102.86 162.53 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.577 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD12 ' A' ' 141' ' ' ILE . 0.9 OUTLIER -128.5 -177.13 4.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.297 -178.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.629 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.4 p90 -175.6 137.04 0.35 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.557 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.2 t -96.27 141.11 30.01 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -91.16 -61.07 2.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -97.01 34.21 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.903 0.382 . . . . 0.0 111.107 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 53.44 30.71 41.98 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -131.53 -72.2 0.55 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.814 0.34 . . . . 0.0 110.982 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -87.63 166.19 14.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.369 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 34.6 m95 -132.11 117.45 18.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.629 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.406 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -107.13 152.13 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.652 -179.176 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -44.45 145.98 0.77 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.392 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.688 HD11 HG11 ' A' ' 83' ' ' VAL . 6.7 tt -116.17 -55.94 2.35 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.414 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.783 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -112.99 157.73 21.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tt0 -46.16 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.397 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.88 60.44 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.22 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.794 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -79.35 159.77 4.45 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.562 0 C-N-CA 122.729 0.411 . . . . 0.0 110.54 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.6 mt-10 -108.88 80.93 1.38 Allowed 'General case' 0 N--CA 1.439 -1.006 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.621 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.794 ' CE1' HG11 ' A' ' 118' ' ' VAL . 44.3 m-85 -70.56 38.9 0.05 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.187 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.745 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -91.37 -17.76 25.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.877 177.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.67 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.19 44.46 0.86 Allowed Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.732 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 122' ' ' MET . 90.2 Cg_endo -85.57 98.44 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.837 2.358 . . . . 0.0 113.509 -178.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.64 -45.89 42.46 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 109.37 5.5 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 115.207 -0.496 . . . . 0.0 110.44 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.572 HD13 ' CD1' ' A' ' 120' ' ' TYR . 1.7 mt -96.88 132.62 40.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.402 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.417 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.62 153.79 29.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.968 179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.783 HG22 ' CD ' ' A' ' 115' ' ' GLU . 4.7 t -134.23 155.98 40.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.06 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.58 165.94 22.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.735 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 58.91 25.95 14.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.658 HD23 ' CD2' ' A' ' 80' ' ' LEU . 24.5 tp -101.95 17.01 24.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.128 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -54.71 89.42 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.001 0.429 . . . . 0.0 110.735 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.415 ' N ' ' O ' ' A' ' 131' ' ' LEU . 11.0 tp -156.38 134.86 11.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.697 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -54.25 130.61 39.3 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.415 HG23 ' CD1' ' A' ' 104' ' ' TYR . 6.0 p -145.42 153.06 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 C-N-CA 120.242 -0.583 . . . . 0.0 111.676 -178.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -106.51 127.92 53.69 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.548 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.37 -172.15 0.02 OUTLIER Glycine 0 C--N 1.316 -0.572 0 C-N-CA 120.848 -0.692 . . . . 0.0 113.786 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.799 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.6 m -155.68 154.33 6.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 C-N-CA 122.523 0.329 . . . . 0.0 110.13 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.556 ' HB2' ' CH2' ' A' ' 111' ' ' TRP . 2.6 ttm-85 -173.48 163.54 4.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.462 -178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.654 ' HG ' ' HA ' ' A' ' 102' ' ' ILE . 0.3 OUTLIER -110.74 159.47 17.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.96 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.793 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 mt -126.11 113.84 35.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.755 0.312 . . . . 0.0 110.651 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.836 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -80.16 142.86 34.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 143' ' ' THR . 6.6 m -127.73 31.27 5.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.117 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.9 tp10 -176.17 -64.22 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.771 0.319 . . . . 0.0 111.394 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.09 161.77 0.15 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.062 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.864 ' HG3' HG21 ' A' ' 149' ' ' THR . 6.8 ptm180 -135.02 151.66 51.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.263 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -84.11 162.79 20.16 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.692 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 45.83 73.43 0.17 Allowed 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 120.957 0.408 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.864 HG21 ' HG3' ' A' ' 146' ' ' ARG . 14.7 t -168.91 150.02 4.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.209 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.92 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 39.4 m0 -108.48 -173.04 2.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.546 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.694 ' CD1' HG13 ' A' ' 153' ' ' VAL . 3.1 tm? -141.41 99.11 3.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.71 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -96.0 121.87 7.1 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.137 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.901 HG11 ' OH ' ' A' ' 32' ' ' TYR . 26.6 m -117.61 153.17 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.628 0.251 . . . . 0.0 110.443 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -116.76 -30.75 5.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.752 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.5 t70 -178.95 179.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.302 0.572 . . . . 0.0 112.15 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.811 ' HB ' HG23 ' A' ' 47' ' ' ILE . 47.0 mt -159.8 135.21 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.158 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -131.74 154.46 49.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.258 0.551 . . . . 0.0 112.085 -179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.543 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.7 m -137.25 152.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.633 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 158' ' ' VAL . 3.3 m-80 64.68 31.03 12.28 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.924 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 59.9 80.41 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.012 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 59.8 44.17 14.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.851 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 61.27 47.77 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.872 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t0 68.64 -67.99 0.19 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.014 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 75.7 p . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.898 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.766 0.317 . . . . 0.0 111.223 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -77.18 -29.19 56.96 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.412 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.3 t 63.05 -79.77 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.811 0.338 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m 60.66 -172.25 0.13 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.03 -59.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 7' ' ' HIS . 5.9 p80 -177.73 -38.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.495 ' CE1' ' CE1' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -144.43 172.88 12.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.04 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -101.75 54.34 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m170 60.89 164.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.925 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -127.02 -45.32 1.57 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -174.16 -43.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.7 m 60.3 -169.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.864 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.439 ' C ' HD12 ' A' ' 14' ' ' LEU . . . -62.56 -117.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.47 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 HD12 ' C ' ' A' ' 13' ' ' GLY . 5.0 mp 62.76 119.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.596 HG12 ' HG3' ' A' ' 17' ' ' ARG . 21.6 t 64.13 77.27 0.31 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.134 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.91 -28.03 37.69 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.538 2.159 . . . . 0.0 112.328 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.596 ' HG3' HG12 ' A' ' 15' ' ' VAL . 54.7 mtm-85 60.97 31.1 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.72 163.73 19.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.535 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.3 t 60.13 30.98 20.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.793 0.33 . . . . 0.0 110.866 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 t-160 -112.15 -34.95 5.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 5.5 ptm -155.67 120.29 4.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.58 -69.53 0.81 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.06 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.7 t -113.71 29.78 7.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.4 OUTLIER -73.45 -60.81 1.58 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.895 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 59.4 Cg_endo -72.19 72.17 2.83 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.49 2.126 . . . . 0.0 112.408 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.496 ' O ' HD12 ' A' ' 28' ' ' ILE . 40.1 m-20 -69.79 -47.46 62.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.811 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.718 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.1 mmm-85 63.4 72.02 0.49 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 27' ' ' ARG . 1.9 mp -144.02 118.02 3.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.809 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 30' ' ' ALA . 31.9 mt -82.35 160.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.602 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.763 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -130.81 98.67 4.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.161 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.98 119.88 26.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.067 0.46 . . . . 0.0 111.267 179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.06 139.37 23.12 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.538 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.493 HG23 ' HG2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -118.94 -176.14 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 121.126 0.488 . . . . 0.0 111.367 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.48 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 50.0 p -177.57 157.4 1.25 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.478 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.458 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.8 t30 -94.62 -25.2 16.87 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.371 179.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -95.48 126.51 40.82 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.254 -179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -73.56 65.07 0.92 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.601 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' OD1' ' CD1' ' A' ' 58' ' ' TYR . 2.8 p30 -112.19 165.62 11.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.945 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -102.58 123.43 42.73 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.199 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.08 135.97 52.7 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.17 1.913 . . . . 0.0 112.316 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.804 HG21 ' HG2' ' A' ' 55' ' ' GLU . 1.4 t -42.8 -51.41 5.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.419 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' H ' HG23 ' A' ' 41' ' ' THR . . . -130.84 -75.81 0.14 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.175 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.58 ' OD1' HG21 ' A' ' 54' ' ' THR . 1.2 p30 -158.56 120.16 1.93 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.553 0.216 . . . . 0.0 110.884 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 56' ' ' LEU . 60.6 Cg_endo -73.4 -1.1 10.15 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.443 2.095 . . . . 0.0 112.25 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 1.1 m-20 -39.61 -33.48 0.18 Allowed 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.38 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.921 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -47.48 -30.06 3.16 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.285 179.432 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.829 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -96.71 -28.68 3.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.37 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.468 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 3.2 m-30 -53.76 -35.72 61.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -141.17 18.49 2.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.44 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 57.3 98.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.739 0.304 . . . . 0.0 111.021 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -146.24 -47.27 0.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.851 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 66.18 37.31 5.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.405 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.7 t -113.31 29.18 8.19 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.071 0.462 . . . . 0.0 110.751 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.921 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -155.42 172.41 18.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.042 -179.608 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.804 ' HG2' HG21 ' A' ' 41' ' ' THR . 5.9 tt0 -101.34 152.63 20.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.931 0.396 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -155.57 117.82 4.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.969 -178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.605 HG22 ' HB ' ' A' ' 41' ' ' THR . 2.6 m -154.04 141.49 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.83 0.348 . . . . 0.0 111.649 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.48 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 14.8 m-30 -104.74 131.33 52.32 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.999 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.05 20.1 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -53.68 -60.35 7.38 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_endo -98.67 110.6 0.08 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 123.242 2.628 . . . . 0.0 111.081 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 7.7 p-10 -71.31 56.85 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 110.853 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 170.83 140.67 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.966 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 HG12 ' HB1' ' A' ' 145' ' ' ALA . 0.2 OUTLIER -153.37 157.23 4.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 0.0 111.883 -179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -118.64 178.19 4.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.454 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 143' ' ' THR . 23.9 t -42.53 97.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.523 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.501 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 156.52 -20.88 0.47 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.827 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -59.66 114.98 3.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.959 0.38 . . . . 0.0 110.312 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.579 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.4 p90 -162.27 170.24 19.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.968 0.413 . . . . 0.0 112.011 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.1 -170.51 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.378 178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.738 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.77 -126.7 1.56 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.087 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.866 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -173.25 119.73 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.136 0.493 . . . . 0.0 110.47 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.521 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.18 148.25 23.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.167 0.508 . . . . 0.0 111.817 -177.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.754 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.8 m-30 -105.11 -172.39 2.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.467 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.03 -29.17 8.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.637 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -149.73 165.33 17.83 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.916 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.8 134.73 28.61 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.534 2.156 . . . . 0.0 112.405 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.695 HG22 HD13 ' A' ' 28' ' ' ILE . 18.9 pt -141.11 136.86 33.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -62.15 96.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.156 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.9 tt -88.86 102.44 15.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 4.2 p-10 -69.6 -13.55 62.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.198 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.5 p30 177.55 130.24 0.05 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.847 0.356 . . . . 0.0 111.46 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.606 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.51 145.53 14.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.908 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 7.1 pt-20 -151.54 122.62 7.66 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.688 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.5 m-85 -106.26 100.72 10.24 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' N ' ' O ' ' A' ' 155' ' ' ASP . 7.1 mt -79.51 87.29 5.12 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.784 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.62 144.97 33.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.051 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.463 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -135.67 -99.14 0.57 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.15 161.94 36.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.71 0.291 . . . . 0.0 110.622 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.465 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.5 p-10 -74.0 -66.07 0.76 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.948 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 t -104.25 -61.46 1.44 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.028 0.442 . . . . 0.0 111.069 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.419 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 72.3 m-80 -95.57 122.05 60.04 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.929 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.7 Cg_endo -53.53 -16.53 7.89 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.643 2.229 . . . . 0.0 113.069 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.406 ' HA ' ' HE1' ' A' ' 122' ' ' MET . 60.8 m-80 -89.66 23.97 2.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.655 0.264 . . . . 0.0 111.535 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -113.28 90.8 3.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 121' ' ' THR . 1.3 t -176.45 -165.27 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.886 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.543 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.8 tpp -39.37 163.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.1 0.476 . . . . 0.0 111.691 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -100.89 -41.21 6.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.339 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.742 ' O ' HG22 ' A' ' 143' ' ' THR . 12.2 mttt -176.93 122.62 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.011 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.841 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.43 158.68 0.86 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.8 170.08 8.11 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.13 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.77 HD11 HG21 ' A' ' 126' ' ' ILE . 1.1 mt -96.7 162.57 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 C-N-CA 120.599 -0.441 . . . . 0.0 111.419 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 9.3 mt-30 -138.75 -170.21 2.79 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.616 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.81 ' HB3' HD12 ' A' ' 114' ' ' LEU . 12.5 p90 -165.56 160.36 17.58 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.57 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.652 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.2 t -111.76 141.27 45.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.886 0.374 . . . . 0.0 110.087 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.31 -60.86 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 112.1 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.402 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -101.08 36.51 1.96 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.045 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.412 ' CA ' ' HD3' ' A' ' 136' ' ' ARG . . . 47.91 29.39 6.28 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.464 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.402 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 7.3 ptm180 -129.29 -56.07 1.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.976 0.417 . . . . 0.0 110.795 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.4 166.34 10.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.272 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.652 ' CZ2' HG22 ' A' ' 105' ' ' THR . 31.9 m95 -136.16 112.68 10.01 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.9 OUTLIER -103.63 152.35 6.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.383 -179.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -46.4 150.56 0.63 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.858 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.81 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.4 tt -128.44 -66.89 0.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.604 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.585 ' HG2' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -86.47 151.25 23.67 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.345 0.593 . . . . 0.0 112.311 -178.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.55 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.8 OUTLIER -46.19 166.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.434 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.03 60.78 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.186 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.851 HG11 ' CE1' ' A' ' 120' ' ' TYR . 3.1 t -80.88 158.59 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.578 0 CA-C-O 121.075 0.464 . . . . 0.0 110.772 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -106.92 78.95 1.28 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.321 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.851 ' CE1' HG11 ' A' ' 118' ' ' VAL . 53.3 m-85 -70.45 38.37 0.05 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.159 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.758 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.76 -18.77 22.51 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.701 177.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.688 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -136.36 42.19 0.67 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.214 178.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 122' ' ' MET . 64.7 Cg_endo -87.37 120.98 1.58 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.745 2.297 . . . . 0.0 113.104 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.93 -42.55 3.78 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 110.306 -1.118 . . . . 0.0 110.306 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.01 105.37 4.64 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.997 -0.602 . . . . 0.0 109.761 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.77 HG21 HD11 ' A' ' 102' ' ' ILE . 2.0 mt -92.68 128.48 44.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.326 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 20.9 mtpt -145.84 162.8 36.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.703 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 115' ' ' GLU . 39.8 t -134.51 155.82 39.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.193 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 128' ' ' VAL . 17.9 mt-10 -132.74 148.25 52.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.51 46.52 9.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.894 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.487 HD22 HG11 ' A' ' 128' ' ' VAL . 20.6 tp -116.3 16.83 15.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 4.7 t70 -54.63 89.83 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.05 0.453 . . . . 0.0 111.107 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.4 ' N ' ' O ' ' A' ' 131' ' ' LEU . 15.0 tp -156.16 129.49 8.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.619 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -54.21 130.11 37.4 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.615 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -146.92 160.61 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.67 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.553 ' O ' HG23 ' A' ' 105' ' ' THR . 0.5 OUTLIER -110.78 128.0 55.58 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 176.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.499 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.57 -173.67 0.09 OUTLIER Glycine 0 C--N 1.316 -0.579 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.871 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.866 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -156.09 151.6 9.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.332 -0.434 . . . . 0.0 109.911 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.63 ' O ' HG22 ' A' ' 102' ' ' ILE . 34.6 ttp180 -173.07 163.37 4.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.13 0.491 . . . . 0.0 111.87 -178.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.596 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -107.5 159.22 16.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.606 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.841 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.8 OUTLIER -129.12 113.45 28.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.857 0.361 . . . . 0.0 110.844 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -79.36 145.56 33.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.413 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.742 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.6 t -127.54 27.93 5.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.887 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.664 ' HA ' HG22 ' A' ' 66' ' ' VAL . 2.3 tp10 -177.28 -46.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.539 ' HB1' HG12 ' A' ' 64' ' ' ILE . . . 63.13 178.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.726 ' HB3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -130.88 174.48 9.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.203 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -123.17 149.47 44.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.571 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 11.7 m-80 48.58 62.75 2.39 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.348 0.594 . . . . 0.0 110.221 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 146' ' ' ARG . 8.8 t -159.65 157.15 29.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.776 -179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.999 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.5 m0 -110.61 -174.32 2.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.694 HD11 ' SD ' ' A' ' 87' ' ' MET . 1.8 tm? -135.72 99.08 4.08 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.13 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.419 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -87.12 120.14 5.42 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.707 -0.758 . . . . 0.0 113.24 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.784 HG13 ' HB2' ' A' ' 87' ' ' MET . 38.6 t -110.63 142.7 22.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.764 0.316 . . . . 0.0 110.603 179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -112.88 -38.8 4.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.304 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -179.81 177.94 0.66 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.251 0.548 . . . . 0.0 111.836 -179.479 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.829 ' HB ' HG23 ' A' ' 47' ' ' ILE . 17.6 mt -157.47 132.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.537 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -129.98 149.46 51.7 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.093 0.473 . . . . 0.0 111.597 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.754 HG11 ' OH ' ' A' ' 74' ' ' TYR . 27.4 m -130.91 148.71 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.567 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 61.89 27.89 17.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.95 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.55 85.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.966 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.04 37.36 26.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.877 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 61.57 69.61 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -136.86 83.05 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.91 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ptt? . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.782 0.325 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.73 78.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.493 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -134.15 31.92 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.827 0.346 . . . . 0.0 110.957 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.0 76.3 3.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.953 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 59.73 30.86 20.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.957 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -177.09 -170.84 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.896 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -117.36 -63.5 1.43 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.884 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -110.14 80.55 1.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.966 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -144.06 32.36 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -149.0 160.11 43.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.908 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.3 m 60.66 106.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.881 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 t -173.76 84.53 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.57 -93.79 0.23 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.537 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.585 ' O ' HG12 ' A' ' 15' ' ' VAL . 12.1 mt 60.59 -169.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.908 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.842 HG22 ' HD2' ' A' ' 16' ' ' PRO . 0.4 OUTLIER 77.75 148.41 0.12 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.117 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.842 ' HD2' HG22 ' A' ' 15' ' ' VAL . 52.8 Cg_exo -52.22 98.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.535 2.157 . . . . 0.0 112.397 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -176.66 -64.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.97 102.46 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.515 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -127.66 137.38 52.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -176.66 164.82 2.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.97 86.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.35 133.65 17.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.114 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.4 t 59.85 29.26 18.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.039 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 60.88 156.19 0.11 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.93 -167.34 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.642 2.228 . . . . 0.0 112.234 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -56.14 -25.77 47.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.086 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.4 tpt180 62.62 102.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.936 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.876 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp -102.08 119.27 50.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.852 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.794 HG22 ' HB3' ' A' ' 75' ' ' SER . 21.2 tt -81.93 161.2 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.006 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.403 ' O ' ' CD1' ' A' ' 48' ' ' PHE . . . -127.69 98.23 5.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.911 0.386 . . . . 0.0 111.015 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.713 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -92.5 154.51 18.42 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.372 179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.753 ' CD2' HD13 ' A' ' 47' ' ' ILE . 2.8 t80 -90.4 140.62 29.54 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.257 0.551 . . . . 0.0 112.067 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.482 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -119.54 167.35 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.569 179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 129.36 0.15 Allowed 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.484 178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.55 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 2.4 t-20 -70.23 -31.21 68.51 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' HB3' ' CG ' ' A' ' 60' ' ' ASN . 14.3 mmt85 -57.49 160.56 4.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.986 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -100.18 88.83 3.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.286 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.407 ' CB ' ' OD1' ' A' ' 60' ' ' ASN . 25.8 t70 -172.86 163.86 5.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -103.37 145.95 31.55 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.069 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.01 120.13 7.75 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.439 2.093 . . . . 0.0 112.024 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -87.46 -171.9 3.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.859 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.632 ' N ' HG23 ' A' ' 41' ' ' THR . . . 36.86 -103.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.485 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.238 179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -158.37 107.43 1.68 Allowed Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.631 0.253 . . . . 0.0 110.522 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.554 ' CA ' HD12 ' A' ' 47' ' ' ILE . 55.7 Cg_endo -69.71 -0.73 7.29 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.547 2.164 . . . . 0.0 112.322 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -36.12 -44.67 0.4 Allowed 'General case' 0 C--N 1.341 0.231 0 CA-C-O 120.685 0.279 . . . . 0.0 111.511 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -46.88 -33.89 4.94 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.555 0.693 . . . . 0.0 109.931 179.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.753 HD13 ' CD2' ' A' ' 32' ' ' TYR . 1.8 mp -87.65 -30.94 5.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.243 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.473 ' CE2' ' HG2' ' A' ' 44' ' ' PRO . 18.8 m-30 -81.12 -21.11 40.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.088 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -147.38 27.29 1.03 Allowed 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 2.7 m120 50.97 25.97 2.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 0.0 111.595 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 4.8 t30 -85.76 80.34 8.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.753 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -70.45 36.55 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ASN . 1.4 t -113.49 28.82 8.47 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.092 0.472 . . . . 0.0 110.188 178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 46' ' ' ASN . 2.5 m -148.72 169.72 19.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.659 -179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' N ' ' CG2' ' A' ' 54' ' ' THR . 3.4 pt-20 -131.68 146.28 52.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.051 0.453 . . . . 0.0 111.615 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -151.35 147.84 27.41 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.323 179.333 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 2.9 m -153.87 149.69 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.91 0.386 . . . . 0.0 111.894 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' OH ' ' CE1' ' A' ' 32' ' ' TYR . 6.0 m-30 -107.96 125.24 51.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.498 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.792 ' HG3' ' CZ2' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -83.54 -60.38 2.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.658 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.573 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.0 OUTLIER 44.52 179.01 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.378 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.62 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.573 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_endo -59.58 109.71 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 120.695 0.93 . . . . 0.0 109.886 178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.592 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 6.5 m120 -37.68 -38.07 0.26 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.637 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 147' ' ' GLU . 3.0 ptp85 -105.93 123.32 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.881 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.758 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.7 pp -139.39 177.44 4.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.69 177.96 4.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.056 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.76 HG12 ' CA ' ' A' ' 144' ' ' GLU . 16.0 m -41.17 134.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.764 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 125.71 -18.43 6.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.639 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.1 m -60.11 110.39 1.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 1.7 p90 -157.55 170.76 21.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.704 0.288 . . . . 0.0 111.602 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.76 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -153.57 -172.3 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.281 0.563 . . . . 0.0 111.671 178.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.76 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.33 -125.56 1.35 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.087 -0.96 . . . . 0.0 111.222 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.891 HG13 ' CG2' ' A' ' 138' ' ' VAL . 0.9 OUTLIER -172.89 116.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.317 0.579 . . . . 0.0 110.707 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 31' ' ' THR . 8.1 ttpt -89.26 144.81 25.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.884 -178.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -106.1 -176.99 3.23 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.736 -179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.794 ' HB3' HG22 ' A' ' 29' ' ' ILE . 83.9 p -87.86 -60.47 1.96 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.728 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' H ' HG23 ' A' ' 28' ' ' ILE . 2.0 m-20 -128.14 167.48 18.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.698 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 7.8 Cg_endo -49.79 142.07 26.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.783 2.322 . . . . 0.0 112.331 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.876 HG22 HD13 ' A' ' 28' ' ' ILE . 2.1 pp -146.18 131.25 12.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.524 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 69.1 p -53.32 95.96 0.01 OUTLIER 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.204 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 131' ' ' LEU . 4.9 tp -77.92 94.39 4.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.067 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -70.09 -27.71 64.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.857 0.36 . . . . 0.0 110.612 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 176.72 130.47 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.52 HG11 HD11 ' A' ' 114' ' ' LEU . 8.6 p -104.95 140.82 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.38 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' HB3' ' HA ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -151.62 114.21 4.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.158 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 102' ' ' ILE . 12.3 m-85 -96.87 100.27 11.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.477 ' N ' ' O ' ' A' ' 155' ' ' ASP . 92.5 mt -80.39 95.43 6.4 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.712 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.74 167.8 21.28 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.267 0.556 . . . . 0.0 111.782 -178.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.459 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -151.58 -113.13 0.56 Allowed Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.197 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.514 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.32 152.1 41.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.832 0.349 . . . . 0.0 110.745 178.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.418 ' ND2' HG11 ' A' ' 57' ' ' VAL . 6.3 t-20 -65.04 -68.48 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.014 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -104.07 -61.53 1.43 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.394 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 m-80 -94.07 121.78 63.24 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.966 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 9.8 Cg_endo -52.62 -18.54 8.77 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.765 2.31 . . . . 0.0 112.842 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -91.41 26.23 2.33 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.624 0.25 . . . . 0.0 111.465 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.04 91.3 3.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.967 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 121' ' ' THR . 0.8 OUTLIER -176.29 -165.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.246 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.538 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.76 159.76 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.812 0.339 . . . . 0.0 111.261 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.625 ' C ' ' HB ' ' A' ' 121' ' ' THR . 6.2 tp60 -97.72 -41.2 8.2 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 15.0 mttm -176.98 122.6 0.13 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.778 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.861 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.62 162.15 0.69 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.518 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -105.63 174.21 5.98 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.886 178.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.714 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.8 OUTLIER -98.37 162.6 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.157 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.446 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.3 OUTLIER -135.45 -175.43 3.94 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.96 0.41 . . . . 0.0 111.495 -179.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.802 ' HB3' HD12 ' A' ' 114' ' ' LEU . 9.8 p90 -169.06 146.14 3.6 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.62 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.2 t -103.3 138.1 40.53 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.58 -60.96 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.436 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.3 OUTLIER -95.64 33.18 1.67 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 111.44 -179.234 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.73 37.04 26.88 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.508 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.436 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.04 -71.53 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.931 0.396 . . . . 0.0 110.59 -179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.14 162.86 14.49 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.284 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.654 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.9 m95 -130.16 123.36 30.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.92 0.39 . . . . 0.0 110.725 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -112.82 164.33 8.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.276 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -55.86 149.11 15.46 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.753 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.802 HD12 ' HB3' ' A' ' 104' ' ' TYR . 10.2 tt -122.48 -59.64 1.61 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.564 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.55 ' HG2' HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -101.08 153.14 19.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.399 0.619 . . . . 0.0 112.669 -178.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.627 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.0 mt-10 -44.48 166.74 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.657 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.78 62.15 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.908 178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -82.02 158.06 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.3 OUTLIER -107.72 77.4 1.12 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.161 178.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 60.7 m-85 -70.51 40.7 0.05 Allowed 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.024 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 96' ' ' THR . 0.3 OUTLIER -91.26 -18.09 24.93 Favored 'General case' 0 CA--C 1.514 -0.422 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 177.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.728 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -137.95 45.4 1.06 Allowed Pre-proline 0 N--CA 1.449 -0.514 0 CA-C-N 114.704 -1.135 . . . . 0.0 108.566 178.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.645 ' HD3' ' N ' ' A' ' 122' ' ' MET . 85.7 Cg_endo -84.82 98.7 0.7 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.875 2.383 . . . . 0.0 113.291 -178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.09 -44.34 29.95 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 110.576 -1.009 . . . . 0.0 110.576 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.19 111.09 6.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.238 178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.614 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -99.73 130.49 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.893 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 23.3 ttpt -159.02 153.7 24.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.64 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.594 HG21 HD22 ' A' ' 131' ' ' LEU . 27.9 m -138.08 155.86 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.378 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -126.76 164.18 21.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.795 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.9 m120 60.65 30.94 20.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.86 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.765 HD23 HD23 ' A' ' 80' ' ' LEU . 12.3 tp -107.62 24.63 12.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.0 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -59.17 90.19 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.614 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.469 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -155.8 126.6 6.92 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.031 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 12.0 ttpp -54.21 136.96 42.01 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 1.2 p -152.19 170.27 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.915 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -118.35 127.75 53.99 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 176.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.505 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.52 -178.28 0.04 OUTLIER Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.702 -0.761 . . . . 0.0 114.129 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.891 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.0 OUTLIER -152.8 155.1 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 122.89 0.476 . . . . 0.0 110.026 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.559 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 8.8 ttm180 -173.43 163.1 4.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.269 0.557 . . . . 0.0 112.107 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.589 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -108.67 159.25 16.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.127 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.861 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -129.22 113.02 26.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 179.682 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -82.18 143.79 31.16 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.361 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.0 m -127.74 33.18 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.206 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.76 ' CA ' HG12 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -175.42 -57.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.674 0.273 . . . . 0.0 111.609 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.758 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 62.12 170.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.918 -179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.626 ' HG2' HG21 ' A' ' 149' ' ' THR . 6.2 ptm180 -142.71 169.64 17.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.895 0.379 . . . . 0.0 111.395 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 25.8 mp0 -90.58 154.19 19.78 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.783 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 8.5 m120 46.1 72.92 0.19 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.055 0.455 . . . . 0.0 110.564 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.626 HG21 ' HG2' ' A' ' 146' ' ' ARG . 5.2 t -153.68 120.15 5.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.329 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.792 ' CZ2' ' HG3' ' A' ' 59' ' ' LYS . 23.2 m0 -89.67 -173.17 3.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.723 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.612 HD12 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -130.04 99.08 4.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.89 0.376 . . . . 0.0 110.35 178.857 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.455 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -92.54 100.59 2.68 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.432 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.712 HG13 ' HB2' ' A' ' 87' ' ' MET . 2.5 t -95.31 153.15 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.765 0.317 . . . . 0.0 110.556 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.413 ' O ' ' HB2' ' A' ' 155' ' ' ASP . 18.8 ttt180 -120.35 -39.23 2.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.758 0.314 . . . . 0.0 110.951 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 86' ' ' LEU . 7.9 t70 178.31 168.37 0.8 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.264 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 47' ' ' ILE . 12.4 mt -146.7 142.28 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.564 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -125.77 154.47 42.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.249 0.547 . . . . 0.0 111.835 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.745 HG13 ' HA ' ' A' ' 163' ' ' ASP . 8.9 p -156.07 138.96 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.608 HD22 HG22 ' A' ' 158' ' ' VAL . 2.1 m-80 61.49 36.73 16.95 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.656 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 60.63 -157.14 0.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.266 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 16.1 mtmt -69.71 66.08 0.22 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.941 0.4 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -152.79 -54.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.986 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.745 ' HA ' HG13 ' A' ' 158' ' ' VAL . 9.5 t0 65.79 146.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.956 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.624 ' O ' HG21 ' A' ' 78' ' ' ILE . 1.7 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.766 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mpp? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.87 109.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.532 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.5 -75.41 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.79 0.328 . . . . 0.0 110.904 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.6 m -177.29 -176.48 0.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.874 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -119.91 85.84 2.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.831 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -81.89 -54.7 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.885 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -165.82 34.04 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 60.34 -176.75 0.1 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.898 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -138.55 -62.75 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.839 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.3 t60 63.59 139.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.894 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.9 p -176.14 37.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.92 -170.02 1.09 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.23 -100.16 1.88 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.547 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.17 31.74 20.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.89 0.376 . . . . 0.0 110.967 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.492 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.6 t -82.77 -45.55 0.9 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.482 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 77.6 Cg_exo -50.17 -61.28 0.59 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.327 2.018 . . . . 0.0 112.384 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.1 mtm-85 -61.34 176.97 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.51 113.74 0.72 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 0.7 OUTLIER -103.69 79.44 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.801 0.334 . . . . 0.0 110.866 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' CG ' ' O ' ' A' ' 19' ' ' SER . 6.6 m80 -169.64 -60.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.8 ptp -132.47 -48.68 0.9 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.915 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -169.11 -75.65 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.089 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.4 m -159.45 38.49 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 61.38 155.0 0.11 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.903 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 84.9 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.532 2.155 . . . . 0.0 112.364 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.92 79.92 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -146.59 34.87 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.948 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.913 HD13 HG22 ' A' ' 78' ' ' ILE . 3.7 mp -64.33 142.46 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.847 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.5 mp -108.8 160.1 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.699 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -119.28 99.09 6.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.791 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.711 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -96.56 122.58 39.63 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.224 0.535 . . . . 0.0 111.545 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.879 ' OH ' HG21 ' A' ' 70' ' ' VAL . 6.4 t80 -53.13 153.61 3.53 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.716 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.487 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -131.68 -179.43 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.371 0.605 . . . . 0.0 111.517 179.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.479 ' CB ' ' CD2' ' A' ' 58' ' ' TYR . 85.8 p -178.04 129.6 0.14 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.645 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 9.3 t-20 -59.28 -35.65 74.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.87 0.367 . . . . 0.0 110.918 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HD3' ' CG ' ' A' ' 61' ' ' PRO . 1.8 mmp_? -83.02 137.74 34.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.11 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.86 68.2 0.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.054 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 8.9 t70 -135.83 138.05 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.45 155.85 48.44 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.66 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -60.95 119.87 7.27 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.307 2.005 . . . . 0.0 111.778 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.756 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.6 t -48.97 -50.82 33.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.43 ' N ' HG23 ' A' ' 41' ' ' THR . . . -100.54 -92.24 2.11 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.191 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 35.5 m-80 -158.59 127.26 2.99 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.466 0.174 . . . . 0.0 111.181 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.721 ' HA ' HD12 ' A' ' 47' ' ' ILE . 25.0 Cg_exo -63.99 -1.29 3.39 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.755 2.303 . . . . 0.0 112.517 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -34.26 -48.9 0.35 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.889 0.376 . . . . 0.0 111.672 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.542 ' ND2' ' O ' ' A' ' 54' ' ' THR . 20.4 m-20 -49.96 -40.94 45.49 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.866 0.841 . . . . 0.0 109.92 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.909 HG23 HD13 ' A' ' 156' ' ' ILE . 1.6 mp -86.78 -41.55 14.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.066 -1.425 . . . . 0.0 112.247 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 8.0 m-30 -54.46 -52.33 62.19 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.946 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -136.27 46.29 2.29 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.9 p30 41.61 97.0 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -132.51 -42.49 0.94 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.948 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.772 ' HB2' ' CG ' ' A' ' 155' ' ' ASP . . . 50.63 25.78 2.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.793 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.0 m -98.93 -50.2 4.28 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.94 0.4 . . . . 0.0 110.358 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.542 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 1.2 t -86.8 172.73 9.91 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -127.59 150.26 49.79 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.85 0.357 . . . . 0.0 111.373 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -150.77 147.27 27.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.04 179.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.756 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.08 151.91 10.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.904 0.383 . . . . 0.0 111.615 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' CD2' ' CB ' ' A' ' 34' ' ' SER . 3.2 m-85 -107.63 147.74 30.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.941 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 61' ' ' PRO . 7.2 mtmt -148.77 -59.05 0.23 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 2.5 t-20 22.51 -84.08 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 123.691 0.62 . . . . 0.0 111.719 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 46.5 Cg_endo -83.45 110.51 1.71 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.291 1.327 . . . . 0.0 111.342 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.03 49.21 1.59 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 0.0 110.559 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.6 OUTLIER 171.17 123.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.383 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.498 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.1 pp -157.92 152.01 7.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.961 0.41 . . . . 0.0 111.637 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -118.75 116.68 27.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.597 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.726 HG22 ' CA ' ' A' ' 144' ' ' GLU . 21.5 t 49.15 92.64 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.364 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.488 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 162.41 -25.65 0.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.596 -0.811 . . . . 0.0 113.157 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.53 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -58.48 105.91 0.34 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 122.614 -0.345 . . . . 0.0 110.479 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.782 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.3 p90 -162.19 167.32 24.29 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.962 0.411 . . . . 0.0 111.838 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.879 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -152.87 -170.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.15 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.748 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 161.33 -121.76 1.05 Allowed Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.886 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.1 p -172.74 116.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.432 0.634 . . . . 0.0 111.784 178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.6 pttm -89.45 145.71 25.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.175 -179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.604 ' OH ' HG11 ' A' ' 158' ' ' VAL . 1.9 m-30 -105.19 -175.0 2.67 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.132 -179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.12 -30.09 10.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.86 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.414 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -148.0 170.42 7.73 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.736 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 64.7 Cg_endo -74.13 133.53 18.11 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.537 2.158 . . . . 0.0 112.659 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.913 HG22 HD13 ' A' ' 28' ' ' ILE . 19.6 pt -140.0 135.41 37.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.066 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.571 ' O ' HG23 ' A' ' 79' ' ' THR . 8.8 t -52.42 96.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 110.165 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.722 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -83.1 104.64 13.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.873 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -69.69 -28.42 65.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.488 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.19 130.33 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.494 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.722 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.91 145.03 13.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 178.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 8.9 mt-10 -148.3 111.78 5.0 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.701 ' CE1' HG21 ' A' ' 102' ' ' ILE . 5.2 m-85 -92.81 100.55 13.01 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.71 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -95.16 87.78 4.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.029 -179.297 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.492 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.86 -179.62 6.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.463 -179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -146.66 -100.72 0.27 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.038 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.428 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.87 157.33 44.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.308 . . . . 0.0 110.726 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 4.7 t-20 -75.07 -68.14 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.149 -179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.67 -61.37 1.44 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.229 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.412 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.8 t-20 -90.67 121.65 67.98 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.84 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 12.8 Cg_endo -55.99 -19.33 25.71 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.532 2.155 . . . . 0.0 112.507 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.84 26.27 3.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.139 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -108.09 93.6 4.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.91 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.1 -165.11 0.14 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.536 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.728 ' N ' HG23 ' A' ' 96' ' ' THR . 2.3 tpp -44.82 159.09 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.675 ' C ' ' HB ' ' A' ' 121' ' ' THR . 23.7 tp60 -98.49 -38.64 9.11 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.556 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.59 122.4 0.15 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.442 -1.253 . . . . 0.0 108.542 176.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.72 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.69 166.84 0.37 Allowed 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.727 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.99 -176.3 3.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.534 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -98.94 162.55 2.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.745 179.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 6.8 mt-30 -131.91 178.11 7.02 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.56 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.706 ' HB3' HD12 ' A' ' 114' ' ' LEU . 11.7 p90 -170.67 143.95 2.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.538 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.639 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.9 t -101.01 141.2 34.24 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.22 -59.53 2.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.405 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 30.7 t70 -95.45 34.42 1.46 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.755 0.312 . . . . 0.0 111.348 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.94 39.48 18.44 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.647 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.7 -69.7 0.45 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.895 0.378 . . . . 0.0 110.804 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -94.48 157.82 15.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.585 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.576 ' HZ3' ' N ' ' A' ' 139' ' ' ARG . 34.5 m95 -124.65 122.47 37.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.517 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.81 164.51 13.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.883 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 4.9 m-20 -48.19 154.54 0.57 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.548 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.758 HD21 HG11 ' A' ' 128' ' ' VAL . 8.8 tt -128.65 -65.72 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.468 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.866 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -97.78 158.85 15.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.638 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mm-40 -45.21 166.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 114.821 -1.082 . . . . 0.0 110.48 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -62.42 61.24 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.971 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.85 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.68 158.58 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 C-N-CA 122.739 0.415 . . . . 0.0 110.591 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.508 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.99 76.4 1.05 Allowed 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.336 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.85 ' CE1' HG11 ' A' ' 118' ' ' VAL . 54.5 m-85 -70.42 39.89 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.196 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.705 ' O ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -93.59 -14.98 25.87 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 177.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.43 44.45 0.84 Allowed Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.002 178.173 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.91 ' HD2' HG21 ' A' ' 96' ' ' THR . 91.7 Cg_endo -84.12 98.67 0.76 Allowed 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.676 2.251 . . . . 0.0 113.306 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.19 -41.11 22.61 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.71 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.14 108.64 5.32 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 115.145 -0.528 . . . . 0.0 110.279 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.605 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.74 131.86 46.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.927 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.463 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -147.72 139.38 23.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.977 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.866 HG22 ' OE1' ' A' ' 115' ' ' GLU . 13.0 t -119.94 100.06 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.02 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -88.59 157.91 18.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.967 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 59.92 57.56 3.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.767 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 128' ' ' VAL . 19.6 tp -134.03 27.18 3.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 89.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.787 0.327 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 16.6 tp -156.08 125.64 6.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.124 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 14.4 mtmm -54.36 135.06 45.5 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.639 HG22 ' O ' ' A' ' 105' ' ' THR . 2.3 p -151.82 166.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 120.036 -0.665 . . . . 0.0 112.102 -178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 105' ' ' THR . 14.2 mtp180 -113.9 128.01 56.22 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 53.09 -174.6 0.27 Allowed Glycine 0 C--N 1.311 -0.823 0 CA-C-N 115.574 -0.739 . . . . 0.0 114.211 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.886 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -163.09 148.08 3.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 115.038 -0.581 . . . . 0.0 109.9 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.576 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 13.9 ttp180 -173.86 163.12 4.07 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.438 0.637 . . . . 0.0 112.489 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -100.53 158.96 15.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.839 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.782 HD13 ' CE2' ' A' ' 69' ' ' TYR . 1.3 mm -138.8 113.14 7.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.851 0.357 . . . . 0.0 110.742 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.569 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -80.25 154.62 27.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.436 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.635 ' HA ' HG13 ' A' ' 66' ' ' VAL . 1.3 m -127.48 28.69 5.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.909 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.726 ' CA ' HG22 ' A' ' 66' ' ' VAL . 37.5 tp10 -176.46 -48.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.103 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.657 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 54.25 178.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.177 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.9 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.0 OUTLIER -138.3 160.93 38.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.083 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -84.12 152.0 24.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 48.08 77.26 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.75 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.9 HG21 ' HG3' ' A' ' 146' ' ' ARG . 6.4 t -165.07 133.27 3.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.362 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.495 ' CH2' ' HD2' ' A' ' 59' ' ' LYS . 47.9 m0 -96.39 -172.93 2.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.272 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD13 ' C ' ' A' ' 151' ' ' LEU . 1.4 tm? -131.78 98.78 4.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.184 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -80.66 153.17 34.51 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.37 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.645 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -149.08 141.47 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.879 0.371 . . . . 0.0 111.04 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -121.17 -39.96 2.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.772 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 3.8 t70 -161.99 159.64 26.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.072 0.463 . . . . 0.0 111.388 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.909 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.73 108.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.164 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -139.46 154.61 47.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 83' ' ' VAL . 27.4 m -104.2 144.66 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.038 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 65.36 54.7 1.14 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.93 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.99 76.48 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.41 38.9 19.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.861 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 61.05 79.26 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.32 157.11 36.33 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.895 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.932 -179.928 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.71 129.21 6.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.562 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -91.87 80.19 5.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.828 0.346 . . . . 0.0 110.894 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.0 m -165.86 87.27 0.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.919 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -91.59 91.67 8.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.852 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -131.21 -55.74 1.03 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.802 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -155.36 87.51 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.2 m170 -77.3 71.3 3.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 62.77 -79.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.042 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.74 174.28 1.83 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.796 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -176.24 149.18 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.906 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.72 -68.35 0.81 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.885 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.63 -74.7 0.22 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.598 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.9 mt 60.7 99.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.78 0.324 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.447 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.2 m -130.33 88.33 47.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -51.93 -61.16 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.545 2.163 . . . . 0.0 112.3 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -174.93 -67.78 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.07 -131.91 1.28 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.487 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -104.68 82.12 1.86 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -166.21 32.79 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -127.44 -73.95 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.923 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.67 57.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.076 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.8 t 60.56 32.77 20.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 59.92 161.64 0.1 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.001 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.15 -47.01 1.22 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.584 2.189 . . . . 0.0 112.208 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 62.87 -79.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.64 -172.48 3.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.892 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 78' ' ' ILE . 24.5 mm -66.2 127.68 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.946 0.403 . . . . 0.0 110.902 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' A' ' 75' ' ' SER . 1.9 tt -82.33 98.63 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.564 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.487 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -86.8 98.19 11.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.568 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.672 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -94.73 119.27 33.08 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-O 121.121 0.486 . . . . 0.0 111.313 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.834 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.8 t80 -52.39 138.37 27.24 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.969 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -119.64 177.98 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.779 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.478 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 14.7 p -177.44 129.58 0.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.19 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.508 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 24.8 t30 -59.01 -33.53 70.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.11 0.481 . . . . 0.0 110.162 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 14.3 mtt180 -67.12 140.44 57.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -78.08 -1.87 34.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.354 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.55 137.38 39.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.81 0.338 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.26 155.33 93.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.15 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 119.94 6.72 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.434 2.089 . . . . 0.0 112.006 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 4.8 t -59.89 161.21 6.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.89 -96.58 0.01 OUTLIER Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.768 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -158.56 118.26 1.81 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.655 0.264 . . . . 0.0 111.192 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.0 -1.29 10.66 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.562 2.174 . . . . 0.0 111.958 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 2.2 m-20 -38.25 -31.29 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.833 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.955 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -45.47 -30.14 1.32 Allowed 'General case' 0 CA--C 1.528 0.121 0 CA-C-O 121.14 0.495 . . . . 0.0 110.8 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.797 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.7 mp -102.74 -28.69 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.937 -178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.43 ' HB2' ' HA ' ' A' ' 45' ' ' ASP . 5.6 m-30 -54.27 -51.53 64.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.779 0.324 . . . . 0.0 110.861 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -133.61 36.84 3.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 43.76 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.721 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -127.88 -49.68 1.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.791 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 61.35 25.9 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.579 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.67 -39.27 6.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.161 0.505 . . . . 0.0 110.6 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.955 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -86.26 171.6 11.12 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.091 179.123 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.22 161.06 13.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.74 0.305 . . . . 0.0 110.982 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' HB3' ' HB ' ' A' ' 153' ' ' VAL . 0.1 OUTLIER -163.87 115.53 1.37 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.101 0.476 . . . . 0.0 111.461 -179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.19 147.61 13.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.408 179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 4.1 m-85 -107.17 177.94 4.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.061 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.654 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.5 mppt? -140.03 -60.82 0.53 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.581 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 45.45 -178.0 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.581 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.7 Cg_endo -50.63 110.37 0.39 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 120.875 1.05 . . . . 0.0 110.899 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.411 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 13.2 p-10 -33.58 -36.34 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.927 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.4 ptt85 -109.9 123.19 49.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.781 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.7 pp -146.81 147.36 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.204 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -118.72 116.75 27.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.542 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.2 t 60.98 143.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.537 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 103.44 -32.85 7.11 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.934 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.554 ' O ' HG22 ' A' ' 68' ' ' THR . 1.0 OUTLIER -54.81 100.65 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.882 0.341 . . . . 0.0 110.239 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 141' ' ' ILE . 2.1 p90 -161.53 167.02 26.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.908 0.385 . . . . 0.0 111.794 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.834 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -151.91 -170.49 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-O 121.424 0.631 . . . . 0.0 111.688 179.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.754 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.03 -124.75 1.3 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.899 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.854 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.5 p -172.84 122.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.206 0.527 . . . . 0.0 111.251 178.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.5 ttpm? -89.43 148.06 23.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.98 0.419 . . . . 0.0 112.053 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.624 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.5 m-30 -104.95 -173.37 2.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.813 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.751 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -96.58 -56.13 2.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.946 0.403 . . . . 0.0 111.108 -179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.428 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 1.5 m-80 -131.42 167.8 20.24 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.697 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.8 Cg_endo -54.17 138.17 71.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.328 2.019 . . . . 0.0 111.495 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.545 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -147.61 131.37 9.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.316 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.529 HG22 ' OD1' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -62.25 96.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.32 -0.4 . . . . 0.0 109.949 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.625 HD21 ' HB ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -85.07 107.82 17.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.971 -179.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -69.58 -22.99 63.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.775 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 178.13 130.43 0.06 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.9 0.381 . . . . 0.0 111.333 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.625 ' HB ' HD21 ' A' ' 80' ' ' LEU . 7.1 p -105.14 142.65 17.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.842 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -151.63 121.09 6.86 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.662 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.8 ' CE1' HG21 ' A' ' 102' ' ' ILE . 4.0 m-85 -102.38 100.38 10.52 Favored 'General case' 0 CA--C 1.527 0.091 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.619 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.3 OUTLIER -86.43 93.75 9.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.352 . . . . 0.0 110.154 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.504 ' HG3' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -141.99 168.36 19.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.419 0.628 . . . . 0.0 112.132 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -134.85 -103.91 0.78 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.072 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 93' ' ' PRO . . . -143.53 175.0 10.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.454 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.0 p-10 -78.41 -62.26 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.297 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.4 m -104.11 -56.62 2.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.175 0.512 . . . . 0.0 110.27 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -116.49 122.14 32.28 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.346 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 48.0 Cg_exo -34.48 -32.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.402 2.734 . . . . 0.0 113.922 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -59.25 -19.62 47.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.622 0.249 . . . . 0.0 111.629 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.59 98.18 3.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.896 0.379 . . . . 0.0 111.386 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.924 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.47 -164.92 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.455 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.703 ' N ' HG23 ' A' ' 96' ' ' THR . 6.1 tpp -45.23 159.15 0.06 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.306 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.616 ' C ' ' HB ' ' A' ' 121' ' ' THR . 19.2 tm0? -97.82 -38.99 9.24 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.552 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 20.5 mtmm -176.28 122.18 0.17 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.584 -1.189 . . . . 0.0 108.602 177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.805 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.33 162.2 0.37 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.658 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.81 174.01 6.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.963 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.8 HG21 ' CE1' ' A' ' 85' ' ' PHE . 0.7 OUTLIER -97.23 162.4 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 120.54 -0.464 . . . . 0.0 111.127 179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.419 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 0.7 OUTLIER -138.39 -169.95 2.71 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.032 0.444 . . . . 0.0 111.579 -179.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.74 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -169.06 158.47 8.53 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.349 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.643 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.3 t -110.8 140.37 45.28 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.459 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.3 t -89.57 -61.1 2.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.4 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -96.71 36.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.76 0.314 . . . . 0.0 111.237 -179.439 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.11 30.25 7.36 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.377 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -129.28 -70.86 0.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.891 0.377 . . . . 0.0 110.791 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -88.84 166.32 14.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.615 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.643 ' CZ2' HG22 ' A' ' 105' ' ' THR . 35.5 m95 -134.26 120.4 19.94 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.651 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -115.86 153.17 17.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.393 -179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -43.23 150.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.5 tt -128.48 -52.77 1.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' HG13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -101.03 155.28 18.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.409 0.624 . . . . 0.0 112.585 -178.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.57 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.8 tp10 -49.01 166.86 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.131 178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.07 61.78 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.215 -0.993 . . . . 0.0 111.094 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.874 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.8 t -82.25 157.37 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 CA-C-O 121.04 0.448 . . . . 0.0 110.738 -179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 121' ' ' THR . 3.8 mt-10 -106.41 77.06 1.18 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.252 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.874 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.8 m-85 -70.63 42.59 0.06 Allowed 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.155 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.712 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -93.31 -15.47 25.75 Favored 'General case' 0 CA--C 1.516 -0.357 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.664 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -138.06 44.07 0.82 Allowed Pre-proline 0 N--CA 1.448 -0.537 0 CA-C-N 114.441 -1.254 . . . . 0.0 108.566 178.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.924 ' HD2' HG21 ' A' ' 96' ' ' THR . 97.5 Cg_endo -84.36 98.39 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.779 2.319 . . . . 0.0 113.249 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -69.52 -49.85 35.21 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 178.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.619 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.54 107.5 4.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.279 -0.46 . . . . 0.0 110.138 178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.673 HG21 HD11 ' A' ' 102' ' ' ILE . 1.4 mt -92.52 132.14 37.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.743 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.413 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 0.1 OUTLIER -157.93 132.75 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.857 179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 115' ' ' GLU . 11.2 t -116.71 128.85 73.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.148 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -103.24 164.49 11.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 60.01 35.11 21.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 83' ' ' VAL . 19.2 tp -107.66 21.77 16.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.529 ' OD1' HG22 ' A' ' 79' ' ' THR . 23.0 t0 -54.89 89.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.004 0.43 . . . . 0.0 111.06 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 32.8 tp -156.24 130.02 8.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.868 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.27 130.09 37.57 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.651 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.3 p -148.02 160.4 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 C-N-CA 120.466 -0.493 . . . . 0.0 111.743 -178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 2.7 mtp180 -111.66 127.98 55.92 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.75 -176.35 0.04 OUTLIER Glycine 0 C--N 1.316 -0.578 0 CA-C-N 115.577 -0.738 . . . . 0.0 113.86 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.854 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.1 m -152.02 150.96 12.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 C-N-CA 122.909 0.484 . . . . 0.0 109.978 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 37.0 ttp180 -173.28 163.32 4.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.341 0.591 . . . . 0.0 112.14 -179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -107.81 159.27 16.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.047 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.805 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 1.6 mm -133.91 113.23 17.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.962 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . . . -69.38 165.74 20.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.418 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.8 m -127.51 -41.03 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.185 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -124.83 -42.69 2.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.321 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.542 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 61.8 173.05 0.12 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.046 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.813 ' HG3' HG21 ' A' ' 149' ' ' THR . 1.7 ptp180 -133.14 167.6 20.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.92 0.39 . . . . 0.0 111.133 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 17.8 mp0 -90.37 161.09 15.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.826 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.411 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.6 p30 41.83 71.58 0.2 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.188 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.813 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.2 t -158.81 137.72 11.21 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.307 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.654 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.6 m0 -97.41 -173.02 2.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.221 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.543 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -126.55 98.56 5.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.805 178.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.504 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -83.0 159.05 37.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.36 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.711 HG11 ' HE2' ' A' ' 32' ' ' TYR . 6.0 t -149.48 150.5 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.758 0.313 . . . . 0.0 111.392 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -124.3 -46.88 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.823 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 86' ' ' LEU . 11.8 t70 -179.16 159.25 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.477 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.797 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.6 mt -140.63 142.12 31.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.998 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.33 144.8 50.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.891 0.377 . . . . 0.0 111.067 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.624 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.1 m -141.15 106.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.98 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.56 ' OD1' HD12 ' A' ' 80' ' ' LEU . 2.0 m-20 69.76 76.47 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.95 43.23 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.842 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt 61.82 109.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 45.29 36.62 2.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.335 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.56 -68.08 0.19 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 46.3 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.905 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.5 tpp . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.841 0.353 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -118.18 28.25 7.0 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.571 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -105.16 -74.5 0.65 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.893 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.99 32.75 2.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.926 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -96.45 -168.79 1.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.93 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 16.4 m80 61.54 89.51 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.906 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.4 ' O ' ' CG ' ' A' ' 8' ' ' HIS . 13.6 p-80 -140.38 31.22 1.92 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.813 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.4 ' CG ' ' O ' ' A' ' 7' ' ' HIS . 6.7 m-70 -176.57 82.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.22 -35.74 76.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -102.43 -175.68 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.93 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.35 149.16 34.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.892 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 52.1 m -60.38 157.83 13.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.18 -31.86 7.78 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.406 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.3 mp -114.77 156.66 24.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.83 0.347 . . . . 0.0 110.965 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' HD2' ' A' ' 16' ' ' PRO . 10.7 p -153.95 139.34 11.97 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.984 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.403 ' HD2' HG23 ' A' ' 15' ' ' VAL . 56.6 Cg_exo -51.98 135.09 50.79 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.508 2.139 . . . . 0.0 112.28 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.1 mtm105 -107.26 148.87 28.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.62 -91.68 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.2 m 68.49 -68.29 0.18 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.1 m170 60.85 79.35 0.25 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.422 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 35.1 mtm -150.34 -169.28 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.885 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . 68.16 -69.21 0.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -59.64 -31.85 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.899 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 t70 60.05 87.74 0.13 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.949 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.58 158.85 55.71 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.52 2.147 . . . . 0.0 112.318 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -129.82 136.34 49.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.812 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtm-85 60.54 172.0 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.872 HD13 HG22 ' A' ' 78' ' ' ILE . 3.5 mp -88.21 126.33 41.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.933 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 30' ' ' ALA . 5.2 mp -92.85 160.27 2.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.606 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.628 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -124.12 108.01 11.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.829 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.698 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.92 123.38 44.11 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 121.062 0.458 . . . . 0.0 111.535 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.86 ' OH ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -54.94 136.87 46.92 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.874 179.447 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.517 HG12 ' HA ' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -114.97 -176.39 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-O 121.152 0.501 . . . . 0.0 110.896 179.008 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.443 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -176.89 149.87 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.72 178.684 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 0.6 OUTLIER -110.78 -20.01 12.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.465 178.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' CG ' HG23 ' A' ' 68' ' ' THR . 19.5 mtt-85 -64.26 -15.15 59.55 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.537 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 70.26 31.19 3.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.924 0.393 . . . . 0.0 110.544 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -116.86 113.28 22.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.784 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.19 138.68 66.22 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.925 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -61.27 120.01 7.46 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.415 2.077 . . . . 0.0 112.06 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.626 HG23 ' N ' ' A' ' 42' ' ' GLY . 0.5 OUTLIER -79.92 -177.2 5.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.794 -179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 41' ' ' THR . . . 45.64 -102.71 0.04 OUTLIER Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.735 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -158.56 105.46 1.64 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 120.693 0.282 . . . . 0.0 110.935 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.574 ' HA ' HD12 ' A' ' 47' ' ' ILE . 79.3 Cg_endo -77.53 -1.51 11.68 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.401 2.068 . . . . 0.0 112.006 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.95 -42.14 3.63 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.907 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.76 -38.09 14.8 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.533 0.682 . . . . 0.0 110.128 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.716 HG21 ' CD2' ' A' ' 32' ' ' TYR . 2.0 mp -80.19 -34.98 15.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.459 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.438 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 2.3 m-30 -54.27 -50.35 67.44 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.72 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -126.63 39.87 3.84 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 42.18 95.16 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.558 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 11.9 t30 -179.75 81.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.12 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.428 ' HA ' ' CB ' ' A' ' 46' ' ' ASN . . . -60.99 64.18 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.495 ' N ' ' O ' ' A' ' 51' ' ' ASN . 74.7 m -113.77 28.73 8.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.921 0.391 . . . . 0.0 110.628 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.907 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -160.36 171.08 19.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.503 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.32 150.41 37.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.901 0.382 . . . . 0.0 111.485 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD21 ' HB ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.77 145.92 9.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.906 179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.624 ' H ' HG22 ' A' ' 41' ' ' THR . 1.2 m -151.6 144.24 16.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.27 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.467 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 7.9 m-30 -100.74 118.3 36.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.993 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.836 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.33 19.63 0.06 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -178.166 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -51.35 -63.8 1.78 Allowed Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 179.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 38.5 Cg_endo -95.29 110.21 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.805 2.337 . . . . 0.0 110.832 177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -74.49 57.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.104 0.478 . . . . 0.0 110.947 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 64' ' ' ILE . 4.7 ptm180 175.91 134.7 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.525 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.693 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.1 OUTLIER -155.43 154.79 6.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.061 0.458 . . . . 0.0 111.481 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' HB3' ' A' ' 145' ' ' ALA . 2.3 t70 -114.71 178.11 4.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.424 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.616 ' O ' HG13 ' A' ' 66' ' ' VAL . 8.6 p -43.99 101.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.991 0.424 . . . . 0.0 111.239 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.475 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.18 -19.92 0.55 Allowed Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.673 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.647 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -57.34 118.29 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.838 0.351 . . . . 0.0 110.759 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 2.1 p90 -162.71 167.82 22.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.688 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.755 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -152.32 -175.25 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.506 0.67 . . . . 0.0 111.945 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.755 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.07 -120.93 0.96 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 114.656 -1.157 . . . . 0.0 110.293 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.1 p -173.51 121.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.252 0.548 . . . . 0.0 111.19 178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' N ' ' O ' ' A' ' 31' ' ' THR . 18.0 tttt -88.91 142.3 27.77 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.882 0.373 . . . . 0.0 111.628 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.533 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 2.4 m-30 -102.18 -178.89 3.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 -28.58 11.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.73 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -148.31 169.46 9.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.741 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.96 134.71 18.22 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.648 2.232 . . . . 0.0 112.656 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.872 HG22 HD13 ' A' ' 28' ' ' ILE . 16.1 pt -139.68 132.03 34.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.095 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -53.36 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.881 0.372 . . . . 0.0 110.141 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.684 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.8 tt -87.21 105.98 17.58 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.042 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -69.83 -26.51 64.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.715 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -177.97 135.95 0.17 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.071 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 114' ' ' LEU . 9.3 p -105.09 145.54 13.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.361 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' HG23 ' A' ' 156' ' ' ILE . 8.2 pt-20 -151.64 130.49 12.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.792 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.715 ' CE1' HG21 ' A' ' 102' ' ' ILE . 8.3 m-85 -115.15 100.75 8.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.931 178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 3.1 mm? -82.01 96.87 7.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.743 0.306 . . . . 0.0 110.325 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.661 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.55 15.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.326 0.584 . . . . 0.0 111.631 -178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.427 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -160.36 -113.09 0.31 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.578 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.48 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.02 164.81 29.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 110.951 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -87.29 -61.05 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.888 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 73.6 p -104.02 -61.37 1.45 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.002 0.429 . . . . 0.0 110.952 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -98.6 121.94 54.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.83 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 10.8 Cg_endo -53.84 -17.11 9.83 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.64 2.227 . . . . 0.0 112.912 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -90.68 26.39 2.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.557 0.218 . . . . 0.0 111.475 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -107.85 85.98 2.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.765 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.49 -165.03 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.482 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.525 ' N ' ' OG1' ' A' ' 96' ' ' THR . 5.1 tpp -39.81 160.85 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.9 0.381 . . . . 0.0 111.425 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.636 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.6 tp60 -99.7 -40.64 7.66 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 8.1 tttp -176.68 122.42 0.15 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.957 177.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.899 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.37 161.67 0.64 Allowed 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.29 173.55 6.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 114.746 -1.116 . . . . 0.0 108.622 178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.715 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.0 OUTLIER -94.93 159.98 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.453 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.537 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 2.0 mt-30 -133.06 -179.73 5.67 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.571 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.814 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.6 p90 -166.69 146.67 5.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.556 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.687 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.0 t -105.38 140.9 37.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.61 -61.09 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.309 -0.405 . . . . 0.0 112.008 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -98.44 36.16 1.67 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.885 0.374 . . . . 0.0 111.026 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.41 ' HA3' ' CD ' ' A' ' 136' ' ' ARG . . . 47.26 36.44 10.36 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.594 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 12.1 ptt180 -134.85 -58.68 0.81 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.954 0.407 . . . . 0.0 111.066 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -103.94 161.02 14.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.366 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.642 ' CZ2' HG22 ' A' ' 105' ' ' THR . 39.9 m95 -129.84 118.87 22.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.664 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -108.09 162.3 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.642 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.537 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 83.9 m-20 -52.9 142.82 18.33 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.948 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.896 HD11 HG11 ' A' ' 83' ' ' VAL . 6.4 tt -118.0 -57.84 2.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.423 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.773 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -104.73 153.9 20.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.591 . . . . 0.0 112.47 -178.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.616 ' O ' ' N ' ' A' ' 118' ' ' VAL . 1.7 mm-40 -44.5 166.8 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.687 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.26 61.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.257 -0.973 . . . . 0.0 111.023 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -81.55 158.08 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 CA-C-O 121.048 0.451 . . . . 0.0 110.783 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.0 OUTLIER -107.11 77.6 1.17 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.5 m-85 -70.34 41.07 0.05 Allowed 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.255 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.765 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.76 -17.69 22.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.279 -0.873 . . . . 0.0 108.8 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.661 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -135.7 43.25 0.85 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 114.65 -1.159 . . . . 0.0 108.656 178.214 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.661 ' HD3' ' N ' ' A' ' 122' ' ' MET . 74.1 Cg_endo -84.91 101.46 0.77 Allowed 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.886 2.391 . . . . 0.0 113.31 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.19 -44.66 22.24 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.07 111.93 6.8 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.191 -0.505 . . . . 0.0 109.941 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -99.75 134.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.182 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 19.8 tttp -158.9 122.9 3.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.5 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.773 HG22 ' HG3' ' A' ' 115' ' ' GLU . 7.6 t -102.1 117.52 47.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.157 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -97.59 170.72 8.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.761 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 59.46 29.57 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.65 HD23 ' CD2' ' A' ' 80' ' ' LEU . 6.7 tp -121.98 79.42 1.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.716 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.504 ' C ' HD23 ' A' ' 133' ' ' LEU . 2.9 t70 -107.62 89.91 3.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.001 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -155.88 131.55 9.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.212 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.36 143.47 23.44 Favored 'General case' 0 C--O 1.231 0.116 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.616 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -156.49 168.32 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 119.962 -0.695 . . . . 0.0 112.191 -178.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.573 ' O ' HG23 ' A' ' 105' ' ' THR . 1.0 OUTLIER -115.43 128.0 55.74 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 176.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.472 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.23 -176.18 0.21 Allowed Glycine 0 C--N 1.312 -0.752 0 C-N-CA 120.796 -0.716 . . . . 0.0 113.827 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.864 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.5 OUTLIER -157.7 151.95 7.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 C-N-CA 123.022 0.529 . . . . 0.0 109.763 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.558 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 8.3 ttp180 -173.6 163.09 4.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.188 0.518 . . . . 0.0 111.926 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -102.38 159.43 15.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.737 179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.899 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -126.58 113.23 32.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.05 0.452 . . . . 0.0 110.837 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.647 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -74.87 153.19 38.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.554 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.486 ' C ' HG23 ' A' ' 66' ' ' VAL . 17.4 p -127.51 16.58 7.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.148 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.569 ' N ' HG23 ' A' ' 66' ' ' VAL . 2.8 pt-20 177.66 -36.69 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.831 0.348 . . . . 0.0 110.929 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.409 ' HB3' ' C ' ' A' ' 65' ' ' ASP . . . 66.38 178.65 0.21 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.34 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.84 ' HB3' HG21 ' A' ' 149' ' ' THR . 13.1 ttt180 -131.15 138.74 49.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.145 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.16 148.26 26.86 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.755 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 43.22 88.63 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.974 0.416 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.84 HG21 ' HB3' ' A' ' 146' ' ' ARG . 3.2 t -177.61 152.75 0.83 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.981 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.836 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 41.1 m0 -110.82 -173.16 2.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.36 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.526 HD13 ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -150.84 98.57 2.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.226 178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 89' ' ' ALA . . . -87.41 78.29 1.86 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.66 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.86 HG21 ' OH ' ' A' ' 32' ' ' TYR . 42.0 t -64.69 149.97 10.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -110.92 -38.04 5.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.517 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.426 ' HA ' HG13 ' A' ' 47' ' ' ILE . 7.0 t0 -179.57 177.72 0.71 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.473 0.654 . . . . 0.0 112.285 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.647 ' HB ' HG23 ' A' ' 47' ' ' ILE . 57.5 mt -151.42 138.32 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.368 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.08 152.72 45.48 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.114 0.483 . . . . 0.0 111.574 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.564 ' CG2' HD12 ' A' ' 80' ' ' LEU . 8.7 p -155.32 140.81 10.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.687 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.431 ' HB3' ' H ' ' A' ' 163' ' ' ASP . 0.8 OUTLIER 70.53 52.7 0.32 Allowed 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 121.028 0.442 . . . . 0.0 110.559 -179.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -58.88 136.23 57.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? 56.31 23.6 7.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.37 -65.12 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.734 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 159' ' ' ASN . 11.8 m-20 69.17 -67.5 0.22 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.075 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.935 179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 mmt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.855 0.36 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 134.13 -64.98 0.59 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.543 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t 60.58 31.36 20.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 0.0 110.963 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 68.08 -70.09 0.13 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.968 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -120.7 105.86 11.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.917 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -176.74 82.29 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.837 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.31 -56.98 2.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.93 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -174.75 79.66 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -108.19 80.06 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -173.34 82.55 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 68.02 -70.8 0.12 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.999 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 m 60.37 -171.37 0.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.864 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.15 108.67 0.67 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.497 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 tp 61.17 112.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.81 0.338 . . . . 0.0 110.858 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.1 m -133.69 81.79 52.48 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.224 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -52.37 92.22 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.579 2.186 . . . . 0.0 112.252 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.1 mmp_? -151.79 -46.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -135.59 112.32 0.98 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.501 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.5 t -64.13 81.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.783 0.325 . . . . 0.0 110.907 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -136.9 -47.59 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -160.5 138.0 9.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.882 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -166.4 -73.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.1 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 p -105.26 31.08 5.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.002 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.4 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 83.1 m-20 61.08 54.06 3.03 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.912 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 58.7 Cg_endo -71.67 162.41 42.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.61 2.207 . . . . 0.0 112.308 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -177.03 -69.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.935 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -176.56 -170.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.878 HD11 ' HB3' ' A' ' 75' ' ' SER . 9.0 tp -144.26 159.99 15.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.116 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.3 mp -82.04 158.72 3.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.473 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.754 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.42 98.41 3.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.034 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.465 ' HA ' ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -92.88 127.11 38.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.036 0.446 . . . . 0.0 110.814 179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.822 ' OH ' HG21 ' A' ' 70' ' ' VAL . 9.4 t80 -52.21 155.76 1.87 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.518 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -134.36 -168.83 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.643 0.735 . . . . 0.0 112.207 -179.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.44 ' HB2' ' CD2' ' A' ' 58' ' ' TYR . 3.0 p -176.41 -176.25 0.74 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.968 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 8.1 t-20 -102.09 -34.87 9.13 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.741 0.305 . . . . 0.0 111.338 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.794 ' NH1' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -103.23 162.89 12.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.066 -179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.0 -23.52 19.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.7 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 39.9 p-10 -53.5 88.6 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.15 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.42 150.36 89.91 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.301 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.69 119.94 6.76 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.274 1.983 . . . . 0.0 111.634 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -67.88 -166.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.44 -179.132 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.588 ' N ' HG23 ' A' ' 41' ' ' THR . . . 41.65 -101.76 0.02 OUTLIER Glycine 0 C--N 1.333 0.413 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.033 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.57 105.39 1.64 Allowed Pre-proline 0 C--N 1.328 -0.37 0 CA-C-O 120.635 0.255 . . . . 0.0 111.404 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 47' ' ' ILE . 57.1 Cg_endo -73.45 -1.13 10.21 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.67 2.247 . . . . 0.0 111.555 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 t70 -43.25 -46.78 6.33 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.16 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.904 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -47.48 -32.84 5.56 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.42 0.629 . . . . 0.0 110.116 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 156' ' ' ILE . 3.8 mp -84.01 -29.92 7.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.606 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 6.9 m-30 -54.39 -40.72 68.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.926 -178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -156.22 55.25 0.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.425 ' HB2' ' CB ' ' A' ' 157' ' ' ASN . 23.3 t-20 44.42 99.07 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.026 0.441 . . . . 0.0 112.078 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 t-20 -176.97 70.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.707 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . . . -62.66 58.46 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 51' ' ' ASN . 2.8 m -114.0 28.68 8.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.245 0.545 . . . . 0.0 110.259 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.904 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -158.09 171.42 20.27 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.367 -179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.41 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -120.28 147.6 44.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.704 0.287 . . . . 0.0 110.854 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -163.79 137.96 5.78 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.766 0.793 . . . . 0.0 111.545 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.79 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 p -155.48 104.87 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.187 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.505 ' O ' ' CD1' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -69.59 112.11 5.86 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.724 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -139.0 -58.63 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.566 ' HB3' ' CD ' ' A' ' 61' ' ' PRO . 18.3 t30 27.47 -86.74 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 123.658 0.599 . . . . 0.0 111.087 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.566 ' CD ' ' HB3' ' A' ' 60' ' ' ASN . 97.5 Cg_endo -78.39 109.84 2.73 Favored 'Trans proline' 0 C--N 1.357 1.008 0 CA-C-N 120.591 1.247 . . . . 0.0 110.706 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -77.55 64.32 2.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.147 0.499 . . . . 0.0 110.807 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.26 123.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.336 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.794 HG23 ' NH1' ' A' ' 36' ' ' ARG . 0.6 OUTLIER -147.29 133.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.673 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -118.98 116.33 26.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.589 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.1 t 42.71 93.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.902 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 151.22 -20.04 0.95 Allowed Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.171 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.491 ' OG1' HG21 ' A' ' 64' ' ' ILE . 1.1 m -52.27 108.8 0.32 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.865 0.333 . . . . 0.0 110.917 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.532 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.6 167.85 22.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.13 0.491 . . . . 0.0 111.897 179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.822 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -150.3 -170.34 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.583 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.73 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 158.18 -125.87 1.61 Allowed Glycine 0 N--CA 1.442 -0.963 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.534 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.818 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -172.96 118.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 121.359 0.6 . . . . 0.0 111.754 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 2.3 ptpt -89.44 150.7 22.39 Favored 'General case' 0 N--CA 1.464 0.263 0 O-C-N 122.066 -0.397 . . . . 0.0 111.667 -178.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.613 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.1 m-30 -107.09 -172.27 2.05 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.093 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.878 ' HB3' HD11 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -93.34 -24.32 18.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.405 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.767 ' O ' HG23 ' A' ' 78' ' ' ILE . 6.5 m-20 -172.88 168.07 2.75 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.966 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.3 Cg_endo -52.64 119.89 6.65 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.585 2.19 . . . . 0.0 111.828 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.811 HG21 ' CB ' ' A' ' 28' ' ' ILE . 1.5 pp -133.87 142.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.588 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -59.03 96.23 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.301 179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.2 tt -83.05 109.72 17.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.063 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -69.75 -31.8 69.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.557 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 172.96 142.21 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.901 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.717 ' HA ' HG12 ' A' ' 158' ' ' VAL . 7.1 p -105.06 153.73 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.472 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.404 ' N ' HG22 ' A' ' 83' ' ' VAL . 32.6 tt0 -151.45 105.89 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.188 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.68 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 50.0 m-85 -99.38 100.82 11.94 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.04 -0.264 . . . . 0.0 110.319 179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 155' ' ' ASP . 0.7 OUTLIER -91.52 102.72 15.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.88 0.371 . . . . 0.0 110.343 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.758 ' HG2' HG13 ' A' ' 153' ' ' VAL . 0.6 OUTLIER -141.86 -179.67 6.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.307 0.575 . . . . 0.0 111.492 -179.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.26 -111.19 0.25 Allowed Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.61 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.33 158.01 43.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.775 0.321 . . . . 0.0 111.07 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.442 ' HB2' HG21 ' A' ' 57' ' ' VAL . 9.3 t30 -85.74 -67.91 0.77 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.478 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.5 m -103.5 -60.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.677 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.563 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 4.0 t-20 -89.48 121.79 68.94 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.579 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -48.21 -24.44 5.77 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.783 2.322 . . . . 0.0 112.722 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.01 26.34 3.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.19 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.609 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 58.7 m-20 -93.9 85.64 4.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.35 . . . . 0.0 111.261 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 121' ' ' THR . 1.7 t -176.91 -165.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.248 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.701 ' CE ' HD22 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -41.76 163.59 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.92 179.474 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.712 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.6 OUTLIER -103.12 -41.49 6.07 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 30.5 mtmt -175.75 122.24 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.043 176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.38 161.75 0.49 Allowed 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.439 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -104.95 172.06 6.99 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.708 178.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.658 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.6 mt -90.14 162.32 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.463 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.473 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.4 OUTLIER -129.02 -172.51 2.74 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.077 -179.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.639 ' CD2' HD13 ' A' ' 114' ' ' LEU . 10.5 p90 -175.03 152.73 1.52 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.403 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.662 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 1.7 t -112.16 139.02 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.478 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -90.02 -60.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -178.661 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.416 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.06 33.82 1.47 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.836 0.351 . . . . 0.0 111.401 -179.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 49.3 36.66 23.12 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -135.23 -71.11 0.48 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.824 0.345 . . . . 0.0 110.729 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 105' ' ' THR . 10.6 pt-20 -90.93 164.56 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.301 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.662 ' CZ2' HG22 ' A' ' 105' ' ' THR . 34.3 m95 -131.0 123.66 29.26 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.768 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.68 164.52 12.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.548 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.473 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 20.0 p30 -48.1 151.07 1.04 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.29 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.751 HD11 HD21 ' A' ' 131' ' ' LEU . 57.2 tp -128.58 -57.66 1.19 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.512 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.658 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -104.01 155.67 18.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.569 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mp0 -46.21 166.92 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.534 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.97 61.54 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.345 -0.931 . . . . 0.0 111.313 178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.787 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -83.77 159.12 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 120.795 0.331 . . . . 0.0 110.519 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.0 mt-10 -106.15 79.3 1.38 Allowed 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.787 ' CE1' HG11 ' A' ' 118' ' ' VAL . 61.5 m-85 -70.63 33.44 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.263 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.828 ' O ' HG23 ' A' ' 96' ' ' THR . 0.6 OUTLIER -89.8 -21.07 22.79 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.461 177.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -136.34 42.07 0.66 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 114.974 -1.012 . . . . 0.0 108.979 178.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 62.5 Cg_endo -88.32 98.63 0.4 Allowed 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.687 2.258 . . . . 0.0 113.288 -178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -70.02 -38.03 73.84 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.03 130.05 21.96 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.151 -0.525 . . . . 0.0 110.192 178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.599 HG21 HD11 ' A' ' 102' ' ' ILE . 3.7 mt -121.31 128.48 75.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.873 -178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.542 ' O ' HG13 ' A' ' 128' ' ' VAL . 30.9 ttpt -159.12 160.17 35.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.073 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 127' ' ' LYS . 2.3 m -159.32 113.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.026 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -88.7 170.04 11.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 11.6 m120 60.93 46.39 8.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.756 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.751 HD21 HD11 ' A' ' 114' ' ' LEU . 16.1 tp -119.34 27.56 8.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.979 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -54.84 95.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.736 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 25.8 tp -155.55 119.25 4.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.225 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 35.2 mttt -54.3 125.52 19.63 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.653 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -150.19 166.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 120.282 -0.567 . . . . 0.0 111.895 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.658 ' O ' HG23 ' A' ' 105' ' ' THR . 0.8 OUTLIER -111.79 128.54 56.13 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.528 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.81 -172.12 0.15 Allowed Glycine 0 C--N 1.314 -0.656 0 C-N-CA 120.807 -0.711 . . . . 0.0 114.309 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.818 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -161.94 149.66 4.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.905 0.482 . . . . 0.0 110.166 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.598 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 30.3 ttp180 -173.87 161.23 3.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.206 0.527 . . . . 0.0 112.071 -179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.701 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -96.5 159.04 15.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.105 179.308 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 6.2 tp -129.31 131.05 67.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.664 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.439 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -98.4 150.28 21.79 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.979 0.419 . . . . 0.0 111.615 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.513 ' O ' HG22 ' A' ' 143' ' ' THR . 86.2 m -127.44 3.12 6.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.219 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -178.42 57.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.957 0.408 . . . . 0.0 110.675 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -48.75 174.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.569 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -121.49 163.37 18.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.977 -179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -83.83 139.96 32.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.825 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 31.5 m120 51.67 86.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.832 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG3' ' A' ' 146' ' ' ARG . 2.0 t -158.17 129.04 6.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.01 0.433 . . . . 0.0 111.414 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.724 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 38.8 m0 -101.19 -172.63 2.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.276 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.711 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -142.1 98.84 3.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.963 179.198 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.06 84.21 1.56 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.417 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.758 HG13 ' HG2' ' A' ' 87' ' ' MET . 48.5 t -80.06 152.52 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.332 . . . . 0.0 111.116 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 6.9 mmm180 -124.27 -40.07 2.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.444 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.511 ' C ' HG22 ' A' ' 156' ' ' ILE . 2.3 t0 -157.94 159.58 36.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.033 0.444 . . . . 0.0 111.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.856 HD13 HG23 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 175.46 111.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.662 179.294 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 50' ' ' ASN . 22.7 p-10 -139.67 154.7 47.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.779 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 83' ' ' VAL . 25.2 m -120.22 148.36 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.239 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.484 HD22 HG23 ' A' ' 158' ' ' VAL . 22.6 m-80 64.1 47.46 3.31 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 76.43 0.46 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.839 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.02 36.96 24.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.854 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 61.78 75.08 0.42 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -74.28 132.03 41.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.937 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 120.765 0.317 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 138.61 -85.37 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.435 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.74 88.41 6.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.776 0.322 . . . . 0.0 110.865 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.6 m -104.51 178.02 4.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.41 39.57 1.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 61.1 172.73 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -73.6 166.77 22.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -147.89 82.73 1.51 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 60.51 103.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.952 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -141.47 -47.63 0.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -164.03 -49.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 64.7 m -63.57 -47.94 79.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' C ' HD12 ' A' ' 14' ' ' LEU . . . -91.14 50.51 3.08 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.453 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.448 HD12 ' C ' ' A' ' 13' ' ' GLY . 3.1 mp -146.73 75.42 1.39 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.856 0.36 . . . . 0.0 110.891 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.486 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 4.6 t -83.45 -45.79 0.81 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.447 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 53.9 Cg_exo -52.29 107.11 0.17 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.353 2.035 . . . . 0.0 112.32 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.5 ptt85 -177.3 126.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.926 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.99 2.4 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.548 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.48 31.81 5.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.16 -174.76 0.53 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.886 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.9 ttt 62.53 118.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.959 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.68 -47.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 65.0 m -107.15 -43.7 4.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.812 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 62.7 147.59 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.901 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.38 -35.9 4.5 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.478 2.119 . . . . 0.0 112.46 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 9.9 p30 44.3 31.13 0.53 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.424 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -177.92 141.0 0.25 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.724 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 78' ' ' ILE . 1.0 OUTLIER -69.1 138.47 22.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.02 0.438 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.783 HD13 ' N ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -82.35 161.08 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.425 179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.783 ' N ' HD13 ' A' ' 29' ' ' ILE . . . -133.68 98.3 4.15 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.778 0.323 . . . . 0.0 111.278 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -90.77 144.75 25.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.336 179.468 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.701 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.2 t80 -83.4 140.38 32.42 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.268 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -115.94 -175.9 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 121.69 0.757 . . . . 0.0 112.133 -179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.473 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 11.4 p -177.6 -174.71 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.127 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 67' ' ' GLY . 4.4 p-10 -105.99 -30.55 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.776 0.322 . . . . 0.0 110.938 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -94.13 145.88 24.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.938 -179.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -53.61 -25.17 16.39 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.552 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 44.5 p-10 -47.6 148.36 1.49 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.859 0.362 . . . . 0.0 111.253 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.76 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.36 168.74 9.13 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.946 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.76 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 59.2 Cg_endo -72.15 119.79 6.39 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.308 2.005 . . . . 0.0 111.925 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.833 HG22 ' H ' ' A' ' 57' ' ' VAL . 13.6 t -59.23 162.77 4.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.636 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 45.72 -97.09 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.617 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -158.61 118.29 1.8 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.597 0.237 . . . . 0.0 111.104 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 59.4 Cg_endo -71.96 -1.26 9.71 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.563 2.175 . . . . 0.0 111.85 178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.428 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.7 OUTLIER -38.88 -31.06 0.05 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.422 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.828 ' ND2' HG23 ' A' ' 54' ' ' THR . 25.2 m-80 -45.39 -31.38 1.64 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.188 0.518 . . . . 0.0 110.5 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.781 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.5 mp -99.94 -33.52 3.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.645 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.457 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.2 m-30 -54.61 -23.02 15.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.819 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -155.81 27.03 0.38 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.615 0.245 . . . . 0.0 111.39 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 p30 42.18 80.79 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.548 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -124.95 -41.87 2.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.081 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 62.95 26.44 15.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.08 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.2 m -103.78 28.73 6.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.076 0.465 . . . . 0.0 110.746 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.828 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.67 171.24 19.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.094 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pm0 -102.62 157.47 16.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 0.0 111.168 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.512 HD13 HG11 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.91 116.93 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.129 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.833 ' H ' HG22 ' A' ' 41' ' ' THR . 1.1 m -154.75 140.99 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.124 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE1' HD21 ' A' ' 56' ' ' LEU . 2.8 m-85 -100.35 124.08 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.835 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.1 OUTLIER -164.14 13.22 0.05 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.655 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 5.8 t30 -48.9 -50.05 64.13 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 118.913 0.779 . . . . 0.0 109.86 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 90.3 Cg_endo -99.33 110.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.153 0 C-N-CA 123.351 2.7 . . . . 0.0 111.105 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 33.4 t30 -76.79 62.33 2.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 110.693 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.34 123.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.443 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.711 ' N ' HD13 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -153.91 121.21 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.136 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -118.64 127.2 53.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.428 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 21.4 t 59.1 108.7 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.269 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.45 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 118.53 -17.56 11.17 Favored Glycine 0 CA--C 1.509 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.862 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.0 m -49.52 96.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.549 0.214 . . . . 0.0 110.813 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.5 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.3 OUTLIER -162.83 171.3 16.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-O 120.944 0.402 . . . . 0.0 111.933 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -155.55 -173.61 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.952 178.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.761 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 166.03 -123.51 1.15 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.868 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -172.89 121.7 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.275 0.56 . . . . 0.0 111.566 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 4.1 ttpp -89.37 145.38 25.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.02 0.438 . . . . 0.0 111.709 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.592 ' OH ' HG21 ' A' ' 158' ' ' VAL . 2.1 m-30 -104.06 -172.47 2.11 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.736 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.41 ' CB ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -104.31 -36.47 7.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.019 179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.557 ' HB2' HD11 ' A' ' 28' ' ' ILE . 2.3 m120 -144.04 167.35 15.51 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.777 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 41.4 Cg_endo -67.75 119.89 6.9 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.394 2.062 . . . . 0.0 112.175 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.786 HG22 HD13 ' A' ' 28' ' ' ILE . 19.9 pt -124.91 136.47 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.203 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.3 t -49.11 96.25 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.96 0.409 . . . . 0.0 110.586 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' A' ' 158' ' ' VAL . 0.2 OUTLIER -75.84 94.21 3.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.915 -179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -69.53 -29.23 66.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.837 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 177.39 131.38 0.06 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.369 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.776 HG11 HD11 ' A' ' 114' ' ' LEU . 7.2 p -104.98 136.98 36.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.9 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.441 ' CB ' ' HA ' ' A' ' 127' ' ' LYS . 4.8 mt-10 -151.42 105.77 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.763 ' HA ' HG23 ' A' ' 156' ' ' ILE . 3.4 m-85 -89.56 100.47 13.26 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 177.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -94.55 88.28 5.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.715 0.293 . . . . 0.0 110.601 -179.469 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.752 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.54 174.79 10.32 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.33 0.586 . . . . 0.0 112.228 -179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -151.3 162.33 29.48 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.312 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -47.57 161.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.976 0.388 . . . . 0.0 111.291 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.45 -68.27 0.66 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.213 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.64 -61.41 1.43 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.303 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -87.32 121.65 71.19 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 -21.93 16.86 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.53 2.153 . . . . 0.0 112.408 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -95.91 26.29 4.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.7 m-20 -106.92 85.79 2.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.945 0.403 . . . . 0.0 110.886 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.43 -165.27 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.221 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.598 ' HE1' HD13 ' A' ' 140' ' ' LEU . 1.2 tpp -40.87 158.99 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.771 0.32 . . . . 0.0 111.056 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.684 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -99.21 -40.87 7.75 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.696 ' O ' HG22 ' A' ' 143' ' ' THR . 6.0 tttp -176.61 121.97 0.15 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.393 176.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.792 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.09 164.39 0.89 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.716 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -105.11 176.29 5.21 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.111 178.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.837 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -94.25 162.31 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.273 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.476 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -134.09 178.36 7.02 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.123 0.487 . . . . 0.0 111.729 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.824 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.9 p90 -167.68 146.71 4.85 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.446 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.661 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.3 t -104.51 138.95 40.12 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -87.63 -60.87 2.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 34.9 t70 -94.87 35.29 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.736 0.303 . . . . 0.0 111.286 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.54 38.24 14.01 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.504 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -137.43 -69.88 0.45 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.873 0.368 . . . . 0.0 110.832 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -93.05 159.48 15.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.439 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.633 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.6 m95 -126.95 124.05 38.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.51 159.71 17.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.441 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.476 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 18.3 m-20 -44.83 152.54 0.22 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.59 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.8 0.82 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.517 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.558 ' HB2' HG13 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -95.3 155.87 16.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 118' ' ' VAL . 4.4 tp10 -45.0 166.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.505 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.18 61.76 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.214 -0.993 . . . . 0.0 110.958 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.871 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -81.43 158.71 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-O 120.977 0.418 . . . . 0.0 110.641 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -107.19 75.85 1.05 Allowed 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.288 179.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.871 ' CE1' HG11 ' A' ' 118' ' ' VAL . 59.0 m-85 -70.4 40.55 0.05 Allowed 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.218 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.791 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -91.14 -16.86 27.07 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.747 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -136.74 45.59 1.26 Allowed Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.217 178.37 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.636 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 92.6 Cg_endo -82.87 98.57 0.88 Allowed 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.872 2.381 . . . . 0.0 113.543 -178.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.26 -44.46 17.59 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 178.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 86' ' ' LEU . . . -142.5 108.52 5.19 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.095 -0.552 . . . . 0.0 110.185 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.617 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.7 mt -96.43 135.31 30.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.799 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -156.61 160.07 39.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.011 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 5.8 t -146.41 155.88 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.952 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -130.21 166.12 20.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 6.6 m120 59.34 35.41 23.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.475 HD23 HG12 ' A' ' 83' ' ' VAL . 20.2 tp -110.61 19.14 18.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.221 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -54.55 89.76 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.916 0.389 . . . . 0.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 20.0 tp -156.24 126.41 6.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.976 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.34 136.48 43.54 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.661 HG22 ' O ' ' A' ' 105' ' ' THR . 2.4 p -152.53 167.66 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.888 -178.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.601 ' O ' HG23 ' A' ' 105' ' ' THR . 10.7 ttt180 -114.66 128.23 56.2 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 176.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.71 -178.74 0.04 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-N 115.601 -0.727 . . . . 0.0 113.986 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.868 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -153.61 150.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.109 -0.545 . . . . 0.0 109.773 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.555 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 0.7 OUTLIER -173.73 154.87 2.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.158 0.504 . . . . 0.0 111.959 -178.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.837 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -93.6 158.28 15.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.3 179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.792 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -120.18 142.06 37.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.55 ' H ' HD13 ' A' ' 141' ' ' ILE . . . -110.94 146.03 37.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.0 0.429 . . . . 0.0 111.78 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.696 HG22 ' O ' ' A' ' 99' ' ' LYS . 11.3 t -127.72 24.68 6.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.948 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' A' ' 145' ' ' ALA . 1.3 tp10 -175.45 -57.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.157 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 144' ' ' GLU . . . 70.79 178.49 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.258 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.63 174.4 9.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.046 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -112.23 142.87 44.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.575 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 50.0 50.26 18.83 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 t -129.14 150.09 50.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.211 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.835 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 45.1 m0 -102.99 -173.27 2.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.808 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.418 ' C ' HD13 ' A' ' 151' ' ' LEU . 0.7 OUTLIER -137.1 98.75 3.82 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 178.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -78.27 152.15 37.6 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.542 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.752 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 21.7 t -146.74 140.17 20.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.952 0.406 . . . . 0.0 111.478 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.35 -44.3 2.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.067 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -177.5 159.11 1.47 Allowed 'General case' 0 CA--C 1.528 0.129 0 CA-C-O 121.357 0.599 . . . . 0.0 112.149 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.781 ' HB ' HG23 ' A' ' 47' ' ' ILE . 38.8 mt -137.83 142.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.508 178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -120.14 129.09 53.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.064 0.459 . . . . 0.0 111.423 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.1 p -137.7 93.6 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.608 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.469 HD21 HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER 75.41 69.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.819 -179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 21.9 ttpp -97.37 105.31 17.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? 60.31 31.51 20.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 60.7 84.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.0 t70 60.73 111.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.941 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.157 -0.925 . . . . 0.0 110.911 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.779 0.323 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -156.88 -44.64 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.456 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 m -143.26 110.98 5.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.755 0.312 . . . . 0.0 110.986 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.5 m -141.14 120.5 13.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.861 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -107.12 109.06 20.8 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -106.04 31.29 5.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.48 ' CD2' ' CE1' ' A' ' 9' ' ' HIS . 2.2 t60 -176.73 83.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -85.18 108.79 17.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.911 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.48 ' CE1' ' CD2' ' A' ' 7' ' ' HIS . 2.5 m80 -123.19 78.94 1.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -88.39 -172.54 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.957 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.5 m -56.52 105.15 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.007 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.5 m 59.58 23.68 12.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.141 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.74 -29.19 9.48 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 15' ' ' VAL . 0.1 OUTLIER 68.79 -68.79 0.17 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.904 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 14' ' ' LEU . 21.8 t -138.16 68.13 47.98 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.047 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.52 -61.81 0.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.617 2.211 . . . . 0.0 112.242 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -173.85 79.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -75.54 -133.74 0.4 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.837 -0.696 . . . . 0.0 112.482 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.6 m -80.19 62.05 4.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.94 0.4 . . . . 0.0 110.882 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 68.93 -67.35 0.22 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.961 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 176.44 7.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.4 55.25 2.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.026 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 t 60.95 30.84 19.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.996 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.61 88.52 0.12 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.979 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.61 141.61 46.33 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.609 2.206 . . . . 0.0 112.19 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -125.58 43.77 2.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.64 150.45 48.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.879 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.884 HG21 HD13 ' A' ' 78' ' ' ILE . 1.5 tp -100.75 155.36 4.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.952 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.812 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.9 tt -81.97 159.83 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -129.77 98.66 4.87 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.889 0.376 . . . . 0.0 111.991 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -93.14 157.23 16.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.816 178.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.576 ' CE2' HD12 ' A' ' 47' ' ' ILE . 2.5 t80 -88.52 154.81 20.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.411 0.624 . . . . 0.0 112.588 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -130.49 174.55 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.546 179.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 71.2 p -178.06 129.35 0.13 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.254 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 28.4 t30 -62.7 -23.47 67.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.147 0.499 . . . . 0.0 110.02 179.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' NH2' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -92.89 140.55 29.38 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.49 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.38 64.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.968 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.42 157.54 45.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.886 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.697 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -114.86 165.52 13.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.854 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.697 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 28.9 Cg_endo -62.66 126.59 18.59 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.332 2.021 . . . . 0.0 111.93 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.834 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.9 t -66.83 -50.22 63.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.901 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.496 ' N ' HG23 ' A' ' 41' ' ' THR . . . -104.48 -129.92 6.68 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.306 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.44 ' O ' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -111.31 100.53 47.75 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-O 120.595 0.236 . . . . 0.0 110.527 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.839 ' CB ' HD11 ' A' ' 47' ' ' ILE . 12.7 Cg_endo -59.94 -1.53 1.25 Allowed 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 122.433 2.089 . . . . 0.0 111.927 179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.434 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 3.3 t0 -34.05 -36.5 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.588 HD21 ' C ' ' A' ' 54' ' ' THR . 28.9 m-20 -51.1 -56.35 13.12 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-O 121.555 0.693 . . . . 0.0 109.95 179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.839 HD11 ' CB ' ' A' ' 44' ' ' PRO . 0.1 OUTLIER -76.25 -26.74 17.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.556 -179.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD1' HG12 ' A' ' 47' ' ' ILE . 8.0 m-30 -84.49 -1.57 55.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.27 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -159.14 29.52 0.21 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-O 120.919 0.39 . . . . 0.0 110.691 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.0 p-10 44.41 29.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.993 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.464 ' N ' ' O ' ' A' ' 46' ' ' ASN . 2.7 t-20 -87.24 -151.32 0.17 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.039 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -177.6 -23.33 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -36.99 59.2 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.784 0.326 . . . . 0.0 111.13 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.588 ' C ' HD21 ' A' ' 46' ' ' ASN . 6.1 t -85.9 171.83 11.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -140.71 156.92 46.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.989 0.423 . . . . 0.0 111.955 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.634 ' C ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -160.75 145.42 14.1 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.902 179.35 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.834 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.77 156.39 5.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.314 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.435 ' OH ' ' CD1' ' A' ' 32' ' ' TYR . 6.2 m-85 -107.65 148.54 29.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.823 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 2.9 mppt? -124.67 -60.76 1.36 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.607 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.2 OUTLIER 47.8 -175.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.607 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.0 Cg_endo -50.27 110.31 0.37 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 CA-C-N 120.343 1.158 . . . . 0.0 110.992 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -37.76 -33.73 0.09 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.69 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -106.01 127.87 53.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.955 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.601 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -157.7 147.38 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -118.68 116.66 27.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.071 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 143' ' ' THR . 21.3 t 61.12 125.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.42 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.477 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 124.94 -38.52 2.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.794 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 4.0 m -47.67 97.94 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.777 0.323 . . . . 0.0 111.04 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 2.2 p90 -162.42 153.31 17.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.378 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -151.74 -171.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.022 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.669 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 171.28 -117.86 0.71 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.961 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.88 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.2 p -172.9 119.71 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-O 121.215 0.531 . . . . 0.0 111.681 179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.53 156.73 18.44 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 121.96 -0.463 . . . . 0.0 111.673 -178.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.52 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.9 m-30 -109.38 -172.44 2.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.636 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.812 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -91.86 -29.84 16.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.212 -179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.674 ' O ' HG23 ' A' ' 78' ' ' ILE . 4.6 m120 -167.0 164.94 9.65 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.684 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.32 120.03 7.34 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.446 2.097 . . . . 0.0 111.948 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.884 HD13 HG21 ' A' ' 28' ' ' ILE . 17.8 pt -127.37 142.23 44.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.89 96.19 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.95 0.405 . . . . 0.0 110.086 179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.833 ' CD2' HD23 ' A' ' 131' ' ' LEU . 5.3 tt -91.55 111.23 22.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.109 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -75.81 -20.61 58.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.788 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.3 p30 177.96 130.37 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.94 0.4 . . . . 0.0 111.459 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.739 HG21 HG11 ' A' ' 138' ' ' VAL . 9.8 p -105.59 140.86 22.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.151 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 126' ' ' ILE . 9.9 pt-20 -151.71 116.62 5.19 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.786 ' HA ' HG23 ' A' ' 156' ' ' ILE . 25.2 m-85 -93.66 100.66 12.85 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.623 HD22 ' N ' ' A' ' 86' ' ' LEU . 2.4 mm? -85.17 87.35 7.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.64 -179.9 6.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.092 0.473 . . . . 0.0 111.698 -178.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.4 -102.18 0.21 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.077 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.662 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -143.12 153.35 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.823 0.344 . . . . 0.0 110.844 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.412 ' N ' ' HA3' ' A' ' 152' ' ' GLY . 28.0 t30 -57.47 -68.43 0.24 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.967 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 51.3 m -103.94 -61.42 1.44 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 15.9 p30 -103.53 121.99 46.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.542 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.662 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 5.8 Cg_exo -38.38 -30.56 0.18 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.267 2.644 . . . . 0.0 113.241 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -62.56 -32.35 73.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.764 0.316 . . . . 0.0 111.172 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -59.87 86.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.299 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.47 -168.3 0.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.331 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.6 ' HG2' ' HB3' ' A' ' 100' ' ' ALA . 5.2 tpp -42.52 161.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.918 0.39 . . . . 0.0 111.198 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.67 ' C ' ' HB ' ' A' ' 121' ' ' THR . 7.2 tt0 -100.13 -39.87 7.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 12.1 mtmt -175.5 122.21 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 114.248 -1.342 . . . . 0.0 108.244 176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.91 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.8 164.2 0.82 Allowed 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.789 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -104.91 -176.32 3.05 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.162 179.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.894 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.0 OUTLIER -102.77 162.55 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.275 179.759 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 30.0 mt-30 -136.09 174.97 10.03 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.111 0.481 . . . . 0.0 111.664 -179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.917 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.1 p90 -164.22 148.41 9.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.596 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.0 t -104.07 141.5 36.11 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -91.28 -60.95 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 49.3 t0 -96.27 35.72 1.42 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.857 0.36 . . . . 0.0 111.362 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.37 38.1 12.7 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.652 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -136.61 -69.85 0.47 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 110.738 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -92.32 163.1 14.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.407 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.618 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 36.4 m95 -130.73 119.19 21.98 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.509 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.62 164.45 8.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.669 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 57.3 m-20 -48.62 152.39 0.97 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.416 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.917 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.8 tt -128.55 -53.97 1.25 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.436 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.574 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -110.35 155.32 22.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.461 0.648 . . . . 0.0 112.726 -178.591 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.615 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -45.07 166.89 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.587 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.13 60.9 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.341 -0.933 . . . . 0.0 111.107 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.854 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -80.11 159.61 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 CA-C-O 121.027 0.442 . . . . 0.0 110.573 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.75 76.3 1.05 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.509 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.854 ' CE1' HG11 ' A' ' 118' ' ' VAL . 62.3 m-85 -70.64 42.42 0.06 Allowed 'General case' 0 CA--C 1.521 -0.143 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.089 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.775 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.94 -17.87 22.52 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.14 -0.936 . . . . 0.0 108.831 177.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.642 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -135.43 43.82 0.99 Allowed Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.246 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.672 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 94.3 Cg_endo -80.09 102.93 1.49 Allowed 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.812 2.342 . . . . 0.0 113.25 -178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.48 -45.11 7.55 Favored Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.39 104.32 4.4 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.184 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.584 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.4 mt -93.0 125.9 45.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.877 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' O ' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -159.22 162.54 36.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.882 179.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.507 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -159.36 155.98 3.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -114.31 -171.18 1.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.77 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 44.29 30.6 0.48 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.533 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 80' ' ' LEU . 9.0 tp -106.73 31.14 5.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.631 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -68.61 89.88 0.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.478 HD23 ' C ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -155.64 129.77 8.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.944 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 19.0 mtmt -54.27 132.27 43.33 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.442 HG23 ' CD1' ' A' ' 104' ' ' TYR . 8.0 p -148.38 155.68 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.714 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.49 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -108.66 127.63 54.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 176.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.52 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -178.82 0.02 OUTLIER Glycine 0 C--N 1.315 -0.616 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.733 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.88 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -149.29 154.93 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.566 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 26.3 ttp180 -173.59 144.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.269 0.557 . . . . 0.0 112.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.894 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -84.6 158.29 20.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.613 178.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.91 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.21 126.88 64.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.978 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -93.96 159.06 15.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.431 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.745 ' O ' HG22 ' A' ' 66' ' ' VAL . 15.4 m -127.62 -45.65 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.772 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -137.64 69.7 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.776 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.16 174.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.663 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.855 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -120.76 174.37 6.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.95 -179.9 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -90.43 146.8 23.86 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.853 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 45.95 81.48 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.85 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.855 HG21 ' HG3' ' A' ' 146' ' ' ARG . 3.7 t -158.77 135.77 9.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.345 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.752 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 45.1 m0 -99.73 -173.22 2.4 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.184 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' O ' ' HB ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER -127.83 98.6 5.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.984 178.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.412 ' HA3' ' N ' ' A' ' 90' ' ' ASN . . . -81.78 153.79 33.32 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.415 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.563 HG21 ' OH ' ' A' ' 32' ' ' TYR . 2.3 t -148.95 149.09 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.891 0.377 . . . . 0.0 111.328 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 24.1 mtm180 -124.13 -45.66 1.97 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.576 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 86' ' ' LEU . 39.6 t0 179.43 150.66 0.33 Allowed 'General case' 0 C--O 1.227 -0.116 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.516 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.786 HG23 ' HA ' ' A' ' 85' ' ' PHE . 5.6 mt -127.14 130.34 71.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -111.24 138.78 47.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.98 0.419 . . . . 0.0 111.28 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.81 HG23 HD12 ' A' ' 80' ' ' LEU . 7.8 p -136.77 123.17 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.774 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.64 ' OD1' HG22 ' A' ' 158' ' ' VAL . 1.7 m-20 64.5 30.3 12.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.989 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 56.76 82.16 0.12 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.99 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.9 ttpt 60.17 36.62 21.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 62.21 68.92 0.64 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 61.72 153.2 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.87 0.367 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.9 -141.3 15.27 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.505 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.9 p -139.05 -60.19 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.883 0.373 . . . . 0.0 110.927 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.66 121.54 4.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.922 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 60.84 156.72 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -172.35 35.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -106.16 99.63 9.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.895 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -85.87 126.97 34.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.943 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -63.29 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.777 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -106.74 35.76 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.8 t -88.62 145.63 25.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 144.37 38.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.87 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.4 44.51 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.485 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 ' HA ' HD23 ' A' ' 14' ' ' LEU . 14.2 mt -156.0 172.54 18.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.774 0.321 . . . . 0.0 110.958 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . 19.4 m -58.31 110.0 2.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.161 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.33 127.41 23.76 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.444 2.096 . . . . 0.0 112.317 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -60.85 124.51 20.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.954 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -112.9 42.98 1.81 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.441 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.39 164.57 13.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.856 0.36 . . . . 0.0 110.886 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 60.63 82.7 0.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.803 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 10.9 tmm? -80.73 141.1 35.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.913 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -157.21 -45.97 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.154 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.9 p -154.38 33.07 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.04 138.57 89.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.15 123.0 9.56 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.571 2.181 . . . . 0.0 112.274 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 21.7 p30 -169.27 141.5 2.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.99 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 59.53 89.34 0.06 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.828 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.857 HG21 HD13 ' A' ' 78' ' ' ILE . 0.8 OUTLIER -109.41 142.7 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.687 HG22 ' HB2' ' A' ' 75' ' ' SER . 12.6 tt -82.24 160.76 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.366 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.9 98.48 5.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.986 0.422 . . . . 0.0 111.16 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -91.93 144.25 25.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.158 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.731 ' OH ' HG21 ' A' ' 153' ' ' VAL . 3.9 t80 -81.4 141.61 33.79 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.179 0.514 . . . . 0.0 111.669 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.544 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.1 OUTLIER -125.9 145.26 33.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.646 179.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.451 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 15.3 p -151.56 129.43 11.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.981 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.485 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 16.9 t30 -58.74 -29.59 66.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.066 0.46 . . . . 0.0 110.424 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' HB3' ' HB3' ' A' ' 60' ' ' ASN . 63.0 mtt-85 -69.69 151.94 45.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.135 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -98.83 27.6 4.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.84 129.36 56.68 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.89 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -61.56 163.72 11.15 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.161 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 70.0 Cg_endo -75.15 143.57 28.76 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.437 2.091 . . . . 0.0 112.273 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.735 HG22 ' H ' ' A' ' 57' ' ' VAL . 5.0 t -62.28 -125.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.467 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 41' ' ' THR . . . -39.78 -82.34 0.02 OUTLIER Glycine 0 C--N 1.338 0.658 0 C-N-CA 121.209 -0.519 . . . . 0.0 112.972 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -158.36 135.62 6.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.719 0.295 . . . . 0.0 111.128 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HA ' HD12 ' A' ' 56' ' ' LEU . 83.2 Cg_endo -81.39 -0.33 10.42 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.817 2.344 . . . . 0.0 111.793 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' HG21 ' A' ' 54' ' ' THR . 59.1 m-20 -34.05 -35.57 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.026 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.822 ' ND2' HG23 ' A' ' 54' ' ' THR . 9.4 m-80 -50.38 -28.83 8.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.449 0.642 . . . . 0.0 110.082 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.616 HG23 HG12 ' A' ' 156' ' ' ILE . 2.4 mp -91.02 -50.94 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.156 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -66.15 -52.56 47.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.729 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.92 -31.86 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.408 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 9.0 m-80 72.01 44.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.911 0.386 . . . . 0.0 111.04 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.3 OUTLIER -109.57 -30.74 7.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.761 179.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' CB ' ' A' ' 155' ' ' ASP . . . 68.12 30.17 5.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.073 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.7 m -107.28 28.88 7.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.777 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.822 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -151.91 171.2 18.15 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.07 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -107.16 166.11 10.87 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.413 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.4 tt -163.74 127.75 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.671 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.735 ' H ' HG22 ' A' ' 41' ' ' THR . 1.3 m -154.28 138.48 9.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.93 0.395 . . . . 0.0 111.4 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' CE1' HD21 ' A' ' 56' ' ' LEU . 22.8 m-85 -107.6 126.15 52.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.951 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.665 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.3 OUTLIER -83.47 -60.43 2.13 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.194 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.608 HD21 HG21 ' A' ' 64' ' ' ILE . 0.2 OUTLIER 45.96 176.78 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.8 Cg_endo -53.14 109.84 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 120.758 0.972 . . . . 0.0 110.043 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 7.0 p-10 -35.91 -37.31 0.1 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.906 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -107.64 130.51 54.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.168 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.716 HD13 ' N ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -157.71 143.78 8.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.201 179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -118.77 116.69 27.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.138 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.562 ' H ' ' HB3' ' A' ' 145' ' ' ALA . 26.0 t 57.62 111.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.552 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 141.58 -33.98 1.92 Allowed Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.925 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.553 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -55.89 103.71 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.593 -0.357 . . . . 0.0 110.786 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.506 ' CD2' ' O ' ' A' ' 67' ' ' GLY . 3.2 p90 -162.3 156.93 22.1 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.689 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.626 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -133.46 -170.39 0.68 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.057 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 165.04 -145.74 10.54 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.1 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.865 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.5 p -163.39 116.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-O 121.404 0.621 . . . . 0.0 110.91 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' N ' ' O ' ' A' ' 31' ' ' THR . 6.5 ttpt -89.45 155.03 19.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.962 -178.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.566 ' OH ' HG11 ' A' ' 158' ' ' VAL . 3.4 m-30 -106.52 -172.52 2.1 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.767 -179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.687 ' HB2' HG22 ' A' ' 29' ' ' ILE . 7.2 t -97.54 -27.23 14.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.01 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.662 ' O ' HG23 ' A' ' 78' ' ' ILE . 8.7 m-20 -165.43 165.9 10.94 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.809 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -56.19 119.77 7.18 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.523 2.149 . . . . 0.0 111.997 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.857 HD13 HG21 ' A' ' 28' ' ' ILE . 13.0 pt -131.26 145.67 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.568 ' O ' HG23 ' A' ' 79' ' ' THR . 8.5 t -56.46 96.1 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.851 0.358 . . . . 0.0 110.186 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.4 tm? -86.84 102.92 14.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.414 ' ND2' ' HA ' ' A' ' 159' ' ' ASN . 0.0 OUTLIER -69.73 -32.48 71.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.621 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.9 p30 170.57 134.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.457 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 158' ' ' VAL . 7.6 p -104.99 154.13 6.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.688 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -151.51 105.78 3.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.783 -0.367 . . . . 0.0 111.644 -178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.636 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 20.3 m-85 -92.18 100.28 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.678 ' CD1' ' HB1' ' A' ' 125' ' ' ALA . 0.5 OUTLIER -88.9 96.1 10.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.54 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 173.58 11.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.292 0.568 . . . . 0.0 112.136 -178.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -147.97 -104.71 0.36 Allowed Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.243 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.731 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.28 179.36 7.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.814 0.34 . . . . 0.0 110.717 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.447 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 7.6 p-10 -87.11 -64.95 1.07 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.874 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.3 m -104.17 -61.22 1.47 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.038 0.447 . . . . 0.0 110.604 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.446 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 27.3 t30 -95.11 122.14 60.67 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.608 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.446 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 6.2 Cg_endo -48.33 -19.61 1.93 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.741 2.294 . . . . 0.0 113.056 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -90.82 26.41 2.08 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.731 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 2.9 m-20 -107.44 90.05 3.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.783 0.325 . . . . 0.0 110.897 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.32 -164.95 0.13 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.325 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.817 ' CE ' HD22 ' A' ' 140' ' ' LEU . 3.2 tpp -37.6 160.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.782 0.325 . . . . 0.0 111.522 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.688 ' C ' ' HB ' ' A' ' 121' ' ' THR . 5.7 tp60 -99.36 -41.71 7.3 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 177.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 3.8 mtmt -175.61 122.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.562 176.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 176.83 167.65 0.52 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 113.153 0.798 . . . . 0.0 113.153 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.476 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.1 -176.13 2.99 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.892 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.906 HG23 ' HG ' ' A' ' 140' ' ' LEU . 1.1 mt -97.29 162.55 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.806 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' CB ' HD13 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -127.36 177.35 6.78 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.158 0.504 . . . . 0.0 111.84 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.727 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.9 p90 -175.25 137.47 0.39 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.315 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.684 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -97.58 140.91 31.29 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.164 178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.2 -59.84 2.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -94.69 32.2 1.66 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.838 0.351 . . . . 0.0 111.362 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.88 38.41 37.7 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.394 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.5 -71.97 0.41 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.831 0.348 . . . . 0.0 110.822 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -90.81 161.4 15.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.474 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.604 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 39.1 m95 -128.13 116.85 20.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.718 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.45 ' O ' ' HG3' ' A' ' 103' ' ' GLN . 0.2 OUTLIER -110.29 154.52 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.393 -179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -41.44 155.28 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.751 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.727 HD12 ' HB3' ' A' ' 104' ' ' TYR . 7.4 tt -125.69 -66.88 0.91 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.611 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.663 ' OE2' HG21 ' A' ' 118' ' ' VAL . 0.3 OUTLIER -96.41 157.37 15.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.452 0.644 . . . . 0.0 112.526 -178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.678 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.9 tm-20 -43.34 167.01 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.642 178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.37 60.57 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.169 -1.015 . . . . 0.0 110.864 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.698 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.5 t -78.97 160.4 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.664 0 C-N-CA 122.818 0.447 . . . . 0.0 110.426 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.55 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -108.71 75.54 0.97 Allowed 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.242 179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.698 ' CE1' HG11 ' A' ' 118' ' ' VAL . 73.2 m-85 -70.57 38.31 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.711 -179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.872 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -92.99 -20.78 20.25 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.092 177.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.683 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -135.4 43.48 0.92 Allowed Pre-proline 0 N--CA 1.448 -0.55 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.158 178.107 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 122' ' ' MET . 65.1 Cg_endo -85.93 98.57 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.799 2.332 . . . . 0.0 113.018 -178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.92 -41.1 83.67 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.678 ' HB1' ' CD1' ' A' ' 86' ' ' LEU . . . -142.02 124.58 15.82 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.182 -0.509 . . . . 0.0 109.897 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 120' ' ' TYR . 2.2 mt -110.4 125.08 67.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.062 -178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -154.84 148.9 25.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.897 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.639 HG21 HD21 ' A' ' 114' ' ' LEU . 5.3 m -146.16 108.12 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.98 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.53 175.06 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 60.36 31.14 20.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.704 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 18.2 tp -106.28 27.72 8.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -54.95 89.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.961 0.41 . . . . 0.0 110.887 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.7 tp -155.92 122.35 5.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.948 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 22.6 mtpt -54.29 131.81 42.49 Favored 'General case' 0 C--O 1.232 0.17 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 105' ' ' THR . 1.9 p -149.91 169.37 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.913 -178.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.547 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -114.76 128.24 56.19 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.519 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 49.71 -175.37 0.04 OUTLIER Glycine 0 C--N 1.314 -0.673 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.943 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.865 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -155.64 148.78 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 109.76 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.57 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 2.7 ttm180 -173.84 158.14 3.17 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.906 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -102.43 158.64 16.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.728 179.026 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 140' ' ' LEU . 1.2 mp -139.0 124.34 22.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.825 0.345 . . . . 0.0 110.851 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.792 ' HB2' ' SD ' ' A' ' 97' ' ' MET . . . -89.08 152.01 21.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.318 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.464 ' HA ' HG13 ' A' ' 66' ' ' VAL . 0.2 OUTLIER -127.58 31.91 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.213 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 66' ' ' VAL . 1.1 tp10 -176.84 -55.5 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.7 0.286 . . . . 0.0 111.452 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.562 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 60.09 175.17 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.98 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.725 ' HG2' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -135.55 164.13 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.959 0.409 . . . . 0.0 111.118 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.51 154.61 26.2 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 6.9 p-10 41.31 80.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.937 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.725 HG21 ' HG2' ' A' ' 146' ' ' ARG . 8.3 t -167.1 131.78 1.99 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.643 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.665 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 48.0 m0 -95.54 -172.96 2.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.801 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.63 98.59 4.1 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.22 -0.446 . . . . 0.0 109.955 178.369 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 57' ' ' VAL . . . -92.51 114.5 4.63 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.918 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.731 HG21 ' OH ' ' A' ' 32' ' ' TYR . 19.3 t -93.45 147.29 5.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.719 0.295 . . . . 0.0 110.704 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 2.4 tpt85 -108.62 -46.27 3.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.268 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 86' ' ' LEU . 8.0 t70 178.77 126.41 0.06 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.742 HD11 ' HB ' ' A' ' 72' ' ' VAL . 0.1 OUTLIER -129.5 139.2 52.31 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -139.66 154.45 47.53 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.325 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 83' ' ' VAL . 34.2 m -133.19 144.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.098 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.444 ' HB2' ' CB ' ' A' ' 163' ' ' ASP . 4.9 m120 56.03 76.85 0.26 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -79.86 14.66 1.68 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.342 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 4.7 tptm -153.04 24.25 0.56 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.963 179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.438 ' HG3' HG23 ' A' ' 79' ' ' THR . 7.1 mm-40 -155.92 -46.28 0.08 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.444 ' CB ' ' HB2' ' A' ' 159' ' ' ASN . 0.4 OUTLIER -120.27 -179.71 4.03 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.901 0.382 . . . . 0.0 111.064 179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.899 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mtp . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.784 0.326 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.81 44.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.526 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.58 107.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.914 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.7 m -163.79 115.2 1.37 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.921 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -150.86 91.44 1.71 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.0 m170 60.35 85.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.916 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -110.98 34.17 4.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -131.9 -50.7 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -128.86 154.69 46.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -146.64 175.92 10.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.891 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.6 t -160.5 146.05 14.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.2 m -60.25 -62.32 1.95 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.929 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.05 -88.66 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.543 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.666 ' O ' HG22 ' A' ' 15' ' ' VAL . 0.2 OUTLIER -98.46 92.28 5.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.566 0.222 . . . . 0.0 110.928 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 14' ' ' LEU . 17.3 m 50.86 164.17 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.018 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 15' ' ' VAL . 31.2 Cg_exo -59.97 -177.0 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.591 2.194 . . . . 0.0 112.26 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? -112.3 31.21 6.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.13 79.42 1.13 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.528 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.7 t -108.34 121.31 44.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.804 0.335 . . . . 0.0 110.874 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -176.76 -41.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.97 -168.27 1.68 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.86 -69.74 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.997 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -90.87 -67.29 0.86 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.776 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -179.16 147.51 0.51 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.917 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.33 -41.0 2.71 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.539 2.16 . . . . 0.0 112.278 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 65.07 -78.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 79.58 0.21 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.89 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.871 HD13 HG22 ' A' ' 78' ' ' ILE . 3.2 mp -59.17 122.39 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.98 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.654 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.3 tt -82.3 161.14 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.86 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -127.55 98.51 5.25 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.401 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.679 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -99.17 156.96 16.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.506 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.512 ' CD1' ' OH ' ' A' ' 58' ' ' TYR . 2.8 t80 -92.05 145.89 24.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.133 0.492 . . . . 0.0 111.857 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.35 176.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.039 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.498 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.8 p -177.9 130.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.795 178.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.8 t30 -69.17 -26.99 65.13 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.57 ' HD3' HG22 ' A' ' 64' ' ' ILE . 16.1 mmm180 -81.48 129.64 34.73 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -55.44 -23.78 27.17 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.772 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 13.1 p30 -51.67 145.18 9.61 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.352 179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -99.54 166.01 13.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.679 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 18.9 Cg_endo -61.08 131.9 39.15 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.175 1.916 . . . . 0.0 111.957 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.664 HG22 ' HA ' ' A' ' 56' ' ' LEU . 2.9 t -41.99 -47.73 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.518 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.443 ' N ' HG23 ' A' ' 41' ' ' THR . . . -137.76 -72.33 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.398 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -153.89 117.26 2.66 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 120.577 0.227 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.455 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.7 Cg_endo -69.66 -0.92 7.52 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.433 2.089 . . . . 0.0 112.185 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -35.99 -34.14 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 122.476 0.31 . . . . 0.0 111.615 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.774 ' ND2' HG23 ' A' ' 54' ' ' THR . 23.8 m-80 -45.43 -33.91 2.85 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.231 0.539 . . . . 0.0 110.146 179.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.785 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.1 mp -93.9 -35.08 6.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.464 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.455 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 19.9 m-30 -54.67 -28.92 50.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.801 -179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -132.61 24.18 4.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.649 0.261 . . . . 0.0 111.533 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.4 m120 46.85 88.73 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.899 0.38 . . . . 0.0 111.224 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -177.01 -171.46 0.36 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.378 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.78 62.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.819 0.343 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 t -109.14 19.14 19.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.023 0.439 . . . . 0.0 111.011 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.774 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -161.08 171.71 18.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -102.25 157.07 17.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.889 0.376 . . . . 0.0 110.978 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.701 HD13 ' CG1' ' A' ' 153' ' ' VAL . 0.2 OUTLIER -160.78 110.42 1.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.102 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.503 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.14 137.6 8.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.427 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.528 ' CD2' HG11 ' A' ' 70' ' ' VAL . 12.5 m-30 -99.89 125.8 45.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.861 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -162.9 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -176.591 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -51.09 -51.75 64.97 Favored Pre-proline 0 C--N 1.331 -0.238 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.649 179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 88.0 Cg_endo -100.42 110.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 123.658 2.905 . . . . 0.0 111.15 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -71.46 61.01 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.141 0.496 . . . . 0.0 110.903 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.11 123.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.596 HG13 ' HB1' ' A' ' 145' ' ' ALA . 21.4 pt -123.33 141.0 45.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.19 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -118.7 177.9 4.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 143' ' ' THR . 21.5 t -49.13 102.1 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.289 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 140.43 -22.48 2.72 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.553 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.669 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -58.23 115.42 2.93 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.864 0.364 . . . . 0.0 110.538 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.716 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.4 OUTLIER -162.68 170.01 19.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.665 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.717 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -158.75 -170.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.871 178.526 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 164.41 -114.29 0.59 Allowed Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.043 -0.823 . . . . 0.0 111.043 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.897 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.3 p -173.36 116.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.366 0.603 . . . . 0.0 111.43 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.79 156.74 18.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.998 0.427 . . . . 0.0 111.743 -178.791 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.54 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.7 m-30 -111.8 -172.59 2.07 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.767 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.654 ' HB2' HG22 ' A' ' 29' ' ' ILE . 4.3 t -105.81 -40.75 5.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.562 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.427 ' HB2' HG13 ' A' ' 28' ' ' ILE . 0.5 OUTLIER -136.41 173.13 5.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.646 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.418 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 74.1 Cg_endo -76.0 138.63 20.91 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.59 2.194 . . . . 0.0 112.688 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.871 HG22 HD13 ' A' ' 28' ' ' ILE . 35.2 pt -140.11 143.45 29.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.025 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.75 95.93 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.797 HD11 ' HB ' ' A' ' 83' ' ' VAL . 10.0 tt -84.92 99.43 10.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.198 -179.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -69.51 -24.83 63.81 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.491 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 177.69 131.57 0.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.797 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -104.83 143.49 16.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.141 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 4.9 mt-10 -151.29 122.43 7.71 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.814 ' CE1' HG21 ' A' ' 102' ' ' ILE . 13.7 m-85 -101.89 100.84 11.19 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -88.7 87.56 7.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.01 0.434 . . . . 0.0 110.377 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.461 ' CB ' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.52 -179.79 6.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.226 -179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -158.97 -126.84 0.88 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.417 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.774 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -116.07 156.58 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.702 0.287 . . . . 0.0 110.786 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.66 -68.69 0.57 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 0.0 110.848 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 t -104.1 -61.44 1.44 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.843 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 2.1 t-20 -89.77 121.98 68.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.663 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 3.8 Cg_endo -46.39 -23.66 2.22 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.829 2.353 . . . . 0.0 112.669 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -89.09 16.51 7.04 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.484 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.774 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 40.0 m-20 -92.21 85.99 5.62 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.014 0.435 . . . . 0.0 110.793 179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.945 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.39 -164.84 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.164 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.719 ' N ' HG23 ' A' ' 96' ' ' THR . 8.1 tpp -45.31 158.03 0.08 Allowed 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.547 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 18.9 tm0? -95.24 -39.63 9.98 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 5.0 mtmm -175.98 122.08 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.302 177.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.938 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 177.55 166.55 0.64 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.773 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.05 -178.68 3.72 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 114.611 -1.177 . . . . 0.0 109.119 179.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.85 HG23 ' HG ' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -100.52 162.64 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 121.149 -0.221 . . . . 0.0 110.459 179.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' HD13 ' A' ' 141' ' ' ILE . 5.1 pt20 -135.42 -175.51 3.96 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.879 0.371 . . . . 0.0 111.457 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.768 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.3 p90 -173.16 143.96 1.17 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.377 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.641 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -98.39 142.0 30.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.428 HG22 ' HE1' ' A' ' 104' ' ' TYR . 2.0 t -90.63 -59.55 2.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 1.3 m-20 -94.41 31.48 1.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.701 0.286 . . . . 0.0 111.295 -179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 51.2 32.09 28.11 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.224 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -131.98 -73.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.978 0.418 . . . . 0.0 110.724 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -90.27 157.92 17.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.456 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.641 ' CZ2' HG22 ' A' ' 105' ' ' THR . 42.8 m95 -124.67 138.66 54.29 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.485 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.02 160.93 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.604 -178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -48.81 153.05 0.89 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.122 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.768 HD12 ' HB3' ' A' ' 104' ' ' TYR . 9.3 tt -128.74 -64.92 0.9 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.799 ' OE2' HG13 ' A' ' 128' ' ' VAL . 1.7 tp10 -94.24 154.43 17.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.628 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.6 mp0 -42.83 166.24 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.122 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.86 63.61 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.228 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.864 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -85.15 158.32 3.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.595 0 CA-C-O 120.939 0.399 . . . . 0.0 110.477 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.487 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.5 mt-10 -108.13 78.23 1.16 Allowed 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.528 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' CE1' HG11 ' A' ' 118' ' ' VAL . 56.1 m-85 -70.64 43.74 0.07 Allowed 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.104 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.7 ' O ' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -93.6 -14.87 25.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.127 -0.942 . . . . 0.0 108.615 177.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.65 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -139.08 44.45 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.497 0 CA-C-N 114.351 -1.295 . . . . 0.0 108.397 178.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.945 ' HD2' HG21 ' A' ' 96' ' ' THR . 89.0 Cg_endo -82.58 98.46 0.9 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.917 2.411 . . . . 0.0 113.183 -178.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.47 -48.2 14.4 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.33 104.57 4.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.23 -0.485 . . . . 0.0 110.024 178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.586 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -92.46 134.51 30.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.784 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -144.94 157.5 44.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.772 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.799 HG13 ' OE2' ' A' ' 115' ' ' GLU . 14.2 t -134.98 105.96 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -88.67 154.44 20.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 59.04 50.57 8.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.768 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.725 HD22 HG11 ' A' ' 128' ' ' VAL . 19.3 tp -121.6 22.33 10.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.142 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 5.5 t0 -54.95 89.29 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.889 0.376 . . . . 0.0 110.849 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.408 ' N ' ' O ' ' A' ' 131' ' ' LEU . 44.9 tp -156.47 129.06 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.994 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -54.38 131.59 42.45 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 80' ' ' LEU . 8.7 p -145.65 158.85 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.9 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 105' ' ' THR . 6.3 mtt180 -109.48 127.51 54.48 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.02 -177.88 0.01 OUTLIER Glycine 0 C--N 1.315 -0.607 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.85 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.897 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.3 OUTLIER -150.85 153.92 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 5.6 ttm-85 -173.29 160.2 3.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.234 0.54 . . . . 0.0 111.849 -179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.85 ' HG ' HG23 ' A' ' 102' ' ' ILE . 0.2 OUTLIER -97.72 158.66 15.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.952 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.938 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 9.4 tp -128.33 118.51 48.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.792 0.33 . . . . 0.0 110.751 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.669 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -81.29 161.8 23.74 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.884 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.702 ' O ' HG13 ' A' ' 66' ' ' VAL . 7.5 m -127.61 -44.88 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.943 179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.596 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.5 tp10 -152.33 66.92 0.83 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.74 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.596 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . -49.03 175.82 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.871 -179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.405 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.1 OUTLIER -126.52 148.18 49.74 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -71.54 160.47 32.64 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 45.79 85.16 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.926 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.405 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.0 t -176.08 134.99 0.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.182 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.861 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 44.9 m0 -94.13 -175.5 3.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.529 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.562 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.9 tm? -131.61 107.02 8.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.412 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.95 135.98 16.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.647 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD13 ' A' ' 56' ' ' LEU . 7.3 t -138.73 118.77 14.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.858 0.361 . . . . 0.0 110.823 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.1 ttt-85 -106.16 -45.55 4.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.748 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 156' ' ' ILE . 35.3 t0 -174.68 161.51 3.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.282 0.563 . . . . 0.0 112.301 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.785 ' HB ' HG23 ' A' ' 47' ' ' ILE . 25.6 mt -139.55 141.7 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.804 178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -126.32 154.39 43.52 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.009 0.433 . . . . 0.0 111.417 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.9 p -161.77 130.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.4 75.17 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.656 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.4 tptm -132.67 68.79 1.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.888 0.375 . . . . 0.0 111.158 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 52.66 51.73 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.127 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 60.68 49.82 6.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.6 t70 62.61 148.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.88 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.903 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.776 0.322 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.14 -168.23 51.76 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.436 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 t -68.68 94.33 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.2 p -140.17 125.31 18.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -131.55 31.45 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -176.47 90.15 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.865 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -106.31 120.48 41.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.967 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.0 p80 -94.79 143.01 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.887 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -79.39 -75.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -177.25 37.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 60.04 176.02 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.0 t -176.55 -64.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.04 143.52 14.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.47 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 tp -105.73 35.89 2.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.798 0.332 . . . . 0.0 110.858 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.3 m -154.35 63.6 4.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.052 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.71 101.33 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.459 2.106 . . . . 0.0 112.427 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 60.79 178.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.62 -86.1 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 63.4 p -103.38 76.82 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.822 0.344 . . . . 0.0 110.841 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 60.56 31.59 20.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.526 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 2.8 mmt -59.99 -172.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.826 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 21' ' ' MET . . . 76.26 5.51 3.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.474 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 t -108.93 -23.63 11.62 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.339 . . . . 0.0 110.752 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 64.19 92.84 0.06 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.927 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.89 63.54 1.31 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.444 2.096 . . . . 0.0 112.315 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.91 -169.69 2.41 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.98 131.74 48.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.93 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.855 HD13 HG22 ' A' ' 78' ' ' ILE . 3.1 mp -65.05 116.91 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.071 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -87.69 158.9 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.277 179.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.716 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -118.22 98.69 6.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.803 0.335 . . . . 0.0 111.337 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.68 120.75 27.45 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.5 t80 -51.76 142.36 15.07 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.89 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.79 163.13 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.824 179.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.486 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -162.32 137.54 7.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.916 0.388 . . . . 0.0 111.468 179.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 3.2 t-20 -78.0 -33.11 51.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.956 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.419 ' NE ' ' HG3' ' A' ' 61' ' ' PRO . 3.2 mmp_? -65.19 158.11 26.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.91 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.96 25.48 5.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.612 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -93.51 162.62 13.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.958 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.19 149.15 38.31 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.688 179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -56.51 120.06 7.69 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.18 1.92 . . . . 0.0 111.886 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.6 t -41.85 -53.57 3.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.652 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 41' ' ' THR . . . -121.34 -73.67 0.33 Allowed Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.256 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -158.47 120.54 1.97 Allowed Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.741 0.305 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.563 ' HA ' HD12 ' A' ' 56' ' ' LEU . 59.3 Cg_endo -76.47 -1.22 11.26 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.362 2.041 . . . . 0.0 111.567 179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 0.6 OUTLIER -41.17 -31.96 0.24 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.846 ' ND2' HG23 ' A' ' 54' ' ' THR . 41.6 m-80 -46.51 -31.07 2.51 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.539 0.685 . . . . 0.0 110.481 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.896 ' CG1' HG23 ' A' ' 156' ' ' ILE . 2.1 mp -100.34 -32.16 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.074 -178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 31' ' ' THR . 4.8 m-30 -54.31 -42.18 69.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.357 -178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -143.15 37.25 1.39 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.403 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.6 p30 43.53 98.06 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.996 0.427 . . . . 0.0 111.873 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 3.5 t-20 -170.44 93.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.509 ' HB1' HH11 ' A' ' 154' ' ' ARG . . . -70.77 51.25 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.866 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -113.62 27.61 9.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.227 0.537 . . . . 0.0 110.229 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.846 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.83 171.34 18.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.076 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -107.86 163.21 13.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.029 0.442 . . . . 0.0 111.513 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.632 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.2 tt -163.97 118.16 1.5 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.911 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.76 ' H ' HG22 ' A' ' 41' ' ' THR . 3.0 m -154.32 141.93 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.959 0.409 . . . . 0.0 111.615 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' CE1' HD21 ' A' ' 56' ' ' LEU . 15.2 m-30 -107.23 139.26 41.96 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.994 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.02 -33.28 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -176.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.62 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.7 OUTLIER -8.64 -66.97 0.01 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 O-C-N 123.079 0.237 . . . . 0.0 110.875 -178.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 41.8 Cg_endo -90.47 109.89 0.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.266 1.977 . . . . 0.0 110.726 177.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.98 -31.53 68.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.942 0.401 . . . . 0.0 110.764 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -90.16 124.75 35.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.655 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.545 HG23 ' OG1' ' A' ' 68' ' ' THR . 1.4 mt -107.4 144.83 15.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.347 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -113.44 161.43 17.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.044 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.527 HG13 ' N ' ' A' ' 144' ' ' GLU . 14.7 t -56.99 107.44 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.044 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.446 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 139.15 -13.73 3.3 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.632 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.745 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -62.74 125.54 24.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.795 0.331 . . . . 0.0 110.654 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.595 ' CD2' HD12 ' A' ' 141' ' ' ILE . 1.4 p90 -162.82 163.18 26.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.012 0.434 . . . . 0.0 111.934 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.731 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -135.16 -170.4 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.357 178.379 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.731 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 154.68 -128.14 2.26 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.086 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.842 HG13 ' CG2' ' A' ' 138' ' ' VAL . 3.0 p -172.5 119.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 120.104 -0.639 . . . . 0.0 112.045 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.0 OUTLIER -89.34 156.33 18.79 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 122.125 -0.36 . . . . 0.0 111.117 -178.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.582 ' CZ ' HG11 ' A' ' 158' ' ' VAL . 3.7 m-30 -111.19 176.56 4.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.354 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.4 p -96.06 -30.11 13.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.713 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.81 169.16 9.62 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.21 134.07 20.49 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.655 2.237 . . . . 0.0 112.585 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.855 HG22 HD13 ' A' ' 28' ' ' ILE . 16.9 pt -140.28 139.04 36.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.108 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 79' ' ' THR . 5.0 t -53.71 96.06 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.068 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 135' ' ' VAL . 3.1 tp -68.01 111.53 4.47 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.159 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -85.2 -34.72 21.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.296 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 168.33 130.36 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.685 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.491 HG22 ' N ' ' A' ' 84' ' ' GLU . 10.5 p -104.79 158.64 5.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.34 179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' N ' HG22 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -150.85 105.76 3.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.311 -179.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.831 ' HD1' HD12 ' A' ' 156' ' ' ILE . 60.9 m-85 -88.76 100.77 13.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' N ' ' O ' ' A' ' 155' ' ' ASP . 3.6 tp -88.24 94.75 9.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.022 0.439 . . . . 0.0 110.303 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.542 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.82 -179.83 6.42 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.118 -179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -168.03 -103.98 0.17 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.921 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HB1' ' O ' ' A' ' 92' ' ' ASN . . . -143.18 153.11 42.52 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.77 0.319 . . . . 0.0 110.996 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.476 ' OD1' HG21 ' A' ' 57' ' ' VAL . 5.2 t30 -75.7 -68.08 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.681 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.2 t -103.53 -61.5 1.41 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.572 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.1 t-20 -90.65 121.67 67.97 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.655 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.494 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 6.1 Cg_endo -48.46 -23.31 5.02 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.75 2.3 . . . . 0.0 112.84 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.6 p30 -93.94 26.5 3.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.304 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.527 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 17.8 m-20 -102.4 86.01 2.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.811 0.339 . . . . 0.0 111.338 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.843 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.51 -165.26 0.13 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.511 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.561 ' CE ' HD22 ' A' ' 140' ' ' LEU . 4.9 tpp -40.25 161.1 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.923 0.392 . . . . 0.0 111.606 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.645 ' C ' ' HB ' ' A' ' 121' ' ' THR . 39.0 tp60 -100.51 -40.21 7.55 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.57 122.44 0.15 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.958 177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.903 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.48 159.88 0.94 Allowed 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -105.33 168.53 9.01 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.919 -1.037 . . . . 0.0 108.644 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.55 HD12 ' OE1' ' A' ' 115' ' ' GLU . 1.1 mt -89.29 162.41 2.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 120.611 -0.435 . . . . 0.0 111.569 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.692 ' OE1' HD13 ' A' ' 141' ' ' ILE . 24.1 mt-30 -132.34 -174.04 3.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.436 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.537 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 13.7 p90 -172.57 154.16 3.02 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.288 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.781 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.9 t -112.87 141.46 46.67 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.419 HG22 ' HE1' ' A' ' 104' ' ' TYR . 0.5 OUTLIER -91.04 -60.3 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -178.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.403 ' HB3' ' CD ' ' A' ' 109' ' ' ARG . 22.7 t70 -103.07 37.25 2.01 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.934 0.397 . . . . 0.0 111.18 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 47.36 34.33 8.89 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.705 179.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' CD ' ' HB3' ' A' ' 107' ' ' ASP . 11.9 ptm180 -131.76 -52.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.973 0.416 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' A' ' 105' ' ' THR . 0.2 OUTLIER -108.49 158.63 17.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.402 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.653 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.0 m95 -131.01 108.09 9.55 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.572 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -106.07 164.42 4.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.578 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 30.7 m-20 -47.34 149.61 1.03 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.753 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.405 HD13 ' HB3' ' A' ' 104' ' ' TYR . 28.1 tp -125.74 -42.37 1.93 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.9 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -119.9 155.53 32.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.322 0.582 . . . . 0.0 112.404 -178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.617 ' O ' ' N ' ' A' ' 118' ' ' VAL . 8.2 tt0 -45.84 166.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.398 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.65 61.17 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.764 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.813 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -79.01 159.66 4.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.522 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.2 mt-10 -107.8 75.43 1.0 Allowed 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.008 178.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.8 m-85 -70.51 41.94 0.06 Allowed 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.903 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.19 -20.31 20.59 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.615 177.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.721 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -134.59 44.39 1.17 Allowed Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 114.592 -1.185 . . . . 0.0 108.469 178.475 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.652 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 87.4 Cg_endo -81.3 98.48 1.02 Allowed 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.92 2.414 . . . . 0.0 113.119 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.55 -44.01 22.46 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.22 110.2 5.88 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.129 -0.536 . . . . 0.0 110.061 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.547 ' CG2' HD11 ' A' ' 102' ' ' ILE . 1.6 mt -97.9 126.28 50.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.963 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.429 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -159.15 162.7 36.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.942 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.436 HG21 ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -158.75 126.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.229 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -100.88 -173.17 2.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 24.2 m120 54.4 24.64 5.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.927 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.683 HD21 HD23 ' A' ' 80' ' ' LEU . 6.4 tp -109.07 92.51 4.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.602 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.711 ' C ' HD23 ' A' ' 133' ' ' LEU . 8.2 m-20 -115.71 90.03 3.24 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.111 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.711 HD23 ' C ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -155.89 120.46 4.64 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.287 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.5 139.35 37.96 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.882 HG12 HD13 ' A' ' 80' ' ' LEU . 1.3 p -154.59 171.14 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 C-N-CA 120.082 -0.647 . . . . 0.0 112.058 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.648 ' O ' HG23 ' A' ' 105' ' ' THR . 1.6 ttp85 -116.68 128.34 55.26 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.498 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 53.79 -174.74 0.42 Allowed Glycine 0 C--N 1.311 -0.822 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.756 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.842 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.7 m -161.03 148.91 5.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.938 0.495 . . . . 0.0 109.872 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.594 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 15.7 ttp180 -173.64 162.85 4.2 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.561 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.71 159.4 14.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.235 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.903 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 3.5 tp -125.7 122.76 63.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.589 0.233 . . . . 0.0 110.592 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.745 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -88.77 140.06 29.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.82 0.343 . . . . 0.0 111.316 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 8.9 t -127.68 26.97 5.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.332 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.527 ' N ' HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -177.05 -46.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 0.0 111.493 -179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' HB1' HG22 ' A' ' 64' ' ' ILE . . . 67.48 167.87 0.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.008 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.903 ' HB3' HG21 ' A' ' 149' ' ' THR . 8.0 ttp85 -130.55 138.37 50.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.835 0.35 . . . . 0.0 111.31 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.98 151.46 31.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.97 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 m120 44.63 78.23 0.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.787 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.903 HG21 ' HB3' ' A' ' 146' ' ' ARG . 0.5 OUTLIER -168.81 150.51 4.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.073 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.994 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 42.4 m0 -106.43 -173.12 2.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.996 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.516 HD13 ' C ' ' A' ' 151' ' ' LEU . 2.4 tm? -131.13 103.28 6.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.596 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -79.32 141.59 24.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.634 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 16.1 t -148.92 126.78 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.836 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.509 HH11 ' HB1' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -117.61 -27.29 6.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.594 -179.435 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.4 t70 -175.91 147.03 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.896 HG23 ' CG1' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -162.78 119.07 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.662 178.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -140.61 154.96 46.66 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.306 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.823 HG21 HD11 ' A' ' 80' ' ' LEU . 9.2 p -113.26 145.7 18.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.602 ' ND2' HG22 ' A' ' 158' ' ' VAL . 5.5 m120 71.88 29.87 2.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.071 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 24.2 mttm 47.34 92.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.071 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.1 tttm 60.59 27.6 17.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.636 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 62.54 67.53 0.71 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -163.07 -76.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.972 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.257 -0.877 . . . . 0.0 110.876 -179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.894 0.378 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.48 43.45 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.524 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.03 -176.23 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.876 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.4 p -173.37 39.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.957 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 m-70 68.73 -67.77 0.2 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.025 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -108.39 -175.74 2.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.898 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -99.0 31.65 2.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.933 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 60.29 87.17 0.09 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.823 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.1 m-70 -165.82 85.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.946 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -128.84 116.83 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 t -163.79 71.28 0.23 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.5 p 49.98 80.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.118 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -170.14 153.94 22.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.527 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.89 158.13 44.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 0.0 110.889 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.45 87.58 14.18 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.091 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.13 -40.87 67.84 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.565 2.177 . . . . 0.0 112.331 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -176.45 131.52 0.21 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.878 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.08 108.16 2.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.467 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.7 m -173.38 -41.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.868 0.366 . . . . 0.0 110.92 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 60.42 84.98 0.12 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.835 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.2 174.21 6.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.46 -162.63 1.16 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.791 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -94.88 32.43 1.65 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.963 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 62.37 148.84 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.984 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.63 108.67 2.45 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.5 2.133 . . . . 0.0 112.247 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -67.34 160.7 26.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.4 158.89 11.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.898 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.935 ' CG2' HD13 ' A' ' 78' ' ' ILE . 3.8 tp -106.09 159.63 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.0 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.796 HG22 ' HB3' ' A' ' 75' ' ' SER . 19.6 tt -82.15 159.91 3.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.596 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -142.61 98.39 3.29 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.685 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.0 121.0 28.0 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.992 0.425 . . . . 0.0 110.964 179.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.1 t80 -55.45 133.03 49.75 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.657 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.516 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.31 173.72 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.414 179.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.468 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 1.4 p -177.64 129.65 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.738 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 12.9 t30 -66.71 -29.83 69.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.267 0.556 . . . . 0.0 109.806 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -62.3 -38.69 90.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.194 -179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 63.59 25.18 14.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.741 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -95.34 144.27 26.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.773 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.68 140.18 67.49 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.004 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.75 139.32 39.96 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.361 2.041 . . . . 0.0 112.216 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.695 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -46.57 -51.79 14.85 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.274 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.437 ' H ' HG23 ' A' ' 41' ' ' THR . . . -128.33 -75.34 0.18 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.338 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -158.36 116.62 1.78 Allowed Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.609 0.242 . . . . 0.0 110.788 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.501 ' HA ' HD12 ' A' ' 56' ' ' LEU . 48.4 Cg_endo -69.58 -1.52 8.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.443 2.095 . . . . 0.0 112.131 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 21.1 t0 -40.97 -30.93 0.15 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.82 ' ND2' HG23 ' A' ' 54' ' ' THR . 22.4 m-80 -47.16 -29.69 2.44 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.191 0.52 . . . . 0.0 110.435 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.805 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.2 mp -102.84 -25.07 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.904 -178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 5.7 m-30 -54.0 -34.02 58.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.224 -179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -153.73 26.42 0.5 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.316 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 31.0 t30 53.62 99.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.346 . . . . 0.0 111.09 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -141.8 -45.7 0.35 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 64.58 21.51 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.308 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -100.5 28.92 4.71 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.187 0.518 . . . . 0.0 110.601 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.82 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.2 OUTLIER -160.29 171.62 18.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.949 -179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.09 161.4 13.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.745 0.307 . . . . 0.0 111.07 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD21 ' CE1' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -163.84 115.13 1.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.369 -179.171 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.695 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 137.02 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.829 179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.587 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.2 m-30 -107.07 145.14 32.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.297 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.791 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 3.9 mppt? -113.25 -60.41 1.89 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.575 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.41 -177.17 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.4 Cg_endo -50.88 109.65 0.33 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 CA-C-N 120.106 1.074 . . . . 0.0 110.153 179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 4.9 m-20 -39.79 -32.58 0.15 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.716 -178.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -104.56 123.16 47.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.681 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -154.6 138.12 8.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.988 0.423 . . . . 0.0 111.478 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.741 ' OD1' HG23 ' A' ' 66' ' ' VAL . 12.4 t70 -118.71 116.76 27.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.847 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.741 HG23 ' OD1' ' A' ' 65' ' ' ASP . 22.8 t 62.17 122.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.304 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 120.85 -33.17 4.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.682 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 68' ' ' THR . 0.9 OUTLIER -59.87 101.41 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.758 ' CE2' HD13 ' A' ' 141' ' ' ILE . 4.4 p90 -160.15 164.38 32.97 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 32' ' ' TYR . 1.1 m -156.65 -171.85 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-O 121.361 0.601 . . . . 0.0 111.56 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.648 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.05 -121.57 0.95 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.164 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.87 120.22 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-O 121.327 0.584 . . . . 0.0 112.327 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.543 ' O ' ' N ' ' A' ' 31' ' ' THR . 0.1 OUTLIER -89.43 153.58 20.72 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.978 -0.451 . . . . 0.0 111.598 -178.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.593 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.8 m-30 -108.87 -172.27 2.02 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.841 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.796 ' HB3' HG22 ' A' ' 29' ' ' ILE . 0.7 OUTLIER -86.13 -45.47 11.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.045 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.762 ' O ' HG23 ' A' ' 78' ' ' ILE . 1.5 m120 -155.33 167.62 13.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.771 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 8.9 Cg_endo -50.66 120.65 6.77 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.592 2.195 . . . . 0.0 111.886 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.935 HD13 ' CG2' ' A' ' 28' ' ' ILE . 23.7 pt -130.33 141.66 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.725 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 t -58.9 96.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.3 tt -84.71 104.66 14.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.172 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -69.64 -27.48 65.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.778 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 179.65 134.08 0.1 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.856 HG11 HD11 ' A' ' 114' ' ' LEU . 10.4 p -105.05 136.87 36.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.416 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 8.3 pt-20 -151.69 124.38 8.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.779 0.323 . . . . 0.0 111.845 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.977 ' CE1' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -108.76 100.54 9.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.22 88.08 7.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.836 0.35 . . . . 0.0 110.427 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.51 -179.85 6.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.068 0.461 . . . . 0.0 111.695 -179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -157.67 -95.88 0.11 Allowed Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.873 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 95' ' ' ASP . . . -143.2 172.58 12.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.044 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 5.1 p-10 -81.64 -64.11 1.25 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.917 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 m -104.19 -61.31 1.46 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 121.066 0.46 . . . . 0.0 110.993 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.9 m120 -95.67 122.1 59.76 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.803 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 4.1 Cg_endo -46.59 -20.5 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.84 2.36 . . . . 0.0 113.045 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -88.37 26.21 1.49 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.546 0.212 . . . . 0.0 111.544 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.507 ' CB ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 t0 -111.29 94.77 5.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.824 0.345 . . . . 0.0 110.867 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.796 HG23 ' O ' ' A' ' 121' ' ' THR . 0.4 OUTLIER -176.26 -165.35 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.153 -179.745 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.828 ' CE ' HD22 ' A' ' 140' ' ' LEU . 7.0 tpp -39.74 157.4 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.722 0.296 . . . . 0.0 110.919 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.602 ' C ' ' HB ' ' A' ' 121' ' ' THR . 54.4 tp60 -96.89 -39.89 9.17 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 177.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.0 OUTLIER -176.13 121.89 0.17 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.176 176.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.634 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.55 162.89 0.09 Allowed 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 0.0 OUTLIER -111.36 172.69 6.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.089 178.421 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.977 HD13 ' CE1' ' A' ' 85' ' ' PHE . 58.5 mt -92.94 158.37 2.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.245 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.495 ' HG2' ' HA ' ' A' ' 113' ' ' ASP . 0.8 OUTLIER -118.85 -174.09 2.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.555 179.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.821 ' HB3' HD12 ' A' ' 114' ' ' LEU . 13.2 p90 -175.37 137.6 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.679 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.532 ' HB ' ' CD1' ' A' ' 111' ' ' TRP . 5.4 t -96.9 130.03 44.26 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.772 0.32 . . . . 0.0 110.159 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.441 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -78.8 -60.94 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.962 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.0 30.22 2.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.7 0.286 . . . . 0.0 111.387 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.84 26.69 41.41 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.425 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.47 -74.47 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.83 0.348 . . . . 0.0 110.679 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.91 163.43 17.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.338 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.554 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 32.6 m95 -129.32 125.85 37.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.851 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -122.1 164.56 18.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.034 0.445 . . . . 0.0 111.744 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 3.7 p30 -49.68 152.37 1.46 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.504 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.856 HD11 HG11 ' A' ' 83' ' ' VAL . 9.1 tt -125.44 -47.1 1.73 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.7 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.549 ' HG3' ' N ' ' A' ' 116' ' ' GLU . 27.2 tp10 -100.01 159.31 15.18 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.594 0.711 . . . . 0.0 112.685 -178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.795 ' O ' ' N ' ' A' ' 118' ' ' VAL . 80.1 mm-40 -67.91 104.31 1.68 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.565 178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.609 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.97 51.55 0.0 OUTLIER Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.714 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.795 ' N ' ' O ' ' A' ' 116' ' ' GLU . 2.5 t -86.94 157.95 3.2 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.605 0 CA-C-O 121.149 0.5 . . . . 0.0 111.138 -178.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.547 ' C ' ' H ' ' A' ' 121' ' ' THR . 0.9 OUTLIER -104.87 82.79 1.92 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.896 179.156 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.813 ' CD2' HG13 ' A' ' 102' ' ' ILE . 14.0 m-85 -70.85 37.48 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.488 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.796 ' O ' HG23 ' A' ' 96' ' ' THR . 0.2 OUTLIER -90.35 -21.07 22.18 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.363 178.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.0 OUTLIER -134.41 42.38 0.79 Allowed Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.618 178.21 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 91.6 Cg_endo -85.22 98.38 0.65 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.764 2.309 . . . . 0.0 113.064 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.25 -45.55 30.44 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.37 105.48 4.59 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.07 -0.565 . . . . 0.0 110.047 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.663 ' CG2' ' CE1' ' A' ' 120' ' ' TYR . 1.3 mt -94.15 137.04 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.779 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.416 ' CB ' ' HB3' ' A' ' 84' ' ' GLU . 4.1 pttt -158.88 154.68 26.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.807 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 16.6 t -138.53 126.25 28.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.236 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -99.34 161.98 13.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.3 m-20 61.38 29.15 18.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.003 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.6 ' CD2' HG12 ' A' ' 83' ' ' VAL . 20.1 tp -99.51 19.25 16.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.038 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -54.83 89.63 0.01 OUTLIER 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.871 0.367 . . . . 0.0 110.924 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.3 tp -156.14 127.58 7.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.5 mtmt -54.34 129.41 35.38 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 105' ' ' THR . 2.6 p -148.45 161.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.703 -178.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 105' ' ' THR . 13.6 tpt180 -112.02 127.73 55.97 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 177.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.593 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 46.89 -176.77 0.01 OUTLIER Glycine 0 C--N 1.317 -0.506 0 CA-C-N 115.566 -0.743 . . . . 0.0 114.223 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.769 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.9 m -151.98 155.92 6.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.011 -0.594 . . . . 0.0 109.65 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.557 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 4.1 ttm105 -173.24 150.06 1.86 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.297 0.57 . . . . 0.0 111.646 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.828 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.7 OUTLIER -96.52 158.72 15.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.72 -179.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.758 HD13 ' CE2' ' A' ' 69' ' ' TYR . 0.7 OUTLIER -137.21 113.26 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.412 . . . . 0.0 110.632 179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -68.54 165.81 18.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.19 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' HG22 ' A' ' 66' ' ' VAL . 5.7 m -126.22 -40.0 2.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.35 -42.58 1.82 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.794 0.33 . . . . 0.0 111.406 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.471 ' HB3' ' H ' ' A' ' 66' ' ' VAL . . . 62.86 175.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.981 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.893 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.2 OUTLIER -138.56 162.06 35.51 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.16 -179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.01 155.23 20.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 20.8 m120 48.54 75.46 0.14 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.001 0.429 . . . . 0.0 110.502 -179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.893 HG21 ' HG3' ' A' ' 146' ' ' ARG . 7.5 t -165.69 130.19 2.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.164 -179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.791 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 48.9 m0 -90.68 -173.11 3.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.2 -0.454 . . . . 0.0 109.972 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.607 HD13 ' C ' ' A' ' 151' ' ' LEU . 3.3 tm? -127.8 98.78 5.29 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -87.4 153.02 24.8 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.886 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.436 ' HA ' ' HB3' ' A' ' 87' ' ' MET . 1.0 OUTLIER -148.98 151.91 12.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.729 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -124.3 -44.06 2.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.998 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -177.39 157.76 1.35 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.193 0.52 . . . . 0.0 111.786 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.805 ' HB ' HG23 ' A' ' 47' ' ' ILE . 52.7 mt -138.42 137.61 43.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.743 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -130.41 154.55 47.59 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.988 0.423 . . . . 0.0 111.492 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.572 HG13 ' O ' ' A' ' 158' ' ' VAL . 11.1 p -154.38 112.49 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.871 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.445 ' ND2' HG22 ' A' ' 158' ' ' VAL . 16.8 p30 45.58 30.13 0.73 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.352 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.15 133.89 43.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.949 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 8.9 tptp 59.8 30.96 20.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.876 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -148.65 -73.75 0.18 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 33.4 t0 60.43 79.49 0.24 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.944 179.931 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.817 0.341 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.5 -137.6 8.73 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.464 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -106.56 34.03 3.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.879 0.371 . . . . 0.0 110.903 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.09 79.97 1.8 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -141.26 -58.15 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.926 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -140.52 31.66 1.88 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m80 -139.41 44.87 1.97 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.843 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -59.56 140.4 56.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.914 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.15 119.18 7.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.916 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 60.33 89.67 0.07 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.866 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 m -74.08 -176.1 2.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.966 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.2 p -97.99 36.31 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -123.71 -103.13 1.58 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.502 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD22 ' HG3' ' A' ' 16' ' ' PRO . 2.3 tt -176.59 -40.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 15' ' ' VAL . 7.5 p 42.85 61.32 9.56 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.588 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.506 ' HG3' HD22 ' A' ' 14' ' ' LEU . 62.2 Cg_exo -51.23 169.77 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.628 2.219 . . . . 0.0 112.333 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -126.0 133.47 51.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.834 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.59 138.06 40.08 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.468 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 m -129.97 31.27 4.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.805 0.336 . . . . 0.0 110.906 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -143.99 72.94 1.37 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.876 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.9 mtp 63.32 -80.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.954 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -179.08 -73.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.007 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 52.3 p -58.95 -27.92 65.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.041 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.27 155.24 0.11 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.978 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.08 171.97 13.83 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.655 2.237 . . . . 0.0 112.286 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 60.56 33.51 20.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.957 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -66.2 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.819 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 78' ' ' ILE . 22.9 mm 63.81 127.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.593 HG22 ' HB2' ' A' ' 75' ' ' SER . 19.8 tt -82.15 160.46 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.371 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.785 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -132.96 98.48 4.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.869 0.366 . . . . 0.0 111.442 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.545 ' O ' ' N ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -85.95 144.11 27.81 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.848 179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' OH ' HG21 ' A' ' 70' ' ' VAL . 4.3 t80 -83.08 140.93 32.38 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.216 0.531 . . . . 0.0 111.913 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.505 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -125.22 145.62 32.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.514 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.446 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 7.3 p -157.24 129.57 7.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.918 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -55.84 -28.03 54.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.012 0.434 . . . . 0.0 110.591 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 HH12 HG23 ' A' ' 68' ' ' THR . 61.5 mtt85 -73.64 147.3 43.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.015 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.27 -24.27 37.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.672 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.46 114.48 4.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.043 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -62.23 168.24 4.17 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 7.2 Cg_endo -50.86 -179.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.414 2.076 . . . . 0.0 112.187 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.862 HG21 HG22 ' A' ' 57' ' ' VAL . 64.6 p -117.76 -106.74 0.38 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.892 -179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -50.66 -75.71 0.2 Allowed Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.4 -0.905 . . . . 0.0 111.687 179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -158.87 123.39 2.18 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.471 0.177 . . . . 0.0 110.545 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.25 -0.97 9.42 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.212 1.942 . . . . 0.0 111.528 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.47 ' HB2' HG21 ' A' ' 54' ' ' THR . 15.4 m-20 -40.5 -32.59 0.21 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.316 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.742 ' CG ' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -52.95 -25.89 13.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.404 0.621 . . . . 0.0 109.707 179.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.539 HG13 HG23 ' A' ' 156' ' ' ILE . 3.2 mp -103.08 -33.68 3.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.097 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 30' ' ' ALA . 18.7 m-30 -83.41 -52.53 6.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.714 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.7 -10.69 21.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.525 -179.845 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.434 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.7 m120 74.75 34.88 0.69 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.806 0.336 . . . . 0.0 110.981 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.422 ' O ' HG22 ' A' ' 54' ' ' THR . 20.2 t30 -104.94 115.99 31.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.569 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -78.59 -16.45 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.874 -179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 56.3 m -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 111.011 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.742 HG23 ' CG ' ' A' ' 46' ' ' ASN . 1.9 t -86.14 172.59 10.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -122.94 173.03 8.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.031 0.444 . . . . 0.0 111.562 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.676 HD23 ' N ' ' A' ' 57' ' ' VAL . 1.6 tt -163.75 128.88 2.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.706 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.862 HG22 HG21 ' A' ' 41' ' ' THR . 1.6 m -153.76 129.73 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.106 0.479 . . . . 0.0 111.761 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.534 ' O ' ' HB3' ' A' ' 150' ' ' TRP . 23.9 m-85 -107.21 115.39 30.09 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 0.9 OUTLIER -83.12 -60.88 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.933 -178.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.628 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER 43.19 176.55 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 -179.844 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 6.6 Cg_endo -49.5 109.91 0.32 Allowed 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 120.878 1.052 . . . . 0.0 109.944 178.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.655 ' HB3' ' HA ' ' A' ' 148' ' ' ASN . 1.6 m120 -33.47 -37.53 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.8 -178.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -101.49 123.15 45.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.453 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.927 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.6 pp -131.07 144.7 37.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.907 0.384 . . . . 0.0 111.487 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -92.23 178.11 5.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.775 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 144' ' ' GLU . 22.3 t -44.0 115.57 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.42 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 147.78 -18.0 1.43 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.478 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.569 ' CB ' HD13 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -59.11 110.8 1.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.707 0.289 . . . . 0.0 110.651 179.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.558 ' CE2' HD12 ' A' ' 141' ' ' ILE . 0.3 OUTLIER -162.52 168.24 22.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.0 111.883 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.729 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.0 OUTLIER -147.1 -170.55 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.514 178.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.729 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.05 -127.86 2.03 Favored Glycine 0 N--CA 1.441 -0.968 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.426 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.835 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.4 p -172.62 119.23 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 CA-C-O 121.35 0.595 . . . . 0.0 111.615 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.4 pttt -89.37 151.78 21.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 111.696 -178.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.78 ' OH ' HG11 ' A' ' 158' ' ' VAL . 2.3 m-30 -103.35 -179.64 4.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.265 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.593 ' HB2' HG22 ' A' ' 29' ' ' ILE . 9.1 t -84.27 -60.26 2.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.892 0.377 . . . . 0.0 111.509 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.484 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 0.8 OUTLIER -134.16 171.58 8.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.668 -179.491 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.56 137.99 57.94 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.321 2.014 . . . . 0.0 111.43 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -147.88 172.18 2.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.812 0.339 . . . . 0.0 111.508 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 7.9 m -101.34 96.18 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.983 178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.481 HD11 ' HB ' ' A' ' 83' ' ' VAL . 7.7 tt -96.96 129.43 44.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 132' ' ' ASP . 0.2 OUTLIER -83.86 -33.18 24.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 128' ' ' VAL . 13.0 p30 178.91 130.24 0.07 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.918 HG23 HG12 ' A' ' 158' ' ' VAL . 7.5 p -105.38 157.12 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.666 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' N ' HG22 ' A' ' 83' ' ' VAL . 14.7 mt-10 -151.49 129.72 11.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.912 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.649 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 16.7 m-85 -108.54 100.57 9.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.923 178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.798 HD11 ' HB1' ' A' ' 125' ' ' ALA . 1.1 mp -90.88 87.65 6.73 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB3' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.57 -179.82 6.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.587 -178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.54 -96.63 0.13 Allowed Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.109 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . . . -142.93 -177.52 5.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.703 0.287 . . . . 0.0 110.903 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.45 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 6.3 p-10 -84.5 -62.98 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.924 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 89.8 p -103.85 -53.55 2.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.08 0.467 . . . . 0.0 110.338 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -117.24 121.96 31.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.385 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.479 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 1.1 Cg_endo -43.52 -27.25 1.29 Allowed 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.753 2.302 . . . . 0.0 112.709 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -59.46 -24.76 63.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.198 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.66 89.55 2.79 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.203 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.818 HG23 ' O ' ' A' ' 121' ' ' THR . 1.1 t -176.38 -165.27 0.13 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.565 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.682 ' CE ' HD22 ' A' ' 140' ' ' LEU . 2.6 tpp -39.41 159.86 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.912 0.387 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.666 ' C ' ' HB ' ' A' ' 121' ' ' THR . 28.1 tp60 -100.16 -40.43 7.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 0.9 OUTLIER -176.27 122.25 0.17 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.393 -1.276 . . . . 0.0 108.673 177.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.84 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 179.0 161.68 0.73 Allowed 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 -179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -105.44 166.29 10.53 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.488 178.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CG1' ' CE2' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -84.35 162.47 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.142 -179.773 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.616 ' OE1' HD13 ' A' ' 141' ' ' ILE . 13.4 mt-30 -129.37 -175.6 3.63 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.919 0.39 . . . . 0.0 111.696 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 111' ' ' TRP . 9.6 p90 -174.94 145.18 0.82 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.38 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.703 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.8 t -103.26 140.35 37.51 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.757 0.313 . . . . 0.0 110.236 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.43 -61.1 2.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.422 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.2 OUTLIER -96.07 33.71 1.68 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.414 -179.182 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.404 ' CA ' ' HG2' ' A' ' 136' ' ' ARG . . . 50.39 35.53 28.45 Favored Glycine 0 C--N 1.328 0.138 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.458 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.61 -72.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.873 0.368 . . . . 0.0 110.67 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.37 165.17 14.54 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.181 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.623 ' CZ2' HG22 ' A' ' 105' ' ' THR . 28.3 m95 -131.04 113.88 14.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.972 0.415 . . . . 0.0 110.64 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -102.41 164.5 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.461 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.421 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 16.1 t0 -54.21 153.71 5.0 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.989 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.828 HD21 HG11 ' A' ' 128' ' ' VAL . 5.7 tt -121.93 -66.19 1.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.153 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.863 ' OE1' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -98.21 156.71 16.56 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.671 ' O ' ' N ' ' A' ' 118' ' ' VAL . 2.5 mm-40 -43.58 166.53 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.655 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -61.01 62.99 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.846 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.714 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.4 t -81.69 159.75 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.591 0 CA-C-O 121.077 0.465 . . . . 0.0 110.596 -178.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.523 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.3 mt-10 -108.15 75.81 1.01 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.104 178.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.714 ' CE1' HG11 ' A' ' 118' ' ' VAL . 71.6 m-85 -70.51 40.48 0.05 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.081 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 96' ' ' THR . 0.1 OUTLIER -92.33 -21.68 20.13 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.561 -0.904 . . . . 0.0 108.561 177.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.606 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -130.99 44.62 1.44 Allowed Pre-proline 0 N--CA 1.448 -0.574 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.513 178.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.663 ' HD3' ' C ' ' A' ' 120' ' ' TYR . 93.6 Cg_endo -80.2 106.0 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.863 2.375 . . . . 0.0 112.765 -178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.61 -45.06 7.01 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 178.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.798 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.42 106.01 4.66 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.067 -0.566 . . . . 0.0 110.015 178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.583 HG23 ' CE1' ' A' ' 120' ' ' TYR . 1.2 mt -93.12 133.32 34.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.937 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 22.8 mtpt -155.03 129.18 8.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.863 HG22 ' OE1' ' A' ' 115' ' ' GLU . 5.9 t -112.3 95.54 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -91.75 170.07 10.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.079 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 57.8 32.22 21.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.0 tp -115.03 52.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 81' ' ' ASN . 30.0 m-20 -70.38 89.68 0.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.0 tp -155.8 123.39 5.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.958 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' THR . 0.0 OUTLIER -55.19 142.63 30.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 105' ' ' THR . 1.4 p -158.63 171.47 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 120.143 -0.623 . . . . 0.0 111.96 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.613 ' O ' HG23 ' A' ' 105' ' ' THR . 0.1 OUTLIER -117.88 128.24 54.64 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.44 -176.32 0.08 OUTLIER Glycine 0 C--N 1.312 -0.798 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.928 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.835 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.4 m -156.58 149.69 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 122.856 0.463 . . . . 0.0 110.049 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.582 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 27.0 ttp180 -173.73 163.05 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.193 0.521 . . . . 0.0 112.13 -179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.682 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.8 OUTLIER -99.46 158.68 15.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.08 179.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.84 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.4 tp -130.37 124.42 57.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.656 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 100' ' ' ALA . . . -95.86 148.16 22.9 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.912 0.387 . . . . 0.0 111.675 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.409 ' HA ' HG13 ' A' ' 66' ' ' VAL . 5.1 t -127.74 24.68 6.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.783 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.467 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.6 tp10 -171.56 -47.2 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.862 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.927 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . 68.06 171.89 0.28 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.406 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' HG21 ' A' ' 149' ' ' THR . 12.7 ttt85 -127.72 152.33 47.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 152.81 18.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.733 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.655 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 10.5 m-80 46.5 72.34 0.24 Allowed 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.007 0.432 . . . . 0.0 110.559 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 146' ' ' ARG . 6.4 t -168.85 142.67 3.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.098 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.633 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 17.2 m0 -98.21 -172.86 2.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.029 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.409 ' HB2' ' NH1' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -127.25 98.8 5.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.277 178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -93.3 142.89 16.19 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.408 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.555 HG21 HD13 ' A' ' 56' ' ' LEU . 1.4 t -126.93 140.87 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.764 0.316 . . . . 0.0 111.029 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 1.8 mmp_? -105.44 -44.1 4.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.325 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 154' ' ' ARG . 1.1 t70 176.45 124.25 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.649 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.1 OUTLIER -130.57 126.6 60.96 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -140.16 154.68 47.04 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.718 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.918 HG12 HG23 ' A' ' 83' ' ' VAL . 33.9 m -113.07 152.72 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.745 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 16.2 m120 60.87 76.82 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.752 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 7.5 pttt -85.42 23.36 1.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.377 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -173.12 34.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.281 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 60.73 43.2 12.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.692 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.06 -81.46 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.844 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.852 179.994 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.786 0.327 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.75 -136.4 3.56 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.608 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -176.19 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.882 0.373 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.0 m -94.38 145.27 24.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 60.28 75.4 0.41 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 76.02 10.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.841 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -128.73 31.05 5.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.5 m80 59.66 -172.85 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.89 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -116.21 -69.54 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.814 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 60.18 106.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.933 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -130.82 107.88 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.859 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -132.41 120.1 21.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.38 -143.09 12.47 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.46 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 14' ' ' LEU . 0.4 OUTLIER -72.89 -31.55 64.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.803 0.335 . . . . 0.0 110.847 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.74 HG12 ' HG2' ' A' ' 17' ' ' ARG . 21.6 t 63.82 80.02 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.114 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.5 -28.77 37.37 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.658 2.239 . . . . 0.0 112.168 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.74 ' HG2' HG12 ' A' ' 15' ' ' VAL . 0.6 OUTLIER 60.17 101.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.915 -179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.01 -152.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.412 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.3 m -130.48 -169.89 2.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -60.28 -178.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.89 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 28.9 tpp -106.24 -60.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -175.01 -54.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.104 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.7 p -131.75 44.13 2.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 8.3 m-20 -59.3 -60.87 9.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.939 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' ASP . 58.4 Cg_endo -71.78 161.77 44.06 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.111 . . . . 0.0 112.284 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -154.34 79.25 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -105.2 107.59 18.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.891 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.747 HD13 HG22 ' A' ' 78' ' ' ILE . 1.5 mp -92.78 131.6 39.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.916 HG22 ' HB2' ' A' ' 75' ' ' SER . 18.1 tt -82.27 161.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.037 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -134.47 123.85 24.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.857 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.479 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -120.34 116.48 25.61 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-O 121.019 0.438 . . . . 0.0 111.269 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.614 ' HE2' HG11 ' A' ' 153' ' ' VAL . 1.0 OUTLIER -54.3 129.42 35.3 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.611 179.55 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.608 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.16 170.62 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.793 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.9 p -177.63 137.84 0.21 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.636 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 15.7 t-20 -67.28 -28.82 68.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.143 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -78.9 126.29 30.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.839 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.93 -24.13 22.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.962 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.3 t0 -60.26 103.35 0.23 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.28 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.39 144.07 88.65 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.435 ' HB3' HD23 ' A' ' 56' ' ' LEU . 2.0 Cg_endo -45.31 119.66 2.7 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.49 2.127 . . . . 0.0 112.013 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.909 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.0 t -75.52 -174.05 2.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.539 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.17 -99.71 0.03 OUTLIER Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.223 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CB ' HG21 ' A' ' 54' ' ' THR . 1.2 t-20 -158.75 103.48 1.61 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 120.451 0.167 . . . . 0.0 111.184 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.566 ' HA ' HD12 ' A' ' 47' ' ' ILE . 72.1 Cg_endo -75.08 -2.17 12.2 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.357 2.038 . . . . 0.0 111.666 179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.447 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 2.2 m-20 -49.43 -28.95 5.76 Favored 'General case' 0 CA--C 1.522 -0.099 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.295 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -60.26 -31.12 69.91 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.084 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.746 HG23 ' HB ' ' A' ' 156' ' ' ILE . 2.6 mp -89.18 -32.81 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.732 179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.447 ' CD2' ' HA ' ' A' ' 45' ' ' ASP . 4.9 m-30 -54.33 -38.2 65.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.226 -179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -139.02 16.71 2.64 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 66.18 99.31 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.888 0.375 . . . . 0.0 111.62 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.719 ' HB3' ' HA ' ' A' ' 46' ' ' ASN . 56.2 t30 -134.37 -41.83 0.79 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.728 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.03 27.82 9.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.385 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.418 ' CB ' ' ND2' ' A' ' 51' ' ' ASN . 5.5 t -92.73 -49.95 5.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.516 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -106.97 162.33 13.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.871 179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -107.08 167.96 9.54 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.299 0.571 . . . . 0.0 112.133 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.678 HD11 HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -161.39 148.64 14.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.845 179.503 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.909 ' H ' HG22 ' A' ' 41' ' ' THR . 2.3 m -153.93 154.28 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.668 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -107.85 128.77 54.9 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.125 177.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.808 ' HB3' ' CG ' ' A' ' 150' ' ' TRP . 0.0 OUTLIER -164.11 25.54 0.07 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -177.564 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.536 ' CB ' ' HD3' ' A' ' 61' ' ' PRO . 1.1 m-20 -60.88 -60.6 10.13 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 60' ' ' ASN . 54.2 Cg_endo -92.62 110.08 0.23 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.796 2.331 . . . . 0.0 111.342 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 148' ' ' ASN . 14.5 t-20 -80.27 59.51 3.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.043 0.449 . . . . 0.0 110.501 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 171.29 123.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.621 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.66 ' O ' HD12 ' A' ' 64' ' ' ILE . 1.4 pp -152.56 129.42 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.3 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -118.89 116.67 26.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.88 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t 57.24 108.85 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.489 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.686 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 130.56 -21.87 4.72 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.709 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.623 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -55.54 103.83 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.0 110.342 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.567 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -162.33 168.82 21.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.654 -179.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.747 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.7 OUTLIER -160.24 -173.48 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.455 0.645 . . . . 0.0 111.431 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.747 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 167.38 -122.6 1.06 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.715 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.793 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.2 p -173.4 122.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.146 0.498 . . . . 0.0 111.113 178.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 1.6 tttm -89.16 142.28 27.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.105 0.479 . . . . 0.0 111.679 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 1.6 m-30 -103.37 -176.26 3.03 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.019 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.916 ' HB2' HG22 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -107.79 -48.04 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.725 179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' HB2' HD11 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -122.53 176.55 2.01 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.48 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 83.1 Cg_endo -79.74 136.48 12.11 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.324 2.016 . . . . 0.0 112.54 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.747 HG22 HD13 ' A' ' 28' ' ' ILE . 24.0 pt -138.2 132.35 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.017 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 t -54.93 95.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.765 HD13 HG12 ' A' ' 135' ' ' VAL . 1.1 tp -76.61 94.18 3.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.148 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -74.7 -20.31 59.91 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.927 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 14.8 p30 178.38 132.66 0.07 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.933 0.397 . . . . 0.0 111.33 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.667 HG11 HD11 ' A' ' 114' ' ' LEU . 7.6 p -105.05 136.34 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.156 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 10.5 mp0 -147.12 122.24 10.14 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.697 ' HD2' HD13 ' A' ' 156' ' ' ILE . 7.3 m-85 -109.25 100.66 9.76 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.67 88.26 5.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.845 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.92 145.05 34.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.059 0.457 . . . . 0.0 111.313 -179.1 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.402 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -133.82 -101.87 0.75 Allowed Glycine 0 C--N 1.331 0.299 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.07 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.496 ' HA ' ' H ' ' A' ' 152' ' ' GLY . . . -142.85 165.14 28.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.827 0.346 . . . . 0.0 111.24 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.409 ' HB2' HG11 ' A' ' 57' ' ' VAL . 4.6 t-20 -87.29 -68.42 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.923 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 p -103.79 -61.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.879 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.415 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 2.8 t-20 -90.13 121.91 68.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.772 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 10.2 Cg_endo -51.43 -21.32 10.05 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.523 2.149 . . . . 0.0 112.527 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.43 26.25 3.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.286 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 29.1 m-20 -104.13 87.14 2.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.936 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.826 HG23 ' O ' ' A' ' 121' ' ' THR . 1.4 t -176.25 -165.13 0.13 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.469 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.531 ' N ' ' OG1' ' A' ' 96' ' ' THR . 2.7 tpp -40.88 167.39 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.021 0.439 . . . . 0.0 111.552 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.7 ' C ' ' HB ' ' A' ' 121' ' ' THR . 4.3 tm0? -104.74 -42.57 5.35 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' HD3' HG23 ' A' ' 143' ' ' THR . 0.0 OUTLIER -177.2 122.56 0.13 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.121 177.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.908 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . -179.42 158.73 0.87 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.436 ' O ' HD23 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -105.57 167.84 9.49 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.811 178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.667 HG21 ' CE1' ' A' ' 85' ' ' PHE . 1.1 mt -95.1 162.55 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 O-C-N 122.059 -0.401 . . . . 0.0 111.563 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.456 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 1.3 mt-30 -134.14 -170.63 2.56 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.479 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.673 ' HB3' HD12 ' A' ' 114' ' ' LEU . 10.5 p90 -174.11 144.29 0.97 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.14 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.535 ' O ' HG22 ' A' ' 135' ' ' VAL . 3.7 t -98.03 130.74 44.84 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.452 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.9 t -76.99 -41.17 31.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 -178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.82 34.37 5.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.747 0.308 . . . . 0.0 111.261 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 48.41 28.21 6.31 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.139 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -126.02 -55.37 1.48 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.029 0.442 . . . . 0.0 110.508 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.14 156.02 20.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.966 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.532 ' CD1' ' HB ' ' A' ' 105' ' ' THR . 40.7 m95 -126.91 120.28 28.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.931 0.396 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.26 156.66 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.459 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -45.85 153.65 0.27 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.443 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 104' ' ' TYR . 8.6 tt -128.5 -66.76 0.83 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.715 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.7 ' OE2' HG22 ' A' ' 128' ' ' VAL . 3.9 tp10 -94.19 156.59 16.47 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.496 0.665 . . . . 0.0 112.674 -178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 118' ' ' VAL . 5.8 tt0 -45.06 166.93 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.601 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -65.72 56.54 0.14 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.501 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.729 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.9 t -75.93 159.93 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.611 0 CA-C-O 120.904 0.383 . . . . 0.0 110.373 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.593 ' HB3' HG22 ' A' ' 121' ' ' THR . 2.0 mt-10 -109.59 83.72 1.8 Allowed 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.864 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.729 ' CE1' HG11 ' A' ' 118' ' ' VAL . 45.1 m-85 -70.57 31.75 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.104 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.826 ' O ' HG23 ' A' ' 96' ' ' THR . 0.8 OUTLIER -89.06 -21.42 23.44 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.06 177.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.71 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -136.51 42.23 0.67 Allowed Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.419 178.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.71 ' HD3' ' N ' ' A' ' 122' ' ' MET . 72.6 Cg_endo -88.77 131.86 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.694 2.263 . . . . 0.0 113.062 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -103.72 -39.53 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.8 103.63 4.38 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-N 115.164 -0.518 . . . . 0.0 110.058 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.653 HG21 HD11 ' A' ' 102' ' ' ILE . 1.8 mt -93.73 128.42 45.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.999 -178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.405 ' HA ' ' HG3' ' A' ' 84' ' ' GLU . 17.5 mtmm -148.38 162.83 38.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.558 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.7 HG22 ' OE2' ' A' ' 115' ' ' GLU . 27.9 t -139.36 152.12 23.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.257 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -133.65 163.41 29.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.834 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 59.09 32.11 21.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 80' ' ' LEU . 2.3 tp -116.34 29.22 8.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.92 89.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.25 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.34 128.71 7.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.105 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 3.4 mtpm? -54.24 141.95 27.8 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.765 HG12 HD13 ' A' ' 80' ' ' LEU . 1.8 p -154.69 168.71 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.842 -178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.476 ' H ' HG22 ' A' ' 135' ' ' VAL . 0.0 OUTLIER -116.49 128.06 55.11 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 176.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.87 -177.35 0.09 OUTLIER Glycine 0 C--N 1.315 -0.609 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.781 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.793 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.9 OUTLIER -154.39 155.25 6.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 122.875 0.47 . . . . 0.0 109.819 179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.529 ' O ' HG22 ' A' ' 102' ' ' ILE . 7.9 ttm180 -173.48 163.16 4.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.216 0.531 . . . . 0.0 111.864 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.604 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -107.64 159.69 16.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.649 -179.686 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.908 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -126.56 123.49 63.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.777 0.322 . . . . 0.0 110.925 179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.686 ' HB3' ' H ' ' A' ' 67' ' ' GLY . . . -90.46 157.35 17.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.183 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.489 HG23 ' HD3' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -127.55 -40.8 1.74 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -146.96 64.62 1.17 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.785 0.326 . . . . 0.0 111.153 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -52.64 178.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.558 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.708 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -121.69 151.03 40.93 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.219 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -75.41 152.22 38.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.027 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 62' ' ' ASN . 34.8 m-80 43.67 90.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.992 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.708 HG21 ' CG ' ' A' ' 146' ' ' ARG . 9.8 t -176.76 127.37 0.17 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.808 ' CG ' ' HB3' ' A' ' 59' ' ' LYS . 46.9 m0 -89.88 -172.88 3.69 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.689 HD22 ' HA ' ' A' ' 96' ' ' THR . 0.1 OUTLIER -148.5 111.79 4.95 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.81 178.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.571 ' N ' HD12 ' A' ' 151' ' ' LEU . . . -88.87 142.43 16.98 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.784 -179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.845 HG13 ' HB2' ' A' ' 87' ' ' MET . 17.3 t -123.67 144.74 32.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -114.05 -36.28 4.8 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.636 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 175.94 179.25 0.17 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 121.411 0.624 . . . . 0.0 111.776 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.746 ' HB ' HG23 ' A' ' 47' ' ' ILE . 51.8 mt -157.23 136.88 3.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.353 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -119.86 142.87 48.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.014 0.435 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.634 HG23 HD11 ' A' ' 80' ' ' LEU . 7.6 p -138.57 104.01 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.937 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.415 ' OD1' ' N ' ' A' ' 159' ' ' ASN . 0.9 OUTLIER 70.6 25.78 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.037 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm 53.71 87.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.889 0.375 . . . . 0.0 111.059 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp 58.8 37.18 24.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 61.31 62.92 1.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.911 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 45.63 -169.12 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.334 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.274 -0.87 . . . . 0.0 110.877 -179.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtm . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 120.846 0.355 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 135.44 140.8 4.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.493 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -73.12 86.75 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.762 0.315 . . . . 0.0 110.853 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m 60.56 102.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -60.35 -64.02 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.908 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.4 m80 -60.49 165.27 3.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 60.55 171.53 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -153.72 -179.8 8.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.831 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 63.2 122.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.984 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.32 35.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.944 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.6 p 58.14 32.38 21.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.005 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m 58.88 78.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.015 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.91 -74.53 1.98 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.437 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.46 -169.47 2.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.82 0.343 . . . . 0.0 110.91 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.6 p -64.6 139.36 97.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.19 -177.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.484 2.123 . . . . 0.0 112.28 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.24 -34.2 15.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 66.84 -93.75 0.22 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.468 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.2 m -152.05 80.88 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.797 0.332 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -131.66 31.15 4.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 11.2 tpp 59.78 85.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -159.62 37.81 0.19 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 m 66.88 96.6 0.06 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.76 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.404 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 1.8 m-20 -57.29 -60.75 8.74 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.103 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.711 ' HB2' HD11 ' A' ' 28' ' ' ILE . 58.8 Cg_endo -71.81 154.6 58.79 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.462 2.108 . . . . 0.0 112.293 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -84.88 -74.69 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 35.7 mtp180 -122.72 146.58 47.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.8 HD13 HG22 ' A' ' 78' ' ' ILE . 3.9 mp -133.13 131.39 58.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.058 0.456 . . . . 0.0 110.973 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.5 HG22 ' N ' ' A' ' 30' ' ' ALA . 37.8 mt -97.31 159.3 3.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.769 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.579 ' HB1' HG21 ' A' ' 72' ' ' VAL . . . -118.46 98.32 6.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.967 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.607 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -91.36 118.7 30.75 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.128 0.49 . . . . 0.0 111.419 179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.771 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.1 t80 -51.98 144.68 11.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.735 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.641 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 178.66 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-O 121.118 0.485 . . . . 0.0 111.305 179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.494 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.1 p -177.6 137.8 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.51 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.551 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 13.8 t30 -72.28 -32.37 66.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.123 0.487 . . . . 0.0 110.054 179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.728 ' NH2' HG21 ' A' ' 64' ' ' ILE . 33.7 mtt85 -60.68 -38.06 83.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.324 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 63.7 23.0 13.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.651 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -92.35 143.61 26.21 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.776 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.17 136.71 58.74 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.94 140.29 41.63 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.296 1.997 . . . . 0.0 112.12 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.737 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.8 t -45.47 -52.81 9.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.274 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' H ' HG23 ' A' ' 41' ' ' THR . . . -127.32 -78.0 0.25 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.046 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -158.78 119.32 1.82 Allowed Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.465 ' HB3' HD11 ' A' ' 56' ' ' LEU . 61.4 Cg_endo -73.8 -1.45 10.81 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.758 2.305 . . . . 0.0 111.231 178.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.451 ' HA ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 t0 -44.51 -32.98 1.57 Allowed 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.837 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.902 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -49.53 -27.49 4.45 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.414 0.626 . . . . 0.0 110.038 178.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.77 HG12 HG23 ' A' ' 156' ' ' ILE . 2.9 mp -98.85 -28.28 3.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.517 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 3.0 m-30 -54.2 -39.91 67.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.092 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.45 22.85 3.43 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.785 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 0.3 OUTLIER 59.54 98.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.278 179.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 43.7 t30 175.91 84.42 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.167 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 155' ' ' ASP . . . -63.68 63.71 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 51' ' ' ASN . 1.3 m -113.9 28.88 8.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.916 0.389 . . . . 0.0 110.933 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.902 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.4 OUTLIER -158.65 171.71 19.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.505 -179.373 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -101.77 140.01 36.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.0 110.319 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.677 HD12 HD13 ' A' ' 47' ' ' ILE . 0.2 OUTLIER -145.23 115.69 7.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.517 -178.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.737 ' H ' HG22 ' A' ' 41' ' ' THR . 1.4 m -154.22 142.84 13.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.603 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 56' ' ' LEU . 16.4 m-30 -107.49 144.0 35.07 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.848 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.948 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 1.6 mppt? -105.11 -60.51 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.57 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.538 ' O ' ' O ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER 46.9 177.12 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 8.7 Cg_endo -51.0 110.27 0.39 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 120.959 1.106 . . . . 0.0 110.108 178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 148' ' ' ASN . 2.3 p-10 -27.16 -42.15 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 O-C-N 123.382 0.426 . . . . 0.0 111.644 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' N ' ' O ' ' A' ' 61' ' ' PRO . 3.2 ptp180 -90.91 123.17 34.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.056 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.728 HG21 ' NH2' ' A' ' 36' ' ' ARG . 22.8 pt -113.18 149.41 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.042 0.449 . . . . 0.0 111.544 -179.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -118.7 177.81 4.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.59 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.701 HG13 ' HA ' ' A' ' 143' ' ' THR . 26.2 t -50.83 98.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.292 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.466 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 158.21 -24.7 0.39 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.715 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.611 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.0 OUTLIER -59.48 117.81 5.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.61 0.243 . . . . 0.0 110.62 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.551 ' CD1' ' HB2' ' A' ' 35' ' ' ASN . 0.3 OUTLIER -162.66 169.99 19.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.882 0.373 . . . . 0.0 111.925 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.8 OUTLIER -149.5 -171.11 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 121.363 0.601 . . . . 0.0 111.044 178.552 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.768 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 157.12 -121.11 1.04 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.853 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -173.31 119.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 120.141 -0.623 . . . . 0.0 112.112 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.568 ' HB2' HD13 ' A' ' 33' ' ' ILE . 6.0 tttp -89.26 148.97 23.29 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.549 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.9 m-30 -107.85 -176.83 3.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.953 0.406 . . . . 0.0 111.378 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.0 t -100.93 -31.8 10.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.031 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.435 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 23.5 m-20 -148.41 157.37 42.05 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 24.5 Cg_endo -61.73 135.54 56.92 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.527 2.151 . . . . 0.0 112.47 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.8 HG22 HD13 ' A' ' 28' ' ' ILE . 22.0 pt -141.5 139.9 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 134' ' ' LYS . 0.8 OUTLIER -48.83 96.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 0.0 110.486 179.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.849 HD23 HD21 ' A' ' 131' ' ' LEU . 11.2 tp -74.51 109.57 8.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.816 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 159' ' ' ASN . 0.5 OUTLIER -90.48 -37.89 13.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.383 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 174.59 135.67 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.055 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -104.87 172.92 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 19.7 mt-10 -151.73 105.45 3.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.698 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.915 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 56.6 m-85 -99.05 100.6 11.77 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.014 178.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.629 HD11 ' HB1' ' A' ' 125' ' ' ALA . 2.2 mp -96.77 88.25 4.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.729 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.816 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.13 129.1 20.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.068 -178.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -111.09 -104.12 2.77 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.79 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.16 161.36 38.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 110.941 179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.439 ' ND2' ' CZ3' ' A' ' 150' ' ' TRP . 15.2 t30 -77.42 -68.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.041 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 p -103.77 -61.51 1.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.271 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -87.79 121.64 70.72 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.943 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.87 -21.73 8.91 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.635 2.224 . . . . 0.0 112.547 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -93.79 26.39 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.665 0.269 . . . . 0.0 111.182 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.761 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 12.6 m-20 -102.91 92.19 4.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.877 0.37 . . . . 0.0 110.916 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.908 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.13 -165.05 0.13 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.319 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.726 ' N ' HG23 ' A' ' 96' ' ' THR . 4.2 tpp -44.66 159.32 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.2 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.61 ' C ' ' HB ' ' A' ' 121' ' ' THR . 33.4 tp60 -98.02 -39.6 8.86 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 24.8 mtmt -176.15 122.15 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.276 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.52 161.94 0.67 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' O ' HD23 ' A' ' 140' ' ' LEU . 5.3 ptpp? -105.09 174.38 5.9 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 114.744 -1.116 . . . . 0.0 108.919 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.688 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -93.25 162.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 120.603 -0.439 . . . . 0.0 111.301 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.775 ' OE1' HD13 ' A' ' 141' ' ' ILE . 22.2 mt-30 -129.58 -173.45 3.02 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 -179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.593 ' CD2' HD13 ' A' ' 114' ' ' LEU . 11.4 p90 -175.24 146.09 0.81 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.658 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 2.8 t -105.85 137.13 44.25 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 110.074 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -86.6 -60.97 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.108 -178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.4 OUTLIER -95.96 29.84 2.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.754 0.311 . . . . 0.0 111.436 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 55.49 27.24 47.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.498 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -124.26 -74.77 0.61 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 0.0 110.522 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.45 166.3 15.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.2 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.658 ' CZ2' HG22 ' A' ' 105' ' ' THR . 27.8 m95 -132.28 116.58 17.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.894 0.378 . . . . 0.0 110.709 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.54 164.42 4.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.313 -179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.434 ' O ' ' CE2' ' A' ' 104' ' ' TYR . 33.2 p30 -54.01 154.82 3.87 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.008 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.593 HD13 ' CD2' ' A' ' 104' ' ' TYR . 61.8 tp -125.99 -54.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.449 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.541 ' OE1' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -109.8 158.69 17.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.556 0.693 . . . . 0.0 112.783 -178.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.592 ' O ' ' N ' ' A' ' 118' ' ' VAL . 20.4 tt0 -46.47 167.1 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.239 178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -63.29 60.27 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.22 -0.99 . . . . 0.0 110.981 178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.853 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.6 t -77.72 158.23 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.627 0 CA-C-O 120.996 0.426 . . . . 0.0 110.608 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.497 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.7 mt-10 -107.61 77.09 1.11 Allowed 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.323 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.853 ' CE1' HG11 ' A' ' 118' ' ' VAL . 58.6 m-85 -70.59 42.35 0.06 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.995 -179.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.729 ' O ' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -93.32 -15.44 25.76 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.669 ' HE3' ' O ' ' A' ' 121' ' ' THR . 0.0 OUTLIER -138.21 43.89 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 114.501 -1.227 . . . . 0.0 108.445 178.569 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.908 ' HD2' HG21 ' A' ' 96' ' ' THR . 78.2 Cg_endo -84.45 98.48 0.73 Allowed 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.777 2.318 . . . . 0.0 113.128 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -72.18 -48.34 25.97 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.629 ' HB1' HD11 ' A' ' 86' ' ' LEU . . . -142.19 107.63 5.04 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.103 -0.549 . . . . 0.0 109.905 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.688 HG21 HD11 ' A' ' 102' ' ' ILE . 1.7 mt -92.57 149.65 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.819 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -156.58 152.79 27.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.672 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 HG13 ' OE1' ' A' ' 115' ' ' GLU . 12.2 t -124.04 95.55 3.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.946 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -92.93 166.98 12.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.981 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 57.24 34.85 25.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.765 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.849 HD21 HD23 ' A' ' 80' ' ' LEU . 3.5 tp -127.73 95.3 4.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.002 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.1 p-10 -114.57 89.69 3.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.249 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 tp -155.92 128.17 7.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.095 -179.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 12.6 mtmm -55.0 140.06 38.92 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 80' ' ' LEU . 1.1 p -153.27 163.75 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.671 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.32 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.625 ' O ' HG23 ' A' ' 105' ' ' THR . 7.8 tpt180 -110.99 128.08 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.549 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 50.9 -177.06 0.05 OUTLIER Glycine 0 C--N 1.313 -0.747 0 C-N-CA 120.68 -0.771 . . . . 0.0 113.887 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.836 ' CG2' HG13 ' A' ' 72' ' ' VAL . 2.8 m -156.97 151.65 8.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 122.886 0.474 . . . . 0.0 109.845 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.545 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 7.7 ttm-85 -173.51 161.38 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.128 0.489 . . . . 0.0 111.819 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.549 HD22 ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -98.69 159.3 15.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.252 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.912 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.9 tp -126.01 122.3 61.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.551 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.611 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -90.16 143.73 26.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.85 0.357 . . . . 0.0 111.439 -179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.701 ' HA ' HG13 ' A' ' 66' ' ' VAL . 17.4 m -127.89 26.6 5.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.405 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.566 ' HA ' HG22 ' A' ' 66' ' ' VAL . 1.4 tp10 -172.05 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.677 ' HB1' HG13 ' A' ' 64' ' ' ILE . . . 77.93 161.88 0.21 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.971 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.794 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -127.27 171.12 11.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.929 0.395 . . . . 0.0 111.415 -179.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 9.5 pm0 -92.04 151.97 20.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.843 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.7 OUTLIER 44.01 79.41 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.966 -179.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.794 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.4 t -163.16 133.46 4.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.227 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.948 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 45.6 m0 -95.61 -173.22 2.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.857 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.623 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.2 tm? -130.52 98.87 4.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.876 178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.404 ' HA3' ' C ' ' A' ' 89' ' ' ALA . . . -89.61 120.39 5.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.963 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.816 HG13 ' HB2' ' A' ' 87' ' ' MET . 20.4 t -113.44 142.03 27.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.677 0.275 . . . . 0.0 110.616 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 10.0 ttt-85 -119.46 -34.27 3.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.639 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 86' ' ' LEU . 8.0 t70 -175.93 154.34 1.47 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.026 0.441 . . . . 0.0 112.075 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.915 ' HB ' ' HA ' ' A' ' 85' ' ' PHE . 0.0 OUTLIER -168.68 129.45 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.652 178.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -139.74 154.75 47.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.89 0.376 . . . . 0.0 111.319 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 163' ' ' ASP . 11.6 p -104.11 129.48 56.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.923 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' ND2' ' ND2' ' A' ' 81' ' ' ASN . 8.3 t-20 62.93 49.58 3.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.731 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 55.98 -162.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.325 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.11 64.82 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.944 0.402 . . . . 0.0 110.548 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -147.35 -58.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.0 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 158' ' ' VAL . 7.4 t70 61.16 40.82 14.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.796 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.764 ' OG ' HD12 ' A' ' 78' ' ' ILE . 71.6 m . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.894 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 mtp . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.78 0.324 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.63 28.45 21.72 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.546 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -157.53 -177.8 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.843 0.354 . . . . 0.0 110.898 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 p -113.81 134.22 54.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -174.84 166.76 3.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.0 m170 60.81 111.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -126.75 -58.92 1.3 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -156.11 -169.4 3.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -97.97 133.64 42.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 31.9 m-70 -88.54 -74.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m 60.18 80.33 0.21 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.6 m -109.32 79.58 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.867 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 59.78 -149.39 40.81 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.484 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 20.2 mt -133.79 108.63 8.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.76 139.21 29.38 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.019 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.61 152.49 16.4 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.389 2.059 . . . . 0.0 112.329 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -168.56 35.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.957 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 67.11 -88.83 0.15 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.533 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.1 m 60.96 169.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.13 176.21 11.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.1 mmt -133.5 -64.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -161.89 -62.1 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.16 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.1 t -131.13 -67.05 0.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -177.53 81.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.824 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.53 -47.34 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.588 2.192 . . . . 0.0 112.279 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 m120 59.03 79.87 0.21 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.017 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -69.5 142.05 53.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.783 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 78' ' ' ILE . 14.2 mm -77.75 135.6 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.216 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.489 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.0 mp -82.45 159.27 3.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.433 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.708 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -143.9 98.32 3.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.627 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.421 ' C ' HG23 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -94.8 118.12 31.25 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.0 111.152 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.775 ' OH ' HG21 ' A' ' 70' ' ' VAL . 2.9 t80 -52.26 136.18 31.06 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.347 179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.48 ' O ' ' HB ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -110.98 172.74 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.451 ' HB3' ' CE2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -177.73 129.52 0.15 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.295 178.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 5.5 t-20 -66.2 -24.98 66.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.044 0.45 . . . . 0.0 109.932 178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 60' ' ' ASN . 0.7 OUTLIER -78.69 116.15 18.86 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.921 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -55.74 -21.87 21.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.423 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -47.53 149.54 1.14 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.877 0.37 . . . . 0.0 111.124 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.44 144.93 58.24 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.158 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.97 119.77 6.56 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.279 1.986 . . . . 0.0 111.658 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.864 HG22 ' H ' ' A' ' 57' ' ' VAL . 1.2 t -71.05 -171.53 0.57 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.767 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 41' ' ' THR . . . 35.29 -109.96 0.07 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.929 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' O ' ' CG2' ' A' ' 54' ' ' THR . 11.9 m-80 -158.85 110.61 1.6 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-O 120.511 0.196 . . . . 0.0 110.983 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.47 ' HA ' HD12 ' A' ' 47' ' ' ILE . 59.8 Cg_endo -72.84 -1.39 10.36 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.15 1.9 . . . . 0.0 111.331 178.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -42.3 -46.38 4.53 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.257 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -46.99 -35.28 6.42 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.387 0.613 . . . . 0.0 109.756 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.723 HG23 HG23 ' A' ' 156' ' ' ILE . 3.3 mp -79.04 -38.63 20.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.383 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-30 -54.66 -52.41 62.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.478 -179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -127.8 38.22 4.07 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.5 p30 42.96 99.07 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.436 ' HB2' ' HA ' ' A' ' 46' ' ' ASN . 9.2 m-20 -134.57 -37.74 0.84 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.692 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.35 39.24 19.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.754 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -113.58 -45.08 3.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.199 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.611 ' O ' ' ND2' ' A' ' 46' ' ' ASN . 9.5 t -86.02 171.82 11.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.425 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -121.82 139.26 53.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.914 0.388 . . . . 0.0 111.366 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -145.06 144.41 30.95 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.891 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.864 ' H ' HG22 ' A' ' 41' ' ' THR . 1.7 m -154.38 145.15 13.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.32 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.453 ' N ' ' CD1' ' A' ' 58' ' ' TYR . 4.9 m-30 -107.11 147.18 30.35 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.727 ' HG3' ' CD2' ' A' ' 150' ' ' TRP . 4.0 mppt? -117.69 -60.03 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.559 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER 52.24 -179.01 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -178.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 7.7 Cg_endo -51.2 110.42 0.41 Allowed 'Trans proline' 0 N--CA 1.46 -0.485 0 CA-C-N 119.888 0.996 . . . . 0.0 110.73 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 61' ' ' PRO . 3.2 p-10 -29.19 -41.39 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.668 -178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.4 OUTLIER -91.57 123.24 34.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.362 179.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 1.005 HD12 ' HB1' ' A' ' 145' ' ' ALA . 1.0 OUTLIER -129.38 154.75 40.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.441 -179.528 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.76 177.89 4.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.754 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.869 HG22 ' HA ' ' A' ' 144' ' ' GLU . 19.5 t -45.37 115.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.504 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.627 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 141.67 -24.55 2.46 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.594 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.816 HG21 HD13 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -65.28 122.98 18.37 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 0.7 OUTLIER -162.66 173.57 13.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.815 0.34 . . . . 0.0 111.645 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.775 HG21 ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -153.67 -174.16 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.239 0.542 . . . . 0.0 111.607 179.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.758 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 162.79 -125.56 1.42 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.238 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.951 HG12 HD11 ' A' ' 156' ' ' ILE . 2.2 p -172.84 119.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.329 0.585 . . . . 0.0 111.289 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 137' ' ' GLY . 0.1 OUTLIER -89.52 149.03 23.08 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.562 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 1.4 m-30 -108.16 -172.47 2.07 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.1 t -93.09 -59.19 2.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 111.465 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.419 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 5.0 m120 -131.2 166.25 29.16 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.62 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 76' ' ' ASN . 9.2 Cg_endo -52.47 139.02 56.84 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.57 2.18 . . . . 0.0 111.788 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.693 HG21 HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -149.57 134.5 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.388 -179.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.28 96.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.864 0.364 . . . . 0.0 110.179 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.694 ' O ' HD23 ' A' ' 80' ' ' LEU . 8.1 tt -82.24 103.03 11.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.013 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.472 ' OD1' ' HA ' ' A' ' 159' ' ' ASN . 23.2 p-10 -69.8 -37.53 76.32 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.516 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -179.04 130.2 0.11 Allowed 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.615 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 80' ' ' LEU . 7.5 p -107.09 149.38 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 126' ' ' ILE . 16.0 mt-10 -150.34 116.26 5.6 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.856 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.753 ' HA ' ' HB ' ' A' ' 156' ' ' ILE . 2.5 m-85 -99.99 100.66 11.58 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.375 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 155' ' ' ASP . 5.8 mp -83.34 105.92 14.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.647 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.0 OUTLIER -141.71 169.94 16.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.335 0.588 . . . . 0.0 111.54 -178.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.464 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -153.12 -105.71 0.27 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.324 179.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.732 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.37 155.44 44.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.634 0.254 . . . . 0.0 110.882 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.504 ' CG ' HG21 ' A' ' 57' ' ' VAL . 4.0 t-20 -82.3 -68.37 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.976 0.417 . . . . 0.0 110.386 179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.88 -61.38 1.44 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.875 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 25.2 t30 -89.92 122.02 68.28 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -43.73 -25.57 0.99 Allowed 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.885 2.39 . . . . 0.0 112.925 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -91.58 26.3 2.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.756 0.312 . . . . 0.0 111.198 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.732 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 15.8 m-20 -98.07 92.53 5.81 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.23 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.7 HG23 ' N ' ' A' ' 97' ' ' MET . 0.6 OUTLIER -176.37 -165.25 0.13 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.179 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.7 ' N ' HG23 ' A' ' 96' ' ' THR . 6.7 mmm -51.58 166.21 0.14 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.62 ' O ' HG21 ' A' ' 121' ' ' THR . 0.7 OUTLIER -101.85 -39.49 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.221 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.548 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 4.3 mtmm -176.6 122.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.709 177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.823 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 178.6 158.7 0.53 Allowed 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 116' ' ' GLU . 0.1 OUTLIER -105.88 168.03 9.39 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.382 177.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.697 HD11 HG21 ' A' ' 126' ' ' ILE . 1.2 mt -96.56 162.35 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.553 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.447 ' HG3' ' HB ' ' A' ' 141' ' ' ILE . 0.0 OUTLIER -132.53 -166.91 1.81 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.227 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.709 ' HB3' HD12 ' A' ' 114' ' ' LEU . 6.5 p90 -175.34 146.83 0.84 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.624 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.668 ' O ' HG22 ' A' ' 135' ' ' VAL . 2.6 t -104.61 140.19 38.38 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -60.96 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -96.18 33.5 1.73 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.76 0.314 . . . . 0.0 111.416 -179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 50.37 36.27 29.74 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.546 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.451 ' HG2' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -134.53 -71.83 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.555 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -89.03 166.38 13.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.307 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.649 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.1 m95 -134.08 117.03 16.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.778 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -108.06 155.52 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.301 -179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -48.8 155.46 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.214 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.864 HD21 HG11 ' A' ' 128' ' ' VAL . 8.2 tt -128.32 -66.88 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.375 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.85 ' CD ' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -94.09 153.69 18.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.288 0.566 . . . . 0.0 112.484 -179.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 118' ' ' VAL . 3.5 mm-40 -45.06 166.62 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.606 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -64.49 60.79 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.275 -0.964 . . . . 0.0 111.173 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 120' ' ' TYR . 2.7 t -79.96 159.43 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 CA-C-O 121.012 0.434 . . . . 0.0 110.595 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 121' ' ' THR . 2.2 mt-10 -108.89 83.68 1.8 Allowed 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.693 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.717 ' CE1' HG11 ' A' ' 118' ' ' VAL . 42.3 m-85 -70.58 34.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.203 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.643 ' O ' HG22 ' A' ' 96' ' ' THR . 0.5 OUTLIER -90.29 -21.78 21.9 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.305 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.718 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -135.97 42.03 0.67 Allowed Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.614 178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.718 ' HD3' ' N ' ' A' ' 122' ' ' MET . 42.4 Cg_endo -91.5 98.58 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.739 2.292 . . . . 0.0 113.358 -178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.97 -42.11 96.99 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -141.99 127.72 19.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.034 -0.583 . . . . 0.0 109.923 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.697 HG21 HD11 ' A' ' 102' ' ' ILE . 3.0 mt -113.71 130.64 67.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.971 -0.559 . . . . 0.0 112.009 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -149.99 138.37 20.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.917 179.605 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.864 HG11 HD21 ' A' ' 114' ' ' LEU . 12.0 t -114.44 100.51 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.081 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -88.62 156.35 19.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.885 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 61.77 61.09 1.48 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.692 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.441 HD23 ' CD2' ' A' ' 80' ' ' LEU . 20.8 tp -138.81 24.76 2.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.093 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.91 89.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.905 0.383 . . . . 0.0 110.928 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 tp -155.96 129.55 8.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.778 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 29.5 mttt -54.7 133.15 46.89 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 105' ' ' THR . 1.6 p -152.1 169.34 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.489 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.588 ' O ' HG23 ' A' ' 105' ' ' THR . 9.4 ttt180 -118.87 127.85 53.89 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.562 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 51.94 -171.8 0.33 Allowed Glycine 0 C--N 1.312 -0.78 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.952 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.807 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.3 m -158.69 153.27 5.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 122.78 0.432 . . . . 0.0 110.218 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.612 ' O ' HG22 ' A' ' 102' ' ' ILE . 21.8 ttp85 -173.36 163.32 4.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.214 0.531 . . . . 0.0 111.935 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.578 HD21 ' HD2' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -106.57 159.12 16.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.025 -179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.823 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -125.89 115.21 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 120.817 0.342 . . . . 0.0 110.679 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -72.06 145.04 48.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.221 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.491 HG23 ' HA ' ' A' ' 100' ' ' ALA . 16.4 p -110.55 -27.8 8.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.914 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . 0.869 ' HA ' HG22 ' A' ' 66' ' ' VAL . 14.3 tp10 -173.54 67.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.779 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 1.005 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . -50.86 165.17 0.12 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.393 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.49 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.0 OUTLIER -114.48 164.83 13.44 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.253 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' ARG . 1.2 pm0 -81.31 158.42 24.75 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.955 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 46.3 78.16 0.07 Allowed 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.897 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 146' ' ' ARG . 9.9 t -165.32 126.05 1.92 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.965 0.412 . . . . 0.0 111.535 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.727 ' CD2' ' HG3' ' A' ' 59' ' ' LYS . 49.8 m0 -94.68 -173.05 2.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.192 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.729 HD12 HG23 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -130.57 103.2 6.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.488 178.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.505 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -102.54 110.16 3.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.433 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.729 HG23 HD12 ' A' ' 151' ' ' LEU . 45.9 t -110.1 151.39 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 0.0 111.294 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.23 -30.04 7.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.578 ' C ' HG22 ' A' ' 156' ' ' ILE . 23.7 t0 -173.37 164.95 4.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.005 0.431 . . . . 0.0 111.453 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.951 HD11 HG12 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -175.67 111.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.509 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -140.43 154.71 46.76 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.459 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.591 HG22 ' ND2' ' A' ' 159' ' ' ASN . 10.3 p -115.45 130.1 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.459 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.591 ' ND2' HG22 ' A' ' 158' ' ' VAL . 12.2 m-80 79.86 -2.32 2.06 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.581 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.7 tptp 45.6 33.03 1.28 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.772 0.32 . . . . 0.0 111.078 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.45 34.62 12.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.474 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -137.47 -49.8 0.61 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.152 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.42 ' CA ' ' HB3' ' A' ' 159' ' ' ASN . 0.6 OUTLIER 64.47 -78.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.895 0.378 . . . . 0.0 110.975 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.285 -0.865 . . . . 0.0 110.867 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.1 tpp . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.718 0.294 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.65 -72.21 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.32 34.04 20.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.822 0.344 . . . . 0.0 110.923 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 p -101.93 82.94 2.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -70.55 79.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -176.31 -56.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.832 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -66.05 -37.92 87.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -106.54 144.61 32.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.6 -169.59 2.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -133.44 -179.17 5.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.949 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.0 m 60.52 38.25 19.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.886 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.8 m -59.93 -41.97 92.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.2 -28.21 1.11 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.552 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.09 58.44 4.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 110.859 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.502 ' N ' ' CD ' ' A' ' 16' ' ' PRO . 6.5 t -82.97 -45.62 0.87 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.368 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' A' ' 15' ' ' VAL . 74.3 Cg_exo -50.71 96.63 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.371 2.048 . . . . 0.0 112.372 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.8 tpt85 -176.64 -65.72 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.29 47.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.574 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.31 122.82 15.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.0 m80 60.63 -176.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.88 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 8.9 mtt -60.17 107.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.914 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.04 -48.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -118.96 -48.36 2.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 62.0 151.62 0.1 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.54 64.04 2.25 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.54 2.16 . . . . 0.0 112.332 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -153.76 -172.76 4.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.907 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 60.85 77.98 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 78' ' ' ILE . 16.4 mm -91.11 133.99 31.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.044 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.461 HG22 ' N ' ' A' ' 30' ' ' ALA . 3.3 mp -82.24 158.64 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.207 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.791 ' HB1' ' CG2' ' A' ' 72' ' ' VAL . . . -144.0 98.2 3.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.339 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.581 ' O ' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -85.89 155.32 20.99 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.797 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' OH ' HG21 ' A' ' 70' ' ' VAL . 3.9 t80 -90.38 146.92 23.8 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.269 0.556 . . . . 0.0 112.091 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.486 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -123.92 170.08 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.087 -179.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.448 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 5.5 p -177.83 129.46 0.14 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.966 178.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' HB2' ' CD1' ' A' ' 69' ' ' TYR . 14.8 t-20 -56.55 -23.62 41.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.06 0.457 . . . . 0.0 110.127 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HA ' ' ND2' ' A' ' 60' ' ' ASN . 13.1 mmt85 -75.47 135.02 40.7 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.786 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -72.87 -25.19 61.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.917 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.66 166.33 1.39 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.07 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -96.98 168.26 10.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.915 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.782 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 32.7 Cg_endo -64.9 146.51 88.04 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.321 2.014 . . . . 0.0 112.299 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 57' ' ' VAL . 2.8 t -52.91 -52.03 59.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.677 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 41' ' ' THR . . . -132.74 -74.42 0.1 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.411 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -155.94 120.98 2.48 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-O 120.628 0.251 . . . . 0.0 110.869 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 72.4 Cg_endo -76.17 -1.03 10.97 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.613 2.209 . . . . 0.0 112.004 179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -39.25 -33.39 0.14 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.794 0.331 . . . . 0.0 111.116 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.951 ' ND2' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -46.58 -31.24 2.68 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.402 0.62 . . . . 0.0 110.068 179.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 156' ' ' ILE . 3.3 mp -94.85 -37.77 8.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.21 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' CZ ' ' HG2' ' A' ' 44' ' ' PRO . 21.0 m-30 -54.73 -23.02 15.83 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.436 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.75 21.03 1.29 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.311 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.6 t30 48.64 95.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.036 0.446 . . . . 0.0 111.278 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.41 ' O ' ' N ' ' A' ' 53' ' ' SER . 48.1 t30 -179.96 95.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.028 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB1' ' HE ' ' A' ' 154' ' ' ARG . . . -66.17 62.75 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 112.073 -179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 51' ' ' ASN . 22.1 t -113.62 26.09 10.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.066 0.46 . . . . 0.0 110.828 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.951 HG23 ' ND2' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -161.01 171.99 17.67 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.011 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -104.38 143.84 32.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.926 0.393 . . . . 0.0 111.115 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.625 HD12 HD13 ' A' ' 47' ' ' ILE . 0.3 OUTLIER -147.12 109.99 4.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.9 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.626 ' H ' HG22 ' A' ' 41' ' ' THR . 0.9 OUTLIER -154.25 144.41 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.879 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CE2' ' CB ' ' A' ' 34' ' ' SER . 22.2 m-85 -107.46 149.42 27.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.185 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.847 ' HG3' ' CE2' ' A' ' 150' ' ' TRP . 2.3 mppt? -111.87 -60.82 1.8 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.8 OUTLIER 48.86 -179.98 0.01 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 9.3 Cg_endo -53.68 110.31 0.48 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 CA-C-N 119.784 0.959 . . . . 0.0 110.384 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 61' ' ' PRO . 8.2 p-10 -26.48 -44.87 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.536 0.522 . . . . 0.0 111.825 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 61' ' ' PRO . 0.7 OUTLIER -103.07 123.15 46.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.013 178.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.639 ' CD1' ' HB1' ' A' ' 145' ' ' ALA . 2.2 pp -135.72 173.29 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.007 0.432 . . . . 0.0 111.821 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -115.48 178.43 4.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.712 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.546 HG12 ' C ' ' A' ' 143' ' ' THR . 9.3 m -35.8 151.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.019 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.546 ' H ' ' HB3' ' A' ' 142' ' ' ALA . . . 108.23 -22.01 27.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.32 -179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.71 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -57.26 108.08 0.49 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.637 0.255 . . . . 0.0 110.608 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -162.75 177.96 8.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.063 0.459 . . . . 0.0 111.803 179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.728 HG23 ' N ' ' A' ' 71' ' ' GLY . 0.9 OUTLIER -152.66 -170.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.948 179.011 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.728 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 163.74 -129.56 2.04 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.762 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.883 HG13 ' CG2' ' A' ' 138' ' ' VAL . 1.4 p -172.83 118.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.28 0.562 . . . . 0.0 110.777 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.482 ' N ' ' O ' ' A' ' 31' ' ' THR . 2.3 tttt -89.41 145.12 25.55 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -177.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 2.1 m-30 -104.96 -172.43 2.1 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.511 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.2 t -93.61 -58.62 2.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 0.0 111.233 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.406 ' CB ' ' HD2' ' A' ' 77' ' ' PRO . 9.5 m-20 -131.94 167.18 23.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.782 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 76' ' ' ASN . 10.4 Cg_endo -53.51 140.13 64.94 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.507 2.138 . . . . 0.0 111.582 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.689 HG21 HG21 ' A' ' 28' ' ' ILE . 0.4 OUTLIER -148.09 130.82 7.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.757 0.313 . . . . 0.0 111.448 -179.12 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.503 ' O ' HG23 ' A' ' 79' ' ' THR . 5.2 t -59.0 96.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.971 0.415 . . . . 0.0 110.304 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' N ' ' A' ' 81' ' ' ASN . 3.8 tt -85.7 148.82 25.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.754 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.701 ' N ' HD23 ' A' ' 80' ' ' LEU . 1.6 p30 -122.22 -39.55 2.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.959 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.451 ' N ' HD23 ' A' ' 80' ' ' LEU . 36.8 m-20 -136.69 130.23 31.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.43 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 83' ' ' VAL . 9.5 p -127.42 125.74 66.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.153 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.565 ' O ' HG23 ' A' ' 156' ' ' ILE . 2.7 pt-20 -151.5 132.24 14.05 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.631 ' CE1' HD11 ' A' ' 102' ' ' ILE . 11.3 m-85 -110.08 100.37 9.31 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.7 mt -76.34 94.4 3.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.787 ' HB2' HG13 ' A' ' 153' ' ' VAL . 0.9 OUTLIER -141.81 161.57 37.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.336 0.588 . . . . 0.0 111.497 -178.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' N ' ' HG2' ' A' ' 87' ' ' MET . . . -149.09 -105.85 0.37 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.348 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.827 ' HB1' ' HB2' ' A' ' 95' ' ' ASP . . . -143.47 155.52 44.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.853 0.358 . . . . 0.0 111.107 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 150' ' ' TRP . 3.0 t-20 -72.45 -68.54 0.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.662 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.9 p -103.96 -61.35 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.23 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.45 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 44.8 m-80 -92.36 121.81 65.75 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.872 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.9 Cg_endo -44.87 -23.06 0.8 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.968 2.446 . . . . 0.0 113.075 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.2 26.32 1.93 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.561 0.219 . . . . 0.0 111.472 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.827 ' HB2' ' HB1' ' A' ' 89' ' ' ALA . 6.8 m-20 -103.77 85.87 2.5 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.983 0.421 . . . . 0.0 111.238 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.798 HG23 ' O ' ' A' ' 121' ' ' THR . 1.5 t -176.73 -165.31 0.12 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.747 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.566 ' HB3' ' HA ' ' A' ' 121' ' ' THR . 4.5 tpp -42.04 156.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.608 ' C ' ' HB ' ' A' ' 121' ' ' THR . 0.7 OUTLIER -98.7 -39.54 8.61 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 98' ' ' GLN . 29.8 mtmt -175.14 122.03 0.22 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.157 -1.383 . . . . 0.0 107.73 176.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 175.8 165.88 0.37 Allowed 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 -178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.7 pttm -105.07 -175.56 2.83 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.681 -1.145 . . . . 0.0 109.125 177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.819 ' HB ' ' CE2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.43 163.41 4.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.719 -179.094 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASP . 2.6 pt20 -137.07 -171.16 2.88 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.057 0.455 . . . . 0.0 111.885 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.875 ' HB3' HD12 ' A' ' 114' ' ' LEU . 17.9 p90 -175.44 157.97 2.22 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.262 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.639 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 3.7 t -117.23 139.89 50.22 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.616 HG22 ' HE1' ' A' ' 104' ' ' TYR . 1.7 t -91.35 -60.94 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.446 ' HB3' ' CG ' ' A' ' 109' ' ' ARG . 25.4 t0 -96.19 30.74 2.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.796 0.331 . . . . 0.0 111.403 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 54.55 28.35 44.83 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.777 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' CG ' ' HB3' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -123.75 -73.0 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.343 . . . . 0.0 110.624 179.875 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -88.54 166.34 14.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.409 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.639 ' CZ2' HG22 ' A' ' 105' ' ' THR . 30.8 m95 -134.41 122.84 23.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.576 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.47 153.06 20.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.992 0.425 . . . . 0.0 111.751 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 83.1 m-20 -57.07 144.15 35.64 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.326 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.875 HD12 ' HB3' ' A' ' 104' ' ' TYR . 1.2 tt -123.17 -13.54 7.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.915 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.597 ' N ' HG22 ' A' ' 102' ' ' ILE . 3.0 tp10 -124.35 144.47 50.0 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.41 0.624 . . . . 0.0 112.326 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.695 ' O ' ' N ' ' A' ' 118' ' ' VAL . 41.4 mt-10 -45.61 167.1 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -60.01 63.83 0.01 OUTLIER Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.006 -1.093 . . . . 0.0 110.703 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG11 ' CE1' ' A' ' 120' ' ' TYR . 8.3 t -86.98 161.86 2.8 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 CA-C-O 121.099 0.476 . . . . 0.0 110.942 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' A' ' 121' ' ' THR . 5.5 mt-10 -105.92 78.22 1.31 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.249 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.83 ' CZ ' ' CG2' ' A' ' 126' ' ' ILE . 8.7 m-30 -70.12 33.35 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.143 0.496 . . . . 0.0 109.748 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 96' ' ' THR . 0.0 OUTLIER -93.2 -23.52 18.53 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.121 178.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.696 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 2.1 mmt -131.32 39.29 0.49 Allowed Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.957 178.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.696 ' HD3' ' N ' ' A' ' 122' ' ' MET . 45.2 Cg_endo -87.98 98.13 0.42 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.703 2.268 . . . . 0.0 112.698 -178.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -64.11 -40.75 98.38 Favored Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.41 112.67 7.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.705 -0.748 . . . . 0.0 109.61 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.83 ' CG2' ' CZ ' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -92.22 136.52 24.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.342 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 84' ' ' GLU . 3.0 mtpp -153.29 162.75 40.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.366 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.4 t -144.9 113.01 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.817 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -88.74 155.54 19.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.68 71.21 0.58 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.822 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 HD22 ' A' ' 80' ' ' LEU . 31.2 tp -141.26 79.01 1.67 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -103.64 88.66 3.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.062 179.249 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 15.0 tp -156.83 131.27 8.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 2.0 mtmp? -58.02 136.0 57.06 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 136' ' ' ARG . 7.8 p -148.28 159.32 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 120.04 -0.664 . . . . 0.0 111.953 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.571 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -112.98 127.28 56.18 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 176.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.494 ' O ' HG13 ' A' ' 138' ' ' VAL . . . 52.04 -169.39 0.56 Allowed Glycine 0 C--N 1.313 -0.703 0 C-N-CA 120.565 -0.826 . . . . 0.0 113.744 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.883 ' CG2' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -163.07 151.88 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 122.657 0.383 . . . . 0.0 110.297 -179.742 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.593 ' N ' ' HZ3' ' A' ' 111' ' ' TRP . 26.3 ttp180 -173.63 160.16 3.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.237 0.542 . . . . 0.0 111.464 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.649 ' N ' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -102.57 158.34 16.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.247 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.75 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -112.64 139.25 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.45 -179.493 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.71 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -110.71 120.26 41.81 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.855 0.359 . . . . 0.0 111.454 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 100' ' ' ALA . 21.2 p -94.76 -20.21 19.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.538 179.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.63 146.81 16.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.639 ' HB1' ' CD1' ' A' ' 64' ' ' ILE . . . -130.1 164.46 24.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.856 ' HG3' HG21 ' A' ' 149' ' ' THR . 0.8 OUTLIER -111.7 160.41 17.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.017 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -75.98 143.8 41.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.871 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 29.8 t-20 47.25 92.96 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.965 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.856 HG21 ' HG3' ' A' ' 146' ' ' ARG . 8.8 t -174.01 132.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.466 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.847 ' CE2' ' HG3' ' A' ' 59' ' ' LYS . 44.3 m0 -95.39 -173.0 2.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.0 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.615 HD11 ' SD ' ' A' ' 87' ' ' MET . 2.7 tm? -128.43 98.61 5.11 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 87' ' ' MET . . . -89.66 108.57 3.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.525 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.787 HG13 ' HB2' ' A' ' 87' ' ' MET . 3.6 t -100.25 147.24 7.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.681 0.277 . . . . 0.0 110.484 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.412 ' HE ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -116.04 -37.19 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.398 -179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.5 t70 179.59 -179.77 0.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.146 0.498 . . . . 0.0 111.551 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.885 ' HB ' HG23 ' A' ' 47' ' ' ILE . 30.0 mt -155.94 143.97 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.132 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.6 126.46 44.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.957 0.408 . . . . 0.0 111.205 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.405 HG11 ' OH ' ' A' ' 74' ' ' TYR . 30.5 m -143.52 132.97 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.878 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.42 ' ND2' ' HG ' ' A' ' 80' ' ' LEU . 3.2 m-80 64.93 47.02 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.975 0.417 . . . . 0.0 110.739 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 162' ' ' GLU . 21.0 mtmt -62.07 -150.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.391 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -67.35 67.21 0.08 Allowed 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.894 0.378 . . . . 0.0 110.679 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 160' ' ' LYS . 1.4 mt-10 -174.56 -49.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.705 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.76 -69.24 0.16 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.056 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.348 -0.834 . . . . 0.0 110.867 -179.996 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.814 0.34 . . . . 0.0 111.19 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 133.71 154.51 7.38 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.495 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.85 113.56 9.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.811 0.339 . . . . 0.0 110.865 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 m -107.61 100.23 9.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -160.68 71.49 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.808 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 59.35 29.28 18.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 8' ' ' HIS . 0.3 OUTLIER -62.23 -28.18 69.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.997 -179.926 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.465 ' CE1' ' CE1' ' A' ' 7' ' ' HIS . 16.0 m170 -92.58 -178.4 4.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.935 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.1 t-80 -175.03 -41.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -101.84 91.75 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.4 t -162.35 153.42 17.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.8 p -82.07 123.98 29.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.4 -106.06 3.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.523 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 68.53 -68.46 0.17 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.0 111.042 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 15' ' ' VAL . 6.3 m -148.7 79.17 8.78 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.111 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.78 -61.9 0.42 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.596 2.197 . . . . 0.0 112.238 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -108.17 -175.34 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 137.76 -49.74 0.84 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.469 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.7 m -104.77 140.28 38.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.762 0.315 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -60.31 139.81 57.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.937 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -110.18 123.22 49.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' PRO . . . -155.44 58.15 0.63 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.094 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 t 61.31 30.69 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.964 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 59.38 67.68 1.8 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.876 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.442 ' HG3' ' HB3' ' A' ' 22' ' ' ALA . 59.4 Cg_endo -72.44 -44.52 0.75 Allowed 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.523 2.149 . . . . 0.0 112.296 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -170.38 137.57 1.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -110.3 -24.01 10.89 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.599 HD13 HG22 ' A' ' 78' ' ' ILE . 1.2 mp -55.44 116.3 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.915 0.388 . . . . 0.0 111.204 -179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.514 HG22 ' N ' ' A' ' 30' ' ' ALA . 4.1 mp -84.93 158.37 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.517 179.256 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.729 ' HB1' HG22 ' A' ' 72' ' ' VAL . . . -119.41 102.06 8.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.344 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.656 HG22 ' CE1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -85.82 121.21 28.14 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.037 0.446 . . . . 0.0 110.954 179.502 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.539 ' OH ' HG21 ' A' ' 70' ' ' VAL . 1.9 t80 -52.27 141.54 18.94 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.258 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.813 HD11 ' O ' ' A' ' 138' ' ' VAL . 0.0 OUTLIER -120.81 -177.69 1.36 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.692 179.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.467 ' CB ' ' CE2' ' A' ' 58' ' ' TYR . 3.9 p -177.82 151.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.062 0.458 . . . . 0.0 111.798 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.461 ' ND2' ' CZ ' ' A' ' 69' ' ' TYR . 6.6 t-20 -87.4 -29.22 21.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.945 178.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' A' ' 36' ' ' ARG . 13.1 mmm180 -80.02 171.4 15.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.67 -179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -109.07 29.64 7.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 12.9 t70 -98.65 126.89 44.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.945 179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 40' ' ' PRO . . . -68.92 162.29 65.7 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.741 179.554 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 33.8 Cg_endo -64.67 119.93 7.09 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.239 1.959 . . . . 0.0 111.848 179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 57' ' ' VAL . 3.7 t -46.86 -48.35 21.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 41' ' ' THR . . . -115.28 -82.58 1.03 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.974 -0.631 . . . . 0.0 111.887 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 44' ' ' PRO . 1.5 t-20 -158.97 132.49 4.87 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 120.429 0.156 . . . . 0.0 111.141 179.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 43' ' ' ASN . 17.9 Cg_exo -66.36 -3.1 8.24 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.55 2.167 . . . . 0.0 111.932 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.445 ' HA ' ' HB2' ' A' ' 48' ' ' PHE . 5.1 t0 -39.3 -34.16 0.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.022 0.439 . . . . 0.0 110.963 179.84 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.619 ' HB2' HD12 ' A' ' 47' ' ' ILE . 98.1 m-20 -51.15 -43.02 61.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.297 179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.696 HD12 ' N ' ' A' ' 47' ' ' ILE . 3.0 mp -103.1 -36.82 4.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.032 -179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.656 ' CE1' HG22 ' A' ' 31' ' ' THR . 0.6 OUTLIER -54.36 -39.56 67.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.617 -179.853 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -130.35 33.36 4.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.249 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.0 p30 44.33 49.43 8.0 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.971 179.674 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -108.05 -170.55 1.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.457 179.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.87 29.6 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.523 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.4 p -100.68 -33.66 10.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.217 0.532 . . . . 0.0 110.331 179.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 8.7 t -86.24 171.77 11.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.379 179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -107.19 164.95 11.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.706 0.289 . . . . 0.0 110.918 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 58' ' ' TYR . 1.1 tt -163.91 112.75 1.2 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.053 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.63 ' H ' HG22 ' A' ' 41' ' ' THR . 2.2 m -153.83 136.09 6.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.806 0.336 . . . . 0.0 111.545 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.575 ' CE1' HD21 ' A' ' 56' ' ' LEU . 9.9 m-30 -107.28 123.08 47.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.846 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 150' ' ' TRP . 0.6 OUTLIER -123.31 -52.02 1.85 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -178.436 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.535 ' HB3' ' HD3' ' A' ' 61' ' ' PRO . 2.3 t-20 13.14 -78.03 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 123.241 0.616 . . . . 0.0 112.277 -178.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 60' ' ' ASN . 43.4 Cg_endo -85.4 110.19 1.2 Allowed 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 121.757 1.638 . . . . 0.0 111.604 178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -33.62 75.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 110.136 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.94 141.33 29.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.132 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.539 HD13 HG21 ' A' ' 68' ' ' THR . 11.1 pt -150.2 117.31 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.067 0.461 . . . . 0.0 111.694 -179.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -119.06 116.46 26.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.072 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 143' ' ' THR . 3.3 m 37.92 94.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.344 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' O ' ' CD2' ' A' ' 69' ' ' TYR . . . 155.23 -37.58 0.64 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.508 -0.853 . . . . 0.0 113.064 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 142' ' ' ALA . 1.2 m -56.67 108.56 0.51 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.738 0.304 . . . . 0.0 110.861 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 140' ' ' LEU . 2.9 p90 -162.69 154.45 18.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.573 179.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.608 HG23 ' N ' ' A' ' 71' ' ' GLY . 1.4 m -152.6 -170.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.375 0.607 . . . . 0.0 111.517 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.608 ' N ' HG23 ' A' ' 70' ' ' VAL . . . 169.88 -114.66 0.56 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.821 179.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.845 HG13 ' CG2' ' A' ' 138' ' ' VAL . 2.6 p -173.41 121.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.984 179.087 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.599 ' O ' ' N ' ' A' ' 31' ' ' THR . 11.3 ttmm -89.7 160.82 16.39 Favored 'General case' 0 C--N 1.33 -0.271 0 O-C-N 121.87 -0.519 . . . . 0.0 111.19 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.559 ' CD1' ' HA2' ' A' ' 137' ' ' GLY . 6.0 m-30 -111.81 -172.69 2.09 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.907 0.384 . . . . 0.0 111.22 -179.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.6 p -94.7 -29.94 14.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.809 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.602 ' O ' HG23 ' A' ' 78' ' ' ILE . 19.9 p30 -166.19 157.58 11.71 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.643 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 76' ' ' ASN . 7.4 Cg_endo -49.59 133.44 32.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.764 2.309 . . . . 0.0 112.514 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 76' ' ' ASN . 19.4 pt -143.39 142.92 25.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.226 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.3 m -52.6 96.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.944 0.402 . . . . 0.0 110.337 179.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 HG11 ' A' ' 135' ' ' VAL . 8.7 tp -84.38 95.97 8.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.08 -179.384 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -69.91 -48.01 60.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.433 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.755 ' O ' HG23 ' A' ' 158' ' ' VAL . 10.5 p30 -156.59 134.33 10.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.935 179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.796 HG11 HD11 ' A' ' 114' ' ' LEU . 8.0 p -104.72 142.7 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.033 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -151.46 126.39 9.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.936 -178.896 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.935 ' CE1' HD13 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -118.47 100.27 7.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.58 178.108 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.473 HD21 ' CG ' ' A' ' 84' ' ' GLU . 9.0 mt -83.83 98.72 9.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.448 ' HB2' ' HA ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -142.03 170.6 15.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.338 0.589 . . . . 0.0 111.911 -178.563 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' N ' ' CG ' ' A' ' 87' ' ' MET . . . -142.77 -102.19 0.42 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.231 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 95' ' ' ASP . . . -143.5 -178.5 5.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.915 0.388 . . . . 0.0 110.923 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.492 ' ND2' ' CE3' ' A' ' 150' ' ' TRP . 4.3 p-10 -87.32 -63.67 1.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.474 179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.1 m -104.39 -61.3 1.47 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.088 0.47 . . . . 0.0 110.498 179.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.447 ' HA ' ' HD2' ' A' ' 93' ' ' PRO . 14.8 m120 -98.33 122.18 54.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.749 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HD2' ' HA ' ' A' ' 92' ' ' ASN . 1.7 Cg_endo -44.84 -20.84 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.968 2.445 . . . . 0.0 113.177 -179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -87.03 26.2 1.2 Allowed 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.558 0.207 . . . . 0.0 111.558 -179.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 89' ' ' ALA . 0.4 OUTLIER -112.15 102.96 11.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.824 0.345 . . . . 0.0 111.067 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.901 HG21 ' HD2' ' A' ' 123' ' ' PRO . 0.6 OUTLIER -176.22 -164.71 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.203 -179.882 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.794 ' CE ' HD22 ' A' ' 140' ' ' LEU . 8.4 tpp -41.86 156.9 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.112 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.637 ' C ' ' HB ' ' A' ' 121' ' ' THR . 17.9 tp60 -96.8 -38.02 10.04 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 177.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 12.9 mttm -176.16 122.69 0.17 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.555 176.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.856 ' HB1' ' O ' ' A' ' 141' ' ' ILE . . . 171.91 171.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.063 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.666 ' HA ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -119.81 169.83 9.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.372 178.507 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.935 HD13 ' CE1' ' A' ' 85' ' ' PHE . 25.0 mt -88.06 158.08 3.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.115 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 139' ' ' ARG . 1.7 mt-30 -121.48 -177.06 3.44 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.744 -179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.701 ' HB3' HD12 ' A' ' 114' ' ' LEU . 14.9 p90 -173.85 134.0 0.46 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.765 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.599 HG22 ' CZ2' ' A' ' 111' ' ' TRP . 4.8 t -93.53 132.78 37.49 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -79.39 -37.55 18.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.29 26.76 8.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.743 0.306 . . . . 0.0 111.276 -179.691 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 60.57 18.96 53.22 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.23 -179.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -114.11 -77.62 0.58 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.455 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -89.5 160.49 16.71 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.997 179.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' TRP . . . . . 0.617 ' CZ3' ' HA ' ' A' ' 104' ' ' TYR . 41.6 m95 -127.59 123.11 34.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.861 0.362 . . . . 0.0 110.866 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -115.83 156.25 16.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.507 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 103' ' ' GLN . 15.7 m-20 -45.88 153.43 0.29 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.531 -179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 128' ' ' VAL . 6.3 tt -124.35 -65.92 1.02 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.818 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.539 ' OE1' HG22 ' A' ' 128' ' ' VAL . 23.4 tp10 -78.64 158.46 28.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.621 0.724 . . . . 0.0 112.709 -178.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.812 ' O ' ' N ' ' A' ' 118' ' ' VAL . 0.6 OUTLIER -64.45 104.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.239 179.212 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.614 ' C ' ' O ' ' A' ' 116' ' ' GLU . . . 6.69 52.7 0.0 OUTLIER Glycine 0 C--N 1.346 1.096 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.023 179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.894 HG11 ' CE1' ' A' ' 120' ' ' TYR . 0.3 OUTLIER -82.85 171.65 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 CA-C-O 121.66 0.743 . . . . 0.0 112.674 -176.855 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.568 ' C ' ' H ' ' A' ' 121' ' ' THR . 1.1 mt-10 -119.75 78.58 1.34 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.566 178.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.894 ' CE1' HG11 ' A' ' 118' ' ' VAL . 13.1 m-30 -70.98 38.02 0.05 Allowed 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.068 179.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.743 ' O ' HG22 ' A' ' 96' ' ' THR . 0.2 OUTLIER -93.68 -18.6 21.96 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.217 178.088 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . 0.716 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -135.95 41.1 0.56 Allowed Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.446 177.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.901 ' HD2' HG21 ' A' ' 96' ' ' THR . 68.2 Cg_endo -87.86 98.21 0.43 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.787 2.325 . . . . 0.0 113.118 -178.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -68.8 -45.89 62.87 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -142.18 115.3 8.82 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.796 -0.702 . . . . 0.0 109.868 178.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.666 HG21 ' CZ ' ' A' ' 120' ' ' TYR . 1.4 mt -101.21 134.63 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.707 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.403 ' CB ' ' HB2' ' A' ' 84' ' ' GLU . 0.2 OUTLIER -158.21 108.14 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.988 -179.957 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.908 HG21 HD22 ' A' ' 114' ' ' LEU . 5.5 t -90.11 146.87 5.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.941 179.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -130.49 170.94 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.2 m120 64.95 26.25 12.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.244 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.675 ' CD1' HD23 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -120.27 40.48 3.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 179.768 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -66.9 90.7 0.18 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.002 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.6 138.04 14.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.806 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -54.26 133.08 44.7 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.769 HG11 HD22 ' A' ' 80' ' ' LEU . 0.4 OUTLIER -146.32 156.69 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.796 -178.335 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' O ' HG23 ' A' ' 105' ' ' THR . 0.0 OUTLIER -109.48 127.45 54.44 Favored 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.596 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.559 ' HA2' ' CD1' ' A' ' 74' ' ' TYR . . . 48.75 -178.42 0.01 OUTLIER Glycine 0 C--N 1.314 -0.688 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.835 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.845 ' CG2' HG13 ' A' ' 72' ' ' VAL . 1.5 m -149.58 152.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.619 ' HE ' HD12 ' A' ' 33' ' ' ILE . 15.8 ttm180 -166.69 158.03 12.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.924 0.392 . . . . 0.0 111.456 -178.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.794 HD22 ' CE ' ' A' ' 97' ' ' MET . 1.0 OUTLIER -101.13 158.54 15.94 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.529 179.849 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.856 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -129.86 119.17 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.809 0.337 . . . . 0.0 110.836 179.84 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 68' ' ' THR . . . -73.4 162.57 29.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.201 -179.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.675 ' O ' HG12 ' A' ' 66' ' ' VAL . 2.8 m -127.6 -36.89 2.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.429 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.79 -44.59 0.53 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.687 0.28 . . . . 0.0 111.447 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.425 ' HB1' HD12 ' A' ' 64' ' ' ILE . . . 65.53 173.93 0.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.012 -179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.611 ' CG ' HG21 ' A' ' 149' ' ' THR . 0.4 OUTLIER -134.06 153.36 51.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 111.108 179.953 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -77.76 153.82 32.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.02 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.5 m120 46.67 80.49 0.05 OUTLIER 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.611 HG21 ' CG ' ' A' ' 146' ' ' ARG . 8.8 t -170.33 150.63 3.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.163 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' TRP . . . . . 0.56 ' CD2' ' HB3' ' A' ' 59' ' ' LYS . 36.2 m0 -106.26 -173.25 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.459 179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.649 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.8 tm? -136.5 99.14 4.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.146 179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 57' ' ' VAL . . . -89.59 164.32 31.61 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.533 -0.841 . . . . 0.0 112.95 -179.533 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 87' ' ' MET . 0.6 OUTLIER -149.05 154.62 9.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.26 -40.69 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 86' ' ' LEU . 10.3 t0 179.44 161.37 0.81 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.081 0.467 . . . . 0.0 111.614 -179.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' HD2' ' A' ' 85' ' ' PHE . 39.4 mt -145.03 135.95 19.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.143 179.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -139.51 154.55 47.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.888 0.375 . . . . 0.0 111.533 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.755 HG23 ' O ' ' A' ' 82' ' ' ASN . 7.2 p -138.92 121.16 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.75 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 59.8 34.19 21.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.809 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 64.13 125.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.071 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? 57.29 28.78 15.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.098 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 43.53 61.21 2.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -158.05 120.29 3.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.049 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.813 -179.959 . . . . . . . . 0 0 . 1 stop_ save_